cancer incidence in massachusetts 1996 – 2000 - State Library of

Loading...

CANCER INCIDENCE IN MASSACHUSETTS 1996 – 2000: C ITY AND T OWN S UPPLEMENT

Center for Health Information, Statistics, Research and Evaluation Massachusetts Department of Public Health April 2004

CANCER INCIDENCE IN MASSACHUSETTS 1996 – 2000: C ITY AND T OWN S UPPLEMENT

Mitt Romney, Governor Kerry Healey, Lieutenant Governor Ronald Preston, Secretary of Health and Human Services Christine C. Ferguson, Commissioner of Public Health

Gerald F. O’Keefe, Director, Center for Health Information Susan T. Gershman, MS, MPH, PhD, CTR, Director, Massachusetts Cancer Registry April 2004

Massachusetts Department of Public Health

ACKNOWLEDGMENTS This report was prepared by Director Susan Gershman and staff and consultants of the Massachusetts Cancer Registry (MCR). Thanks to Mary Mroszczyk, Hung Tran, Ben Jackson, Helen Hawk, Annie MacMillan, Reggie Kenney, Melissa Liu, and Greg Tocco for their diligent work in coordinating and reviewing this report. Thanks to the risk factor list reviewers for lending their expertise. Thanks to the staff in approximately eighty facilities for submitting the data.

Massachusetts Cancer Registry Staff Susan T. Gershman, M.S., M.P.H., Ph.D., C.T.R., Director Troy C. Arthur, C.T.R., Cancer Registrar

Ann MacMillan, M.P.H., Data Analyst

Donna Barlow, L.P.N., C.T.R., Cancer Registrar

Ruth Maranda, L.P.N., C.T.R., Cancer Registrar

Bruce M. Caldwell, Jr., Geocoder Patricia J. Drew, C.T.R., Cancer Registrar

Mary Mroszczyk, C.T.R., Geocoding/Special Projects Coordinator

Elena A. Hawk, Ph.D, Epidemiologist

Sadie Phillips-Scott, Administrative Assistant

Loi Huynh, Software Developer

Judith Raymond, C.T.R., Cancer Registrar

Ben Jackson, Systems Analyst

David Rousseau, Quality Assurance Supervisor

Regina Kenney, Data Acquisition Coordinator

Pamela Shuttle, C.T.R., R.H.I.T., Cancer Registrar

Mary Jane King, M.P.H.,C.T.R., Data Acquisition Supervisor

Hung Tran, Software Developer Donna J. Vincent, R.H.I.A., Geocoder

Melissa J. Liu, M.S., Epidemiologist

Massachusetts Cancer Registry Advisory Committee Nancy Mueller, Sc.D., Chair Theodore Colton, Sc.D. Suzanne Condon, M.S. Frederick Li, M.D. Regina Mead J. David Naparstek, Sc.M., C.H.O. Philip Nasca, Ph.D.

Susan O'Hara, C.T.R. Robert Osteen, M.D. David Ozonoff, M.D., M.P.H. Carol Rowen-West, M.P.H. Lawrence Shulman, M.D. Carol Venuti, C.T.R.

Other Advisors Barbara F. Banner, M.D., of the University of Massachusetts Medical School is the Massachusetts Cancer Registry's pathology adviser.

For further information, please contact the following: •

at the Massachusetts Department of Public Health (for Massachusetts information): Center for Health Information, Statistics, Research and Evaluation Massachusetts Cancer Registry ...................................................... 617-988-3380 Center for Environmental Health Community Assessment Program................................................... 617-624-5757 Center for Community Health Comprehensive Cancer Prevention and Control Program......... 617-624-5070 Massachusetts Department of Public Health website........... www.state.ma.us/dph



for U.S. data, information on treatment and screening, and further information on risk factors: National Cancer Institute, Cancer Information Service ...............1-800-422-6237 National Cancer Institute website ................................................www.cancer.gov American Cancer Society, New England......................................1-800-227-2345 American Cancer Society website ..........................................www.cancer.org Centers for Disease Control and Prevention ......................... 1-800-311-3435 Centers for Disease Control and Prevention website.................. www.cdc.org North America Association of Central Cancer Registries.......www.naaccr.org

Data contained in this report are intended for public use and may be reproduced without permission. Proper acknowledgment of the source is requested.

TABLE OF CONTENTS

INTRODUCTION, CANCER INCIDENCE, AND METHODS

Page

Introduction ...........................................................................................................1 Content.......................................................................................................................................1 Comparison with Previous Reports ...........................................................................................1

City / Town Cancer Incidence, 1996 - 2000 ..................................................................... 2 Content.......................................................................................................................................2 Interpretation of the Data...........................................................................................................3

Methods ........................................................................................................................... 3 Data Collection ..........................................................................................................................3 Data Presentation .......................................................................................................................5 Expected and Observed Case Counts..................................................................................5 Standardized Incidence Ratios ............................................................................................5 Measures of Statistical Significance....................................................................................6 Calculation of an SIR ..........................................................................................................7 Data Limitations ........................................................................................................................8 Border Areas and Neighboring States .................................................................................8 Cases Diagnosed in Non-Hospital Settings.........................................................................8 City/Town Misassignment ..................................................................................................8

TABLES Expected and Observed Counts, with Standardized Incidence Ratios, by Sex, for 351 Cities and Towns, 1996 - 2000 .........................................................................9

APPENDICES APPENDIX I International Classification of Diseases for Oncology (Second Edition) Codes Used for This Report...................................................................................................365 APPENDIX II Risk Factors for Selected Cancer Types ................................................................................367 Reviewers of Risk Factors .....................................................................................................378 APPENDIX III Massachusetts Department of Public Health Cancer Control Initiatives and Publications ..........................................................................379

REFERENCES............................................................................................................................389

INTRODUCTION Content The purpose of this report is to provide standardized incidence ratios (SIRs) for twenty-three types of cancer and all cancer types combined in the 351 cities and towns of Massachusetts for the five-year time period 1996 through 2000. An SIR is an estimate of the occurrence of cancer in a population relative to what might be expected if the population had the same cancer experience as some larger comparison population. Usually, the state as a whole is selected to be the comparison population. The report is organized into the following six sections: CITY / TOWN CANCER INCIDENCE summarizes the data tabulated in this report. METHODS provides a detailed explanation of the data collection, data processing and statistical techniques employed in this report. TABLES present data for selected types of cancer by city/town and sex. APPENDIX I provides a listing of International Classification of Diseases for Oncology codes used for the preparation of this report. APPENDIX II provides a listing of risk factors for selected cancer types and a listing of the individuals who reviewed the risk factor list. APPENDIX III describes current Massachusetts Department of Public Health efforts to reduce the risk of specific cancers and provides a list of related educational materials. Comparison with Previous Reports This report updates previous annual reports published by the Massachusetts Cancer Registry (MCR). Hard-copy versions of these reports are published every five years, and on-line versions are updated annually. The data contained in this on-line report are also available by contacting the MCR: Massachusetts Cancer Registry Center for Health Information, Statistics, Research and Evaluation Massachusetts Department of Public Health 2 Boylston Street / 6th Flr Boston, MA 02116-4704 telephone 617-988-3380; fax 617-988-3277 The preceding report, 1995-1999 City and Town Supplement, included data for diagnosis years 1995 through 1999. This report contains data for diagnosis years 1996 through 2000. There have been no changes in this report's format. It is important to note that the standardized incidence ratios (SIRs) presented in this report cannot be compared with SIRs in the 1995-1999 City and Town Supplement because the numbers of expected cases used to calculate SIRs in the earlier publication were based on 1997 city/town population

estimates; in this report, the city/town population estimates used to calculate expected case counts were for 1998. See Expected and Observed Case Counts on page 5 for further information Information on cancer control programs of the Massachusetts Department of Public Health is available in Appendix III of this report and elsewhere on the Department's website (www.state.ma.us/dph/cancerct/home.htm). Cancer incidence and mortality data are also available through MassCHIP (http://masschip.state.ma.us), the Department's Internet-based public access information service. MassCHIP provides users with detailed health data on a variety of geographic levels while protecting data confidentiality. . CITY / TOWN CANCER INCIDENCE, 1996 - 2000 Content Each city and town in Massachusetts is listed alphabetically in the TABLES section. The expected number of cases, the observed number of cases, and standardized incidence ratios are presented for twenty-three main types of cancer and for all cancer types combined.1 The all cancers combined category includes the twenty three main types presented in this report and other malignant neoplasms. This category is meant to provide a summary of the total cancer experience in a community. As different cancers have different causes, this category does not reflect any specific risk factor that may be important for this community. Next to the number of observed cases for each cancer type in a city/town is the corresponding SIR. Any SIR value that is not followed by a symbol described below is not statistically significant at the levels of significance testing used in this report. A pound symbol ( # ) following an SIR value indicates that this cancer incidence excess (#+) or deficit (#-) is statistically significant at the p<0.05 level. A tilde symbol ( ~ ) following an SIR indicates that this cancer excess (~+) or deficit (~-) is statistically significant at the p<0.01 level. A caret symbol ( ^ ) following an SIR indicates that this cancer excess (^+) or deficit (^-) is statistically significant at the p<0.001 level. (See Measures of Statistical Significance on page 6 for a detailed discussion of the significance testing used in this report.) Whenever the number of observed cases was less than five, the corresponding SIR was neither calculated nor tested for statistical significance. This is indicated with an SIR of "not calculated" followed by an asterisk (NC*). The number of observed and expected cases is shown in these circumstances.

1

The number of cases for a certain type of cancer is not necessarily equivalent to the number of people with that type of cancer. A single person may contribute multiple cases to an observed number of cases. 2

Interpretation of the Data

The information contained in this report and in the data tables does not provide proof of the association of individual risk factors with cancer excesses in any town, but rather should be used as a guide for further surveillance, epidemiologic investigations, and other public health activities. When reviewing the data tables, it is important to keep in mind that an SIR compares the observed cancer incidence in a particular community with the expected incidence based on statewide average age-specific incidence rates. This means that valid comparisons can only be made between a community and the state as a whole. SIRs for different cities and towns CANNOT and SHOULD NOT be compared to each other. (Comparisons between two communities would be valid only if there were no differences in the age and sex distributions of the two communities' populations.) METHODS Data Collection The Massachusetts Cancer Registry (MCR) collects reports of all newly2 diagnosed cancer cases from all Massachusetts acute care hospitals and one health maintenance organization (76 reporting facilities in 2000). The MCR compiles summaries of cancer incidence, such as this report, and also produces special reports. These undertakings require data collection efforts that necessitate extensive interaction with hospital tumor registrars. Intensive data evaluation is also required to ensure data quality. The fundamental requirements of any central cancer registry include: (1) complete registration, (2) prevention of case duplication, (3) collection of uniform data, i.e., standardization of items, definitions, rules, classification and nomenclature of primary site, histology, staging and procedures, (4) quality control, and (5) efficient data processing. MCR case ascertainment improved during the years covered by this report. For diagnosis year 2000, the MCR's total case count was estimated by the North American Association of Central Cancer Registries to be complete. This report includes (for the diagnosis years indicated) two case sources that were not available for most previous editions of the City and Town Supplement -- physician office cases reported by hospitals and death certificate-only cases: for diagnosis years 1996 and onward, the MCR collects information from reporting hospitals, where available, on cases diagnosed and treated in staff physician offices. Not all hospitals report this type of case, however, and some hospitals report such cases as if the patients had been diagnosed and treated by the hospital directly. Collecting this type of data makes the MCR's overall case ascertainment more complete. Because these cases are not reported by every hospital however, reporting is more complete in some geographic areas than in others. Physician office cases most often reported to the MCR are prostate cancers and melanomas. For diagnosis years 1997 through 2000, the MCR identified previously unreported cancer cases through death certificate clearance to further improve case completeness. In some instances a cancerrelated cause of death recorded on a Massachusetts death certificate is the only source of information for a cancer case. These "death certificate-only" cancer diagnoses are therefore poorly documented and have not been medically confirmed (confirmed by review of complete clinical information). Such cases are included

2

In keeping with national data standards, the recurrence of a previously diagnosed cancer should also be reported to the MCR in certain circumstances. 3

in this report for diagnosis years 1997, 1998 1999, and 2000; they comprise approximately 2% of all cancer cases for these years. Coding for cancer types in this report follows the International Classification of Diseases for Oncology (Second Edition) system (see APPENDIX I on page 365). The list of reportable neoplasms is essentially the same as that used for the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program data, with the exception of in situ neoplasms. The MCR began collecting information on in situ neoplasms diagnosed as of January 1, 1992; however, in situ cases are not included in this report. You may contact the MCR for information on in situ neoplasms. The data summarized in this report are drawn from data entered on MCR computer files on or before October, 1, 2003. The numbers presented in this report may change slightly in future reports, reflecting late reported cases, address corrections, or other changes based on subsequent details from reporting facilities. Additionally, using different population estimates or statistical methodologies, such as grouping ages differently or rounding off numbers at different points during calculations, may also produce results slightly different from those published in this report.

4

Data Presentation Three measures of cancer incidence are presented in this report's data tables: expected case counts, observed case counts, and standardized incidence ratios (SIRs). Expected and Observed Case Counts A city/town's expected case count (Exp) for a certain type of cancer for this time period is a calculated number based on that city/town's population distribution (by sex and among six age groups) for 1998 (the midpoint of 1996 through 2000), and the corresponding statewide average age-specific incidence rates. See Calculation of an SIR (page 7) for an example of how a hypothetical expected count is calculated. The expected case counts in this report are rounded to the nearest hundredth (two decimal places). If the total expected case count is not exactly equal to the sum of the male and female expected counts, this is attributable to rounding error. For the computation of statewide average age-specific incidence rates used for this report, the 1998 statewide population estimates (by sex and six age groups) were obtained from the Massachusetts Institute for Social and Economic Research (MISER). Different methodologies may be used to derive slightly different population estimates, yielding slightly different results. In this report, the observed case count (Obs) for a particular type of cancer in a city/town is the actual number of newly3 diagnosed cases reported to have been diagnosed in residents of that city/town from 1996 through 2000. The "Total" observed case count for each cancer type is the sum of the number of observed male and female cases only. The MCR added two additional gender classifications (transsexuals and persons with sex chromosome abnormalities/hermaphrodites) for cases diagnosed as of January 1, 1995. (Cases diagnosed before this date were limited to male or female only.) Any case classified in either of the new gender categories4 is not included in this report because the population data used in the statistical calculations include only male and female categories. Standardized Incidence Ratios The data tables present SIRs (rounded to the nearest whole number) for males, females and the total population of each city/town for twenty-three types of cancer and for all cancers combined. An SIR is an indirect method of adjustment for age and sex that describes in numerical terms how a city/town's average experience in 1996-2000 compared with that of the state as a whole. The SIR is a useful tool for screening incidence data and generating leads for further public health investigations.

• An SIR of exactly 100 indicates that a city/town's incidence for a certain type of cancer is equal to that expected based on statewide average age-specific incidence rates.

• An SIR of more than 100 indicates that a city/town's incidence for a certain type of cancer is higher than expected for that type of cancer based on statewide average age-specific incidence rates. For example, an SIR of 105 indicates that a city/town's cancer incidence is 5% higher than expected based on statewide average age-specific incidence rates.

3 4

In certain circumstances the recurrence of a previously diagnosed cancer is also included here. Nineteen cases classified in the new gender categories are recorded at the MCR for 1996-2000. 5

• An SIR of less than 100 indicates that a city/town's incidence for a certain type of cancer is lower than expected based on statewide average age-specific incidence rates. For example, an SIR of 85 indicates that a city/town’s cancer incidence is 15% lower than expected based on statewide average age-specific incidence rates. Measures of Statistical Significance Tests of statistical significance allow an estimate of the probability (referred to as a "p" value) that the difference between the observed and expected case count is due to chance alone. A p value of less than or equal to 5% (p<0.05) means that there is, at most, a 5% chance that the difference between the observed and expected case count is due to chance alone; thus, a cancer excess or deficit with such a p value is considered statistically significant. The presence or absence of statistical significance does not necessarily imply biological or public health significance. In this report, three levels of statistical significance are employed to identify cities and towns with excess cancer incidence (and deficits) as compared with statewide average incidence -- p<0.05, p<0.01, and p<0.001. The use of p<0.001 highlights those cancer excesses least likely to have occurred by chance alone. Use of this stringent criteria, however, makes it difficult to identify elevated SIRs for towns with relatively small populations and small numbers of cancer cases. The use of p<0.05 constitutes a less stringent criterion and identifies a greater number of cancer excesses. Use of p<0.05 can provide investigators with a broader context for identifying patterns of excess cancer incidence than use of p<0.01 or p<0.001. p<0.05: In the data tables, p<0.05 is used to identify cancer types having significant excesses or deficits at the least stringent level used herein. This indicates that there is, at most, 1 chance in 20 that the identified excess or deficit of cancer cases is due to chance alone. A pound symbol (#) following an SIR marks that excess or deficit as statistically significant at the p<0.05 level, but not at the higher levels (p<0.01 and p<0.001). Based on the number of tests performed for this report (eighteen male/female sites and five single-sex sites), one would expect by chance alone to find 360 significant excesses at this p level; 353 were found. p<0.01: A p value of less than or equal to 0.01 indicates that there is, at most, 1 chance in 100 that the excess or deficit of cancer cases is due to chance alone. (All cancer excesses and deficits which are statistically significant at this level are also significant at the less stringent p<0.05 level, but not all data significant at the p<0.05 level are significant at the p<0.01 level.) A tilde symbol (~) following an SIR indicates that these data are significant at both the p<0.05 and p<0.01 levels, but not at the more stringent p<0.001 level. Based on the number of tests performed for this report, one would expect by chance alone to find 72 significant excesses at the p<0.01 level; 151 were found. p<0.001: This is the most stringent criterion employed in this report to highlight cancer excesses and deficits that are least likely to be due to chance alone. This p value indicates that there is, at most, 1 chance in 1000 that the excess or deficit in observed cases is due to chance alone. A caret symbol (^) following an SIR indicates that these data are significant at all three levels of significance testing used here. Based on the number of tests performed for this report, one would expect by chance alone to find 7 significant excesses at the p<0.001 level; 58 were found. Calculation of an SIR 6

OBSERVED CASES SIR = EXPECTED CASES X 100 The following example illustrates the method of calculation for a hypothetical town for one type of cancer for the year 1997: Town X Age Group

Population

State Age-Specific Incidence Rate

Town X Expected Cases

Town X Observed Cases

(A)

(B)

(C) = (A) x (B)

(D)

0-19

74,657

0.0001

7.47

11

20-44

134,957

0.0002

26.99

25

45-64

54,463

0.0005

27.23

30

65-74

25,136

0.0015

37.70

40

75-84

17,012

0.0018

30.62

30

85+

6,337

0.0010

6.34

8

total: 136.35 SIR =

144

(column D total) 144 Observed Cases Expected Cases X 100 = (column C total ) X 100 = 136.35 X 100 ≅ 106

Thus the SIR for this type of cancer in Town X is 106, indicating that the incidence of this cancer in Town X is approximately 6% higher than the corresponding statewide average incidence for this cancer.

7

Data Limitations It should be remembered that apparent increases or decreases in cancer incidence over time may reflect changes in diagnostic methods or case reporting rather than true changes in cancer incidence. Three other limitations must be considered when interpreting cancer incidence data for Massachusetts cities and towns: under-reporting in areas close to neighboring states; under-reporting for cancers that may not be diagnosed in hospitals; and cases being assigned to incorrect cities/towns. Border Areas and Neighboring States Some areas of Massachusetts appear to have low cancer incidence, but this may be the result of underreporting -- that is, a loss of cases diagnosed or treated in neighboring states that are not reported to the MCR. Presently the MCR has reciprocal reporting agreements with fifteen states -- Alaska, Arkansas, Connecticut, Florida, Maine, Mississippi, New Hampshire, New York, North Carolina, Rhode Island, South Carolina, Texas, Vermont, Wisconsin and Wyoming. Cases Diagnosed in Non-Hospital Settings During the time period covered by this report (1996 through 2000), the MCR's information sources for nearly all cancer cases were hospitals. Some types of cancer in this report are undoubtedly underreported because they may be diagnosed by private physicians, private laboratories, health maintenance organizations or radiotherapy centers that escape hospital case identification systems. Examples may include melanoma of skin, prostate cancer, and certain hematologic malignancies such as leukemia and multiple myeloma. The extent of this under-reporting has not been determined exactly. However, the North American Association of Central Cancer Registries has estimated the overall completeness for the period 1997 to 2000 to be 99.5%. City/Town Misassignment In accordance with standard central cancer registry procedures, each case reported to the MCR should ideally be assigned to the city/town in which the patient lived at the time of diagnosis, based on the address provided by the reporting hospital. In practice, however, a patient may provide the hospital with his/her mailing address (e.g., a post office box located outside the patient’s city/town of residence); a business address; a temporary address (e.g., the patient is staying with a relative while receiving treatment and reports the relative’s address as his/her own); or a locality or post office name (e.g., “Chestnut Hill” rather than “Boston”, “Brookline” or “Newton”). In addition, if a patient has moved since being diagnosed, the hospital may report the patient's current address. Because of the large number of cases reported to the MCR, and because data are reported to the MCR via electronic media, most city/town case assignments are performed by an automated computer process. This simplified matching process may misassign some cases based on the reported locality name. When MCR staff become aware of such misassignments, the errors are corrected manually. Furthermore, in order to minimize such errors, cases from fifty geographic localities prone to city/town misassignment are reviewed manually by the MCR.

8

TABLES

9

10

APPENDICES

363

364

APPENDIX I: INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY (SECOND EDITION) CODES USED FOR THIS REPORT 1 Cancer Site / Type

Primary Site Codes

Histologic Type Codes 2

Bladder, Urinary

C67.0 - C67.9

all except 9590 - 9989

Brain and Other Central Nervous System

C70.0 - C72.9

all except 9590 - 9989

Breast

C50.0 - C50.9

all except 9590 - 9989

Cervix Uteri (cervical cancer)

C53.0 - C53.9

all except 9590 - 9989

Colon / Rectum

C18.0 - C18.9, C19.9, C20.9, C26.0

all except 9590 - 9989

Esophagus

C15.0 - C15.9

all except 9590 - 9989

Hodgkin's Disease

C00.0 - C80.9

9650 - 9667

Kidney and Renal Pelvis 3

C64.9, C65.9

all except 9590 - 9989

Larynx

C32.0 - C32.9

all except 9590 - 9989

Leukemia

C00.0 - C80.9 C42.0, C42.1, C42.4

9800 - 9822, 9824-9826, 9828-9941 9823, 9827

Liver and Intrahepatic Bile Ducts

C22.0, C22.1

all except 9590 - 9989

Lung and Bronchus

C34.0 - C34.9

all except 9590 - 9989

Melanoma of Skin

C44.0 - C44.9

8720 - 8790

Multiple Myeloma

C00.0 - C80.9

9731, 9732

Non-Hodgkin's Lymphoma

C00.0 - C80.9

9590 - 9595, 9670 - 9717

Oral Cavity and Pharynx

C00.0 - C14.8

all except 9590 - 9989

Ovary

C56.9

all except 9590 - 9989

Pancreas

C25.0 - C25.9

all except 9590 - 9989

Prostate

C61.9

all except 9590 - 9989

Stomach

C16.0 - C16.9

all except 9590 - 9989

Testis

C62.0 - C62.9

all except 9590 - 9989

Thyroid

C73.9

all except 9590 - 9989

Uteri, Corpus and Uterus, NOS

C54.0 - C54.9, C55.9

all except 9590 - 9989

All Sites / Types

C00.0 - C80.9

8000 - 9989

1

includes codes added to the International Classification of Diseases for Oncology, Second Edition since its publication

2

Only invasive cancers (those with invasive behaviors) are included in this publication. Non-invasive (in situ) cancers are not included.

3

Massachusetts hospital coding conventions may have assigned some cases to a "not otherwise specified" site category that is not included in this cancer type.

365

366

APPENDIX II: RISK FACTORS FOR SELECTED CANCER TYPES AND REVIEWERS OF RISK FACTORS This Appendix contains a list of risk factors for thirteen types of cancer. The list briefly summarizes available information from the scientific literature. The list was last revised in 2000. Cancers are complex diseases, many of which have multiple factors that may contribute to their development. It should be noted that there is no single agreed-upon list of risk factors -- even the experts may disagree. This list should be viewed only as a starting point for the interested reader, and should not be viewed as constituting a definitive or comprehensive summary of cancer risk factors. Future risk factor lists may change as new research findings emerge. The list separates those characteristics for which research clearly indicates a strong association in the development of the cancer ("Risk Factors") from those characteristics for which weaker associations exist ("Possible Risk Factors") or which are now coming under investigation ("Under Investigation"). For additional information on cancer risk factors or prevention, you may wish to contact the following: Cancer Information Service (National Cancer Institute): 1-800-4-CANCER Cancer Response Line (American Cancer Society):

1-800-ACS-2345

In addition, the following selected Internet websites provide information on cancer. Many of these also provide links to other sites (not listed) which may be of interest. Massachusetts Department of Public Health: http://www.state.ma.us/dph American Cancer Society: http://www.cancer.org Centers for Disease Control and Prevention Home Page: http://www.cdc.gov Cancer Prevention and Control Program: http://www.cdc.gov/cancer National Cancer Institute Information: CANCERLIT® (literature): SEER data: 5-A-Day Program (nutrition):

http://www.cancer.gov http://www.cancer.gov/search/cancer_literature http://seer.cancer.gov http://www.5aday.gov

Harvard Center for Cancer Prevention Home Page: http://www.hsph.harvard.edu/cancer Your Cancer Risk: http://www.yourcancerrisk.harvard.edu OncoLink (University of Pennsylvania Cancer Center): http://www.oncolink.upenn.edu Cancer News on the Net® (information on diagnosis and treatment for cancer patients and their families): http://www.cancernews.com National Coalition for Cancer Survivorship: http://www.canceradvocacy.org

367

BLADDER, URINARY Risk Factors: •

Age (In Massachusetts, incidence rates increase markedly in the 65 to 74 year age group, and are highest in the 75 years and older age groups.)



Cigarette smoking



Excessive use of certain pain medications such as those containing phenacetin



Treatment with alkylating agent chemotherapy drugs such as Cytoxan (cyclophosphamide)



Having had radiation therapy to the bladder

Possible Risk Factors: •

Occupations in which workers are suspected of having an elevated bladder cancer risk due to certain chemical exposures include working in the rubber and/or leather industries, dye manufacturing, painters, professional drivers of trucks and other motor vehicles, aluminum workers, machinists, chemical workers, printers, metal workers, hairdressers and textile workers



Urologic conditions such as urinary tract infections and urinary stasis



Dietary factors

368

BREAST Risk Factors: •

Age (In Massachusetts, incidence rates increase markedly in the 45 to 64 year age group, and are highest in the 75 years and older age groups.)



Family (mother, sister or daughter) history of breast cancer, especially if it was detected premenopausally (before the change of life)



High-dose radiation therapy to the chest, especially from age 11 until age 30



Never giving birth



First childbirth after age 30



Menstruating since age 12 or younger



Late age (older than 55) at menopause (change of life)



Having inherited a mutation in breast cancer susceptibility genes such as BRCA1 or BRCA2



Increasing body fat in post-menopausal women



Estrogen taken post-menopausally (after the change of life)



More than three alcoholic drinks per day

Possible Risk Factors: •

Diet low in fruits and vegetables

Under Investigation: •

Pesticide exposure



Other environmental exposures

369

CERVIX UTERI (cervical cancer) Risk Factors: •

Age (In Massachusetts, incidence rates are highest in the 45 years and older age groups.)



Certain types of human papilloma virus (HPV, the virus that causes genital warts)



Sexual intercourse before age 19



Multiple sexual partners



Unprotected intercourse (having sex without a condom)



Smoking



Infection with HIV (human immunodeficiency virus, the virus that causes AIDS)

Possible Risk Factors: •

Too little vitamin A, vitamin C and/or folic acid in the diet



Exposure to secondhand smoke (other people's smoke)

Use of the medication diethylstilbestrol (DES) during pregnancy is associated with later vaginal clear cell adenocarcinoma (a form of cervical and vaginal cancer) in the female children of those pregnancies.

370

COLON / RECTUM Risk Factors: •

Age (In Massachusetts, incidence rates increase markedly in the 45 to 64 year age group, and continue to increase markedly in the 65 to 74 year and 75 to 84 year age groups.)



A personal history of colorectal polyps or colorectal cancer



Family history of colorectal cancer or polyps, including the various polyposis syndromes such as familial adenomatous polyposis, Gardner's Syndrome or Peutz-Jeghers Syndrome



Personal history of inflammatory bowel disease such as ulcerative colitis or Crohn's Disease



Personal history of ovarian, breast or endometrial cancer



Diet high in red meat, and low in fruits, vegetables and folic acid



Physical inactivity

Possible Risk Factors: •

Alcohol, especially beer



Smoking



Increasing body fat

371

LEUKEMIA Risk Factors: •

Exposure to ionizing radiation



Exposure to benzene



Treatment with chemotherapy drugs (especially alkylating agents)



Certain genetic conditions such as Down’s syndrome



Exposure to ethylene oxide

Possible Risk Factors: •

Exposure to low level solvent and metal mixtures



Smoking

Under Investigation: •

Exposure to electromagnetic fields (e.g., from power lines)

LUNG AND BRONCHUS Risk Factors: •

Smoking Note: 85% of all lung cancers are caused by smoking. The risk of lung cancer is 10 times greater for persons who smoke up to one pack of cigarettes a day and 20 times greater for persons who smoke more than one pack of cigarettes a day than for persons who do not smoke.



Occupational, and in some cases environmental, exposures (e.g., asbestos, metals)



Exposure to secondhand smoke (other people’s smoke)

372

MELANOMA OF SKIN Note: changing or changed moles, or new moles which appear after age 30 that itch and are tender are early, potentially malignant lesions, and should be examined by a health care professional. Risk Factors: •

Age (In Massachusetts, incidence rates begin to increase markedly in the 45 to 65 year age group, and are highest in the 75 to 84 year age group.)



One or more large or unevenly colored lesions such as: -- Dysplastic mole(s), with or without a family history of melanoma -- Lentigo maligna



Familial atypical mole and melanoma syndrome



Giant congenital melanocytic nevi (pigmented patches of skin)



Nevus (birthmark) since birth



Caucasian



Previous melanoma



Family history of melanoma



Immunosuppression (when the body's defenses are weakened, such as after transplant surgery)



Sun sensitivity



Repeated sunburns, especially as a child



Easily sunburned



Freckling



Unable to tan easily

373

NON-HODGKIN’S LYMPHOMA (now known as non-Hodgkin lymphoma) Risk Factors: •

Age (In Massachusetts, incidence rates begin to increase in the 45 to 65 year age group, and are highest in the 75 to 84 year age group.)



Abnormalities of the immune system, either congenital or resulting from suppression due to organ transplantation or disease



Infection with HIV (human immunodeficiency virus, the virus that causes AIDS)



Exposure to radiation or chemotherapy



Exposure to certain herbicides

Possible Risk Factors: •

Smoking



Other chemical exposures

ORAL CAVITY AND PHARYNX Risk Factors: •

Tobacco use (including cigarettes, pipes, cigars, chewing tobacco and snuff)



Heavy alcohol use



Age (In Massachusetts, incidence rates begin to increase in the 45 to 64 year age group, and are highest in the 75 to 84 year age group.)



Poor nutrition, especially chronic iron deficiency

Possible Risk Factors: •

Chronic irritation of the mouth due to ill-fitting dentures or broken teeth



Poor oral hygiene

374

OVARY Risk Factors: •

Age (In Massachusetts, incidence rates increase markedly in the 45 to 64 year age group, and are highest in the 65 to 74 year age group.)



Never giving birth



Personal history of endometrial (lining of the uterus), colon or breast cancer



Family history of ovarian cancer (mother, sister or daughter)



Having one of three inherited ovarian cancer conditions: -- breast-ovarian cancer syndrome -- site-specific ovarian cancer syndrome -- hereditary nonpolyposis colorectal cancer or Lynch II syndrome (includes early-onset colorectal cancer, endometrial cancer, breast cancer and ovarian cancer)



Never having used oral contraceptives, or having used oral contraceptives for fewer than five years



Caucasian

Possible Risk Factors: •

Fertility drugs



Use of talc powder containing asbestos fibers in the perineal or external genitalia area



High fat diet

375

PROSTATE Risk Factors: •

Age (In Massachusetts, incidence rates begin to increase markedly in the 45 to 64 year age group, and are highest in the 65 to 74 year age group.)



Family history of prostate cancer



Hormonal factors



African-American

Possible Risk Factors: •

Alcohol consumption



Having a history of benign prostate disease



Smoking



Physical inactivity



Diet high in fat

TESTIS Risk Factors: •

Age (In Massachusetts, incidence rates are highest in the 20 to 44 year age group.)



Undescended testicle

Possible Risk Factors: •

Inguinal hernia



Testicular trauma



Familial factors



Occupations related to leather processing

376

UTERI, CORPUS AND UTERUS, NOS (uterine cancer) Risk Factors: •

Age (In Massachusetts, incidence rates are highest in the 45 years and older age groups.)



Personal history of colon and/or breast cancer



Family history of uterine cancer



Being more than 20 pounds overweight



Never giving birth



Presence of estrogen-producing ovarian tumors



Postmenopausal (change of life) use of estrogen without progesterone



Tamoxifen (a drug given to women who have had breast cancer to lower the risk of recurrence)



Late age (older than 55) at menopause (change of life)

Possible Risk Factors: •

Diet high in fatty foods



Hypertension (high blood pressure)



Diabetes (high blood sugar)



Chronic anovulation (ovaries do not produce eggs)



Menstrual problems



Radiation therapy to the pelvis



Malignant tumors on the ovaries



Never having used oral contraceptives, or having used oral contraceptives for fewer than five years

377

Reviewers of Risk Factors This Appendix was assembled under the auspices of the American Cancer Society (New England Division) through seeking the advice of leading cancer experts. The following clinicians, researchers and public health professionals reviewed the risk factors for the type(s) of cancers indicated: Ross Berkowitz, MD (ovarian, uterine)

Frederick Li, MD (all types)

Cynthia Boddie-Willis, MD, MPH (prostate)

John Lisco, MPH (colorectal)

Risa Burns, MD (breast, cervical)

Robert Mayer, MD (colorectal)

Richard Clapp, ScD (all types)

Kenneth Miller, MD (leukemia)

Graham Colditz, DrPH (colorectal)

Michael Monopoli, DMD (oral)

Suzanne Condon, MS (all types)

Nancy Mueller, ScD (non-Hodgkin's lymphoma)

Greg Connolly, DMD (lung)

J. David Naparstek, ScM, CHO (all types)

Daniel Cramer, MD (ovarian)

Robert Osteen, MD (breast)

Letitia Davis, ScD (all types)

James Petros, MD (colorectal)

Catherine DuBeau, MD (prostate)

Marianne Prout, MD, MPH (all types)

Kathleen Egan, PhD (breast)

Lowell Schnipper, MD (non-Hodgkin's lymphoma)

Richard Fabian, MD (oral) Marc Garnick, MD (prostate, testicular)

Paul Schroy, MD, MPH (colorectal)

Alan Geller, RN, MPH (melanoma)

Ellen Sheets, MD (cervical)

Annekathryn Goodman, MD (uterine)

William Shipley, MD (bladder)

Lauren Holm, RN, MSN (all types)

Art Skarin, MD (lung)

David Hunter, MD, BS, ScD (all types)

Arthur Sober, MD (melanoma)

Joe Jacobson, MD (prostate)

Bonnie Tavares, MEd (breast, cervical)

Phil Kantoff, MD (bladder, prostate)

Howard Weinstein, MD (leukemia)

Howard Koh, MD, MPH (melanoma)

Martha Crosier Wood, MBA (all types)

Robert Krane, MD (testicular) and staff members of the Massachusetts Department of Public Health’s Center of Environmental Health Assessment (all types), Colorectal Cancer Working Group (colorectal), Skin Cancer Prevention Program (melanoma), and Massachusetts Women’s Health Network (breast, cervical). We would also particularly like to thank Lauren Holm, former Vice President for Planning and Evaluation, American Cancer Society (New England Division) and Martha Crosier Wood, former Director, Comprehensive Cancer Prevention and Control, Massachusetts Department of Public Health for their assistance in the development of this Appendix.

378

APPENDIX III: MDPH CANCER CONTROL INITIATIVES AND PUBLICATIONS This Appendix was developed by the Comprehensive Cancer Prevention and Control Program of the Bureau of Family and Community Health, Massachusetts Department of Public Health (MDPH). The MDPH is working to reduce the incidence and mortality of cancer throughout the Commonwealth. The following is a description of some of the current efforts to reduce the risk of specific cancers. For further information about specific cancers or cancer-related programs and issues, please call the Coordinator of Comprehensive Cancer Prevention and Control at 617-624-5480. BLADDER CANCER •

The incidence of bladder cancer increases with age and is three times more common in men than in women. Smoking appears to double a person's risk of bladder cancer.



MDPH is currently working to reduce the incidence of bladder cancer through the following activities: initiating an extensive program of tobacco-control activities. For specific activities, refer to the strategies of the Massachusetts Tobacco Control Program as listed under the section for Lung Cancer; developing statistical publications, such as Selected Cancers in Massachusetts Men 1982-1996, which include information on bladder cancer.

• •

BREAST CANCER Breast cancer is the most common cancer in women in Massachusetts and throughout the United States. In 1992, MDPH launched a breast and cervical cancer screening program for uninsured and underinsured eligible women in order to detect these diseases when they are most treatable. In addition, in 1992 the state legislature allocated moneys for a breast cancer research program. Funding for research increased in subsequent years however, the research program was eliminated in 2002 due to state budget cuts. MDPH is currently involved in numerous activities to address breast cancer in Massachusetts, including: • providing free mammograms and clinical breast examinations for uninsured and underinsured eligible women via the Massachusetts Women's Health Network; • developing and disseminating materials on the Massachusetts Women's Health Network, especially for low-literacy, culturally diverse, and non-English speaking women; • training community health outreach workers on communicating risk factors and screening options with culturally and ethnically diverse populations; • enhancing clinical and diagnostic skills of clinicians throughout Massachusetts by providing continuing education training; • providing continuing education for mammography technologists; • promoting public and professional awareness of issues related to the genetics of breast cancer; • working to reduce possible risk factors associated with breast cancer such as poor nutrition and lack of physical activity; • providing a clearinghouse of publications concerning breast cancer; •

developing statistical publications, such as Cancer in Massachusetts Women 1989-1998, which include information on breast cancer. 379

CERVICAL CANCER Cancer of the cervix uteri is highly curable when detected at an early, pre-invasive stage. MDPH is currently involved in the following cervical cancer prevention and control activities: • providing free Pap tests for uninsured and underinsured eligible women and teens via the Massachusetts Women's Health Network and Family Planning programs; • training community health outreach workers on communicating risk factors and screening options with culturally and ethnically diverse populations; • educating medical professionals on counseling patients about cervical cancer and performing cervical cancer screenings; • working to reduce the risk of cervical cancer associated with exposure to tobacco smoke and sexually transmitted diseases; • providing continuing education for cytotechnologists on cervical cytology; • developing statistical publications, such as Cancer in Massachusetts Women 1989-1998, which include information on cervical cancer; • providing a clearinghouse of publications concerning cervical cancer; • implementing prevention programs to address viral sexually transmitted diseases, such as HPV, herpes virus and HIV infection. COLORECTAL CANCER Colorectal cancer is the second leading cause of cancer death in Massachusetts. It may be prevented through lifestyle changes including a healthy diet, increased physical activity, and tobacco cessation. Both incidence and mortality from colorectal cancer can be greatly decreased through routine screening and early detection. To reduce the burden of this disease, MDPH formed the Massachusetts Colorectal Cancer Working Group in partnership with the American Cancer Society, University of Massachusetts Medical School, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston University Medical School, and others. MDPH is working to reduce the incidence of colorectal cancer through the following activities: • co-sponsoring trainings and conferences for health care outreach workers and health care professionals; • distributing information on colorectal cancer prevention and screening to health care professionals in the Commonwealth; • developing statistical publications, such as Selected Cancers in Massachusetts Men 1982-1996 and Cancer in Massachusetts Women 1989-1998, which include information on colorectal cancer; • producing public information posters and brochures, including You Can Prevent Colorectal Cancer and Take Control: Get Tested for Colorectal Cancer; in a variety of languages. • Conducting surveys to determine Massachusetts health care providers' knowledge, perceptions, and screening practices regarding colorectal cancer; • increasing public understanding of colorectal cancer risk factors; • conducting statewide media campaigns to increase public awareness.

380

LEUKEMIA Leukemia is the most common cancer to be diagnosed in children. However, adults account for almost 90% of new cases of leukemia, despite the common belief that it is primarily a childhood disease. There are several types of acute and chronic leukemia, which are classified according to the cell type involved. Although the incidence of leukemia has not changed dramatically over the past 50 years, survival rates have increased for some forms of the disease. MDPH's current activities around leukemia include: • responding to citizen inquiries about leukemia; • providing technical assistance and resources to schools on care of children with leukemia in educational settings; • providing information on care coordination for children with leukemia for families who request it; • providing support and networking opportunities with other families for families of children with leukemia; • developing statistical publications, such as Childhood Cancer in Massachusetts, which include information on leukemia; • conducting environmental epidemiological investigations in several Massachusetts communities. LUNG CANCER Lung cancer is the leading cause of cancer death for both men and women. Despite high incidence and mortality rates and the lack of screening tests, lung cancer is a largely preventable disease. Since 85% of lung cancers can be attributed to cigarette smoke, the most effective strategy for preventing lung cancer is through tobacco control. Several prospective studies show that a former smoker's risk of developing lung cancer can be reduced by half within five years. The risk of lung cancer from smoking may be augmented by other factors including exposure to carcinogens. MDPH, mainly through the Massachusetts Tobacco Control Program, is working to reduce the risk of lung cancer through the following activities: • helping smokers quit smoking through statewide services including the Try to Stop Tobacco Resource Center's telephone helpline (1-800-trytostop), website (www.trytostop.org), and educational print materials; • Utilizing QuitWorks program to provide health care clinicians with a simple approach to treating their patients who smoke by linking them to proactive telephone counseling and the state's range of effective tobacco treatment services; • providing funding and training to local boards of health to promote and enforce local regulations that reduce youth access to tobacco products and reduce exposure to environmental tobacco smoke; • raising public awareness about the health issues related to tobacco use and the need for tobacco control public policy initiatives through community-based Tobacco Free Community Mobilization Networks; • measuring changes in adult and youth attitudes toward tobacco use; • developing statistical publications, such as Selected Cancers in Massachusetts Men 1982-1996 and Cancer in Massachusetts Women 1989-1998, which include information on lung cancer; • conducting public awareness programs around the risk of lung cancer that is associated with exposure to radon gas; • researching possible environmental links to lung cancer.

381

NON-HODGKIN'S LYMPHOMA Massachusetts’ activities around non-Hodgkin’s lymphoma include: • responding to citizen inquiries about non-Hodgkin’s lymphoma; • developing statistical publications, such as Selected Cancers in Massachusetts Men 1982-1996, which include information on non-Hodgkin's lymphoma. ORAL CANCER Tobacco and excessive alcohol use are the greatest risk factors for oral cancer. However, poor nutrition, poor oral hygiene, and chronic irritation of the mouth due to ill-fitting dentures or broken teeth also play a role. Early detection of oral cancer can significantly reduce morbidity and mortality. MDPH, in partnership with the Boston University School of Dental Medicine, Harvard School of Dental Medicine, Tufts University School of Dental Medicine, Forsythe Institute, American Cancer Society, and Massachusetts Dental Society, has formed the Oral Cancer Partnership and is currently involved in reducing the risk of oral cancer through the following activities: • educating the public about oral cancer through outreach and distribution of educational materials; • educating primary care providers involved with populations at high risk for oral cancer; • promoting tobacco cessation; • developing statistical publications, such as Selected Cancers in Massachusetts Men 1982-1996, which include information on oral cancer; OVARIAN CANCER Ovarian cancer is the fourth most frequent cause of cancer death in women in the United States. It is curable when detected early. However, because there is no general screening method, and it has no symptoms in its early stages, ovarian cancer often goes undetected. MDPH, in partnership with the Massachusetts Chapter of the National Ovarian Cancer Coalition, the Ovarian Cancer Education and Awareness Network (OCEAN), the Rendon Group, Massachusetts General Hospital, Harvard Medical School, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, has formed the Massachusetts Ovarian Cancer Awareness Partnership and is currently involved in raising awareness of ovarian cancer through the following activities: • promoting public and professional awareness of issues related to ovarian cancer; • promoting public awareness of how to decrease the risk of ovarian cancer through the Massachusetts Women's Health Network, Women, Infants and Children (WIC) and Family Planning; • developing statistical publications, such as Cancer in Massachusetts Women 1989-1998, which include information on ovarian cancer.

382

PROSTATE CANCER Prostate cancer is the most common cancer in men in Massachusetts, with the exception of skin cancer. MDPH, in partnership with the Massachusetts Prostate Cancer Coalition, and community based partnership organizations works to reduce prostate cancer incidence and mortality and to address issues of quality of life for prostate cancer survivors and their families. The following MDPH activities are currently underway to address prostate cancer: • increasing knowledge and awareness among men and their families about prostate cancer through a variety of community-based programs and media strategies; • developing and distributing educational materials about prostate cancer that are culturally sensitive and available in several (six) languages and at varying literacy levels; • linking uninsured and underinsured men with medical care, including prostate cancer screening through thirteen Men's Health Partnership sites; • funding prostate cancer survivor support groups across Massachusetts; • developing statistical publications, such as Selected Cancers in Massachusetts Men 1996-2000, which include information on prostate cancer; • co-sponsoring an annual prostate cancer symposium; • providing publications concerning prostate cancer through the Massachusetts Health Promotion Clearinghouse; • co-sponsoring trainings for health care outreach workers and health care professionals. SKIN CANCER (INCLUDING MELANOMA) Skin cancer is the most common and preventable form of cancer in the United States. Almost all skin cancers are curable if detected and treated early, before they have spread to other tissues. Exposure to ultraviolet radiation, most frequently from the sun but also from tanning beds and booths, is the primary cause of skin cancer. MDPH, in partnership with the American Cancer Society, Boston University School of Medicine, the Dana-Farber Cancer Institute, the Harvard School of Public Health, the Massachusetts Melanoma Foundation, and other organizations and individuals, have formed the Massachusetts Skin Cancer Prevention Collaborative to address skin cancer in Massachusetts. MDPH is currently involved in the following activities to prevent skin cancer: • helping hospital maternity units to develop skin cancer prevention programs for mothers of newborns; • assisting communities developing local skin cancer prevention programs; • helping summer camps, child care centers, and schools develop programs and policies to prevent skin cancer; • training child care workers on safe sun practices; • developing and distributing skin cancer prevention materials including tip cards and posters; • increasing awareness among health professionals; • developing statistical publications, such as Selected Cancers in Massachusetts Men 1982-1996 and Cancer in Massachusetts Women 1989-1998, which include information on melanoma, the most deadly form of skin cancer; • exploring other venues of recreational exposure, including Little Leagues.

383

TESTICULAR CANCER Testicular cancer accounts for 1% of all cancers in Massachusetts males. In Massachusetts, testicular cancer is the most common cancer in men ages 20 to 44. Massachusetts is currently working to reduce the risk of testicular cancer through the following efforts: • including testicular cancer self-examination as part of Massachusetts’ recommended school health curriculum; • developing and distributing testicular cancer public and professional information materials; • developing statistical publications, such as Selected Cancers in Massachusetts Men 1982-1996, and 1996-2000, which include information on testicular cancer. UTERINE CANCER There is currently no screening test for uterine cancer. The Pap smear, which is used to detect cervical cancer, finds fewer than half of endometrial (uterine) cancers. MDPH is currently working to address uterine cancer through the following activities: • providing information concerning uterine cancer through the Massachusetts Women's Health Network and Family Planning programs; • developing statistical publications, such as Cancer in Massachusetts Women 1989-1998, which include information on uterine cancer.

384

Cancer-Related Publications from the Massachusetts Department of Public Health (MDPH) Breast and Cervical Cancer available through Massachusetts Health Promotion Clearinghouse, telephone 1-800-952-6637, website www.maclearinghouse.com: Bilingual Mammography Patient’s “Bill of Rights” (information card, available in English/Spanish) Bilingual Mammography Patient's "Bill of Rights" (poster, available in English/Spanish) Massachusetts Breast Cancer Research Program (booklet for researchers) They Say The Best Things In Life Are Free (poster) What You Should Know about Breast Cancer (brochure, available in English, Spanish, Portuguese, Haitian Creole, Vietnamese, and Chinese) What You Should Know about Cervical Cancer (brochure, available in English, Spanish, Portuguese, Haitian Creole, Vietnamese, and Chinese) available through Massachusetts Department of Public Health Women's Health Network, telephone 1877-414-4447: Women’s Health Network Bilingual Information Card (eligibility criteria and contact information for free health screening, available in Chinese, English, Haitian Creole, Khmer, Lao, Portuguese, Russian, Spanish, Vietnamese) Bilingual Women's Health Network (wallet card) Women's Health Network Passport Health Guide (booklet, available in English, Spanish, Portuguese, Chinese, and Vietnamese) Women’s Health Network Program Point of Purchase Display (stand with tear-off cards) You are the difference (video, 12:55 min ,in English, promotes the importance of regular screenings and includes personal accounts from women who have participated in WHN, #BC083). Colorectal Cancer available through Massachusetts Health Promotion Clearinghouse, telephone 1-800-952-6637, website

www.maclearinghouse.com: Colorectal Cancer Prevention (laminated reference card for health care professionals) Take Control. Get Tested for Colorectal Cancer (public brochure, available in Chinese, English, French, Portuguese, Russian, Spanish) You Can Prevent Colorectal Cancer (public brochure, available in Chinese, English, French, Khmer, Portuguese, Russian, Spanish, Vietnamese; also available as a fact sheet in Bosnian) available through American Digestive Health Foundation, telephone 1-800-668-5237: Women and Colorectal Cancer: What Are the Facts (brochure, available in English and Spanish) Ovarian Cancer To order any of these pamphlets, send requests via mail or fax to: National Ovarian Cancer Coalition, Inc. 500 NE Spanish River Blvd, Ste 14 Boca Raton, FL 33431-4516 main telephone: 561-393-0005, fax 561-393-7275 information line: 1-888-682-7426 (1-888-OVARIAN) website: www.ovarian.org Myths & Facts about Ovarian Cancer. What You Need to Know (2nd ed.) by M. Steven Piver, MD and Gamal Eltabbakh, MD National Ovarian Cancer Coalition. Working to Raise Awareness About Ovarian Cancer Risks and Symptoms Ovarian Cancer…It Whispers…So Listen Patient to Patient (patient resource for women with ovarian cancer)

385

What Every Woman Should Know About Ovarian Cancer Ovarian Cancer Reference Card (a wallet- sized card that provides facts, symptoms and resources) Prostate Cancer available through Massachusetts Health Promotion Clearinghouse, telephone 1-800-952-6637: What Every Man Should Know About Prostate Cancer (public brochure, available in Chinese, English, Haitian Creole, Portuguese, Russian, Spanish) Prostate Cancer Fact Sheet (fact sheet available in English, Spanish, Portuguese) available through MDPH Men's Health Initiative, fax 617-624-5075: Skin Cancer To order the following materials, send requests to: MDPH Skin Cancer Prevention Program 250 Washington St, 4th Floor Boston, MA 02108-4619 telephone: 617-624-5441 fax: 617-624-5075 Massachusetts Department of Public Health materials: Ban the Burn Tip Sheet -- General (available in English, Portuguese, Spanish) Ban the Burn Tip Sheet -- Newborns (available in English, Portuguese, Spanish) Ban the Burn Tip Sheet -- Preschoolers (available in English, Portuguese, Spanish) Ban the Burn Resource Guide Every Day is a SunDay Coloring Calendar and Curriculum Guide Ban the Burn Temporary Tattoos Have a Changing Mole? (poster) Have a Changing Mole? (pocket card for patients) Have a Changing Mole? (pocket card for physicians) Ban the Burn (poster) Centers for Disease Control and Prevention materials: Choose Your Cover: Parents (brochure) American Academy of Dermatology materials: Kids, Use Your ABC's For Safe Fun in the Sun Stop! Look for the Danger Signs Created by Boston University: Sun Protection Policy and Counselor Handbook (for camp counselors) Nutrition available through Massachusetts 5 A Day Program, Massachusetts Department of Public Health, telephone 617-624-5418: African Americans Take the 5 A Day Challenge for Better Health (brochure) Eat 5 Fruits and Vegetables Every Day (brochure, available in English and Spanish) Energizing Tips for a Healthier Family (brochure) Time to Take Five: Eat 5 Fruits and Vegetables A Day (brochure) 5 A Day Recipe Cards (set of 10 cards)

386

available through Massachusetts Department of Public Health Cancer Prevention and Control Program, telephone 617-624-5070: Snack Your Way to 5 A Day (brochure available in English) Down Home Healthy Cookin' Recipe Book (book in English) Color Your Way Pocket Guide (purse size brochure) Men Eat 9 A Day ( brochure in English for men of color) Physical Activity To order any of these materials, send requests via mail or fax to: Massachusetts Health Promotion Clearinghouse The Medical Foundation 95 Berkeley St Boston, MA 02116 fax: 617-536-8012 Physical Activity Fact Sheets (reproducible facts sheets from the American Council on Exercise) A Walk A Day… Active Seniors Enjoy Life More Exercise and Menopause Exercise and Pregnancy Kids in Motion Making Time for Exercise is Easy Moderate Exercise Will Do You A Lot of Good Physical Activity Pyramid The Right Exercise Program for You Starts Here Three Things Every Exercise Program Should Have Tobacco These materials may be ordered from: Try-to-Stop Tobacco Resource Center JSI Research and Training Institute, Inc. 44 Farnsworth St Boston, MA 02122-1211 telephone: 617-482-9485, fax: 617-482-0617 e-mail: [email protected] The Try-to-Stop Tobacco Resource Center offers education pamphlets, booklets, signs, posters, fact sheets and other items. Tobacco information and cessation materials are available in ten languages. You may obtain a copy of the current order form by contacting the Try-to-Stop Tobacco Resource Center at 617-482-9485. Miscellaneous Take Charge: Medicare Part B Benefits and You (video, 15 min, in English, provides an overview of the screening benefits covered under Medicare Part B.Video is designed to increase awareness about the prevention benefits under Medicare Part B, and to increase screening rates for Medicare beneficiaries, # BC089). Other Massachusetts Cancer Registry Publications

387

available through the Massachusetts Cancer Registry, telephone 617-988-3380: Cancer Incidence and Mortality in Massachusetts 1996-2000,1997-2001(to be released) Cancer in Massachusetts Women 1989-1998 Childhood Cancer in Massachusetts 1990-1999 Selected Cancers in Massachusetts Men 1982-1996 Massachusetts Cancer Registry Public Information Brochure (available in English, Portuguese, Spanish)

388

REFERENCES

American Cancer Society, Massachusetts Division (Murphy GP, Lawrence W Jr., Lenhard RE Jr., eds): American Cancer Society Textbook of Clinical Oncology, American Cancer Society, Atlanta, GA, 1995. American Cancer Society, Massachusetts Division (Osteen RT, ed-in-chief): Cancer Manual, 9th Ed., ACS Massachusetts Division, Inc., Boston, MA, 1996. Breslow NE and Day NE: Statistical Methods in Cancer Research, Volume II, International Agency for Research on Cancer, Lyon, 1987. Ries LAG, et al. (eds): SEER Cancer Statistics Review, 1973-1999, National Cancer Institute, Bethesda, MD, 2002, http://seer.cancer.gov/csr/1973_1999/. Schottenfeld D and Fraumeni JF (eds): Cancer Epidemiology and Prevention, 2nd Ed., Oxford University Press, New York City, 1996. World Health Organization (Percy C, VanHolten V and Muir C, eds): International Classification of Diseases for Oncology, 2nd Ed., WHO, Geneva, 1990.

Massachusetts Department of Public Health (2003). Center for Health Information, Statistics, Research and Evaluation: Cancer Incidence and Mortality In Massachusetts 1996-2000: Statewide Repor

389

Abington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 8.58 Male Female 3.50 12.09 Total Brain and Other Nervous System Male 3.08 2.64 Female 5.71 Total Breast 0.44 Male 60.24 Female Total 60.68 Cervix Uteri Female

3.33

Colon / Rectum 21.77 Male Female 23.05 Total 44.82 Esophagus 3.30 Male Female 1.09 Total 4.38 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.46 1.26 Female Total 2.72 Kidney & Renal Pelvis Male 5.53 3.55 Female 9.08 Total Larynx Male 3.01 0.79 Female Total 3.80 Leukemia Male 4.55 3.88 Female Total 8.43 Liver and Intrahepatic Bile Ducts Male 2.38 0.99 Female 3.37 Total Lung and Bronchus Male 28.25 Female 25.06 Total 53.31

Obs

SIR

10 3 13

116 NC* 108

0 0 0

NC* NC* NC*

0 56 56

NC* 93 92

3

NC*

26 29 55

119 126 123

Exp

Obs

SIR

4 2 6

NC* NC* 50

3 8 11

NC* 459 ~+ 310 ~+

10 0 10

135 NC* 69

6 6 12

103 203 137

6.99

7

100

3.92 4.46 8.38

1 5 6

NC* 112 72

57.59

57

99

Male Female Total

3.78 2.50 6.28

1 4 5

NC* NC* 80

Male

2.32

3

NC*

Male 1.36 4.06 Female Total 5.42 Uteri, Corpus and Uterus, NOS

0 7 7

NC* 173 129

11.36

15

132

185.04 189.64 374.68

185 203 388

100 107 104

Melanoma of Skin 6.58 Male Female 5.42 12.00 Total Multiple Myeloma Male 1.80 1.74 Female 3.55 Total Non-Hodgkin('s) Lymphoma 7.41 Male 7.00 Female Total 14.41 Oral Cavity & Pharynx 5.82 Male Female 2.96 Total 8.78 Ovary Female Pancreas

0 1 1

NC* NC* NC*

0 1 1

NC* NC* NC*

9 6 15

163 169 165

Male Female Total Prostate Male

Stomach

Testis 3 2 5

NC* NC* 131

8 2 10

176 NC* 119

1 1 2

NC* NC* NC*

Thyroid

30 26 56

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

106 104 105

10

Acton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 10.37 Male Female 3.54 13.91 Total Brain and Other Nervous System Male 4.04 3.13 Female 7.18 Total Breast 0.56 Male 75.96 Female Total 76.51 Cervix Uteri Female

4.34

Colon / Rectum 26.74 Male Female 22.83 Total 49.56 Esophagus 4.33 Male Female 1.10 Total 5.42 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.90 1.55 Female Total 3.44 Kidney & Renal Pelvis Male 7.26 4.19 Female 11.45 Total Larynx Male 4.06 1.00 Female Total 5.06 Leukemia Male 5.71 4.31 Female Total 10.02 Liver and Intrahepatic Bile Ducts Male 3.16 1.02 Female 4.17 Total Lung and Bronchus Male 35.74 Female 28.77 Total 64.51

Obs

SIR

9 2 11

87 NC* 79

2 2 4

NC* NC* NC*

1 100 101

NC* 132 ~+ 132 ~+

4

NC*

32 14 46

120 61 93

Exp

Obs

SIR

4 5 9

NC* 74 58

0 1 1

NC* NC* NC*

12 4 16

127 NC* 93

2 4 6

NC* NC* 52

8.71

7

80

4.94 4.44 9.38

4 2 6

NC* NC* 64

75.45

67

89

Male Female Total

4.67 2.44 7.11

4 3 7

NC* NC* 98

Male

2.94

1

NC*

Male 1.86 5.37 Female Total 7.23 Uteri, Corpus and Uterus, NOS

5 6 11

270 112 152

14.54

10

69

236.94 221.55 458.49

192 206 398

81 ~93 87 ~-

Melanoma of Skin 8.66 Male Female 6.74 15.40 Total Multiple Myeloma Male 2.27 1.91 Female 4.18 Total Non-Hodgkin('s) Lymphoma 9.45 Male 7.73 Female Total 17.19 Oral Cavity & Pharynx 7.95 Male Female 3.49 Total 11.44 Ovary Female Pancreas

5 3 8

116 NC* 148

3 1 4

NC* NC* NC*

6 2 8

83 NC* 70

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

5 4 9

88 NC* 90

3 1 4

NC* NC* NC*

Thyroid

13 17 30

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

36 ^59 #47 ^-

11

Acushnet

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.97 Male Female 2.79 10.76 Total Brain and Other Nervous System Male 2.56 2.03 Female 4.59 Total Breast 0.40 Male 50.23 Female Total 50.63 Cervix Uteri Female

2.56

Colon / Rectum 20.13 Male Female 18.11 Total 38.24 Esophagus 3.05 Male Female 0.86 Total 3.91 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.08 0.88 Female Total 1.96 Kidney & Renal Pelvis Male 5.00 2.95 Female 7.95 Total Larynx Male 2.77 0.70 Female Total 3.47 Leukemia Male 3.93 2.98 Female Total 6.91 Liver and Intrahepatic Bile Ducts Male 2.16 0.79 Female 2.95 Total Lung and Bronchus Male 26.21 Female 21.17 Total 47.38

Obs

SIR

10 4 14

125 NC* 130

3 1 4

NC* NC* NC*

0 40 40

NC* 80 79

1

NC*

25 14 39

124 77 102

Exp

Obs

SIR

5 2 7

86 NC* 69

3 2 5

NC* NC* 162

2 6 8

NC* 107 66

3 0 3

NC* NC* NC*

5.73

4

NC*

3.62 3.55 7.17

7 3 10

193 NC* 139

53.79

47

87

Male Female Total

3.48 1.93 5.42

1 4 5

NC* NC* 92

Male

1.60

0

NC*

Male 1.12 3.03 Female Total 4.14 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

9.74

7

72

168.81 154.48 323.29

168 121 289

100 78 ~89

Melanoma of Skin 5.80 Male Female 4.28 10.08 Total Multiple Myeloma Male 1.67 1.43 Female 3.10 Total Non-Hodgkin('s) Lymphoma 6.50 Male 5.59 Female Total 12.09 Oral Cavity & Pharynx 5.25 Male Female 2.43 Total 7.68 Ovary Female Pancreas

5 1 6

164 NC* 153

1 1 2

NC* NC* NC*

6 3 9

120 NC* 113

Male Female Total Prostate Male

Stomach

Testis 5 0 5

180 NC* 144

4 0 4

NC* NC* NC*

1 1 2

NC* NC* NC*

Thyroid

30 15 45

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

114 71 95

12

Adams

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.57 Male Female 3.28 10.85 Total Brain and Other Nervous System Male 2.05 1.96 Female 4.02 Total Breast 0.35 Male 46.00 Female Total 46.36 Cervix Uteri Female

2.17

Colon / Rectum 18.66 Male Female 21.72 Total 40.38 Esophagus 2.57 Male Female 1.02 Total 3.59 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.82 0.78 Female Total 1.60 Kidney & Renal Pelvis Male 4.19 2.92 Female 7.11 Total Larynx Male 2.23 0.64 Female Total 2.87 Leukemia Male 3.48 3.17 Female Total 6.65 Liver and Intrahepatic Bile Ducts Male 1.78 0.91 Female 2.69 Total Lung and Bronchus Male 23.14 Female 21.70 Total 44.84

Obs

SIR

9 0 9

119 NC* 83

1 0 1

NC* NC* NC*

0 39 39

NC* 85 84

5

230

26 24 50

139 111 124

Exp

Obs

SIR

3 5 8

NC* 127 92

0 2 2

NC* NC* NC*

8 4 12

143 NC* 104

7 4 11

169 NC* 168

5.31

6

113

3.25 4.22 7.48

4 3 7

NC* NC* 94

45.18

34

75

Male Female Total

3.23 2.36 5.59

2 2 4

NC* NC* NC*

Male

1.19

1

NC*

Male 0.83 2.44 Female Total 3.27 Uteri, Corpus and Uterus, NOS

0 2 2

NC* NC* NC*

8.78

10

114

146.43 155.45 301.88

141 140 281

96 90 93

Melanoma of Skin 4.80 Male Female 3.93 8.73 Total Multiple Myeloma Male 1.49 1.55 Female 3.04 Total Non-Hodgkin('s) Lymphoma 5.61 Male 5.97 Female Total 11.59 Oral Cavity & Pharynx 4.14 Male Female 2.42 Total 6.57 Ovary Female Pancreas

4 1 5

NC* NC* 139

0 2 2

NC* NC* NC*

7 0 7

167 NC* 98

Male Female Total Prostate Male

Stomach

Testis 3 1 4

NC* NC* NC*

5 5 10

144 158 150

3 1 4

NC* NC* NC*

Thyroid

17 16 33

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

73 74 74

13

Agawam

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 19.99 Male Female 8.01 28.00 Total Brain and Other Nervous System Male 6.33 5.53 Female 11.86 Total Breast 0.98 Male 131.21 Female Total 132.20 Cervix Uteri Female

6.89

Colon / Rectum 50.15 Male Female 52.48 Total 102.62 Esophagus 7.35 Male Female 2.48 Total 9.83 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.78 2.50 Female Total 5.27 Kidney & Renal Pelvis Male 12.11 7.84 Female 19.96 Total Larynx Male 6.59 1.76 Female Total 8.35 Leukemia Male 9.87 8.42 Female Total 18.29 Liver and Intrahepatic Bile Ducts Male 5.20 2.24 Female 7.44 Total Lung and Bronchus Male 63.93 Female 56.14 Total 120.07

Obs

SIR

18 5 23

90 62 82

8 7 15

126 127 127

1 131 132

NC* 100 100

8

116

50 67 117

100 128 114

Exp

Obs

SIR

13 8 21

92 69 82

3 5 8

NC* 127 100

12 11 23

74 71 73

17 7 24

136 107 126

15.15

13

86

8.93 10.20 19.13

6 12 18

67 118 94

128.84

110

85

Male Female Total

8.72 5.74 14.45

11 6 17

126 105 118

Male

4.24

3

NC*

Male 2.73 8.18 Female Total 10.91 Uteri, Corpus and Uterus, NOS

2 9 11

NC* 110 101

24.92

22

88

412.74 417.95 830.70

388 416 804

94 100 97

Melanoma of Skin 14.17 Male Female 11.54 25.71 Total Multiple Myeloma Male 4.10 3.94 Female 8.03 Total Non-Hodgkin('s) Lymphoma 16.13 Male 15.47 Female Total 31.60 Oral Cavity & Pharynx 12.53 Male Female 6.53 Total 19.06 Ovary Female Pancreas

9 5 14

122 202 142

5 3 8

180 NC* 152

12 11 23

99 140 115

Male Female Total Prostate Male

Stomach

Testis 4 1 5

NC* NC* 60

6 7 13

61 83 71

6 0 6

115 NC* 81

Thyroid

71 49 120

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

111 87 100

14

Alford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.58 Male Female 0.14 0.72 Total Brain and Other Nervous System Male 0.13 0.09 Female 0.22 Total Breast 0.02 Male 2.27 Female Total 2.29 Cervix Uteri Female

0.10

Colon / Rectum 1.42 Male Female 0.90 Total 2.32 Esophagus 0.19 Male Female 0.04 Total 0.23 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.04 0.03 Female Total 0.07 Kidney & Renal Pelvis Male 0.30 0.13 Female 0.43 Total Larynx Male 0.16 0.03 Female Total 0.19 Leukemia Male 0.25 0.14 Female Total 0.38 Liver and Intrahepatic Bile Ducts Male 0.13 0.04 Female 0.17 Total Lung and Bronchus Male 1.66 Female 0.99 Total 2.65

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0

NC*

1 1 2

NC* NC* NC*

Exp

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 1 1

NC* NC* NC*

0.25

1

NC*

0.25 0.17 0.42

0 0 0

NC* NC* NC*

3.24

2

NC*

Male Female Total

0.26 0.09 0.35

0 0 0

NC* NC* NC*

Male

0.03

0

NC*

Male 0.05 0.11 Female Total 0.15 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.45

0

NC*

10.58 7.09 17.67

9 4 13

85 NC* 74

Melanoma of Skin 0.34 Male Female 0.18 0.51 Total Multiple Myeloma Male 0.11 0.07 Female 0.18 Total Non-Hodgkin('s) Lymphoma 0.40 Male 0.26 Female Total 0.65 Oral Cavity & Pharynx 0.30 Male Female 0.11 Total 0.42 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

3 0 3

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

15

Amesbury

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.79 Male Female 3.34 11.14 Total Brain and Other Nervous System Male 2.98 2.59 Female 5.57 Total Breast 0.40 Male 57.86 Female Total 58.26 Cervix Uteri Female

3.33

Colon / Rectum 19.85 Male Female 21.82 Total 41.67 Esophagus 3.05 Male Female 1.03 Total 4.08 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.47 1.30 Female Total 2.77 Kidney & Renal Pelvis Male 5.16 3.41 Female 8.56 Total Larynx Male 2.80 0.75 Female Total 3.55 Leukemia Male 4.31 3.80 Female Total 8.11 Liver and Intrahepatic Bile Ducts Male 2.22 0.94 Female 3.17 Total Lung and Bronchus Male 25.69 Female 23.69 Total 49.38

Obs

SIR

9 2 11

115 NC* 99

0 1 1

NC* NC* NC*

0 54 54

NC* 93 93

8

240 #+

26 29 55

131 133 132

Exp

Obs

SIR

10 4 14

161 NC* 121

1 5 6

NC* 302 181

7 7 14

100 104 102

7 3 10

127 NC* 120

6.78

3

NC*

3.60 4.24 7.84

5 9 14

139 212 179

52.67

62

118

Male Female Total

3.48 2.41 5.90

6 4 10

172 NC* 170

Male

2.37

1

NC*

Male 1.34 4.11 Female Total 5.45 Uteri, Corpus and Uterus, NOS

2 3 5

NC* NC* 92

10.81

18

166

170.82 181.99 352.81

200 211 411

117 #+ 116 #+ 116 ~+

Melanoma of Skin 6.22 Male Female 5.33 11.55 Total Multiple Myeloma Male 1.65 1.66 Female 3.31 Total Non-Hodgkin('s) Lymphoma 6.98 Male 6.72 Female Total 13.69 Oral Cavity & Pharynx 5.51 Male Female 2.83 Total 8.34 Ovary Female Pancreas

4 2 6

NC* NC* 147

2 1 3

NC* NC* NC*

8 6 14

155 176 163

Male Female Total Prostate Male

Stomach

Testis 0 1 1

NC* NC* NC*

6 4 10

139 NC* 123

2 1 3

NC* NC* NC*

Thyroid

31 33 64

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

121 139 130

16

Amherst

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 10.84 Male Female 4.27 15.11 Total Brain and Other Nervous System Male 5.89 4.93 Female 10.82 Total Breast 0.61 Male 92.56 Female Total 93.17 Cervix Uteri Female

7.30

Colon / Rectum 28.25 Male Female 28.03 Total 56.29 Esophagus 4.27 Male Female 1.31 Total 5.58 Hodgkin's Disease (Hodgkin Lymphoma) Male 4.01 3.31 Female Total 7.32 Kidney & Renal Pelvis Male 7.95 5.07 Female 13.02 Total Larynx Male 3.98 1.04 Female Total 5.02 Leukemia Male 7.60 6.27 Female Total 13.87 Liver and Intrahepatic Bile Ducts Male 3.38 1.26 Female 4.64 Total Lung and Bronchus Male 35.81 Female 31.74 Total 67.55

Obs

SIR

5 2 7

46 NC* 46 #-

3 2 5

NC* NC* 46

0 73 73

NC* 79 #78 #-

1

NC*

25 24 49

88 86 87

Exp

Obs

SIR

5 9 14

46 89 67

0 5 5

NC* 228 110

4 8 12

NC* 78 53 #-

3 3 6

NC* NC* 47

11.42

10

88

5.12 5.32 10.43

6 3 9

117 NC* 86

70.04

83

118

Male Female Total

5.03 3.15 8.18

1 1 2

NC* NC* NC*

Male

7.85

3

NC*

Male 3.00 9.95 Female Total 12.94 Uteri, Corpus and Uterus, NOS

1 3 4

NC* NC* NC*

16.00

17

106

256.86 279.01 535.87

195 210 405

76 ^75 ^76 ^-

Melanoma of Skin 10.88 Male Female 10.16 21.04 Total Multiple Myeloma Male 2.34 2.19 Female 4.53 Total Non-Hodgkin('s) Lymphoma 12.41 Male 10.31 Female Total 22.71 Oral Cavity & Pharynx 8.53 Male Female 4.23 Total 12.76 Ovary Female Pancreas

3 1 4

NC* NC* NC*

2 4 6

NC* NC* 82

4 3 7

NC* NC* 54

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

6 4 10

79 NC* 72

2 3 5

NC* NC* 108

Thyroid

20 20 40

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

56 ~63 #59 ^-

17

Andover

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 19.26 Male Female 6.87 26.13 Total Brain and Other Nervous System Male 6.90 5.53 Female 12.43 Total Breast 1.02 Male 136.30 Female Total 137.32 Cervix Uteri Female

7.22

Colon / Rectum 49.24 Male Female 44.72 Total 93.96 Esophagus 7.84 Male Female 2.13 Total 9.98 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.95 2.47 Female Total 5.42 Kidney & Renal Pelvis Male 13.02 7.71 Female 20.73 Total Larynx Male 7.31 1.84 Female Total 9.15 Leukemia Male 10.11 7.85 Female Total 17.95 Liver and Intrahepatic Bile Ducts Male 5.66 1.96 Female 7.61 Total Lung and Bronchus Male 65.86 Female 54.39 Total 120.25

Obs

SIR

21 5 26

109 73 100

6 2 8

87 NC* 64

4 135 139

NC* 99 101

6

83

39 45 84

79 101 89

Exp

Obs

SIR

18 12 30

119 103 112

4 2 6

NC* NC* 77

16 14 30

96 97 97

11 6 17

79 94 83

15.49

13

84

9.02 8.70 17.72

9 9 18

100 103 102

138.17

124

90

Male Female Total

8.52 4.72 13.24

4 6 10

NC* 127 76

Male

4.23

7

165

Male 3.04 8.68 Female Total 11.71 Uteri, Corpus and Uterus, NOS

1 14 15

NC* 161 128

26.40

27

102

428.66 406.36 835.02

345 384 729

80 ^94 87 ^-

Melanoma of Skin 15.14 Male Female 11.69 26.82 Total Multiple Myeloma Male 4.18 3.63 Female 7.81 Total Non-Hodgkin('s) Lymphoma 16.60 Male 14.39 Female Total 30.99 Oral Cavity & Pharynx 14.00 Male Female 6.42 Total 20.41 Ovary Female Pancreas

5 3 8

64 NC* 80

6 5 11

203 202 203 #+

11 7 18

84 91 87

Male Female Total Prostate Male

Stomach

Testis 3 1 4

NC* NC* NC*

6 6 12

59 76 67

1 2 3

NC* NC* NC*

Thyroid

38 43 81

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

58 ^79 67 ^-

18

Aquinnah (Gay Head)

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary Male 0.26 Female 0.09 0.35 Total Brain and Other Nervous System Male 0.07 0.05 Female 0.12 Total Breast 0.01 Male 1.24 Female Total 1.25 Cervix Uteri Female

0.06

Colon / Rectum Male 0.64 0.57 Female Total 1.21 Esophagus Male 0.09 Female 0.03 Total 0.12 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.02 Female 0.02 0.04 Total Kidney & Renal Pelvis 0.14 Male 0.08 Female 0.22 Total Larynx Male 0.08 Female 0.02 0.09 Total Leukemia 0.12 Male Female 0.08 Total 0.20 Liver and Intrahepatic Bile Ducts Male 0.06 0.02 Female Total 0.08 Lung and Bronchus 0.80 Male 0.55 Female Total 1.35

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0

NC*

1 0 1

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0.14

0

NC*

0.11 0.11 0.22

0 0 0

NC* NC* NC*

1.57

0

NC*

Male Female Total

0.11 0.06 0.17

0 0 0

NC* NC* NC*

Male

0.02

0

NC*

0.02 Male Female 0.06 Total 0.09 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.24

0

NC*

4.98 4.11 9.09

6 1 7

120 NC* 77

Melanoma of Skin Male 0.16 Female 0.10 0.26 Total Multiple Myeloma Male 0.05 0.04 Female 0.09 Total Non-Hodgkin('s) Lymphoma 0.18 Male 0.15 Female Total 0.34 Oral Cavity & Pharynx 0.14 Male Female 0.06 Total 0.20 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

1 0 1

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

19

Arlington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 30.24 Male Female 14.22 44.46 Total Brain and Other Nervous System Male 9.12 8.97 Female 18.09 Total Breast 1.46 Male 210.82 Female Total 212.29 Cervix Uteri Female

10.87

Colon / Rectum 75.60 Male Female 93.60 Total 169.20 Esophagus 10.81 Male Female 4.40 Total 15.20 Hodgkin's Disease (Hodgkin Lymphoma) Male 4.07 4.01 Female Total 8.08 Kidney & Renal Pelvis Male 17.58 13.05 Female 30.63 Total Larynx Male 9.54 2.85 Female Total 12.39 Leukemia Male 14.45 14.15 Female Total 28.60 Liver and Intrahepatic Bile Ducts Male 7.55 3.94 Female 11.49 Total Lung and Bronchus Male 95.73 Female 94.80 Total 190.53

Obs

SIR

21 14 35

69 98 79

13 14 27

143 156 149

1 225 226

NC* 107 106

10

92

75 85 160

99 91 95

Exp

Obs

SIR

25 21 46

121 112 117

4 7 11

NC* 103 86

28 26 54

118 98 107

25 10 35

140 92 122

24.50

18

73

13.30 18.21 31.50

9 16 25

68 88 79

191.17

173

90

Male Female Total

13.06 10.31 23.36

11 4 15

84 NC* 64

Male

6.47

9

139

Male 3.94 12.73 Female Total 16.67 Uteri, Corpus and Uterus, NOS

2 18 20

NC* 141 120

39.71

37

93

612.98 697.51 1310.49

588 671 1259

96 96 96

Melanoma of Skin 20.62 Male Female 18.67 39.30 Total Multiple Myeloma Male 6.07 6.78 Female 12.85 Total Non-Hodgkin('s) Lymphoma 23.78 Male 26.46 Female Total 50.24 Oral Cavity & Pharynx 17.91 Male Female 10.85 Total 28.76 Ovary Female Pancreas

8 4 12

74 NC* 79

3 4 7

NC* NC* 87

24 17 41

137 130 134

Male Female Total Prostate Male

Stomach

Testis 7 2 9

73 NC* 73

15 16 31

104 113 108

5 6 11

66 152 96

Thyroid

92 73 165

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

96 77 #87

20

Ashburnham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 3.16 Male Female 1.05 4.21 Total Brain and Other Nervous System Male 1.27 0.94 Female 2.21 Total Breast 0.17 Male 21.93 Female Total 22.10 Cervix Uteri Female

1.29

Colon / Rectum 8.14 Male Female 6.81 Total 14.95 Esophagus 1.33 Male Female 0.32 Total 1.66 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.60 0.48 Female Total 1.08 Kidney & Renal Pelvis Male 2.27 1.22 Female 3.48 Total Larynx Male 1.26 0.28 Female Total 1.54 Leukemia Male 1.79 1.29 Female Total 3.07 Liver and Intrahepatic Bile Ducts Male 0.98 0.30 Female 1.28 Total Lung and Bronchus Male 10.89 Female 8.31 Total 19.20

Obs

SIR

3 0 3

NC* NC* NC*

0 2 2

NC* NC* NC*

0 17 17

NC* 78 77

0

NC*

6 9 15

74 132 100

Exp

Obs

SIR

2 3 5

NC* NC* 106

0 0 0

NC* NC* NC*

0 3 3

NC* NC* NC*

1 0 1

NC* NC* NC*

2.53

1

NC*

1.52 1.32 2.83

3 3 6

NC* NC* 212

22.95

15

65

Male Female Total

1.43 0.73 2.16

2 1 3

NC* NC* NC*

Male

0.92

0

NC*

Male 0.58 1.62 Female Total 2.20 Uteri, Corpus and Uterus, NOS

1 0 1

NC* NC* NC*

4.15

1

NC*

72.70 64.73 137.43

53 56 109

73 #87 79 #-

Melanoma of Skin 2.71 Male Female 1.99 4.70 Total Multiple Myeloma Male 0.70 0.56 Female 1.26 Total Non-Hodgkin('s) Lymphoma 2.94 Male 2.29 Female Total 5.23 Oral Cavity & Pharynx 2.49 Male Female 1.01 Total 3.50 Ovary Female Pancreas

3 0 3

NC* NC* NC*

0 1 1

NC* NC* NC*

1 1 2

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

2 3 5

NC* NC* 163

2 0 2

NC* NC* NC*

Thyroid

6 8 14

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

55 96 73

21

Ashby

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.65 Male Female 0.55 2.20 Total Brain and Other Nervous System Male 0.59 0.44 Female 1.03 Total Breast 0.09 Male 10.33 Female Total 10.42 Cervix Uteri Female

0.56

Colon / Rectum 4.22 Male Female 3.56 Total 7.77 Esophagus 0.66 Male Female 0.17 Total 0.83 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.25 0.20 Female Total 0.46 Kidney & Renal Pelvis Male 1.09 0.60 Female 1.69 Total Larynx Male 0.61 0.14 Female Total 0.75 Leukemia Male 0.86 0.63 Female Total 1.49 Liver and Intrahepatic Bile Ducts Male 0.47 0.16 Female 0.63 Total Lung and Bronchus Male 5.60 Female 4.27 Total 9.88

Obs

SIR

4 1 5

NC* NC* 227

3 0 3

NC* NC* NC*

0 8 8

NC* 77 77

0

NC*

3 3 6

NC* NC* 77

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

2 1 3

NC* NC* NC*

3 1 4

NC* NC* NC*

1.19

1

NC*

0.77 0.70 1.47

0 0 0

NC* NC* NC*

11.73

11

94

Male Female Total

0.73 0.38 1.11

0 0 0

NC* NC* NC*

Male

0.37

1

NC*

Male 0.26 0.68 Female Total 0.93 Uteri, Corpus and Uterus, NOS

2 0 2

NC* NC* NC*

1.99

0

NC*

36.42 31.53 67.96

37 28 65

102 89 96

Melanoma of Skin 1.27 Male Female 0.90 2.17 Total Multiple Myeloma Male 0.35 0.28 Female 0.64 Total Non-Hodgkin('s) Lymphoma 1.41 Male 1.14 Female Total 2.55 Oral Cavity & Pharynx 1.17 Male Female 0.50 Total 1.66 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 2 2

NC* NC* NC*

3 0 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 2 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

4 6 10

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* 140 101

22

Ashfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.35 Male Female 0.39 1.73 Total Brain and Other Nervous System Male 0.42 0.31 Female 0.74 Total Breast 0.07 Male 7.63 Female Total 7.70 Cervix Uteri Female

0.41

Colon / Rectum 3.37 Male Female 2.53 Total 5.90 Esophagus 0.50 Male Female 0.12 Total 0.62 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.17 0.14 Female Total 0.32 Kidney & Renal Pelvis Male 0.83 0.43 Female 1.26 Total Larynx Male 0.45 0.10 Female Total 0.55 Leukemia Male 0.67 0.45 Female Total 1.11 Liver and Intrahepatic Bile Ducts Male 0.36 0.11 Female 0.47 Total Lung and Bronchus Male 4.27 Female 3.03 Total 7.30

Obs

SIR

2 0 2

NC* NC* NC*

0 1 1

NC* NC* NC*

0 10 10

NC* 131 130

0

NC*

5 5 10

148 197 169

Exp

Obs

SIR

3 0 3

NC* NC* NC*

0 1 1

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0.87

2

NC*

0.61 0.49 1.10

2 1 3

NC* NC* NC*

8.64

8

93

Male Female Total

0.59 0.27 0.86

0 0 0

NC* NC* NC*

Male

0.24

0

NC*

Male 0.18 0.50 Female Total 0.68 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

1.47

1

NC*

27.72 22.85 50.58

32 26 58

115 114 115

Melanoma of Skin 0.96 Male Female 0.66 1.63 Total Multiple Myeloma Male 0.28 0.20 Female 0.48 Total Non-Hodgkin('s) Lymphoma 1.08 Male 0.81 Female Total 1.90 Oral Cavity & Pharynx 0.87 Male Female 0.36 Total 1.23 Ovary Female Pancreas

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

3 1 4

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 1 2

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

5 2 7

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

117 NC* 96

23

Ashland

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.17 Male Female 2.65 9.82 Total Brain and Other Nervous System Male 2.72 2.25 Female 4.97 Total Breast 0.38 Male 51.56 Female Total 51.93 Cervix Uteri Female

3.02

Colon / Rectum 18.33 Male Female 17.24 Total 35.57 Esophagus 2.85 Male Female 0.82 Total 3.67 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.33 1.15 Female Total 2.48 Kidney & Renal Pelvis Male 4.81 2.95 Female 7.76 Total Larynx Male 2.64 0.68 Female Total 3.32 Leukemia Male 3.91 3.11 Female Total 7.02 Liver and Intrahepatic Bile Ducts Male 2.08 0.76 Female 2.84 Total Lung and Bronchus Male 24.02 Female 20.51 Total 44.53

Obs

SIR

4 1 5

NC* NC* 51

3 4 7

NC* NC* 141

0 48 48

NC* 93 92

4

NC*

19 25 44

104 145 124

Exp

Obs

SIR

6 6 12

104 127 114

2 2 4

NC* NC* NC*

8 0 8

124 NC* 66

9 0 9

175 NC* 119

6.00

9

150

3.34 3.36 6.69

4 4 8

NC* NC* 120

49.57

38

77

Male Female Total

3.20 1.84 5.04

6 2 8

188 NC* 159

Male

2.17

3

NC*

Male 1.24 3.77 Female Total 5.01 Uteri, Corpus and Uterus, NOS

0 2 2

NC* NC* NC*

9.74

6

62

158.98 156.19 315.17

144 144 288

91 92 91

Melanoma of Skin 5.79 Male Female 4.71 10.50 Total Multiple Myeloma Male 1.53 1.38 Female 2.91 Total Non-Hodgkin('s) Lymphoma 6.44 Male 5.66 Female Total 12.09 Oral Cavity & Pharynx 5.15 Male Female 2.44 Total 7.59 Ovary Female Pancreas

5 0 5

175 NC* 136

0 0 0

NC* NC* NC*

4 5 9

NC* 170 116

Male Female Total Prostate Male

Stomach

Testis 1 1 2

NC* NC* NC*

3 1 4

NC* NC* NC*

1 1 2

NC* NC* NC*

Thyroid

20 14 34

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

83 68 76

24

Athol

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 8.05 Male Female 3.25 11.30 Total Brain and Other Nervous System Male 2.41 2.15 Female 4.55 Total Breast 0.38 Male 48.83 Female Total 49.21 Cervix Uteri Female

2.48

Colon / Rectum 19.99 Male Female 21.38 Total 41.37 Esophagus 2.81 Male Female 1.00 Total 3.81 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.03 0.94 Female Total 1.97 Kidney & Renal Pelvis Male 4.58 3.04 Female 7.62 Total Larynx Male 2.45 0.67 Female Total 3.12 Leukemia Male 3.90 3.33 Female Total 7.23 Liver and Intrahepatic Bile Ducts Male 1.96 0.91 Female 2.86 Total Lung and Bronchus Male 24.78 Female 22.10 Total 46.88

Obs

SIR

11 2 13

137 NC* 115

2 0 2

NC* NC* NC*

0 35 35

NC* 72 #71 #-

2

NC*

24 26 50

120 122 121

Exp

Obs

SIR

4 4 8

NC* NC* 83

3 2 5

NC* NC* 159

5 4 9

80 NC* 73

6 3 9

129 NC* 126

5.67

5

88

3.51 4.16 7.68

1 3 4

NC* NC* NC*

49.13

44

90

Male Female Total

3.50 2.33 5.82

6 2 8

172 NC* 137

Male

1.55

2

NC*

Male 0.99 2.90 Female Total 3.89 Uteri, Corpus and Uterus, NOS

6 1 7

607 ~+ NC* 180

9.27

10

108

159.60 161.18 320.78

165 144 309

103 89 96

Melanoma of Skin 5.34 Male Female 4.28 9.62 Total Multiple Myeloma Male 1.59 1.56 Female 3.15 Total Non-Hodgkin('s) Lymphoma 6.22 Male 6.13 Female Total 12.35 Oral Cavity & Pharynx 4.65 Male Female 2.51 Total 7.16 Ovary Female Pancreas

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

4 5 9

NC* 165 118

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

5 3 8

128 NC* 111

3 0 3

NC* NC* NC*

Thyroid

26 18 44

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

105 81 94

25

Attleboro

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 22.06 Male Female 8.73 30.79 Total Brain and Other Nervous System Male 7.89 6.68 Female 14.56 Total Breast 1.12 Male 148.77 Female Total 149.89 Cervix Uteri Female

8.39

Colon / Rectum 55.81 Male Female 57.13 Total 112.94 Esophagus 8.32 Male Female 2.70 Total 11.02 Hodgkin's Disease (Hodgkin Lymphoma) Male 3.80 3.28 Female Total 7.08 Kidney & Renal Pelvis Male 13.94 8.88 Female 22.83 Total Larynx Male 7.54 1.98 Female Total 9.52 Leukemia Male 11.73 9.72 Female Total 21.44 Liver and Intrahepatic Bile Ducts Male 6.00 2.46 Female 8.46 Total Lung and Bronchus Male 72.03 Female 62.78 Total 134.81

Obs

SIR

13 11 24

59 126 78

10 3 13

127 NC* 89

1 140 141

NC* 94 94

9

107

49 62 111

88 109 98

Exp

Obs

SIR

22 20 42

132 147 139 #+

8 4 12

174 NC* 135

14 21 35

74 119 96

20 14 34

138 191 #+ 156 #+

17.42

15

86

9.98 11.12 21.11

6 19 25

60 171 #+ 118

145.72

126

86

Male Female Total

9.67 6.20 15.86

6 5 11

62 81 69

Male

6.14

6

98

Male 3.46 10.31 Female Total 13.77 Uteri, Corpus and Uterus, NOS

7 13 20

203 126 145

27.98

32

114

471.01 471.50 942.51

475 503 978

101 107 104

Melanoma of Skin 16.64 Male Female 13.57 30.21 Total Multiple Myeloma Male 4.59 4.33 Female 8.92 Total Non-Hodgkin('s) Lymphoma 18.91 Male 17.57 Female Total 36.48 Oral Cavity & Pharynx 14.52 Male Female 7.33 Total 21.85 Ovary Female Pancreas

5 4 9

60 NC* 82

9 3 12

237 #+ NC* 170

13 9 22

93 101 96

Male Female Total Prostate Male

Stomach

Testis 13 2 15

172 NC* 158

11 8 19

94 82 89

6 6 12

100 243 142

Thyroid

85 63 148

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

118 100 110

26

Auburn

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 12.10 Male Female 4.53 16.63 Total Brain and Other Nervous System Male 3.64 3.04 Female 6.68 Total Breast 0.59 Male 72.80 Female Total 73.40 Cervix Uteri Female

3.58

Colon / Rectum 30.24 Male Female 29.63 Total 59.87 Esophagus 4.38 Male Female 1.40 Total 5.78 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.52 1.27 Female Total 2.79 Kidney & Renal Pelvis Male 7.14 4.45 Female 11.59 Total Larynx Male 3.89 1.02 Female Total 4.91 Leukemia Male 5.80 4.64 Female Total 10.44 Liver and Intrahepatic Bile Ducts Male 3.07 1.27 Female 4.33 Total Lung and Bronchus Male 38.58 Female 32.45 Total 71.03

Obs

SIR

13 8 21

107 177 126

2 1 3

NC* NC* NC*

0 72 72

NC* 99 98

3

NC*

28 24 52

93 81 87

Exp

Obs

SIR

7 2 9

85 NC* 62

2 1 3

NC* NC* NC*

9 13 22

95 149 121

5 2 7

69 NC* 64

8.36

8

96

5.35 5.80 11.15

4 9 13

NC* 155 117

77.36

77

100

Male Female Total

5.21 3.18 8.40

4 4 8

NC* NC* 95

Male

2.25

2

NC*

Male 1.52 4.15 Female Total 5.68 Uteri, Corpus and Uterus, NOS

2 7 9

NC* 169 159

14.06

17

121

246.14 233.53 479.67

236 228 464

96 98 97

Melanoma of Skin 8.25 Male Female 6.20 14.45 Total Multiple Myeloma Male 2.46 2.24 Female 4.70 Total Non-Hodgkin('s) Lymphoma 9.45 Male 8.70 Female Total 18.15 Oral Cavity & Pharynx 7.28 Male Female 3.66 Total 10.94 Ovary Female Pancreas

6 0 6

137 NC* 104

1 3 4

NC* NC* NC*

10 7 17

140 157 147

Male Female Total Prostate Male

Stomach

Testis 5 0 5

128 NC* 102

5 5 10

86 108 96

2 0 2

NC* NC* NC*

Thyroid

35 30 65

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

91 92 92

27

Avon

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 3.16 Male Female 1.22 4.38 Total Brain and Other Nervous System Male 0.98 0.85 Female 1.83 Total Breast 0.15 Male 20.16 Female Total 20.31 Cervix Uteri Female

1.04

Colon / Rectum 7.93 Male Female 7.92 Total 15.84 Esophagus 1.15 Male Female 0.38 Total 1.53 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.43 0.38 Female Total 0.81 Kidney & Renal Pelvis Male 1.87 1.24 Female 3.11 Total Larynx Male 1.03 0.29 Female Total 1.31 Leukemia Male 1.53 1.25 Female Total 2.78 Liver and Intrahepatic Bile Ducts Male 0.81 0.34 Female 1.15 Total Lung and Bronchus Male 10.17 Female 9.06 Total 19.23

Obs

SIR

4 2 6

NC* NC* 137

1 1 2

NC* NC* NC*

0 22 22

NC* 109 108

3

NC*

14 4 18

177 NC* 114

Exp

Obs

SIR

2 2 4

NC* NC* NC*

3 0 3

NC* NC* NC*

3 3 6

NC* NC* 122

0 0 0

NC* NC* NC*

2.34

3

NC*

1.40 1.57 2.97

1 1 2

NC* NC* NC*

20.52

19

93

Male Female Total

1.36 0.84 2.20

2 0 2

NC* NC* NC*

Male

0.66

1

NC*

Male 0.42 1.23 Female Total 1.65 Uteri, Corpus and Uterus, NOS

1 1 2

NC* NC* NC*

3.89

4

NC*

65.01 64.34 129.35

71 76 147

109 118 114

Melanoma of Skin 2.18 Male Female 1.75 3.93 Total Multiple Myeloma Male 0.64 0.61 Female 1.25 Total Non-Hodgkin('s) Lymphoma 2.50 Male 2.41 Female Total 4.91 Oral Cavity & Pharynx 1.92 Male Female 1.01 Total 2.92 Ovary Female Pancreas

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

1 3 4

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 1 2

NC* NC* NC*

1 1 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

12 20 32

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

118 221 ~+ 166 ~+

28

Ayer

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.21 Male Female 1.11 3.32 Total Brain and Other Nervous System Male 0.89 0.83 Female 1.72 Total Breast 0.12 Male 17.35 Female Total 17.47 Cervix Uteri Female

0.99

Colon / Rectum 5.60 Male Female 7.29 Total 12.90 Esophagus 0.81 Male Female 0.34 Total 1.16 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.48 0.42 Female Total 0.89 Kidney & Renal Pelvis Male 1.41 1.08 Female 2.49 Total Larynx Male 0.74 0.23 Female Total 0.97 Leukemia Male 1.28 1.23 Female Total 2.52 Liver and Intrahepatic Bile Ducts Male 0.60 0.31 Female 0.91 Total Lung and Bronchus Male 7.19 Female 7.63 Total 14.82

Obs

SIR

7 1 8

316 #+ NC* 241 #+

0 1 1

NC* NC* NC*

0 26 26

NC* 150 149

0

NC*

15 10 25

268 ~+ 137 194 ~+

Exp

Obs

SIR

2 1 3

NC* NC* NC*

0 1 1

NC* NC* NC*

6 2 8

299 #+ NC* 191

4 2 6

NC* NC* 259

2.06

6

291 #+

0.99 1.42 2.41

1 5 6

NC* 352 #+ 249

14.13

23

163 #+

Male Female Total

0.96 0.80 1.76

1 3 4

NC* NC* NC*

Male

0.83

0

NC*

Male 0.39 1.22 Female Total 1.61 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

3.23

5

155

47.58 57.09 104.67

97 95 192

204 ^+ 166 ^+ 183 ^+

Melanoma of Skin 1.73 Male Female 1.62 3.35 Total Multiple Myeloma Male 0.46 0.54 Female 0.99 Total Non-Hodgkin('s) Lymphoma 2.01 Male 2.19 Female Total 4.20 Oral Cavity & Pharynx 1.43 Male Female 0.88 Total 2.32 Ovary Female Pancreas

3 0 3

NC* NC* NC*

0 0 0

NC* NC* NC*

5 1 6

354 #+ NC* 241

Male Female Total Prostate Male

Stomach

Testis 2 1 3

NC* NC* NC*

3 4 7

NC* NC* 278 #+

0 0 0

NC* NC* NC*

Thyroid

16 21 37

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

223 ~+ 275 ^+ 250 ^+

29

Barnstable

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 46.23 Male Female 16.17 62.41 Total Brain and Other Nervous System Male 11.69 9.88 Female 21.57 Total Breast 2.09 Male 233.09 Female Total 235.18 Cervix Uteri Female

11.03

Colon / Rectum 113.17 Male Female 106.53 Total 219.70 Esophagus 15.12 Male Female 5.01 Total 20.13 Hodgkin's Disease (Hodgkin Lymphoma) Male 4.43 3.96 Female Total 8.38 Kidney & Renal Pelvis Male 24.35 14.69 Female 39.04 Total Larynx Male 12.87 3.25 Female Total 16.11 Leukemia Male 20.59 15.85 Female Total 36.44 Liver and Intrahepatic Bile Ducts Male 10.33 4.48 Female 14.81 Total Lung and Bronchus Male 137.79 Female 108.53 Total 246.32

Obs

SIR

56 21 77

121 130 123

16 7 23

137 71 107

3 240 243

NC* 103 103

6

54

79 86 165

70 ^81 #75 ^-

Exp

Obs

SIR

51 28 79

184 ^+ 141 166 ^+

7 5 12

78 65 72

31 19 50

94 64 80

21 16 37

89 132 103

26.86

22

82

19.55 20.78 40.32

24 30 54

123 144 134 #+

265.79

340

128 ^+

Male Female Total

19.65 11.59 31.24

19 7 26

97 60 83

Male

6.24

7

112

Male 4.51 12.46 Female Total 16.97 Uteri, Corpus and Uterus, NOS

6 7 13

133 56 77

44.66

45

101

866.79 778.37 1645.16

909 756 1665

105 97 101

Melanoma of Skin 27.68 Male Female 19.84 47.52 Total Multiple Myeloma Male 8.92 7.71 Female 16.62 Total Non-Hodgkin('s) Lymphoma 32.94 Male 29.66 Female Total 62.60 Oral Cavity & Pharynx 23.68 Male Female 12.15 Total 35.83 Ovary Female Pancreas

18 9 27

119 180 134

4 5 9

NC* 126 107

21 8 29

86 54 74

Male Female Total Prostate Male

Stomach

Testis 10 6 16

78 185 99

23 21 44

112 133 121

11 2 13

106 NC* 88

Thyroid

119 123 242

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

86 113 98

30

Barre

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 3.29 Male Female 1.21 4.50 Total Brain and Other Nervous System Male 1.08 0.88 Female 1.96 Total Breast 0.16 Male 19.97 Female Total 20.13 Cervix Uteri Female

1.06

Colon / Rectum 8.22 Male Female 8.00 Total 16.22 Esophagus 1.20 Male Female 0.38 Total 1.57 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.48 0.40 Female Total 0.88 Kidney & Renal Pelvis Male 2.02 1.19 Female 3.21 Total Larynx Male 1.08 0.27 Female Total 1.34 Leukemia Male 1.68 1.32 Female Total 2.99 Liver and Intrahepatic Bile Ducts Male 0.86 0.34 Female 1.20 Total Lung and Bronchus Male 10.45 Female 8.54 Total 18.99

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 19 19

NC* 95 94

3

NC*

7 7 14

85 88 86

Exp

Obs

SIR

3 1 4

NC* NC* NC*

0 2 2

NC* NC* NC*

3 1 4

NC* NC* NC*

1 2 3

NC* NC* NC*

2.31

3

NC*

1.46 1.54 3.01

0 2 2

NC* NC* NC*

20.80

15

72

Male Female Total

1.43 0.86 2.29

0 0 0

NC* NC* NC*

Male

0.74

0

NC*

Male 0.46 1.28 Female Total 1.74 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

3.78

0

NC*

67.73 63.79 131.52

51 58 109

75 #91 83 #-

Melanoma of Skin 2.36 Male Female 1.77 4.14 Total Multiple Myeloma Male 0.68 0.60 Female 1.27 Total Non-Hodgkin('s) Lymphoma 2.70 Male 2.38 Female Total 5.07 Oral Cavity & Pharynx 2.06 Male Female 0.99 Total 3.06 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

5 2 7

248 NC* 218

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

4 1 5

NC* NC* 167

0 0 0

NC* NC* NC*

Thyroid

9 12 21

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

86 141 111

31

Becket

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.27 Male Female 0.35 1.61 Total Brain and Other Nervous System Male 0.41 0.27 Female 0.68 Total Breast 0.06 Male 6.40 Female Total 6.47 Cervix Uteri Female

0.34

Colon / Rectum 3.18 Male Female 2.24 Total 5.42 Esophagus 0.47 Male Female 0.11 Total 0.58 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.18 0.12 Female Total 0.30 Kidney & Renal Pelvis Male 0.78 0.38 Female 1.16 Total Larynx Male 0.42 0.09 Female Total 0.51 Leukemia Male 0.63 0.39 Female Total 1.02 Liver and Intrahepatic Bile Ducts Male 0.33 0.10 Female 0.43 Total Lung and Bronchus Male 4.07 Female 2.70 Total 6.77

Obs

SIR

0 0 0

NC* NC* NC*

0 2 2

NC* NC* NC*

0 7 7

NC* 109 108

0

NC*

2 3 5

NC* NC* 92

Exp

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

1 0 1

NC* NC* NC*

0.74

0

NC*

0.57 0.44 1.01

0 0 0

NC* NC* NC*

8.21

2

NC*

Male Female Total

0.55 0.24 0.79

1 0 1

NC* NC* NC*

Male

0.26

0

NC*

Male 0.17 0.41 Female Total 0.58 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

1.24

1

NC*

26.29 19.66 45.95

8 15 23

30 ^76 50 ^-

Melanoma of Skin 0.91 Male Female 0.55 1.46 Total Multiple Myeloma Male 0.26 0.18 Female 0.44 Total Non-Hodgkin('s) Lymphoma 1.03 Male 0.72 Female Total 1.74 Oral Cavity & Pharynx 0.81 Male Female 0.31 Total 1.12 Ovary Female Pancreas

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

0 0 0

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

32

Bedford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 10.43 Male Female 2.64 13.07 Total Brain and Other Nervous System Male 3.04 1.91 Female 4.95 Total Breast 0.50 Male 44.22 Female Total 44.72 Cervix Uteri Female

2.30

Colon / Rectum 26.00 Male Female 17.14 Total 43.14 Esophagus 3.70 Male Female 0.81 Total 4.51 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.25 0.86 Female Total 2.11 Kidney & Renal Pelvis Male 5.97 2.66 Female 8.63 Total Larynx Male 3.25 0.61 Female Total 3.86 Leukemia Male 4.92 2.87 Female Total 7.79 Liver and Intrahepatic Bile Ducts Male 2.56 0.74 Female 3.30 Total Lung and Bronchus Male 33.05 Female 18.99 Total 52.04

Obs

SIR

12 2 14

115 NC* 107

3 4 7

NC* NC* 141

0 73 73

NC* 165 ^+ 163 ^+

2

NC*

16 24 40

62 #140 93

Exp

Obs

SIR

11 9 20

160 233 #+ 186 #+

3 1 4

NC* NC* NC*

15 5 20

189 #+ 97 152

6 5 11

100 228 134

5.12

11

215 #+

4.56 3.36 7.92

5 4 9

110 NC* 114

66.01

63

95

Male Female Total

4.46 1.87 6.33

4 2 6

NC* NC* 95

Male

1.86

1

NC*

Male 1.24 2.75 Female Total 3.99 Uteri, Corpus and Uterus, NOS

1 7 8

NC* 255 #+ 200

8.47

19

224 ~+

209.44 140.01 349.45

201 226 427

96 161 ^+ 122 ^+

Melanoma of Skin 6.86 Male Female 3.86 10.73 Total Multiple Myeloma Male 2.09 1.31 Female 3.40 Total Non-Hodgkin('s) Lymphoma 7.95 Male 5.17 Female Total 13.13 Oral Cavity & Pharynx 6.01 Male Female 2.19 Total 8.20 Ovary Female Pancreas

4 1 5

NC* NC* 111

1 0 1

NC* NC* NC*

5 7 12

84 263 #+ 139

Male Female Total Prostate Male

Stomach

Testis 2 1 3

NC* NC* NC*

5 4 9

102 NC* 115

0 2 2

NC* NC* NC*

Thyroid

29 28 57

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

88 147 110

33

Belchertown

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 6.68 Male Female 2.34 9.02 Total Brain and Other Nervous System Male 2.48 1.98 Female 4.46 Total Breast 0.35 Male 45.16 Female Total 45.51 Cervix Uteri Female

2.65

Colon / Rectum 16.96 Male Female 15.33 Total 32.29 Esophagus 2.61 Male Female 0.73 Total 3.34 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.17 1.01 Female Total 2.18 Kidney & Renal Pelvis Male 4.45 2.56 Female 7.01 Total Larynx Male 2.41 0.58 Female Total 2.99 Leukemia Male 3.63 2.78 Female Total 6.41 Liver and Intrahepatic Bile Ducts Male 1.91 0.67 Female 2.58 Total Lung and Bronchus Male 22.02 Female 17.70 Total 39.72

Obs

SIR

5 4 9

75 NC* 100

3 2 5

NC* NC* 112

0 33 33

NC* 73 73

1

NC*

14 13 27

83 85 84

Exp

Obs

SIR

6 3 9

113 NC* 95

2 1 3

NC* NC* NC*

6 4 10

101 NC* 92

2 4 6

NC* NC* 87

5.25

5

95

3.09 2.96 6.05

0 0 0

NC* NC* NC*

44.97

34

76

Male Female Total

2.97 1.65 4.62

1 2 3

NC* NC* NC*

Male

1.84

0

NC*

Male 1.11 3.31 Female Total 4.41 Uteri, Corpus and Uterus, NOS

1 3 4

NC* NC* NC*

8.49

7

82

145.58 137.07 282.65

105 119 224

72 ^87 79 ^-

Melanoma of Skin 5.31 Male Female 4.14 9.45 Total Multiple Myeloma Male 1.43 1.21 Female 2.64 Total Non-Hodgkin('s) Lymphoma 5.91 Male 4.95 Female Total 10.87 Oral Cavity & Pharynx 4.73 Male Female 2.14 Total 6.87 Ovary Female Pancreas

1 0 1

NC* NC* NC*

0 1 1

NC* NC* NC*

2 1 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 1 2

NC* NC* NC*

0 2 2

NC* NC* NC*

2 0 2

NC* NC* NC*

Thyroid

17 20 37

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

77 113 93

34

Bellingham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.94 Male Female 2.90 10.84 Total Brain and Other Nervous System Male 3.09 2.49 Female 5.58 Total Breast 0.43 Male 56.94 Female Total 57.37 Cervix Uteri Female

3.29

Colon / Rectum 20.41 Male Female 18.75 Total 39.15 Esophagus 3.24 Male Female 0.89 Total 4.13 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.48 1.25 Female Total 2.73 Kidney & Renal Pelvis Male 5.44 3.28 Female 8.72 Total Larynx Male 3.02 0.77 Female Total 3.78 Leukemia Male 4.39 3.43 Female Total 7.82 Liver and Intrahepatic Bile Ducts Male 2.36 0.83 Female 3.19 Total Lung and Bronchus Male 27.31 Female 22.86 Total 50.17

Obs

SIR

5 2 7

63 NC* 65

4 3 7

NC* NC* 125

0 48 48

NC* 84 84

3

NC*

24 17 41

118 91 105

Exp

Obs

SIR

4 8 12

NC* 155 103

1 0 1

NC* NC* NC*

9 5 14

125 80 105

2 0 2

NC* NC* NC*

6.62

2

NC*

3.72 3.67 7.40

5 5 10

134 136 135

56.98

54

95

Male Female Total

3.52 2.00 5.51

1 0 1

NC* NC* NC*

Male

2.35

2

NC*

Male 1.39 4.10 Female Total 5.49 Uteri, Corpus and Uterus, NOS

0 3 3

NC* NC* NC*

10.83

9

83

179.69 172.03 351.73

162 137 299

90 80 ~85 ~-

Melanoma of Skin 6.48 Male Female 5.15 11.64 Total Multiple Myeloma Male 1.72 1.52 Female 3.24 Total Non-Hodgkin('s) Lymphoma 7.17 Male 6.23 Female Total 13.40 Oral Cavity & Pharynx 5.84 Male Female 2.69 Total 8.53 Ovary Female Pancreas

1 0 1

NC* NC* NC*

2 1 3

NC* NC* NC*

5 1 6

92 NC* 69

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

3 1 4

NC* NC* NC*

2 0 2

NC* NC* NC*

Thyroid

23 16 39

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

84 70 78

35

Belmont

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 19.30 Male Female 8.01 27.31 Total Brain and Other Nervous System Male 5.57 5.18 Female 10.75 Total Breast 0.90 Male 122.94 Female Total 123.85 Cervix Uteri Female

6.41

Colon / Rectum 47.95 Male Female 52.79 Total 100.74 Esophagus 6.74 Male Female 2.48 Total 9.22 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.39 2.33 Female Total 4.72 Kidney & Renal Pelvis Male 10.93 7.44 Female 18.37 Total Larynx Male 5.89 1.62 Female Total 7.51 Leukemia Male 9.07 8.17 Female Total 17.24 Liver and Intrahepatic Bile Ducts Male 4.68 2.22 Female 6.91 Total Lung and Bronchus Male 59.51 Female 53.35 Total 112.86

Obs

SIR

13 6 19

67 75 70

5 6 11

90 116 102

2 129 131

NC* 105 106

3

NC*

47 45 92

98 85 91

Exp

Obs

SIR

13 17 30

102 156 127

4 2 6

NC* NC* 78

9 18 27

61 120 91

11 5 16

99 80 92

14.22

19

134

8.43 10.21 18.64

14 5 19

166 49 102

118.13

131

111

Male Female Total

8.38 5.85 14.23

4 3 7

NC* NC* 49

Male

3.67

7

191

Male 2.36 7.54 Female Total 9.90 Uteri, Corpus and Uterus, NOS

5 9 14

212 119 141

23.12

21

91

382.12 400.49 782.61

335 381 716

88 #95 91 #-

Melanoma of Skin 12.78 Male Female 10.89 23.67 Total Multiple Myeloma Male 3.82 3.84 Female 7.66 Total Non-Hodgkin('s) Lymphoma 14.83 Male 14.98 Female Total 29.81 Oral Cavity & Pharynx 11.14 Male Female 6.24 Total 17.38 Ovary Female Pancreas

6 2 8

89 NC* 87

5 2 7

209 NC* 148

7 3 10

64 NC* 54

Male Female Total Prostate Male

Stomach

Testis 2 2 4

NC* NC* NC*

8 14 22

88 171 128

4 3 7

NC* NC* 101

Thyroid

24 45 69

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

40 ^84 61 ^-

36

Berkley

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.40 Male Female 0.75 3.15 Total Brain and Other Nervous System Male 1.04 0.78 Female 1.83 Total Breast 0.13 Male 17.35 Female Total 17.48 Cervix Uteri Female

1.10

Colon / Rectum 6.23 Male Female 4.85 Total 11.08 Esophagus 1.03 Male Female 0.23 Total 1.26 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.51 0.43 Female Total 0.94 Kidney & Renal Pelvis Male 1.76 0.94 Female 2.70 Total Larynx Male 0.98 0.22 Female Total 1.20 Leukemia Male 1.43 1.03 Female Total 2.46 Liver and Intrahepatic Bile Ducts Male 0.77 0.22 Female 0.99 Total Lung and Bronchus Male 8.40 Female 6.26 Total 14.65

Obs

SIR

3 0 3

NC* NC* NC*

0 0 0

NC* NC* NC*

0 14 14

NC* 81 80

0

NC*

5 1 6

80 NC* 54

Exp

Obs

SIR

1 1 2

NC* NC* NC*

0 0 0

NC* NC* NC*

1 4 5

NC* NC* 123

0 1 1

NC* NC* NC*

2.03

1

NC*

1.16 0.94 2.10

1 3 4

NC* NC* NC*

17.85

13

73

Male Female Total

1.09 0.52 1.62

2 0 2

NC* NC* NC*

Male

0.80

1

NC*

Male 0.47 1.42 Female Total 1.90 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

3.25

3

NC*

56.54 50.16 106.70

39 36 75

69 #72 #70 ~-

Melanoma of Skin 2.12 Male Female 1.64 3.76 Total Multiple Myeloma Male 0.54 0.41 Female 0.95 Total Non-Hodgkin('s) Lymphoma 2.31 Male 1.76 Female Total 4.07 Oral Cavity & Pharynx 1.94 Male Female 0.78 Total 2.73 Ovary Female Pancreas

2 1 3

NC* NC* NC*

0 0 0

NC* NC* NC*

3 0 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

5 3 8

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

60 NC* 55

37

Berlin

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.72 Male Female 0.55 2.28 Total Brain and Other Nervous System Male 0.55 0.41 Female 0.95 Total Breast 0.08 Male 9.66 Female Total 9.75 Cervix Uteri Female

0.51

Colon / Rectum 4.34 Male Female 3.58 Total 7.92 Esophagus 0.65 Male Female 0.17 Total 0.82 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.23 0.18 Female Total 0.41 Kidney & Renal Pelvis Male 1.06 0.58 Female 1.63 Total Larynx Male 0.59 0.13 Female Total 0.72 Leukemia Male 0.84 0.60 Female Total 1.45 Liver and Intrahepatic Bile Ducts Male 0.46 0.16 Female 0.61 Total Lung and Bronchus Male 5.57 Female 4.11 Total 9.68

Obs

SIR

2 1 3

NC* NC* NC*

0 0 0

NC* NC* NC*

0 10 10

NC* 103 103

1

NC*

6 4 10

138 NC* 126

Exp

Obs

SIR

0 2 2

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

2 0 2

NC* NC* NC*

1.12

1

NC*

0.78 0.71 1.48

0 0 0

NC* NC* NC*

11.46

12

105

Male Female Total

0.76 0.39 1.15

0 0 0

NC* NC* NC*

Male

0.32

0

NC*

Male 0.23 0.60 Female Total 0.84 Uteri, Corpus and Uterus, NOS

0 2 2

NC* NC* NC*

1.86

1

NC*

36.04 30.13 66.17

33 28 61

92 93 92

Melanoma of Skin 1.23 Male Female 0.84 2.07 Total Multiple Myeloma Male 0.35 0.28 Female 0.63 Total Non-Hodgkin('s) Lymphoma 1.38 Male 1.10 Female Total 2.49 Oral Cavity & Pharynx 1.12 Male Female 0.47 Total 1.59 Ovary Female Pancreas

1 0 1

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

Thyroid

5 4 9

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

90 NC* 93

38

Bernardston

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.65 Male Female 0.56 2.21 Total Brain and Other Nervous System Male 0.49 0.38 Female 0.87 Total Breast 0.08 Male 9.30 Female Total 9.38 Cervix Uteri Female

0.47

Colon / Rectum 4.10 Male Female 3.69 Total 7.80 Esophagus 0.59 Male Female 0.17 Total 0.77 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.20 0.16 Female Total 0.36 Kidney & Renal Pelvis Male 0.97 0.55 Female 1.52 Total Larynx Male 0.52 0.13 Female Total 0.65 Leukemia Male 0.79 0.59 Female Total 1.38 Liver and Intrahepatic Bile Ducts Male 0.42 0.16 Female 0.57 Total Lung and Bronchus Male 5.17 Female 3.96 Total 9.14

Obs

SIR

1 3 4

NC* NC* NC*

1 0 1

NC* NC* NC*

0 7 7

NC* 75 75

0

NC*

2 6 8

NC* 162 103

Exp

Obs

SIR

1 3 4

NC* NC* NC*

0 0 0

NC* NC* NC*

3 1 4

NC* NC* NC*

1 0 1

NC* NC* NC*

1.06

0

NC*

0.73 0.72 1.45

0 0 0

NC* NC* NC*

10.31

9

87

Male Female Total

0.71 0.40 1.12

0 0 0

NC* NC* NC*

Male

0.28

0

NC*

Male 0.20 0.54 Female Total 0.74 Uteri, Corpus and Uterus, NOS

0 2 2

NC* NC* NC*

1.78

3

NC*

33.15 29.42 62.57

25 29 54

75 99 86

Melanoma of Skin 1.12 Male Female 0.80 1.92 Total Multiple Myeloma Male 0.33 0.28 Female 0.61 Total Non-Hodgkin('s) Lymphoma 1.28 Male 1.08 Female Total 2.36 Oral Cavity & Pharynx 0.99 Male Female 0.46 Total 1.45 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

3 0 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

Thyroid

3 1 4

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

39

Beverly

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 26.34 Male Female 10.55 36.89 Total Brain and Other Nervous System Male 8.51 7.49 Female 16.00 Total Breast 1.32 Male 172.80 Female Total 174.12 Cervix Uteri Female

9.23

Colon / Rectum 66.28 Male Female 69.08 Total 135.36 Esophagus 9.76 Male Female 3.26 Total 13.02 Hodgkin's Disease (Hodgkin Lymphoma) Male 3.80 3.46 Female Total 7.26 Kidney & Renal Pelvis Male 16.05 10.44 Female 26.49 Total Larynx Male 8.76 2.34 Female Total 11.11 Leukemia Male 13.10 11.19 Female Total 24.29 Liver and Intrahepatic Bile Ducts Male 6.91 2.96 Female 9.87 Total Lung and Bronchus Male 85.54 Female 74.95 Total 160.48

Obs

SIR

32 11 43

122 104 117

16 4 20

188 #+ NC* 125

0 189 189

NC* 109 109

9

98

69 71 140

104 103 103

Exp

Obs

SIR

25 25 50

133 163 #+ 146 #+

8 3 11

148 NC* 104

22 22 44

103 106 105

10 12 22

61 139 88

20.08

15

75

11.77 13.47 25.24

10 15 25

85 111 99

172.72

163

94

Male Female Total

11.40 7.48 18.88

8 5 13

70 67 69

Male

5.94

8

135

Male 3.67 11.07 Female Total 14.74 Uteri, Corpus and Uterus, NOS

3 5 8

NC* 45 54

32.78

26

79

549.76 552.95 1102.71

541 576 1117

98 104 101

Melanoma of Skin 18.79 Male Female 15.35 34.14 Total Multiple Myeloma Male 5.42 5.20 Female 10.61 Total Non-Hodgkin('s) Lymphoma 21.40 Male 20.66 Female Total 42.05 Oral Cavity & Pharynx 16.51 Male Female 8.62 Total 25.14 Ovary Female Pancreas

5 2 7

51 NC* 54

4 1 5

NC* NC* 69

22 9 31

137 86 117

Male Female Total Prostate Male

Stomach

Testis 5 4 9

57 NC* 81

12 9 21

92 80 86

4 3 7

NC* NC* 71

Thyroid

78 91 169

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

91 121 105

40

Billerica

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 16.57 Male Female 5.81 22.38 Total Brain and Other Nervous System Male 7.15 5.43 Female 12.58 Total Breast 0.91 Male 122.50 Female Total 123.41 Cervix Uteri Female

7.50

Colon / Rectum 42.88 Male Female 37.79 Total 80.67 Esophagus 6.89 Male Female 1.80 Total 8.68 Hodgkin's Disease (Hodgkin Lymphoma) Male 3.78 2.89 Female Total 6.67 Kidney & Renal Pelvis Male 11.91 6.80 Female 18.71 Total Larynx Male 6.49 1.57 Female Total 8.05 Leukemia Male 9.81 7.33 Female Total 17.14 Liver and Intrahepatic Bile Ducts Male 5.15 1.68 Female 6.83 Total Lung and Bronchus Male 56.94 Female 46.13 Total 103.06

Obs

SIR

15 5 20

91 86 89

4 6 10

NC* 111 80

0 141 141

NC* 115 114

7

93

58 45 103

135 #+ 119 128 #+

Exp

Obs

SIR

14 12 26

95 105 100

4 7 11

NC* 227 163

20 11 31

124 85 107

15 7 22

116 124 118

14.27

17

119

7.91 7.30 15.21

7 5 12

89 68 79

118.30

141

119 #+

Male Female Total

7.52 4.05 11.57

4 3 7

NC* NC* 61

Male

6.40

5

78

Male 3.38 9.52 Female Total 12.90 Uteri, Corpus and Uterus, NOS

2 15 17

NC* 157 132

22.99

22

96

384.52 362.52 747.04

442 405 847

115 ~+ 112 #+ 113 ^+

Melanoma of Skin 14.67 Male Female 11.39 26.06 Total Multiple Myeloma Male 3.66 3.08 Female 6.74 Total Non-Hodgkin('s) Lymphoma 16.14 Male 12.91 Female Total 29.06 Oral Cavity & Pharynx 12.97 Male Female 5.66 Total 18.63 Ovary Female Pancreas

9 1 10

131 NC* 115

5 2 7

132 NC* 105

12 7 19

101 103 102

Male Female Total Prostate Male

Stomach

Testis 5 3 8

77 NC* 99

8 9 17

82 123 99

4 4 8

NC* NC* 117

Thyroid

77 57 134

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

135 #+ 124 130 ~+

41

Blackstone

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.57 Male Female 1.75 6.32 Total Brain and Other Nervous System Male 1.72 1.43 Female 3.16 Total Breast 0.23 Male 31.96 Female Total 32.19 Cervix Uteri Female

1.87

Colon / Rectum 11.59 Male Female 11.54 Total 23.12 Esophagus 1.75 Male Female 0.54 Total 2.29 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.87 0.73 Female Total 1.60 Kidney & Renal Pelvis Male 2.98 1.85 Female 4.83 Total Larynx Male 1.59 0.41 Female Total 2.01 Leukemia Male 2.51 2.03 Female Total 4.55 Liver and Intrahepatic Bile Ducts Male 1.28 0.50 Female 1.78 Total Lung and Bronchus Male 14.78 Female 12.92 Total 27.71

Obs

SIR

2 1 3

NC* NC* NC*

0 1 1

NC* NC* NC*

0 34 34

NC* 106 106

3

NC*

12 11 23

104 95 99

Exp

Obs

SIR

1 1 2

NC* NC* NC*

2 0 2

NC* NC* NC*

3 6 9

NC* 165 116

2 0 2

NC* NC* NC*

3.73

6

161

2.09 2.23 4.32

1 4 5

NC* NC* 116

29.93

18

60 #-

Male Female Total

2.04 1.24 3.28

5 2 7

245 NC* 213

Male

1.45

1

NC*

Male 0.78 2.32 Female Total 3.11 Uteri, Corpus and Uterus, NOS

1 1 2

NC* NC* NC*

5.99

2

NC*

98.65 99.10 197.75

87 91 178

88 92 90

Melanoma of Skin 3.62 Male Female 2.95 6.57 Total Multiple Myeloma Male 0.96 0.89 Female 1.85 Total Non-Hodgkin('s) Lymphoma 4.09 Male 3.64 Female Total 7.73 Oral Cavity & Pharynx 3.16 Male Female 1.54 Total 4.70 Ovary Female Pancreas

0 1 1

NC* NC* NC*

1 0 1

NC* NC* NC*

2 0 2

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 2 1 3

NC* NC* NC*

6 1 7

239 NC* 154

1 0 1

NC* NC* NC*

Thyroid

18 10 28

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

122 77 101

42

Blandford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.86 Male Female 0.23 1.09 Total Brain and Other Nervous System Male 0.29 0.19 Female 0.48 Total Breast 0.04 Male 4.81 Female Total 4.86 Cervix Uteri Female

0.26

Colon / Rectum 2.19 Male Female 1.49 Total 3.68 Esophagus 0.35 Male Female 0.07 Total 0.42 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.11 0.09 Female Total 0.20 Kidney & Renal Pelvis Male 0.57 0.27 Female 0.84 Total Larynx Male 0.32 0.07 Female Total 0.39 Leukemia Male 0.43 0.27 Female Total 0.70 Liver and Intrahepatic Bile Ducts Male 0.25 0.07 Female 0.31 Total Lung and Bronchus Male 2.91 Female 1.94 Total 4.85

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 2 2

NC* NC* NC*

0

NC*

1 2 3

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0.55

0

NC*

0.40 0.29 0.69

0 1 1

NC* NC* NC*

6.10

4

NC*

Male Female Total

0.38 0.15 0.53

0 1 1

NC* NC* NC*

Male

0.15

1

NC*

Male 0.12 0.31 Female Total 0.44 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.94

1

NC*

18.80 14.17 32.97

12 12 24

64 85 73

Melanoma of Skin 0.65 Male Female 0.41 1.06 Total Multiple Myeloma Male 0.19 0.13 Female 0.31 Total Non-Hodgkin('s) Lymphoma 0.72 Male 0.50 Female Total 1.22 Oral Cavity & Pharynx 0.61 Male Female 0.22 Total 0.83 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

1 1 2

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

43

Bolton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.32 Male Female 0.68 3.01 Total Brain and Other Nervous System Male 0.93 0.65 Female 1.58 Total Breast 0.13 Male 16.64 Female Total 16.77 Cervix Uteri Female

0.89

Colon / Rectum 6.02 Male Female 4.42 Total 10.44 Esophagus 1.02 Male Female 0.21 Total 1.24 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.40 0.29 Female Total 0.69 Kidney & Renal Pelvis Male 1.74 0.88 Female 2.62 Total Larynx Male 0.98 0.22 Female Total 1.20 Leukemia Male 1.31 0.88 Female Total 2.19 Liver and Intrahepatic Bile Ducts Male 0.76 0.20 Female 0.96 Total Lung and Bronchus Male 8.18 Female 5.99 Total 14.17

Obs

SIR

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 16 16

NC* 96 95

1

NC*

2 6 8

NC* 136 77

Exp

Obs

SIR

1 2 3

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

2 0 2

NC* NC* NC*

1.86

5

269

1.14 0.85 1.99

1 0 1

NC* NC* NC*

17.63

12

68

Male Female Total

1.07 0.46 1.53

2 0 2

NC* NC* NC*

Male

0.56

0

NC*

Male 0.43 1.09 Female Total 1.52 Uteri, Corpus and Uterus, NOS

1 1 2

NC* NC* NC*

3.25

6

184

54.65 46.45 101.10

33 47 80

60 ~101 79 #-

Melanoma of Skin 2.04 Male Female 1.40 3.45 Total Multiple Myeloma Male 0.53 0.39 Female 0.92 Total Non-Hodgkin('s) Lymphoma 2.17 Male 1.55 Female Total 3.72 Oral Cavity & Pharynx 1.95 Male Female 0.74 Total 2.69 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

9 7 16

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

110 117 113

44

Boston

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 262.42 Male Female 112.67 375.09 Total Brain and Other Nervous System Male 98.16 88.71 Female 186.87 Total Breast 13.18 Male 1899.53 Female Total 1912.71 Cervix Uteri Female

121.24

Obs

SIR

204 101 305

78 ^90 81 ^-

88 68 156

90 77 #83 #-

15 1773 1788

114 93 ~93 ~-

155

128 ~+

Colon / Rectum 662.57 697 Male Female 741.76 839 Total 1404.33 1536 Esophagus 94.90 109 Male Female 34.72 38 Total 129.62 147 Hodgkin's Disease (Hodgkin Lymphoma) Male 55.69 48 49.92 52 Female Total 105.61 100 Kidney & Renal Pelvis Male 163.01 182 112.18 122 Female 275.18 304 Total Larynx Male 84.80 128 23.77 37 Female Total 108.58 165 Leukemia Male 143.27 142 126.78 114 Female Total 270.05 256 Liver and Intrahepatic Bile Ducts Male 69.44 120 31.80 47 Female 101.24 167 Total Lung and Bronchus Male 826.73 945 Female 774.83 857 Total 1601.56 1802

Note: Explanation of all symbols is on page 361

Exp

Obs

SIR

188 155 343

92 83 #88 #-

59 57 116

110 104 107

270 244 514

114 #+ 106 110 #+

223 126 349

132 ^+ 135 ~+ 133 ^+

227.07

214

94

117.33 143.10 260.43

127 146 273

108 102 105

1620.74

1947

120 ^+

Male Female Total

116.35 82.18 198.53

189 114 303

162 ^+ 139 ~+ 153 ^+

Male

102.07

84

82

Male 46.50 154.26 Female Total 200.76 Uteri, Corpus and Uterus, NOS

44 159 203

95 103 101

343.78

348

101

5529.06 6081.53 11610.59

6328 6279 12607

114 ^+ 103 #+ 109 ^+

Melanoma of Skin 205.10 Male Female 186.59 391.69 Total Multiple Myeloma Male 53.46 54.79 Female 108.24 Total Non-Hodgkin('s) Lymphoma 236.39 Male 229.46 Female Total 465.85 Oral Cavity & Pharynx 168.69 Male Female 93.40 Total 262.09 Ovary

105 113 ^+ 109 ^+

Female Pancreas

115 109 113

Male Female Total Prostate Male

86 104 95

Stomach 112 109 110 Testis 151 ^+ 156 #+ 152 ^+ Thyroid 99 90 95 173 ^+ 148 #+ 165 ^+

Female All Sites / Types Male Female Total

114 ^+ 111 ~+ 113 ^+

45

Bourne

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 13.34 Male Female 4.51 17.85 Total Brain and Other Nervous System Male 3.92 3.06 Female 6.98 Total Breast 0.64 Male 70.49 Female Total 71.13 Cervix Uteri Female

3.57

Colon / Rectum 33.17 Male Female 29.60 Total 62.77 Esophagus 4.66 Male Female 1.40 Total 6.05 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.66 1.33 Female Total 2.99 Kidney & Renal Pelvis Male 7.55 4.35 Female 11.90 Total Larynx Male 4.07 0.98 Female Total 5.05 Leukemia Male 6.36 4.67 Female Total 11.03 Liver and Intrahepatic Bile Ducts Male 3.23 1.26 Female 4.50 Total Lung and Bronchus Male 41.87 Female 31.68 Total 73.55

Obs

SIR

15 8 23

112 177 129

5 1 6

128 NC* 86

0 79 79

NC* 112 111

4

NC*

42 41 83

127 139 132 #+

Exp

Obs

SIR

13 11 24

149 179 162 #+

2 4 6

NC* NC* 124

6 12 18

59 139 96

7 5 12

93 140 108

8.17

6

73

5.79 5.79 11.58

3 5 8

NC* 86 69

82.94

110

133 ~+

Male Female Total

5.69 3.19 8.88

7 4 11

123 NC* 124

Male

2.53

0

NC*

Male 1.59 4.19 Female Total 5.78 Uteri, Corpus and Uterus, NOS

2 7 9

NC* 167 156

13.48

20

148

265.75 229.38 495.13

310 294 604

117 ~+ 128 ^+ 122 ^+

Melanoma of Skin 8.72 Male Female 6.13 14.85 Total Multiple Myeloma Male 2.65 2.20 Female 4.85 Total Non-Hodgkin('s) Lymphoma 10.18 Male 8.66 Female Total 18.84 Oral Cavity & Pharynx 7.54 Male Female 3.58 Total 11.12 Ovary Female Pancreas

14 0 14

301 ^+ NC* 231 ~+

1 3 4

NC* NC* NC*

8 5 13

106 115 109

Male Female Total Prostate Male

Stomach

Testis 4 0 4

NC* NC* NC*

9 4 13

142 NC* 118

8 2 10

247 #+ NC* 222 #+

Thyroid

41 50 91

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

98 158 ~+ 124

46

Boxborough

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.70 Male Female 0.52 2.22 Total Brain and Other Nervous System Male 0.84 0.59 Female 1.43 Total Breast 0.10 Male 13.67 Female Total 13.77 Cervix Uteri Female

0.92

Colon / Rectum 4.47 Male Female 3.32 Total 7.79 Esophagus 0.76 Male Female 0.16 Total 0.92 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.46 0.35 Female Total 0.81 Kidney & Renal Pelvis Male 1.36 0.71 Female 2.06 Total Larynx Male 0.74 0.17 Female Total 0.91 Leukemia Male 1.09 0.75 Female Total 1.84 Liver and Intrahepatic Bile Ducts Male 0.59 0.15 Female 0.74 Total Lung and Bronchus Male 6.02 Female 4.56 Total 10.57

Obs

SIR

0 1 1

NC* NC* NC*

0 1 1

NC* NC* NC*

0 19 19

NC* 139 138

0

NC*

7 2 9

157 NC* 116

Exp

Obs

SIR

1 1 2

NC* NC* NC*

1 0 1

NC* NC* NC*

3 0 3

NC* NC* NC*

0 1 1

NC* NC* NC*

1.59

2

NC*

0.85 0.64 1.49

0 1 1

NC* NC* NC*

12.75

10

78

Male Female Total

0.80 0.36 1.16

0 0 0

NC* NC* NC*

Male

0.79

0

NC*

Male 0.41 1.20 Female Total 1.61 Uteri, Corpus and Uterus, NOS

2 3 5

NC* NC* 310 #+

2.54

2

NC*

41.93 37.97 79.89

30 36 66

72 95 83

Melanoma of Skin 1.71 Male Female 1.31 3.02 Total Multiple Myeloma Male 0.39 0.30 Female 0.69 Total Non-Hodgkin('s) Lymphoma 1.83 Male 1.29 Female Total 3.12 Oral Cavity & Pharynx 1.53 Male Female 0.59 Total 2.12 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

3 2 5

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* 47

47

Boxford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 5.11 Male Female 1.60 6.71 Total Brain and Other Nervous System Male 1.96 1.42 Female 3.37 Total Breast 0.28 Male 36.36 Female Total 36.64 Cervix Uteri Female

1.90

Colon / Rectum 13.21 Male Female 10.33 Total 23.54 Esophagus 2.21 Male Female 0.50 Total 2.71 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.82 0.62 Female Total 1.44 Kidney & Renal Pelvis Male 3.70 1.97 Female 5.67 Total Larynx Male 2.11 0.49 Female Total 2.60 Leukemia Male 2.77 1.97 Female Total 4.74 Liver and Intrahepatic Bile Ducts Male 1.61 0.46 Female 2.08 Total Lung and Bronchus Male 17.97 Female 13.64 Total 31.61

Obs

SIR

2 0 2

NC* NC* NC*

2 1 3

NC* NC* NC*

0 35 35

NC* 96 96

1

NC*

9 6 15

68 58 64

Exp

Obs

SIR

7 4 11

163 NC* 150

0 0 0

NC* NC* NC*

4 1 5

NC* NC* 62

4 2 6

NC* NC* 104

4.08

4

NC*

2.48 2.01 4.49

0 2 2

NC* NC* NC*

38.68

28

72

Male Female Total

2.31 1.08 3.40

0 1 1

NC* NC* NC*

Male

1.13

2

NC*

Male 0.88 2.29 Female Total 3.17 Uteri, Corpus and Uterus, NOS

0 3 3

NC* NC* NC*

7.13

6

84

118.56 103.50 222.06

73 85 158

62 ^82 71 ^-

Melanoma of Skin 4.30 Male Female 3.04 7.35 Total Multiple Myeloma Male 1.15 0.89 Female 2.04 Total Non-Hodgkin('s) Lymphoma 4.61 Male 3.51 Female Total 8.12 Oral Cavity & Pharynx 4.10 Male Female 1.65 Total 5.75 Ovary Female Pancreas

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

1 2 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

2 1 3

NC* NC* NC*

2 1 3

NC* NC* NC*

Thyroid

6 10 16

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

33 ~73 51 ~-

48

Boylston

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.42 Male Female 0.79 3.21 Total Brain and Other Nervous System Male 0.84 0.62 Female 1.46 Total Breast 0.12 Male 14.94 Female Total 15.06 Cervix Uteri Female

0.80

Colon / Rectum 6.14 Male Female 5.14 Total 11.28 Esophagus 0.95 Male Female 0.24 Total 1.19 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.37 0.28 Female Total 0.66 Kidney & Renal Pelvis Male 1.58 0.86 Female 2.44 Total Larynx Male 0.87 0.20 Female Total 1.07 Leukemia Male 1.25 0.88 Female Total 2.13 Liver and Intrahepatic Bile Ducts Male 0.68 0.22 Female 0.91 Total Lung and Bronchus Male 8.04 Female 6.10 Total 14.14

Obs

SIR

1 0 1

NC* NC* NC*

2 0 2

NC* NC* NC*

0 20 20

NC* 134 133

0

NC*

5 8 13

81 156 115

Exp

Obs

SIR

3 0 3

NC* NC* NC*

0 0 0

NC* NC* NC*

1 1 2

NC* NC* NC*

0 0 0

NC* NC* NC*

1.71

1

NC*

1.11 1.00 2.12

1 1 2

NC* NC* NC*

16.59

20

121

Male Female Total

1.07 0.55 1.61

0 0 0

NC* NC* NC*

Male

0.56

1

NC*

Male 0.37 0.97 Female Total 1.34 Uteri, Corpus and Uterus, NOS

0 4 4

NC* NC* NC*

2.88

7

243

52.42 45.33 97.75

47 51 98

90 113 100

Melanoma of Skin 1.85 Male Female 1.30 3.15 Total Multiple Myeloma Male 0.51 0.41 Female 0.92 Total Non-Hodgkin('s) Lymphoma 2.06 Male 1.63 Female Total 3.69 Oral Cavity & Pharynx 1.67 Male Female 0.71 Total 2.39 Ovary Female Pancreas

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

2 1 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 3 0 3

NC* NC* NC*

0 2 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

4 5 9

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* 82 64

49

Braintree

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 25.37 Male Female 10.06 35.43 Total Brain and Other Nervous System Male 7.67 6.71 Female 14.38 Total Breast 1.24 Male 159.21 Female Total 160.45 Cervix Uteri Female

8.09

Colon / Rectum 63.47 Male Female 65.67 Total 129.14 Esophagus 9.14 Male Female 3.10 Total 12.24 Hodgkin's Disease (Hodgkin Lymphoma) Male 3.30 2.93 Female Total 6.24 Kidney & Renal Pelvis Male 14.85 9.75 Female 24.60 Total Larynx Male 8.09 2.21 Female Total 10.30 Leukemia Male 12.17 10.28 Female Total 22.45 Liver and Intrahepatic Bile Ducts Male 6.39 2.80 Female 9.19 Total Lung and Bronchus Male 81.07 Female 70.79 Total 151.86

Obs

SIR

31 12 43

122 119 121

3 7 10

NC* 104 70

0 169 169

NC* 106 105

10

124

78 84 162

123 128 #+ 125 ~+

Exp

Obs

SIR

27 25 52

157 #+ 181 ~+ 167 ^+

5 3 8

98 NC* 80

15 21 36

76 109 92

13 9 22

86 112 95

18.41

17

92

11.17 12.86 24.04

14 11 25

125 86 104

162.41

164

101

Male Female Total

10.90 7.13 18.03

12 5 17

110 70 94

Male

5.08

5

98

Male 3.24 9.48 Female Total 12.72 Uteri, Corpus and Uterus, NOS

2 6 8

NC* 63 63

30.46

35

115

516.64 513.92 1030.56

551 565 1116

107 110 #+ 108 ~+

Melanoma of Skin 17.24 Male Female 13.83 31.07 Total Multiple Myeloma Male 5.13 4.92 Female 10.05 Total Non-Hodgkin('s) Lymphoma 19.84 Male 19.24 Female Total 39.08 Oral Cavity & Pharynx 15.08 Male Female 8.03 Total 23.11 Ovary Female Pancreas

14 4 18

153 NC* 147

3 6 9

NC* 204 144

17 4 21

114 NC* 85

Male Female Total Prostate Male

Stomach

Testis 8 1 9

99 NC* 87

8 16 24

66 156 107

11 0 11

172 NC* 120

Thyroid

94 84 178

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

116 119 117 #+

50

Brewster

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 11.71 Male Female 3.44 15.15 Total Brain and Other Nervous System Male 2.83 2.18 Female 5.01 Total Breast 0.53 Male 52.72 Female Total 53.25 Cervix Uteri Female

2.43

Colon / Rectum 28.64 Male Female 22.53 Total 51.17 Esophagus 3.85 Male Female 1.07 Total 4.91 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.96 0.84 Female Total 1.80 Kidney & Renal Pelvis Male 6.13 3.31 Female 9.44 Total Larynx Male 3.28 0.76 Female Total 4.04 Leukemia Male 5.08 3.38 Female Total 8.46 Liver and Intrahepatic Bile Ducts Male 2.61 0.96 Female 3.57 Total Lung and Bronchus Male 35.11 Female 24.68 Total 59.78

Obs

SIR

12 3 15

102 NC* 99

0 2 2

NC* NC* NC*

2 87 89

NC* 165 ^+ 167 ^+

2

NC*

22 8 30

77 36 ^59 ~-

Exp

Obs

SIR

13 9 22

190 #+ 206 196 ~+

2 0 2

NC* NC* NC*

5 5 10

61 77 68

8 1 9

135 NC* 104

6.04

9

149

4.95 4.44 9.38

4 5 9

NC* 113 96

68.09

83

122

Male Female Total

4.95 2.39 7.34

4 1 5

NC* NC* 68

Male

1.20

0

NC*

Male 1.05 2.74 Female Total 3.79 Uteri, Corpus and Uterus, NOS

1 1 2

NC* NC* NC*

10.29

8

78

218.84 172.17 391.00

213 193 406

97 112 104

Melanoma of Skin 6.85 Male Female 4.37 11.22 Total Multiple Myeloma Male 2.26 1.69 Female 3.95 Total Non-Hodgkin('s) Lymphoma 8.13 Male 6.51 Female Total 14.64 Oral Cavity & Pharynx 5.95 Male Female 2.70 Total 8.65 Ovary Female Pancreas

1 4 5

NC* NC* 102

0 0 0

NC* NC* NC*

5 3 8

82 NC* 85

Male Female Total Prostate Male

Stomach

Testis 3 0 3

NC* NC* NC*

8 1 9

157 NC* 106

1 1 2

NC* NC* NC*

Thyroid

27 30 57

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

77 122 95

51

Bridgewater

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 11.40 Male Female 3.77 15.18 Total Brain and Other Nervous System Male 5.07 3.38 Female 8.46 Total Breast 0.64 Male 74.91 Female Total 75.55 Cervix Uteri Female

4.60

Colon / Rectum 29.64 Male Female 24.65 Total 54.29 Esophagus 4.80 Male Female 1.17 Total 5.97 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.85 1.81 Female Total 4.66 Kidney & Renal Pelvis Male 8.43 4.22 Female 12.65 Total Larynx Male 4.56 0.95 Female Total 5.51 Leukemia Male 6.82 4.68 Female Total 11.50 Liver and Intrahepatic Bile Ducts Male 3.63 1.08 Female 4.72 Total Lung and Bronchus Male 39.20 Female 28.63 Total 67.83

Obs

SIR

12 4 16

105 NC* 105

5 4 9

99 NC* 106

0 88 88

NC* 117 116

8

174

24 14 38

81 57 #70 #-

Exp

Obs

SIR

10 8 18

94 114 102

3 3 6

NC* NC* 133

8 10 18

69 123 91

3 1 4

NC* NC* NC*

8.77

11

125

5.51 4.75 10.26

1 9 10

NC* 189 97

81.23

80

98

Male Female Total

5.25 2.68 7.93

3 2 5

NC* NC* 63

Male

5.06

7

138

Male 2.54 5.83 Female Total 8.37 Uteri, Corpus and Uterus, NOS

2 9 11

NC* 154 131

13.95

13

93

268.37 226.06 494.43

239 233 472

89 103 95

Melanoma of Skin 10.62 Male Female 7.04 17.65 Total Multiple Myeloma Male 2.55 1.95 Female 4.50 Total Non-Hodgkin('s) Lymphoma 11.58 Male 8.15 Female Total 19.74 Oral Cavity & Pharynx 9.28 Male Female 3.52 Total 12.80 Ovary Female Pancreas

5 1 6

104 NC* 100

1 1 2

NC* NC* NC*

12 7 19

142 166 150

Male Female Total Prostate Male

Stomach

Testis 4 0 4

NC* NC* NC*

5 5 10

73 107 87

5 1 6

138 NC* 127

Thyroid

37 22 59

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

94 77 87

52

Brimfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.24 Male Female 0.76 3.01 Total Brain and Other Nervous System Male 0.74 0.56 Female 1.30 Total Breast 0.11 Male 13.69 Female Total 13.80 Cervix Uteri Female

0.71

Colon / Rectum 5.66 Male Female 4.96 Total 10.62 Esophagus 0.86 Male Female 0.24 Total 1.09 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.31 0.25 Female Total 0.56 Kidney & Renal Pelvis Male 1.40 0.79 Female 2.20 Total Larynx Male 0.78 0.18 Female Total 0.96 Leukemia Male 1.13 0.85 Female Total 1.98 Liver and Intrahepatic Bile Ducts Male 0.61 0.21 Female 0.82 Total Lung and Bronchus Male 7.21 Female 5.57 Total 12.78

Obs

SIR

3 3 6

NC* NC* 200

0 0 0

NC* NC* NC*

0 16 16

NC* 117 116

1

NC*

3 5 8

NC* 101 75

Exp

Obs

SIR

0 3 3

NC* NC* NC*

0 0 0

NC* NC* NC*

1 2 3

NC* NC* NC*

2 0 2

NC* NC* NC*

1.56

0

NC*

1.03 0.96 1.99

1 1 2

NC* NC* NC*

14.90

8

54

Male Female Total

1.00 0.54 1.55

1 1 2

NC* NC* NC*

Male

0.44

0

NC*

Male 0.32 0.84 Female Total 1.16 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

2.63

2

NC*

47.25 42.05 89.30

34 53 87

72 126 97

Melanoma of Skin 1.64 Male Female 1.18 2.82 Total Multiple Myeloma Male 0.46 0.39 Female 0.85 Total Non-Hodgkin('s) Lymphoma 1.84 Male 1.51 Female Total 3.35 Oral Cavity & Pharynx 1.51 Male Female 0.66 Total 2.17 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

1 2 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

3 2 5

NC* NC* 252

0 1 1

NC* NC* NC*

Thyroid

7 7 14

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

97 126 110

53

Brockton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 53.39 Male Female 22.08 75.46 Total Brain and Other Nervous System Male 17.66 15.85 Female 33.50 Total Breast 2.60 Male 352.78 Female Total 355.38 Cervix Uteri Female

19.38

Colon / Rectum 133.73 Male Female 144.97 Total 278.70 Esophagus 19.23 Male Female 6.82 Total 26.05 Hodgkin's Disease (Hodgkin Lymphoma) Male 8.22 7.57 Female Total 15.79 Kidney & Renal Pelvis Male 31.80 21.34 Female 53.14 Total Larynx Male 17.06 4.66 Female Total 21.71 Leukemia Male 27.29 23.99 Female Total 51.28 Liver and Intrahepatic Bile Ducts Male 13.64 6.18 Female 19.82 Total Lung and Bronchus Male 168.63 Female 151.18 Total 319.81

Obs

SIR

71 22 93

133 #+ 100 123

18 13 31

102 82 93

0 292 292

NC* 83 ^82 ^-

31

160 #+

131 118 249

98 81 #89

Exp

Obs

SIR

38 31 69

101 97 99

10 14 24

93 131 112

46 35 81

106 82 94

45 17 62

138 #+ 96 123

41.28

29

70

23.65 28.13 51.78

26 23 49

110 82 95

336.67

344

102

Male Female Total

23.27 15.98 39.24

23 21 44

99 131 112

Male

13.07

16

122

Male 7.49 23.49 Female Total 30.98 Uteri, Corpus and Uterus, NOS

3 25 28

NC* 106 90

66.08

58

88

1095.86 1140.84 2236.70

1218 1044 2262

111 ^+ 92 ~101

Melanoma of Skin 37.69 Male Female 32.05 69.73 Total Multiple Myeloma Male 10.78 10.71 Female 21.48 Total Non-Hodgkin('s) Lymphoma 43.57 Male 42.83 Female Total 86.40 Oral Cavity & Pharynx 32.63 Male Female 17.74 Total 50.36 Ovary Female Pancreas

28 12 40

146 176 154 #+

10 5 15

122 66 95

18 16 34

57 #75 64 ~-

Male Female Total Prostate Male

Stomach

Testis 19 5 24

111 107 111

30 20 50

110 83 98

17 7 24

125 113 121

Thyroid

215 177 392

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

127 ^+ 117 #+ 123 ^+

54

Brookfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.05 Male Female 0.86 2.91 Total Brain and Other Nervous System Male 0.66 0.59 Female 1.26 Total Breast 0.10 Male 13.49 Female Total 13.60 Cervix Uteri Female

0.69

Colon / Rectum 5.12 Male Female 5.67 Total 10.79 Esophagus 0.75 Male Female 0.27 Total 1.02 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.29 0.26 Female Total 0.55 Kidney & Renal Pelvis Male 1.25 0.83 Female 2.08 Total Larynx Male 0.67 0.18 Female Total 0.86 Leukemia Male 1.03 0.90 Female Total 1.94 Liver and Intrahepatic Bile Ducts Male 0.54 0.24 Female 0.78 Total Lung and Bronchus Male 6.56 Female 6.02 Total 12.59

Obs

SIR

4 2 6

NC* NC* 206

1 1 2

NC* NC* NC*

0 18 18

NC* 133 132

1

NC*

4 4 8

NC* NC* 74

Exp

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

3 3 6

NC* NC* 181

1 1 2

NC* NC* NC*

1.57

1

NC*

0.91 1.10 2.01

1 2 3

NC* NC* NC*

13.09

11

84

Male Female Total

0.88 0.61 1.49

3 0 3

NC* NC* NC*

Male

0.44

0

NC*

Male 0.28 0.82 Female Total 1.10 Uteri, Corpus and Uterus, NOS

0 3 3

NC* NC* NC*

2.57

1

NC*

42.24 43.92 86.16

47 49 96

111 112 111

Melanoma of Skin 1.46 Male Female 1.18 2.64 Total Multiple Myeloma Male 0.42 0.42 Female 0.84 Total Non-Hodgkin('s) Lymphoma 1.66 Male 1.66 Female Total 3.32 Oral Cavity & Pharynx 1.28 Male Female 0.68 Total 1.96 Ovary Female Pancreas

4 0 4

NC* NC* NC*

0 0 0

NC* NC* NC*

1 1 2

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

1 2 3

NC* NC* NC*

0 1 1

NC* NC* NC*

Thyroid

8 6 14

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

122 100 111

55

Brookline

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 35.89 Male Female 17.19 53.08 Total Brain and Other Nervous System Male 11.50 11.60 Female 23.10 Total Breast 1.73 Male 273.65 Female Total 275.39 Cervix Uteri Female

15.73

Colon / Rectum 89.94 Male Female 113.36 Total 203.30 Esophagus 12.95 Male Female 5.32 Total 18.27 Hodgkin's Disease (Hodgkin Lymphoma) Male 5.57 5.87 Female Total 11.44 Kidney & Renal Pelvis Male 21.45 16.08 Female 37.53 Total Larynx Male 11.50 3.43 Female Total 14.93 Leukemia Male 17.76 18.02 Female Total 35.79 Liver and Intrahepatic Bile Ducts Male 9.19 4.77 Female 13.96 Total Lung and Bronchus Male 112.19 Female 112.31 Total 224.50

Obs

SIR

33 12 45

92 70 85

12 11 23

104 95 100

3 272 275

NC* 99 100

9

57

88 106 194

98 94 95

Exp

Obs

SIR

30 31 61

116 122 119

5 8 13

69 97 84

41 31 72

139 95 116

21 16 37

94 117 103

31.96

29

91

15.97 21.78 37.76

13 20 33

81 92 87

223.82

224

100

Male Female Total

15.84 12.83 28.67

13 13 26

82 101 91

Male

9.31

5

54

Male 5.23 19.14 Female Total 24.37 Uteri, Corpus and Uterus, NOS

13 32 45

249 ~+ 167 ~+ 185 ^+

50.26

60

119

734.43 880.55 1614.98

689 815 1504

94 93 #93 ~-

Melanoma of Skin 25.84 Male Female 25.45 51.28 Total Multiple Myeloma Male 7.24 8.23 Female 15.47 Total Non-Hodgkin('s) Lymphoma 29.57 Male 32.66 Female Total 62.23 Oral Cavity & Pharynx 22.33 Male Female 13.66 Total 35.98 Ovary Female Pancreas

9 0 9

70 NC* 49 #-

4 8 12

NC* 136 105

22 11 33

103 68 88

Male Female Total Prostate Male

Stomach

Testis 10 1 11

87 NC* 74

22 14 36

124 78 101

6 6 12

65 126 86

Thyroid

65 78 143

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

58 ^69 ^64 ^-

56

Buckland

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.33 Male Female 0.45 1.78 Total Brain and Other Nervous System Male 0.43 0.33 Female 0.76 Total Breast 0.07 Male 7.85 Female Total 7.92 Cervix Uteri Female

0.41

Colon / Rectum 3.34 Male Female 2.96 Total 6.30 Esophagus 0.50 Male Female 0.14 Total 0.63 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.18 0.15 Female Total 0.33 Kidney & Renal Pelvis Male 0.82 0.46 Female 1.28 Total Larynx Male 0.45 0.10 Female Total 0.55 Leukemia Male 0.66 0.49 Female Total 1.16 Liver and Intrahepatic Bile Ducts Male 0.35 0.13 Female 0.48 Total Lung and Bronchus Male 4.28 Female 3.26 Total 7.54

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 9 9

NC* 115 114

0

NC*

4 3 7

NC* NC* 111

Exp

Obs

SIR

0 1 1

NC* NC* NC*

0 1 1

NC* NC* NC*

1 0 1

NC* NC* NC*

1 0 1

NC* NC* NC*

0.90

0

NC*

0.60 0.57 1.17

0 0 0

NC* NC* NC*

8.66

3

NC*

Male Female Total

0.58 0.32 0.90

0 0 0

NC* NC* NC*

Male

0.27

1

NC*

Male 0.18 0.49 Female Total 0.67 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

1.50

1

NC*

27.67 24.45 52.12

19 22 41

69 90 79

Melanoma of Skin 0.95 Male Female 0.68 1.64 Total Multiple Myeloma Male 0.28 0.23 Female 0.50 Total Non-Hodgkin('s) Lymphoma 1.08 Male 0.89 Female Total 1.97 Oral Cavity & Pharynx 0.85 Male Female 0.38 Total 1.23 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

2 3 5

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* 66

57

Burlington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 13.66 Male Female 4.79 18.45 Total Brain and Other Nervous System Male 5.15 4.06 Female 9.21 Total Breast 0.73 Male 95.98 Female Total 96.70 Cervix Uteri Female

5.58

Colon / Rectum 35.23 Male Female 30.62 Total 65.85 Esophagus 5.56 Male Female 1.47 Total 7.03 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.51 2.08 Female Total 4.59 Kidney & Renal Pelvis Male 9.16 5.51 Female 14.67 Total Larynx Male 5.15 1.31 Female Total 6.46 Leukemia Male 7.28 5.54 Female Total 12.82 Liver and Intrahepatic Bile Ducts Male 3.99 1.36 Female 5.36 Total Lung and Bronchus Male 47.40 Female 38.50 Total 85.90

Obs

SIR

14 5 19

102 104 103

4 3 7

NC* NC* 76

1 102 103

NC* 106 107

6

108

37 29 66

105 95 100

Exp

Obs

SIR

16 14 30

146 161 153 #+

2 2 4

NC* NC* NC*

12 11 23

99 106 102

9 6 15

92 133 105

11.17

5

45

6.38 6.06 12.44

6 6 12

94 99 96

99.44

116

117

Male Female Total

6.02 3.28 9.30

10 8 18

166 244 #+ 194 #+

Male

4.13

5

121

Male 2.38 6.95 Female Total 9.33 Uteri, Corpus and Uterus, NOS

4 9 13

NC* 129 139

18.31

13

71

309.44 287.49 596.93

340 275 615

110 96 103

Melanoma of Skin 10.96 Male Female 8.68 19.64 Total Multiple Myeloma Male 2.93 2.53 Female 5.45 Total Non-Hodgkin('s) Lymphoma 12.15 Male 10.34 Female Total 22.49 Oral Cavity & Pharynx 9.83 Male Female 4.50 Total 14.34 Ovary Female Pancreas

4 2 6

NC* NC* 85

3 1 4

NC* NC* NC*

11 1 12

120 NC* 82

Male Female Total Prostate Male

Stomach

Testis 5 3 8

97 NC* 124

11 5 16

151 90 125

3 1 4

NC* NC* NC*

Thyroid

46 28 74

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

97 73 86

58

Cambridge

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

44.50

28

Female

20.10

Total

64.61

Obs

SIR

36.43

37

102

63 #-

Male

19

95

Female

33.31

24

72

47

73 #-

Total

69.74

61

87

9.22

11

119

Multiple Myeloma

Brain and Other Nervous System Male

Exp Melanoma of Skin

17.17

16

93

Male

Female

15.37

15

98

Female

9.83

9

92

Total

32.54

31

95

Total

19.05

20

105

Non-Hodgkin('s) Lymphoma

Breast Male

2.29

3

NC*

Male

41.41

23

56 ~-

Female

344.30

329

96

Female

40.61

36

89

Total

346.59

332

96

Total

82.02

59

72 ~-

Oral Cavity & Pharynx

Cervix Uteri Female

21.57

16

74

Male

30.14

26

86

Female

16.80

14

83

Total

46.94

40

85

Female

40.77

42

103

Ovary

Colon / Rectum Male

113.06

100

88

Female

132.41

104

79 #-

Total

245.47

204

83 ~Pancreas

Esophagus Male

16.56

15

91

Male

20.20

20

99

Female

6.21

5

81

Female

25.48

26

102

Total

22.77

20

88

Total

45.68

46

101

Male

281.05

312

111

19.94

19

95

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

10.00

11

110

Female

8.52

6

70

Total

18.52

17

92

Kidney & Renal Pelvis Male

Stomach 28.66

27

94

Male

Female

20.02

16

80

Female

14.73

16

109

Total

48.68

43

88

Total

34.66

35

101

Male

18.63

11

59

Testis

Larynx Male

14.99

16

107

Female

4.29

4

NC*

Total

19.28

20

104

Male

24.53

20

82

Male

8.47

11

130

Female

22.21

21

95

Female

27.18

31

114

Total

46.73

41

88

Total

35.66

42

118

62.61

57

91

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

12.23

10

82

Female

5.66

7

124

Total

17.88

17

95

Female All Sites / Types

Lung and Bronchus Male

142.19

124

87

Male

958.42

903

94

Female

138.29

106

77 ~-

Female

1090.29

982

90 ^-

Total

280.47

230

82 ~-

Total

2048.71

1885

92 ^-

Exp

Obs

SIR

Canton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

12.17

14

115

Male

9.29

7

75

Female

4.73

9

190

Female

7.49

7

93

Total

16.90

23

136

Total

16.77

14

83

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

4.26

4

NC*

Male

2.59

2

NC*

Female

3.61

5

138

Female

2.42

3

NC*

Total

7.87

9

114

Total

5.01

5

100

8

77

Non-Hodgkin('s) Lymphoma

Breast Male

0.64

0

NC*

Male

10.36

Female

85.22

95

111

Female

9.69

16

165

Total

85.86

95

111

Total

20.05

24

120

8.31

4

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

4.60

3

NC*

Female

4.13

3

NC*

Total

12.44

7

56

Female

9.85

12

122

Ovary

Colon / Rectum Male

31.02

43

139 #+

Female

30.73

54

176 ^+

Total

61.76

97

157 ^+ Pancreas

Esophagus Male

4.79

6

125

Male

5.58

8

143

Female

1.46

6

411 ~+

Female

6.03

10

166

Total

6.25

12

192

Total

11.61

18

155

Male

85.17

108

127 #+

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.94

5

258

Female

1.68

2

NC*

Total

3.62

7

194

Kidney & Renal Pelvis

Stomach

Male

7.92

11

139

Male

5.30

1

NC*

Female

5.04

6

119

Female

3.25

3

NC*

Total

12.95

17

131

Total

8.55

4

NC*

Male

3.03

1

NC*

159

Male

1.89

1

NC*

Larynx

Testis Male

4.40

3

NC*

Female

1.18

1

NC*

Total

5.57

4

NC*

Leukemia

Thyroid Male

6.28

10

Female

5.15

11

214 #+

Female

5.56

9

162

Total

11.43

21

184 #+

Total

7.45

10

134

12

73

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.43

3

NC*

Female

1.34

0

NC*

Total

4.77

3

NC*

Lung and Bronchus

Female All Sites / Types

16.36

Male

41.29

40

97

Male

266.46

288

108

Female

36.10

47

130

Female

263.83

338

128 ^+

Total

77.39

87

112

Total

530.30

626

118 ^+

Exp

Obs

SIR

Carlisle

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

3.03

0

NC*

Male

2.42

1

NC*

Female

0.87

0

NC*

Female

1.65

3

NC*

Total

3.91

0

NC*

Total

4.07

4

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

1.08

3

NC*

Male

0.67

0

NC*

Female

0.75

1

NC*

Female

0.49

0

NC*

Total

1.83

4

NC*

Total

1.16

0

NC*

Male

0.16

0

NC*

Male

2.60

2

NC*

Female

20.01

17

85

Female

1.90

1

NC*

Total

20.17

17

84

Total

4.50

3

NC*

Male

2.34

2

NC*

Female

0.91

0

NC*

Total

3.24

2

NC*

Female

2.23

2

NC*

1.45

2

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 1.03

0

NC*

Colon / Rectum

Ovary

Male

7.80

1

NC*

Female

5.59

2

NC*

Total

13.39

3

NC*

Esophagus Male

Pancreas 1.29

0

NC*

Male

Female

0.27

0

NC*

Female

1.09

1

NC*

Total

1.56

0

NC*

Total

2.55

3

NC*

Male

22.84

14

61

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.41

0

NC*

Female

0.32

2

NC*

Total

0.73

2

NC* Stomach

Kidney & Renal Pelvis Male

2.11

1

NC*

Male

1.36

1

NC*

Female

1.08

1

NC*

Female

0.59

0

NC*

Total

3.20

2

NC*

Total

1.95

1

NC*

Male

1.22

0

NC*

Male

0.51

1

NC*

Female

0.27

0

NC*

Total

1.49

0

NC*

Male

1.57

1

NC*

Male

0.47

0

NC*

Female

1.06

1

NC*

Female

1.22

2

NC*

Total

2.62

2

NC*

Total

1.70

2

NC*

2

NC*

Larynx

Testis

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.93

0

NC*

Female

0.25

0

NC*

Female

3.95

Total

1.18

0

NC*

Lung and Bronchus Male

All Sites / Types 10.58

1

NC*

Male

68.95

36

52 ^-

Female

7.50

3

NC*

Female

56.58

39

69 #-

Total

18.08

4

NC*

Total

125.53

75

60 ^-

Exp

Obs

SIR

Carver

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

7.68

12

156

Male

5.42

5

92

Female

2.89

5

173

Female

4.19

7

167

Total

10.57

17

161

Total

9.61

12

125

1.57

2

NC*

Multiple Myeloma

Brain and Other Nervous System Male

2.45

0

NC*

Male

Female

2.09

1

NC*

Female

1.43

1

NC*

Total

4.54

1

NC*

Total

3.01

3

NC*

11

178

Breast

Non-Hodgkin('s) Lymphoma Male

0.37

0

NC*

Male

Female

48.06

32

67 #-

Female

5.69

7

123

Total

48.43

32

66 #-

Total

11.88

18

152

Oral Cavity & Pharynx

Cervix Uteri Female

6.18

2.49

1

NC*

Colon / Rectum

Male

4.82

12

249 ~+

Female

2.39

2

NC*

Total

7.21

14

194 #+

Female

5.54

3

NC*

Ovary

Male

19.17

15

78

Female

19.06

24

126

Total

38.23

39

102

Male

2.79

5

179

Male

3.43

3

NC*

Female

0.90

2

NC*

Female

3.69

4

NC*

Total

3.69

7

190

Total

7.12

7

98

Male

48.17

47

98

129

Male

3.37

3

NC*

Esophagus

Pancreas

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.04

1

NC*

Female

0.92

1

NC*

Total

1.95

2

NC* Stomach

Kidney & Renal Pelvis Male

4.66

6

Female

2.88

6

208

Female

2.03

2

NC*

Total

7.54

12

159

Total

5.40

5

93

Male

1.49

1

NC*

Testis

Larynx Male

2.50

4

NC*

Female

0.65

2

NC*

Total

3.15

6

190

Leukemia

Thyroid Male

3.87

3

NC*

Male

1.02

2

NC*

Female

3.11

6

193

Female

2.95

4

NC*

Total

6.98

9

129

Total

3.97

6

151

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.99

0

NC*

Female

0.82

0

NC*

Total

2.81

0

NC*

Male

24.07

24

100

Female

20.79

30

Total

44.86

54

Female

9.19

6

65

Male

156.53

179

114

144

Female

152.93

160

105

120

Total

309.46

339

110

Exp

Obs

SIR

All Sites / Types

Lung and Bronchus

Charlemont

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.82

1

NC*

Male

0.61

0

NC*

Female

0.28

0

NC*

Female

0.44

0

NC*

Total

1.11

1

NC*

Total

1.05

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.27

0

NC*

Male

0.17

1

NC*

Female

0.21

0

NC*

Female

0.14

0

NC*

Total

0.49

0

NC*

Total

0.32

1

NC*

Male

0.04

0

NC*

Male

0.68

1

NC*

Female

5.13

6

117

Female

0.57

0

NC*

Total

5.18

6

116

Total

1.24

1

NC*

Male

0.55

0

NC*

Female

0.25

1

NC*

Total

0.80

1

NC*

Female

0.59

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.26

0

NC*

Colon / Rectum Male

Ovary 2.08

0

NC*

Female

1.84

4

NC*

Total

3.91

4

NC*

Esophagus

Pancreas

Male

0.32

0

NC*

Male

0.37

2

NC*

Female

0.09

0

NC*

Female

0.36

0

NC*

Total

0.40

0

NC*

Total

0.73

2

NC*

Male

5.54

4

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.11

0

NC*

Female

0.09

0

NC*

Total

0.21

0

NC*

Male

0.53

0

NC*

Male

0.36

0

NC*

Female

0.30

0

NC*

Female

0.20

0

NC*

Total

0.82

0

NC*

Total

0.56

0

NC*

Male

0.29

1

NC*

Male

0.16

1

NC*

Female

0.07

0

NC*

Total

0.36

1

NC*

Kidney & Renal Pelvis

Stomach

Larynx

Testis

Leukemia

Thyroid Male

0.42

0

NC*

Male

0.12

0

NC*

Female

0.32

0

NC*

Female

0.31

0

NC*

Total

0.74

0

NC*

Liver and Intrahepatic Bile Ducts Male

0.23

Total

0.43

0

NC*

1

NC*

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.08

0

NC*

Total

0.31

0

NC*

Lung and Bronchus

Female

0.99

All Sites / Types

Male

2.71

5

184

Male

17.49

17

97

Female

2.10

4

NC*

Female

15.73

18

114

Total

4.81

9

187

Total

33.22

35

105

Exp

Obs

SIR

4.21

0

NC*

Charlton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 4.79

9

188

Male

Female

1.61

1

NC*

Female

3.28

4

NC*

Total

6.40

10

156

Total

7.49

4

NC*

1.07

2

NC*

Brain and Other Nervous System Male

2.06

Multiple Myeloma 2

NC*

Male

Female

1.56

2

NC*

Female

0.85

0

NC*

Total

3.63

4

NC*

Total

1.93

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.27

0

NC*

Male

4.61

4

NC*

Female

34.67

42

121

Female

3.61

4

NC*

Total

34.93

42

120

Total

8.22

8

97

Oral Cavity & Pharynx

Cervix Uteri Female

2.19

0

NC*

Colon / Rectum

Male

3.80

2

NC*

Female

1.59

1

NC*

Total

5.39

3

NC*

Female

4.05

3

NC*

Ovary

Male

12.41

12

97

Female

10.45

12

115

Total

22.86

24

105

Esophagus

Pancreas

Male

2.03

1

NC*

Male

2.30

1

NC*

Female

0.50

0

NC*

Female

2.01

3

NC*

Total

2.52

1

NC*

Total

4.31

4

NC*

Male

35.09

30

86

2.16

1

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.03

Prostate 2

NC*

Female

0.86

0

NC*

Total

1.88

2

NC*

Kidney & Renal Pelvis Male

Stomach 3.49

7

200

Male

Female

1.90

3

NC*

Female

1.14

1

NC*

Total

5.39

10

185

Total

3.30

2

NC*

Male

1.64

0

NC*

Larynx

Testis Male

1.92

1

NC*

Female

0.43

0

NC*

Total

2.35

1

NC*

Leukemia

Thyroid

Male

2.85

3

NC*

Male

0.94

0

NC*

Female

2.11

2

NC*

Female

2.81

5

178

Total

4.95

5

101

Total

3.75

5

133

6.45

11

171

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.51

1

NC*

Female

0.47

1

NC*

Total

1.98

2

NC*

Female All Sites / Types

Lung and Bronchus Male

16.75

11

66

Male

112.08

94

84

Female

12.63

7

55

Female

101.97

111

109

Total

29.38

18

61 #-

Total

214.06

205

96

Exp

Obs

SIR

Chatham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

11.28

13

115

Male

5.86

16

273 ^+

Female

4.05

8

197

Female

3.93

5

127

Total

15.33

21

137

Total

9.79

21

215 ~+

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

2.26

3

NC*

Male

2.07

0

NC*

Female

1.98

1

NC*

Female

1.84

1

NC*

Total

4.24

4

NC*

Total

3.91

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.47

0

NC*

Male

7.21

6

83

Female

48.38

67

138 #+

Female

6.79

10

147

Total

48.85

67

137 #+

Total

14.01

16

114

4.96

8

161

Oral Cavity & Pharynx

Cervix Uteri

Male Female

1.91

1

NC*

Female

2.70

5

185

Total

7.66

13

170

Female

5.53

6

109

Ovary

Colon / Rectum Male

27.18

12

44 ~-

Female

26.96

26

96

Total

54.14

38

70 #Pancreas

Esophagus Male

3.41

4

NC*

Male

4.61

4

NC*

Female

1.26

1

NC*

Female

5.23

3

NC*

Total

4.67

5

107

Total

9.84

7

71

Male

60.18

95

158 ^+

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.67

0

NC*

Female

0.63

0

NC*

Total

1.30

0

NC*

Male

5.29

7

132

Male

4.75

2

NC*

Female

3.23

5

155

Female

2.98

1

NC*

Total

8.52

12

141

Total

7.73

3

NC*

Male

0.77

2

NC*

Kidney & Renal Pelvis

Stomach

Larynx

Testis Male

2.77

5

180

Female

0.68

0

NC*

Total

3.45

5

145

Leukemia

Thyroid Male

4.51

6

133

Male

0.78

1

NC*

Female

3.59

3

NC*

Female

1.91

0

NC*

Total

8.10

9

111

Total

2.69

1

NC*

14

151

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.23

1

NC*

Female

1.10

1

NC*

Total

3.33

2

NC*

Female

9.28

All Sites / Types

Lung and Bronchus Male

31.87

20

63 #-

Male

196.86

221

112

Female

24.63

19

77

Female

173.26

193

111

Total

56.50

39

69 #-

Total

370.12

414

112 #+

Exp

Obs

SIR

16.28

13

80

Chelmsford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 20.84

19

91

Male

Female

7.46

7

94

Female

12.61

9

71

Total

28.31

26

92

Total

28.88

22

76

Multiple Myeloma

Brain and Other Nervous System Male

7.50

11

147

Male

4.46

5

112

Female

5.92

4

NC*

Female

3.89

4

NC*

Total

13.42

15

112

Total

8.35

9

108

Non-Hodgkin('s) Lymphoma

Breast Male

1.10

1

NC*

Male

18.03

20

111

Female

143.88

144

100

Female

15.52

16

103

Total

144.97

145

100

Total

33.55

36

107

Male

14.77

10

68

Female

6.82

7

103

Total

21.60

17

79

Female

16.53

25

151

9.68

4

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

7.85

7

89 Ovary

Colon / Rectum Male

53.32

62

116

Female

48.19

56

116

Total

101.51

118

116 Pancreas

Esophagus Male

8.36

7

84

Male

Female

2.30

1

NC*

Female

9.45

13

138

Total

10.67

8

75

Total

19.13

17

89

Male

148.08

151

102

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

3.41

2

NC*

Female

2.79

3

NC*

Total

6.19

5

81 Stomach

Kidney & Renal Pelvis

Larynx

Male

13.82

20

145

Male

9.19

6

65

Female

8.25

7

85

Female

5.17

8

155

Total

22.08

27

122

Total

14.36

14

97

Testis

Male

5.25

5

95

46

Male

3.35

3

NC*

11

131

Female

9.54

14

147

16

83

Total

12.89

17

132

27.65

26

94

462.13

450

97

Male

7.73

7

91

Female

1.95

1

NC*

Total

9.68

8

83

Male

10.92

5

Female

8.43

Total

19.34

Thyroid

Leukemia

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

6.01

8

133

Female

2.11

1

NC*

Total

8.12

9

111 All Sites / Types

Lung and Bronchus Male

Female

70.99

60

85

Male

Female

58.07

56

96

Female

433.70

458

106

Total

129.06

116

90

Total

895.83

908

101

Exp

Obs

SIR

Chelsea

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

16.25

10

62

Male

11.32

3

NC*

Female

5.96

4

NC*

Female

9.11

4

NC*

Total

22.21

14

63

Total

20.43

7

34 ~-

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

5.41

7

129

Male

3.23

8

248 #+

Female

4.57

4

NC*

Female

2.88

1

NC*

Total

9.97

11

110

Total

6.11

9

147

14

105

Non-Hodgkin('s) Lymphoma

Breast Male

0.78

0

NC*

Male

Female

95.90

84

88

Female

11.90

7

59

Total

96.68

84

87

Total

25.21

21

83

Oral Cavity & Pharynx

Cervix Uteri Female

13.32

5.70

10

175

Colon / Rectum

Male

9.41

21

223 ~+

Female

4.81

4

NC*

Total

14.22

25

176 #+

Female

11.41

13

114

Ovary

Male

40.50

48

119

Female

39.23

38

97

Total

79.73

86

108

Male

5.61

14

249 ~+

Male

7.07

11

156

Female

1.84

4

NC*

Female

7.61

9

118

Total

7.45

18

242 ~+

Total

14.68

20

136

Male

97.73

79

81

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.70

2

NC*

Female

2.37

1

NC*

Total

5.07

3

NC* Stomach

Kidney & Renal Pelvis Male

9.40

13

138

Male

7.03

10

142

Female

5.83

5

86

Female

4.30

2

NC*

Total

15.23

18

118

Total

11.33

12

106

Male

4.57

3

NC*

Testis

Larynx Male

4.91

10

204

Female

1.25

2

NC*

Total

6.15

12

195 #+

Leukemia

Thyroid Male

8.41

3

NC*

Male

2.30

4

NC*

Female

6.67

7

105

Female

7.12

7

98

Total

15.07

10

66

Total

9.43

11

117

17.66

18

102

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

4.00

6

150

Female

1.68

3

NC*

Total

5.68

9

158

Male

50.22

92

183 ^+

Male

326.94

378

116 ~+

Female

40.99

59

144 ~+

Female

312.21

318

102

Total

91.21

151

166 ^+

Total

639.15

696

109 #+

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Cheshire

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

2.89

3

NC*

Male

2.05

1

NC*

Female

0.88

0

NC*

Female

1.43

0

NC*

Total

3.77

3

NC*

Total

3.48

1

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.91

2

NC*

Male

0.60

0

NC*

Female

0.68

1

NC*

Female

0.46

0

NC*

Total

1.58

3

NC*

Total

1.05

0

NC*

Male

0.14

0

NC*

Male

2.31

2

NC*

Female

16.43

11

67

Female

1.81

1

NC*

Total

16.58

11

66

Total

4.12

3

NC*

Male

1.86

1

NC*

Female

0.79

0

NC*

Total

2.65

1

NC*

Female

1.88

2

NC*

1.30

1

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.88

0

NC*

Colon / Rectum Male

Ovary 7.27

7

96

Female

5.73

4

NC*

Total

13.00

11

85

Esophagus Male

Pancreas 1.09

1

NC*

Male

Female

0.27

0

NC*

Female

1.12

0

NC*

Total

1.37

1

NC*

Total

2.43

1

NC*

Male

19.29

14

73

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.37

1

NC*

Female

0.31

0

NC*

Total

0.68

1

NC*

Kidney & Renal Pelvis

Stomach

Male

1.78

1

NC*

Male

1.26

1

NC*

Female

0.95

1

NC*

Female

0.61

2

NC*

Total

2.74

2

NC*

Total

1.87

3

NC*

Male

0.99

0

NC*

Male

0.52

0

NC*

Female

0.22

1

NC*

Total

1.21

1

NC*

Larynx

Testis

Leukemia

Thyroid Male

1.41

4

NC*

Male

0.39

0

NC*

Female

0.97

0

NC*

Female

1.06

1

NC*

Total

2.38

4

NC*

Total

1.44

1

NC*

3.17

3

NC*

60.47

49

81

Liver and Intrahepatic Bile Ducts Male

0.77

Uteri, Corpus and Uterus, NOS 1

NC*

Female

0.25

0

NC*

Total

1.02

1

NC*

Lung and Bronchus Male

Female All Sites / Types

9.41

8

85

Male

Female

6.80

9

132

Female

50.12

38

76

Total

16.21

17

105

Total

110.59

87

79 #-

Exp

Obs

SIR

Chester

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.88

1

NC*

Male

0.70

0

NC*

Female

0.28

1

NC*

Female

0.47

0

NC*

Total

1.16

2

NC*

Total

1.17

0

NC*

0.19

0

NC*

Brain and Other Nervous System Male

0.32

Multiple Myeloma 0

NC*

Male

Female

0.23

0

NC*

Female

0.15

0

NC*

Total

0.55

0

NC*

Total

0.34

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.05

0

NC*

Male

0.77

1

NC*

Female

5.29

15

284 ^+

Female

0.60

0

NC*

Total

5.33

15

281 ^+

Total

1.37

1

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 0.29

2

NC*

Colon / Rectum

Male

0.63

0

NC*

Female

0.25

0

NC*

Total

0.88

0

NC*

Female

0.61

0

NC*

Ovary

Male

2.25

2

NC*

Female

1.84

1

NC*

Total

4.09

3

NC*

Male

0.35

1

NC*

Male

0.41

1

NC*

Female

0.09

0

NC*

Female

0.36

0

NC*

Total

0.44

1

NC*

Total

0.77

1

NC*

Male

6.24

9

144

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.15

0

NC*

Female

0.11

0

NC*

Total

0.26

0

NC*

Kidney & Renal Pelvis Male

Stomach 0.59

0

NC*

Male

0.39

1

NC*

Female

0.31

0

NC*

Female

0.19

0

NC*

Total

0.90

0

NC*

Total

0.58

1

NC*

Male

0.23

1

NC*

Larynx

Testis Male

0.33

0

NC*

Female

0.07

0

NC*

Total

0.40

0

NC*

Leukemia

Thyroid Male

0.47

2

NC*

Male

0.14

0

NC*

Female

0.32

0

NC*

Female

0.36

0

NC*

Total

0.79

2

NC*

Total

0.50

0

NC*

1.02

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.26

0

NC*

Female

0.08

0

NC*

Total

0.34

0

NC*

Male

3.01

0

NC*

Male

19.60

19

97

Female

2.22

3

NC*

Female

16.24

25

154

Total

5.23

3

NC*

Total

35.84

44

123

Exp

Obs

SIR

Lung and Bronchus

Female All Sites / Types

Chesterfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.70

0

NC*

Male

0.53

0

NC*

Female

0.20

0

NC*

Female

0.36

0

NC*

Total

0.90

0

NC*

Total

0.89

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.24

0

NC*

Male

0.15

1

NC*

Female

0.17

1

NC*

Female

0.10

1

NC*

Total

0.41

1

NC*

Total

0.25

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.04

0

NC*

Male

0.59

0

NC*

Female

4.03

3

NC*

Female

0.42

0

NC*

Total

4.07

3

NC*

Total

1.01

0

NC*

0.48

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.23

0

NC*

Colon / Rectum Male

Female

0.19

0

NC*

Total

0.67

0

NC*

Female

0.46

1

NC*

Ovary 1.78

0

NC*

Female

1.27

2

NC*

Total

3.05

2

NC*

Esophagus

Pancreas

Male

0.27

1

NC*

Male

0.32

0

NC*

Female

0.06

0

NC*

Female

0.25

0

NC*

Total

0.33

1

NC*

Total

0.57

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

4.76

5

105

NC*

Male

0.31

0

NC*

1

NC*

Female

0.14

0

NC*

3

NC*

Total

0.44

0

NC*

Male

0.14

1

NC*

NC*

Male

0.10

0

NC*

Male

0.10

0

NC*

Female

0.08

1

NC*

Total

0.18

1

NC*

Male

0.46

2

Female

0.23

Total

0.68

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

0.25

0

NC*

Female

0.05

0

NC*

Total

0.30

0

NC*

Leukemia

Thyroid Male

0.37

1

Female

0.23

0

NC*

Female

0.28

0

NC*

Total

0.60

1

NC*

Total

0.39

0

NC*

0

NC*

Liver and Intrahepatic Bile Ducts Male

0.20

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.06

0

NC*

Total

0.25

0

NC*

Lung and Bronchus

Female

0.77

All Sites / Types

Male

2.33

1

NC*

Male

15.08

16

106

Female

1.56

1

NC*

Female

11.95

11

92

Total

3.89

2

NC*

Total

27.03

27

100

Exp

Obs

SIR

26.75

28

105

Chicopee

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 40.77

50

123

Male

Female

17.20

18

105

Female

22.09

15

68

Total

57.97

68

117

Total

48.84

43

88

Multiple Myeloma

Brain and Other Nervous System Male

11.84

10

84

Male

8.14

10

123

Female

10.95

18

164

Female

8.24

8

97

Total

22.79

28

123

Total

16.38

18

110

Non-Hodgkin('s) Lymphoma

Breast Male

1.96

2

NC*

Male

31.11

24

77

Female

253.80

256

101

Female

32.17

22

68

Total

255.76

258

101

Total

63.28

46

73 #-

Male

23.19

22

95

Female

13.12

10

76

Total

36.32

32

88

Female

29.48

36

122

Oral Cavity & Pharynx

Cervix Uteri Female

12.64

12

95 Ovary

Colon / Rectum Male

101.41

91

90

Female

112.91

108

96

Total

214.32

199

93 Pancreas

Esophagus Male

14.30

21

147

Male

17.73

22

124

Female

5.31

7

132

Female

22.09

27

122

Total

19.61

28

143

Male

Total

39.82

49

123

Male

254.38

255

100

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) 4.96

0

NC*

Female

4.70

7

149

Total

9.66

7

72 Stomach

Kidney & Renal Pelvis Male

23.21

15

65

Male

17.39

24

138

Female

15.96

11

69

Female

12.26

16

131

Total

39.17

26

66 #-

Total

29.65

40

135

Male

7.51

10

133

Testis

Larynx Male

12.54

10

80

Female

3.53

6

170

Total

16.08

16

100

Male

19.25

18

94

Male

4.86

4

NC*

Female

17.10

11

64

Female

14.66

7

48 #-

Total

36.35

29

80

Total

19.52

11

56

48.36

61

126

Thyroid

Leukemia

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

9.94

7

70

Female

4.77

4

NC*

Total

14.72

11

75

Female All Sites / Types

Lung and Bronchus Male

128.36

148

115

Male

813.35

823

101

Female

117.23

104

89

Female

842.82

836

99

Total

245.59

252

103

Total

1656.17

1659

100

Exp

Obs

SIR

Chilmark

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

0.65

2

NC*

Male

0.41

1

NC*

Female

0.19

0

NC*

Female

0.28

1

NC*

Total

0.85

2

NC*

Total

0.69

2

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.18

0

NC*

Male

0.12

0

NC*

Female

0.14

1

NC*

Female

0.10

0

NC*

Total

0.31

1

NC*

Total

0.22

0

NC*

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.03

0

NC*

Male

0.48

Female

3.20

8

250 #+

Female

0.38

1

NC*

Total

3.23

8

248 #+

Total

0.86

2

NC*

0.36

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.17

0

NC*

Colon / Rectum

0.16

0

NC*

Total

0.52

0

NC*

Female

0.37

1

NC*

Ovary

Male

1.61

2

NC*

Female

1.28

3

NC*

Total

2.89

5

173

Esophagus

Female

Pancreas

Male

0.22

0

NC*

Male

0.28

0

NC*

Female

0.06

2

NC*

Female

0.25

0

NC*

Total

0.28

2

NC*

Total

0.53

0

NC*

Male

3.83

13

340 ^+

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.07

0

NC*

Female

0.06

0

NC*

Total

0.13

0

NC*

Kidney & Renal Pelvis

Stomach

Male

0.35

1

NC*

Male

0.29

0

NC*

Female

0.19

0

NC*

Female

0.14

0

NC*

Total

0.54

1

NC*

Total

0.42

0

NC*

Male

0.11

0

NC*

NC*

Male

0.07

0

NC*

Larynx

Testis Male

0.19

0

NC*

Female

0.04

0

NC*

Total

0.23

0

NC*

Leukemia

Thyroid Male

0.30

1

Female

0.20

0

NC*

Female

0.20

0

NC*

Total

0.50

1

NC*

Total

0.27

0

NC*

0.61

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.15

0

NC*

Female

0.05

0

NC*

Total

0.20

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

1.93

2

NC*

Male

12.49

24

192 ~+

Female

1.37

3

NC*

Female

10.19

21

206 ~+

Total

3.31

5

151

Total

22.68

45

198 ^+

Exp

Obs

SIR

Clarksburg

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

1.42

3

NC*

Male

1.01

2

NC*

Female

0.52

0

NC*

Female

0.73

0

NC*

Total

1.94

3

NC*

Total

1.75

2

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.45

0

NC*

Male

0.30

0

NC*

Female

0.35

0

NC*

Female

0.26

0

NC*

Total

0.80

0

NC*

Total

0.56

0

NC*

Male

0.07

0

NC*

Male

1.13

1

NC*

Female

8.71

2

NC*

Female

1.00

2

NC*

Total

8.78

2

NC*

Total

2.14

3

NC*

Male

0.92

1

NC*

Female

0.43

1

NC*

Total

1.36

2

NC*

Female

0.99

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.43

1

NC*

Colon / Rectum

Ovary

Male

3.59

5

139

Female

3.40

2

NC*

Total

6.99

7

100

Esophagus Male

Pancreas 0.55

0

NC*

Male

0.64

1

NC*

Female

0.16

0

NC*

Female

0.67

0

NC*

Total

0.71

0

NC*

Total

1.31

1

NC*

Male

9.78

7

72

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.18

1

NC*

Female

0.14

0

NC*

Total

0.33

1

NC* Stomach

Kidney & Renal Pelvis Male

0.88

1

NC*

Male

0.62

0

NC*

Female

0.52

0

NC*

Female

0.37

0

NC*

Total

1.40

1

NC*

Total

0.98

0

NC*

Male

0.50

0

NC*

Male

0.26

0

NC*

Female

0.12

0

NC*

Total

0.62

0

NC*

Male

0.69

1

NC*

Male

0.19

0

NC*

Female

0.54

1

NC*

Female

0.49

0

NC*

Total

1.23

2

NC*

Total

0.68

0

NC*

1.69

2

NC*

30.17

31

103

Larynx

Testis

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.38

1

NC*

Female

0.15

0

NC*

Total

0.53

1

NC*

Lung and Bronchus Male

Female All Sites / Types

4.73

4

NC*

Male

Female

3.78

5

132

Female

27.45

17

62 #-

Total

8.51

9

106

Total

57.62

48

83

Exp

Obs

SIR

Clinton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

7.82

9

115

Male

5.64

3

NC*

Female

3.39

1

NC*

Female

4.91

1

NC*

Total

11.22

10

89

Total

10.55

4

NC*

1.59

1

NC*

Brain and Other Nervous System Male

2.61

Multiple Myeloma 0

NC*

Male

Female

2.43

2

NC*

Female

1.64

2

NC*

Total

5.04

2

NC*

Total

3.23

3

NC*

8

123

Breast

Non-Hodgkin('s) Lymphoma Male

0.39

0

NC*

Male

Female

53.26

50

94

Female

6.65

6

90

Total

53.65

50

93

Total

13.14

14

107

Oral Cavity & Pharynx

Cervix Uteri Female Colon / Rectum

6.49

3.00

3

NC* Ovary

Male

4.81

6

125

Female

2.69

1

NC*

Total

7.51

7

93

Male

19.65

22

112

Female

22.39

27

121

Total

42.03

49

117

Male

2.83

3

NC*

Female

1.05

1

NC*

Total

3.88

4

NC*

6.27

11

175

Male

3.47

4

NC*

Female

4.35

4

NC*

Total

7.81

8

102

Male

49.62

50

101

106

Male

3.39

4

NC*

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.27

2

NC*

Female

1.19

1

NC*

Total

2.46

3

NC* Stomach

Kidney & Renal Pelvis Male

Female

4.72

5

Female

3.26

6

184

Female

2.42

0

NC*

Total

7.99

11

138

Total

5.81

4

NC*

Male

2.11

0

NC*

Larynx

Testis Male

2.52

6

238

Female

0.71

0

NC*

Total

3.23

6

186

Leukemia

Thyroid Male

4.00

2

NC*

Male

1.14

2

NC*

Female

3.59

3

NC*

Female

3.66

4

NC*

Total

7.59

5

66

Total

4.81

6

125

9.92

8

81

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

2.02

5

247

Female

0.95

1

NC*

Total

2.97

6

202

Male

24.99

26

104

Male

161.98

168

104

Female

23.43

27

115

Female

174.23

181

104

Total

48.42

53

109

Total

336.21

349

104

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Cohasset

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Exp Melanoma of Skin

Male

5.48

8

146

Male

3.96

3

NC*

Female

2.09

3

NC*

Female

3.03

10

330 ~+

Total

7.57

11

145

Total

6.99

13

186

Multiple Myeloma

Brain and Other Nervous System Male

1.77

5

282

Male

1.15

0

NC*

Female

1.45

0

NC*

Female

1.05

0

NC*

Total

3.22

5

155

Total

2.20

0

NC*

Male

0.28

1

NC*

Male

4.42

4

NC*

Female

35.70

43

120

Female

4.06

4

NC*

Total

35.97

44

122

Total

8.48

8

94

Male

3.66

8

219

Female

1.76

3

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.78

4

NC*

Colon / Rectum Male

Total

5.41

11

203 #+

Female

4.08

5

123

Ovary 13.90

23

165 #+

Female

13.56

16

118

Total

27.46

39

142 #+ Pancreas

Esophagus Male

2.14

3

NC*

Male

2.50

1

NC*

Female

0.65

0

NC*

Female

2.66

0

NC*

Total

2.78

3

NC*

Total

5.16

1

NC*

Male

38.21

46

120

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.71

0

NC*

Female

0.61

1

NC*

Total

1.32

1

NC*

Male

3.46

2

NC*

Male

2.39

1

NC*

Female

2.12

0

NC*

Female

1.48

0

NC*

Total

5.58

2

NC*

Total

3.87

1

NC*

Male

1.95

2

NC*

Male

0.97

1

NC*

Female

0.49

1

NC*

Total

2.44

3

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis

Leukemia

Thyroid Male

2.71

2

NC*

Male

0.75

3

NC*

Female

2.21

2

NC*

Female

2.07

0

NC*

Total

4.91

4

NC*

Total

2.82

3

NC*

8

116

Liver and Intrahepatic Bile Ducts Male

1.50

Uteri, Corpus and Uterus, NOS 3

NC*

Female

0.58

1

NC*

Total

2.09

4

NC*

Female

6.91

All Sites / Types

Lung and Bronchus Male

18.36

15

82

Male

117.60

136

116

Female

15.21

11

72

Female

111.50

117

105

Total

33.56

26

77

Total

229.09

253

110

Exp

Obs

SIR

0.86

0

NC*

Colrain

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 1.17

1

NC*

Male

Female

0.36

0

NC*

Female

0.59

0

NC*

Total

1.53

1

NC*

Total

1.45

0

NC*

0.24

3

NC*

Brain and Other Nervous System Male

0.40

Multiple Myeloma 1

NC*

Male

Female

0.29

0

NC*

Female

0.19

1

NC*

Total

0.68

1

NC*

Total

0.43

4

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.06

0

NC*

Male

0.98

1

NC*

Female

6.73

7

104

Female

0.74

0

NC*

Total

6.79

7

103

Total

1.72

1

NC*

Cervix Uteri

Oral Cavity & Pharynx

Female

0.36

1

NC*

Colon / Rectum

Male

0.76

0

NC*

Female

0.32

1

NC*

Total

1.09

1

NC*

Female

0.77

1

NC*

Ovary

Male

2.95

2

NC*

Female

2.33

5

214

Total

5.29

7

132

Esophagus

Pancreas

Male

0.44

0

NC*

Male

0.53

1

NC*

Female

0.11

0

NC*

Female

0.45

0

NC*

Total

0.55

0

NC*

Total

0.98

1

NC*

Male

7.69

5

65

NC*

Male

0.51

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.18

Prostate 0

NC*

Female

0.13

0

NC*

Total

0.31

0

NC* Stomach

Kidney & Renal Pelvis Male

0.74

0

Female

0.39

1

NC*

Female

0.25

0

NC*

Total

1.13

1

NC*

Total

0.76

0

NC*

Male

0.27

0

NC*

Larynx

Testis Male

0.40

1

NC*

Female

0.09

0

NC*

Total

0.49

1

NC*

Leukemia

Thyroid Male

0.60

2

NC*

Male

0.17

0

NC*

Female

0.41

1

NC*

Female

0.44

1

NC*

Total

1.01

3

NC*

Total

0.61

1

NC*

1.30

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.32

0

NC*

Female

0.10

0

NC*

Total

0.42

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

3.80

0

NC*

Male

24.69

18

73

Female

2.77

1

NC*

Female

20.53

23

112

Total

6.58

1

NC*

Total

45.22

41

91

Exp

Obs

SIR

Concord

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

14.55

8

55

Male

10.96

19

173 #+

Female

4.60

3

NC*

Female

6.97

13

186

Total

19.15

11

57

Total

17.93

32

178 ~+

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

4.87

2

NC*

Male

3.07

3

NC*

Female

3.33

4

NC*

Female

2.38

4

NC*

Total

8.20

6

73

Total

5.45

7

129

Non-Hodgkin('s) Lymphoma

Breast Male

0.75

0

NC*

Male

12.18

13

107

Female

83.94

97

116

Female

9.20

14

152

Total

84.69

97

115

Total Male

Female

21.38

27

126

9.91

5

50

Oral Cavity & Pharynx

Cervix Uteri 4.11

3

NC*

Female

4.06

2

NC*

Total

13.96

7

50

Female

9.52

6

63

Ovary

Colon / Rectum Male

37.01

24

65 #-

Female

29.72

34

114

Total

66.73

58

87 Pancreas

Esophagus Male

5.70

5

88

Male

6.68

5

75

Female

1.42

1

NC*

Female

5.85

7

120

Total

7.12

6

84

Total

12.53

12

96

Male

100.93

89

88

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.17

3

NC*

Female

1.36

2

NC*

Total

3.53

5

142

Male

9.33

3

NC*

Male

6.39

4

NC*

Female

4.92

5

102

Female

3.16

4

NC*

Total

14.26

8

56

Total

9.55

8

84

Male

3.35

4

NC*

2.20

1

NC*

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

5.21

2

NC*

Female

1.18

2

NC*

Total

6.40

4

NC*

Leukemia

Thyroid Male

7.26

5

69

Male

Female

4.92

5

102

Female

4.79

2

NC*

Total

12.19

10

82

Total

6.98

3

NC*

13

79

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

4.05

3

NC*

Female

1.29

2

NC*

Total

5.34

5

94

Female

16.46

All Sites / Types

Lung and Bronchus Male

48.73

26

53 ^-

Male

315.14

231

73 ^-

Female

35.48

22

62 #-

Female

256.25

263

103

Total

84.21

48

57 ^-

Total

571.39

494

86 ~-

Exp

Obs

SIR

0.84

1

NC*

Conway

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 1.03

1

NC*

Male

Female

0.34

1

NC*

Female

0.61

2

NC*

Total

1.38

2

NC*

Total

1.44

3

NC*

Brain and Other Nervous System

Breast

Multiple Myeloma

Male

0.38

0

NC*

Male

0.23

0

NC*

Female

0.29

0

NC*

Female

0.18

0

NC*

Total

0.67

0

NC*

Total

0.41

0

NC*

Non-Hodgkin('s) Lymphoma

Male

0.05

0

NC*

Male

0.91

0

NC*

Female

6.97

8

115

Female

0.72

1

NC*

Total

7.03

8

114

Total

1.63

1

NC*

Male

0.78

1

NC*

Female

0.33

0

NC*

Total

1.11

1

NC*

Female

0.79

0

NC*

0.49

0

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

0.38

1

NC*

Colon / Rectum

Ovary

Male

2.65

2

NC*

Female

2.23

3

NC*

Total

4.88

5

103

Esophagus Male

Pancreas 0.43

0

NC*

Male

Female

0.11

0

NC*

Female

0.43

0

NC*

Total

0.54

0

NC*

Total

0.92

0

NC*

Male

7.48

6

80

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.16

Prostate 0

NC*

Female

0.13

0

NC*

Total

0.29

0

NC* Stomach

Kidney & Renal Pelvis Male

0.72

1

NC*

Male

0.46

0

NC*

Female

0.39

0

NC*

Female

0.24

0

NC*

Total

1.11

1

NC*

Total

0.70

0

NC*

Male

0.22

1

NC*

Larynx

Testis Male

0.40

1

NC*

Female

0.09

0

NC*

Total

0.49

1

NC*

Male

0.55

1

NC*

Male

0.17

0

NC*

Female

0.41

1

NC*

Female

0.46

1

NC*

Total

0.96

2

NC*

Total

0.63

1

NC*

1.34

0

NC*

23.25

19

82

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.31

0

NC*

Female

0.10

0

NC*

Total

0.41

0

NC*

Lung and Bronchus Male

Female All Sites / Types

3.54

1

NC*

Male

Female

2.68

2

NC*

Female

20.61

21

102

Total

6.21

3

NC*

Total

43.86

40

91

Exp

Obs

SIR

Cummington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

0.61

1

NC*

Male

0.44

0

NC*

Female

0.21

0

NC*

Female

0.29

0

NC*

Total

0.82

1

NC*

Total

0.73

0

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.20

0

NC*

Male

0.13

1

NC*

Female

0.14

0

NC*

Female

0.10

1

NC*

Total

0.34

0

NC*

Breast

Total

0.23

2

NC*

0

NC*

Non-Hodgkin('s) Lymphoma Male

0.03

0

NC*

Male

0.50

Female

3.41

4

NC*

Female

0.40

0

NC*

Total

3.44

4

NC*

Total

0.90

0

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 0.17

0

NC*

Colon / Rectum

Male

0.39

0

NC*

Female

0.17

1

NC*

Total

0.56

1

NC*

Female

0.39

0

NC*

Ovary

Male

1.53

2

NC*

Female

1.37

2

NC*

Total

2.90

4

NC*

Male

0.23

0

NC*

Male

0.27

0

NC*

Female

0.06

0

NC*

Female

0.27

0

NC*

Total

0.29

0

NC*

Total

0.54

0

NC*

Male

3.96

3

NC*

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.09

0

NC*

Female

0.06

1

NC*

Total

0.15

1

NC*

Kidney & Renal Pelvis

Stomach

Male

0.37

0

NC*

Male

0.27

0

NC*

Female

0.20

0

NC*

Female

0.15

0

NC*

Total

0.58

0

NC*

Total

0.41

0

NC*

Male

0.13

0

NC*

Larynx

Testis Male

0.20

0

NC*

Female

0.05

0

NC*

Total

0.25

0

NC*

Leukemia

Thyroid Male

0.30

1

NC*

Male

0.08

0

NC*

Female

0.22

0

NC*

Female

0.20

0

NC*

Total

0.52

1

NC*

Total

0.29

0

NC*

0.65

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.16

0

NC*

Female

0.06

0

NC*

Total

0.22

0

NC*

Male

1.96

0

NC*

Male

12.67

8

63

Female

1.47

1

NC*

Female

10.85

11

101

Total

3.44

1

NC*

Total

23.52

19

81

Exp

Obs

SIR

Lung and Bronchus

Female All Sites / Types

Dalton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.99

6

120

Male

3.48

3

NC*

Female

1.83

4

NC*

Female

2.61

2

NC*

Total

6.83

10

146

Total

6.09

5

82

Brain and Other Nervous System

Multiple Myeloma

Male

1.55

0

NC*

Male

1.02

0

NC*

Female

1.27

1

NC*

Female

0.92

1

NC*

Total

2.82

1

NC*

Total

1.93

1

NC*

Male

0.24

0

NC*

Male

3.96

3

NC*

Female

30.66

32

104

Female

3.57

5

140

Total

30.90

32

104

Total

7.53

8

106

Male

3.11

1

NC*

Female

1.52

1

NC*

Total

4.63

2

NC*

Female

3.51

3

NC*

2.23

1

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.53

1

NC*

Colon / Rectum Male

Ovary 12.51

12

96

Female

11.98

13

109

Total

24.49

25

102

Esophagus Male

Pancreas 1.84

0

NC*

Male

Female

0.57

1

NC*

Female

2.34

3

NC*

Total

2.40

1

NC*

Total

4.57

4

NC*

Male

32.29

31

96

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.65

1

NC*

Female

0.54

1

NC*

Total

1.19

2

NC*

Kidney & Renal Pelvis

Stomach

Male

3.00

1

NC*

Male

2.18

1

NC*

Female

1.84

3

NC*

Female

1.29

0

NC*

Total

4.84

4

NC*

Total

3.46

1

NC*

Male

1.64

0

NC*

Male

0.95

2

NC*

Female

0.42

0

NC*

Total

2.07

0

NC*

Larynx

Testis

Leukemia

Thyroid Male

2.44

4

NC*

Male

0.65

1

NC*

Female

1.92

0

NC*

Female

1.79

3

NC*

Total

4.36

4

NC*

Total

2.44

4

NC*

5.92

7

118

102.66

86

84

Liver and Intrahepatic Bile Ducts Male

1.29

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.51

1

NC*

Total

1.81

1

NC* All Sites / Types

Lung and Bronchus Male

Female

15.94

16

100

Male

Female

13.31

17

128

Female

96.84

104

107

Total

29.26

33

113

Total

199.50

190

95

Exp

Obs

SIR

Danvers

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

17.39

28

161 #+

Male

12.56

13

103

Female

6.81

7

103

Female

10.02

14

140

Total

24.20

35

145 #+

Male

5.66

Total

22.59

27

120

3.62

2

NC*

Multiple Myeloma

Brain and Other Nervous System 5

88

Male

Female

4.86

4

NC*

Female

3.41

1

NC*

Total

10.52

9

86

Total

7.02

3

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.88

1

NC*

Male

14.17

15

106

Female

115.30

106

92

Female

13.45

15

112

Total

116.18

107

92

Total

27.62

30

109

Oral Cavity & Pharynx

Cervix Uteri Female

5.99

7

117

Male

11.24

9

80

Female

5.70

8

140

Total

16.93

17

100

Female

13.31

15

113

Ovary

Colon / Rectum Male

44.05

50

113

Female

44.32

46

104

Total

88.37

96

109

Male

6.64

6

90

Male

7.86

10

127

Female

2.10

2

NC*

Female

8.69

11

127

Total

8.74

8

92

Total

16.55

21

127

Male

118.79

102

86

7.52

4

NC*

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.47

0

NC*

Female

2.17

0

NC*

Total

4.64

0

NC* Stomach

Kidney & Renal Pelvis Male

10.79

11

102

Male

Female

6.93

4

NC*

Female

4.76

3

NC*

Total

17.72

15

85

Total

12.28

7

57

Male

3.79

2

NC*

Testis

Larynx Male

6.01

3

NC*

Female

1.60

0

NC*

Total

7.61

3

NC*

Leukemia

Thyroid Male

8.59

6

70

Male

2.46

1

NC*

Female

7.20

4

NC*

Female

7.13

7

98

Total

15.79

10

63

Total

9.59

8

83

22.14

19

86

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

4.68

5

107

Female

1.91

1

NC*

Total

6.59

6

91

Male

57.88

73

126

Male

370.52

369

100

Female

49.94

57

114

Female

363.70

361

99

Total

107.82

130

121 #+

Total

734.22

730

99

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Dartmouth

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary

Obs

Exp

SIR Melanoma of Skin

Male

22.21

18

81

Male

15.88

14

88

Female

8.53

4

NC*

Female

12.21

14

115

Total

30.75

22

72

Total

28.09

28

100

Multiple Myeloma

Brain and Other Nervous System Male

7.06

8

113

Male

4.59

2

NC*

Female

5.91

5

85

Female

4.25

5

118

Total

12.97

13

100

Total

8.84

7

79

Non-Hodgkin('s) Lymphoma

Breast Male

1.10

1

NC*

Male

17.93

15

84

Female

142.94

130

91

Female

16.57

19

115

Total

144.04

131

91

Total

34.50

34

99

14.26

9

63

Oral Cavity & Pharynx

Cervix Uteri

Male Female

7.17

4

NC*

7.08

1

NC*

Total

21.35

10

47 #-

Female

16.36

14

86

Ovary

Colon / Rectum Male

Female

55.89

60

107

Female

55.82

38

68 #-

Total

111.71

98

88 Pancreas

Esophagus Male

8.33

5

60

Male

10.01

13

130

Female

2.64

2

NC*

Female

10.88

9

83

Total

10.97

7

64

Total

20.89

22

105

Male

146.51

159

109

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

3.00

5

167

Female

2.51

1

NC*

Total

5.50

6

109

Male

13.66

19

139

Male

9.71

10

103

Female

8.53

6

70

Female

6.02

5

83

Total

22.19

25

113

Total

15.73

15

95

Male

4.42

2

NC*

3.04

1

NC*

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

7.51

11

146

Female

1.96

1

NC*

Total

9.47

12

127

Leukemia

Thyroid Male

10.95

11

100

Male

Female

8.97

6

67

Female

8.38

7

84

Total

19.91

17

85

Total

11.42

8

70

27.54

24

87

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

5.89

8

136

Female

2.39

2

NC*

Total

8.28

10

121

Female All Sites / Types

Lung and Bronchus Male

71.91

53

74 #-

Male

463.81

446

96

Female

61.55

36

58 ^-

Female

450.86

364

81 ^-

Total

133.46

89

67 ^-

Total

914.67

810

89 ^-

Dedham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Exp

Obs

SIR

Melanoma of Skin

Male

17.57

24

137

Male

11.83

13

110

Female

6.63

9

136

Female

9.13

13

142

Total

24.20

33

136

Total

20.97

26

124

3.53

6

170

Multiple Myeloma

Brain and Other Nervous System Male

5.25

7

133

Male

Female

4.48

1

NC*

Female

3.26

2

NC*

Total

9.73

8

82

Total

6.79

8

118

13.65

10

73

Non-Hodgkin('s) Lymphoma

Breast Male

0.85

0

NC*

Male

Female

105.59

113

107

Female

12.80

16

125

Total

106.44

113

106

Total

26.45

26

98

Oral Cavity & Pharynx

Cervix Uteri Female

5.34

4

NC*

Male

10.35

16

155

Female

5.32

1

NC*

Total

15.68

17

108

Female

12.21

12

98

Ovary

Colon / Rectum Male

43.94

51

116

Female

43.31

39

90

Total

87.25

90

103

Male

6.30

6

95

Male

7.72

11

142

Female

2.05

2

NC*

Female

8.50

10

118

Total

8.35

8

96

Total

16.23

21

129

Male

112.23

117

104

88

Male

7.56

5

66

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.26

4

NC*

Female

1.94

3

NC*

Total

4.21

7

166

Kidney & Renal Pelvis Male

Stomach 10.18

9

Female

6.50

9

139

Female

4.65

4

NC*

Total

16.68

18

108

Total

12.21

9

74

Male

3.49

5

143

Testis

Larynx Male

5.56

4

NC*

Female

1.48

0

NC*

Total

7.04

4

NC* Thyroid

Leukemia Male

8.36

6

72

Male

2.22

4

NC*

Female

6.77

6

89

Female

6.26

6

96

Total

15.13

12

79

Total

8.48

10

118

20.28

19

94

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

4.38

3

NC*

Female

1.85

4

NC*

Total

6.23

7

112

Male

55.95

71

127

Male

356.55

403

113 #+

Female

47.45

58

122

Female

340.75

364

107

Total

103.40

129

125 #+

Total

697.30

767

110 ~+

Female All Sites / Types

Lung and Bronchus

Deerfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Exp

Obs

SIR

2.78

2

NC*

Melanoma of Skin 3.82

3

NC*

Male

Female

1.41

2

NC*

Female

2.10

2

NC*

Total

5.23

5

96

Total

4.88

4

NC*

0.79

1

NC*

Brain and Other Nervous System Male

1.22

Multiple Myeloma 1

NC*

Male

Female

0.99

2

NC*

Female

0.71

0

NC*

Total

2.21

3

NC*

Total

1.50

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.19

0

NC*

Male

3.13

2

NC*

Female

24.38

15

62

Female

2.76

2

NC*

Total

24.57

15

61

Total

5.89

4

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 1.25

1

NC*

Colon / Rectum

Male

2.49

0

NC*

Female

1.19

0

NC*

Total

3.68

0

NC*

Female

2.78

3

NC*

Ovary

Male

9.60

8

83

Female

9.24

6

65

Total

18.85

14

74

Esophagus

Pancreas

Male

1.43

0

NC*

Male

1.73

1

NC*

Female

0.44

0

NC*

Female

1.79

0

NC*

Total

1.87

0

NC*

Total

3.52

1

NC*

Male

24.74

19

77

NC*

Male

1.69

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.53

Prostate 1

NC*

Female

0.43

0

NC*

Total

0.96

1

NC*

Kidney & Renal Pelvis Male

Stomach 2.37

1

Female

1.43

1

NC*

Female

1.00

0

NC*

Total

3.80

2

NC*

Total

2.68

0

NC*

Male

0.80

0

NC*

Larynx

Testis Male

1.29

0

NC*

Female

0.33

0

NC*

Total

1.62

0

NC*

Male

1.89

3

NC*

Male

0.54

1

NC*

Female

1.50

1

NC*

Female

1.48

0

NC*

Total

3.39

4

NC*

Total

2.01

1

NC*

4.68

2

NC*

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.02

0

NC*

Female

0.40

0

NC*

Total

1.41

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

12.22

7

57

Male

79.47

55

69 ~-

Female

10.21

11

108

Female

75.95

53

70 ~-

Total

22.44

18

80

Total

155.42

108

69 ^-

Exp

Obs

SIR

Dennis

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

18.70

31

166 #+

Male

10.19

15

147

Female

7.03

2

NC*

Female

7.39

16

216 ~+

Total

25.73

33

128

Total

17.58

31

176 ~+

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

4.09

6

147

Male

3.49

8

229

Female

3.73

6

161

Female

3.25

7

216

Total

7.82

12

153

Total

6.73

15

223 ~+

18

145

Non-Hodgkin('s) Lymphoma

Breast Male

0.80

2

NC*

Male

12.40

Female

89.82

123

137 ~+

Female

12.16

16

132

Total

90.62

125

138 ^+

Total

24.56

34

138

8.68

9

104

Oral Cavity & Pharynx

Cervix Uteri

Male Female

3.78

3

NC*

Female

4.89

9

184

Total

13.57

18

133

Female

10.29

10

97

Ovary

Colon / Rectum Male

45.32

42

93

Female

46.56

55

118

Total

91.87

97

106 Pancreas

Esophagus Male

5.81

7

120

Male

7.73

7

91

Female

2.18

2

NC*

Female

9.06

10

110

Total

7.99

9

113

Total

16.80

17

101

Male

102.62

150

146 ^+

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.33

1

NC*

Female

1.29

1

NC*

Total

2.63

2

NC*

Kidney & Renal Pelvis

Stomach

Male

9.12

8

88

Male

7.90

8

101

Female

5.89

9

153

Female

5.11

3

NC*

Total

15.01

17

113

Total

13.02

11

85

Male

1.66

0

NC*

1.47

1

NC*

Testis

Larynx Male

4.80

2

NC*

Female

1.27

3

NC*

Total

6.07

5

82

Leukemia

Thyroid Male

7.78

5

64

Male

Female

6.45

9

140

Female

3.97

2

NC*

Total

14.23

14

98

Total

5.43

3

NC*

18

104

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

3.86

2

NC*

Female

1.93

3

NC*

Total

5.79

5

86

Lung and Bronchus

Female All Sites / Types

17.27

Male

53.87

57

106

Male

334.75

401

120 ^+

Female

44.42

49

110

Female

313.35

393

125 ^+

Total

98.28

106

108

Total

648.10

794

123 ^+

Exp

Obs

SIR

Dighton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.14

5

121

Male

3.09

1

NC*

Female

1.41

2

NC*

Female

2.22

1

NC*

Total

5.55

7

126

Total

5.31

2

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

1.40

3

NC*

Male

0.86

2

NC*

Female

1.06

0

NC*

Female

0.71

1

NC*

Total

2.46

3

NC*

Total

1.58

3

NC*

Male

0.21

1

NC*

Male

3.48

5

144

Female

25.34

34

134

Female

2.83

3

NC*

Total

25.54

35

137

Total

6.32

8

127

Male

2.74

4

NC*

Female

1.23

0

NC*

Total

3.97

4

NC*

Female

2.91

4

NC*

1.88

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.36

2

NC*

Colon / Rectum

Ovary

Male

10.43

9

86

Female

9.21

7

76

Total

19.64

16

81

Esophagus Male

Pancreas 1.56

1

NC*

Male

Female

0.44

0

NC*

Female

1.79

2

NC*

Total

2.00

1

NC*

Total

3.67

2

NC*

Male

27.10

26

96

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.64

0

NC*

Female

0.48

1

NC*

Total

1.12

1

NC* Stomach

Kidney & Renal Pelvis Male

2.62

0

NC*

Male

1.82

2

NC*

Female

1.47

2

NC*

Female

0.99

1

NC*

Total

4.09

2

NC*

Total

2.82

3

NC*

Male

1.42

0

NC*

Male

0.99

1

NC*

Female

0.34

1

NC*

Total

1.76

1

NC*

Male

2.13

4

NC*

Male

0.62

1

NC*

Female

1.55

0

NC*

Female

1.63

3

NC*

Total

3.68

4

NC*

Total

2.25

4

NC*

3

NC*

Larynx

Testis

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.12

1

NC*

Female

0.40

1

NC*

Female

4.84

Total

1.52

2

NC*

Lung and Bronchus Male

All Sites / Types 13.39

15

112

Male

87.40

84

96

Female

10.41

15

144

Female

78.13

85

109

Total

23.79

30

126

Total

165.53

169

102

Exp

Obs

SIR

Douglas

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

3.31

3

NC*

Male

2.62

3

NC*

Female

1.22

0

NC*

Female

1.97

1

NC*

Total

4.53

3

NC*

Total

4.59

4

NC*

0.70

1

NC*

Brain and Other Nervous System Male

1.24

Multiple Myeloma 0

NC*

Male

Female

0.98

2

NC*

Female

0.61

1

NC*

Total

2.22

2

NC*

Total

1.31

2

NC*

6

204

Breast

Non-Hodgkin('s) Lymphoma Male

0.17

0

NC*

Male

2.94

Female

21.67

24

111

Female

2.48

2

NC*

Total

21.83

24

110

Total

5.42

8

148

Oral Cavity & Pharynx

Cervix Uteri Female

1.23

1

NC*

Male

2.33

3

NC*

Female

1.05

2

NC*

Total

3.38

5

148

Female

2.52

1

NC*

Ovary

Colon / Rectum Male

8.41

9

107

Female

8.04

4

NC*

Total

16.45

13

79

Male

1.28

0

NC*

Male

1.53

3

NC*

Female

0.38

0

NC*

Female

1.54

1

NC*

Total

1.66

0

NC*

Total

3.07

4

NC*

Male

22.04

15

68

NC*

Male

1.49

1

NC*

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.60

2

NC*

Female

0.48

0

NC*

Total

1.08

2

NC* Stomach

Kidney & Renal Pelvis Male

2.17

1

Female

1.26

2

NC*

Female

0.87

1

NC*

Total

3.43

3

NC*

Total

2.36

2

NC*

Male

0.95

0

NC*

Larynx

Testis Male

1.18

1

NC*

Female

0.28

0

NC*

Total

1.45

1

NC*

Leukemia

Thyroid Male

1.82

3

NC*

Male

0.55

0

NC*

Female

1.42

1

NC*

Female

1.51

4

NC*

Total

3.24

4

NC*

Total

2.07

4

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.94

0

NC*

Female

0.35

0

NC*

Total

1.28

0

NC*

Male

10.77

6

56

Female

8.75

5

Total

19.52

11

Female

4.07

4

NC*

Male

71.80

61

85

57

Female

67.58

60

89

56

Total

139.38

121

87

Exp

Obs

SIR

All Sites / Types

Lung and Bronchus

Dover

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.60

4

NC*

Male

3.29

1

NC*

Female

1.34

0

NC*

Female

2.22

4

NC*

Total

5.94

4

NC*

Total

5.50

5

91

Multiple Myeloma

Brain and Other Nervous System Male

1.45

0

NC*

Male

0.96

1

NC*

Female

1.05

3

NC*

Female

0.72

1

NC*

Total

2.50

3

NC*

Total

1.67

2

NC*

Male

0.23

0

NC*

Male

3.66

3

NC*

Female

26.75

21

79

Female

2.78

2

NC*

Total

26.97

21

78

Total

6.44

5

78

Male

3.08

1

NC*

Female

1.26

3

NC*

Total

4.34

4

NC*

Female

3.02

2

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.33

0

NC*

Colon / Rectum Male

Ovary 11.65

11

94

Female

8.60

9

105

Total

20.25

20

99

Esophagus

Pancreas

Male

1.80

0

NC*

Male

2.11

1

NC*

Female

0.42

0

NC*

Female

1.70

1

NC*

Total

2.21

0

NC*

Total

3.80

2

NC*

Male

31.97

31

97

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.55

1

NC*

Female

0.44

0

NC*

Total

0.99

1

NC*

Male

2.88

1

NC*

Male

2.02

1

NC*

Female

1.53

1

NC*

Female

0.91

0

NC*

Total

4.40

2

NC*

Total

2.94

1

NC*

Male

1.63

0

NC*

Male

0.72

1

NC*

Female

0.38

0

NC*

Total

2.01

0

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis

Leukemia

Thyroid Male

2.23

3

NC*

Male

0.61

0

NC*

Female

1.51

0

NC*

Female

1.57

2

NC*

Total

3.74

3

NC*

Liver and Intrahepatic Bile Ducts Male

1.25

Total

2.18

2

NC*

4

NC*

Uteri, Corpus and Uterus, NOS 1

NC*

Female

0.38

1

NC*

Total

1.63

2

NC*

Lung and Bronchus

Female

5.27

All Sites / Types

Male

15.24

2

NC*

Male

98.00

67

68 ~-

Female

10.85

6

55

Female

79.24

64

81

Total

26.09

8

31 ^-

Total

177.24

131

74 ^-

Exp

Obs

SIR

11.71

5

43 #-

Dracut

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 14.69

16

109

Male

Female

5.57

7

126

Female

9.52

7

74

Total

20.26

23

114

Total

21.22

12

57 #-

3.14

5

159

Multiple Myeloma

Brain and Other Nervous System Male

5.56

4

NC*

Male

Female

4.60

5

109

Female

2.86

6

210

Total

10.16

9

89

Total

6.00

11

183

Non-Hodgkin('s) Lymphoma

Breast Male

0.78

1

NC*

Male

13.09

14

107

Female

104.22

84

81 #-

Female

11.75

12

102

Total

105.00

85

81

Total

24.84

26

105

Oral Cavity & Pharynx

Cervix Uteri Female

6.05

7

116

Male

10.33

12

116

Female

4.99

6

120

Total

15.33

18

117

Female

12.18

18

148

Ovary

Colon / Rectum Male

37.53

36

96

Female

36.18

40

111

Total

73.72

76

103 Pancreas

Esophagus Male

5.80

9

155

Male

6.79

7

103

Female

1.72

1

NC*

Female

7.08

11

155

Total

7.52

10

133

Total

13.87

18

130

Male

101.72

76

75 ~-

6.47

5

77

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.72

2

NC*

Female

2.33

4

NC*

Total

5.05

6

119

Kidney & Renal Pelvis Male

Stomach 9.77

7

72

Male

Female

6.08

8

132

Female

3.86

4

NC*

Total

15.86

15

95

Total

10.33

9

87

Male

4.44

8

180

Testis

Larynx Male

5.35

5

94

Female

1.40

2

NC*

Total

6.75

7

104

Leukemia

Thyroid

Male

8.01

8

100

Male

2.51

3

NC*

Female

6.39

7

110

Female

7.53

2

NC*

Total

14.41

15

104

Total

10.03

5

50

19.71

21

107

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

4.22

5

118

Female

1.59

2

NC*

Total

5.81

7

121

Female All Sites / Types

Lung and Bronchus Male

49.54

66

133 #+

Male

325.22

310

95

Female

42.73

53

124

Female

320.34

334

104

Total

92.27

119

129 ~+

Total

645.55

644

100

Exp

Obs

SIR

Dudley

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

6.29

8

127

Male

4.54

1

NC*

Female

2.27

1

NC*

Female

3.49

2

NC*

Total

8.56

9

105

Total

8.03

3

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

2.10

2

NC*

Male

1.29

2

NC*

Female

1.70

0

NC*

Female

1.14

0

NC*

Total

3.79

2

NC*

Total

2.44

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.31

0

NC*

Male

5.18

3

NC*

Female

39.46

35

89

Female

4.56

7

153

Total

39.77

35

88

Total

9.74

10

103

4.02

2

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

2.12

1

NC*

Colon / Rectum

Female

1.93

0

NC*

Total

5.95

2

NC*

Female

4.57

7

153

Ovary

Male

15.84

19

120

Female

14.82

13

88

Total

30.66

32

104 Pancreas

Esophagus Male

2.34

3

NC*

Male

2.83

3

NC*

Female

0.70

0

NC*

Female

2.90

3

NC*

Total

3.04

3

NC*

Total

5.72

6

105

Male

41.19

38

92

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.95

2

NC*

Female

0.79

1

NC*

Total

1.73

3

NC*

Male

3.86

3

NC*

Male

2.75

3

NC*

Female

2.35

3

NC*

Female

1.59

2

NC*

Total

6.21

6

97

Total

4.34

5

115

Male

1.46

0

NC*

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

2.11

3

NC*

Female

0.54

2

NC*

Total

2.64

5

189

Leukemia

Thyroid Male

3.20

3

NC*

Male

0.90

1

NC*

Female

2.48

0

NC*

Female

2.56

2

NC*

Total

5.68

3

NC*

Total

3.46

3

NC*

11

146

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.66

0

NC*

Female

0.64

2

NC*

Total

2.30

2

NC*

Female

7.53

All Sites / Types

Lung and Bronchus Male

20.32

22

108

Male

131.79

129

98

Female

16.76

13

78

Female

123.69

110

89

Total

37.08

35

94

Total

255.48

239

94

Exp

Obs

SIR

1.18

1

NC*

Dunstable

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 1.31

0

NC*

Male

Female

0.39

0

NC*

Female

0.89

0

NC*

Total

1.70

0

NC*

Total

2.07

1

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.57

2

NC*

Male

0.30

0

NC*

Female

0.41

0

NC*

Female

0.22

0

NC*

Total

0.98

2

NC*

Total

0.52

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.07

0

NC*

Male

1.27

2

NC*

Female

9.75

5

51

Female

0.94

0

NC*

Total

9.82

5

51

Total

2.21

2

NC*

Male

1.10

3

NC*

Female

0.43

0

NC*

Total

1.53

3

NC*

Female

1.12

1

NC*

0.64

0

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 0.59

0

NC*

Colon / Rectum

Ovary

Male

3.40

2

NC*

Female

2.52

3

NC*

Total

5.92

5

84

Esophagus Male

Pancreas 0.58

0

NC*

Male

Female

0.12

0

NC*

Female

0.49

0

NC*

Total

0.70

0

NC*

Total

1.13

0

NC*

Male

9.93

15

151

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.27

Prostate 0

NC*

Female

0.22

0

NC*

Total

0.49

0

NC* Stomach

Kidney & Renal Pelvis

Larynx

Male

0.98

0

NC*

Male

0.60

0

NC*

Female

0.52

0

NC*

Female

0.26

0

NC*

Total

1.50

0

NC*

Total

0.86

0

NC*

Testis

Male

0.41

0

NC*

NC*

Male

0.26

0

NC*

1

NC*

Female

0.76

0

NC*

1

NC*

Total

1.02

0

NC*

1.86

2

NC*

31.19

33

106

Male

0.55

0

NC*

Female

0.13

0

NC*

Total

0.68

0

NC*

Male

0.77

0

Female

0.53

Total

1.30

Thyroid

Leukemia

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.43

0

NC*

Female

0.12

0

NC*

Total

0.54

0

NC*

Lung and Bronchus Male

Female All Sites / Types

4.62

3

NC*

Male

Female

3.48

3

NC*

Female

27.42

15

55 #-

Total

8.10

6

74

Total

58.60

48

82

Exp

Obs

SIR

Duxbury

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

9.60

9

94

Male

7.61

13

171

Female

3.46

6

173

Female

5.76

4

NC*

Total

13.06

15

115

Total

13.37

17

127

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

3.42

2

NC*

Male

2.09

3

NC*

Female

2.70

3

NC*

Female

1.82

3

NC*

Total

6.12

5

82

Total

3.92

6

153

5

60

Non-Hodgkin('s) Lymphoma

Breast Male

0.50

1

NC*

Male

Female

68.55

62

90

Female

7.08

6

85

Total

69.05

63

91

Total

15.36

11

72

Oral Cavity & Pharynx

Cervix Uteri Female

8.29

3.49

4

NC*

Male

7.16

3

NC*

Female

3.22

2

NC*

Total

10.39

5

48

Female

7.71

9

117

Ovary

Colon / Rectum Male

24.55

18

73

Female

22.57

24

106

Total

47.11

42

89

Male

3.95

2

NC*

Male

4.54

3

NC*

Female

1.08

2

NC*

Female

4.36

4

NC*

Total

5.03

4

NC*

Total

8.90

7

79

Male

68.97

78

113

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.41

3

NC*

Female

1.14

2

NC*

Total

2.55

5

196 Stomach

Kidney & Renal Pelvis Male

6.57

5

76

Male

4.30

4

NC*

Female

3.82

8

209

Female

2.42

0

NC*

Total

10.39

13

125

Larynx

Total

6.73

4

NC*

Male

1.91

5

261

Testis Male

3.70

2

NC*

Female

0.91

2

NC*

Total

4.61

4

NC* Thyroid

Leukemia Male

5.03

6

119

Male

1.51

0

NC*

Female

3.97

7

177

Female

4.13

6

145

Total

8.99

13

145

Total

5.64

6

106

13.32

15

113

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

2.86

1

NC*

Female

0.98

1

NC*

Total

3.84

2

NC*

Male

32.64

20

61 #-

Male

213.86

196

92

Female

26.76

31

116

Female

203.08

217

107

Total

59.40

51

86

Total

416.94

413

99

Female All Sites / Types

Lung and Bronchus

East Bridgewater

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Exp

Obs

SIR

5.53

4

NC*

Melanoma of Skin 6.51

7

107

Male

Female

2.40

2

NC*

Female

4.39

6

137

Total

8.91

9

101

Total

9.92

10

101

1.43

4

NC*

Multiple Myeloma

Brain and Other Nervous System Male

2.64

4

NC*

Male

Female

2.09

1

NC*

Female

1.27

2

NC*

Total

4.73

5

106

Total

2.70

6

222

Non-Hodgkin('s) Lymphoma

Breast Male

0.35

0

NC*

Male

6.08

1

NC*

Female

49.17

47

96

Female

5.18

5

97

Total

49.52

47

95

Total

11.26

6

53

Oral Cavity & Pharynx

Cervix Uteri Female

2.80

3

NC*

Male

5.00

6

120

Female

2.29

2

NC*

Total

7.29

8

110

Female

5.66

4

NC*

Ovary

Colon / Rectum Male

16.77

22

131

Female

15.60

17

109

Total

32.37

39

120

Esophagus

Pancreas

Male

2.69

5

186

Male

3.09

2

NC*

Female

0.74

0

NC*

Female

3.03

5

165

Total

3.43

5

146

Total

6.12

7

114

Male

46.45

56

121

2.94

2

NC*

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.30

1

NC*

Female

1.02

3

NC*

Total

2.32

4

NC*

Kidney & Renal Pelvis Male

Stomach 4.59

5

109

Male

Female

2.76

2

NC*

Female

1.66

1

NC*

Total

7.34

7

95

Total

4.60

3

NC*

Male

2.07

6

289 #+

Larynx

Testis Male

2.52

2

NC*

Female

0.65

3

NC*

Total

3.17

5

158

Male

3.71

3

NC*

Male

1.21

1

NC*

Female

2.89

2

NC*

Female

3.47

4

NC*

Total

6.60

5

76

Total

4.68

5

107

9.39

5

53

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.99

2

NC*

Female

0.69

0

NC*

Total

2.68

2

NC*

Female All Sites / Types

Lung and Bronchus Male

22.23

29

130

Male

148.67

170

114

Female

19.07

17

89

Female

145.96

148

101

Total

41.29

46

111

Total

294.63

318

108

Exp

Obs

SIR

East Brookfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

1.57

2

NC*

Male

1.10

0

NC*

Female

0.48

1

NC*

Female

0.76

1

NC*

Total

2.05

3

NC*

Total

1.87

1

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.49

0

NC*

Male

0.32

0

NC*

Female

0.37

0

NC*

Female

0.24

0

NC*

Total

0.86

0

NC*

Total

0.57

0

NC*

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.08

1

NC*

Male

1.26

Female

8.58

10

117

Female

0.98

1

NC*

Total

8.66

11

127

Total

2.24

1

NC*

0.98

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.47

1

NC*

Colon / Rectum

Female

0.42

0

NC*

Total

1.39

0

NC*

Female

0.99

1

NC*

Ovary

Male

3.91

2

NC*

Female

3.19

3

NC*

Total

7.10

5

70

Esophagus

Pancreas

Male

0.57

0

NC*

Male

0.70

1

NC*

Female

0.15

0

NC*

Female

0.62

0

NC*

Total

0.72

0

NC*

Total

1.31

1

NC*

Male

9.89

6

61

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.21

0

NC*

Female

0.17

0

NC*

Total

0.38

0

NC* Stomach

Kidney & Renal Pelvis Male

0.95

0

NC*

Male

0.68

1

NC*

Female

0.50

0

NC*

Female

0.34

1

NC*

Total

1.45

0

NC*

Total

1.03

2

NC*

Male

0.31

0

NC*

NC*

Male

0.21

0

NC*

Larynx

Testis Male

0.51

1

NC*

Female

0.11

0

NC*

Total

0.62

1

NC*

Leukemia

Thyroid Male

0.78

0

Female

0.53

0

NC*

Female

0.57

0

NC*

Total

1.31

0

NC*

Total

0.78

0

NC*

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.41

0

NC*

Female

0.14

0

NC*

Total

0.54

0

NC*

Lung and Bronchus

Female All Sites / Types

1.63

Male

4.94

5

101

Male

31.99

21

66

Female

3.55

2

NC*

Female

26.69

25

94

Total

8.49

7

82

Total

58.68

46

78

Exp

Obs

SIR

East Longmeadow

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

11.27

11

98

Male

7.80

13

167

Female

4.34

4

NC*

Female

5.92

6

101

Total

15.62

15

96

Total

13.72

19

139

Multiple Myeloma

Brain and Other Nervous System Male

3.45

2

NC*

Male

2.31

3

NC*

Female

2.86

4

NC*

Female

2.13

1

NC*

Total

6.31

6

95

Total

4.44

4

NC*

Male

0.56

0

NC*

Male

8.85

9

102

Female

69.75

78

112

Female

8.20

8

98

Total

70.30

78

111

Total

17.05

17

100

Male

7.03

3

NC*

Female

3.50

9

257 #+

Total

10.53

12

114

Female

7.98

6

75

5.04

5

99

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

3.40

0

NC* Ovary

Colon / Rectum Male

28.32

23

81

Female

28.32

31

109

Total

56.65

54

95 Pancreas

Esophagus Male

4.19

0

NC*

Male

Female

1.34

2

NC*

Female

5.53

3

NC*

Total

5.54

2

NC*

Total

10.57

8

76

Male

74.58

61

82

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.40

2

NC*

Female

1.18

2

NC*

Total

2.58

4

NC* Stomach

Kidney & Renal Pelvis Male

6.79

6

88

Male

4.88

5

102

Female

4.21

4

NC*

Female

3.11

6

193

Total

11.00

10

91

Total

7.99

11

138

Male

3.76

3

NC*

Male

1.99

2

NC*

Female

0.96

0

NC*

Total

4.72

3

NC*

Male

5.43

4

NC*

Male

1.45

0

NC*

Female

4.49

3

NC*

Female

3.92

4

NC*

Total

9.92

7

71

Total

5.37

4

NC*

16

119

Testis

Larynx

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.93

1

NC*

Female

1.21

1

NC*

Female

13.44

Total

4.14

2

NC*

Lung and Bronchus

All Sites / Types

Male

36.57

20

55 ~-

Male

Female

30.36

Total

66.93

233.55

184

79 ^-

25

82

45

67 ~-

Female

222.64

231

104

Total

456.19

415

91

Exp

Obs

SIR

Eastham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

6.05

10

165

Male

3.45

2

NC*

Female

1.94

0

NC*

Female

2.27

5

221

Total

7.99

10

125

Total

5.72

7

122

1.16

7

601 ^+

Multiple Myeloma

Brain and Other Nervous System Male

1.42

2

NC*

Male

Female

1.14

3

NC*

Female

0.93

0

NC*

Total

2.56

5

195

Total

2.09

7

334 #+

8

194

Breast

Non-Hodgkin('s) Lymphoma Male

0.27

0

NC*

Male

Female

27.47

49

178 ^+

Female

3.56

2

NC*

Total

27.74

49

177 ^+

Total

7.69

10

130

Oral Cavity & Pharynx

Cervix Uteri Female

4.13

1.22

0

NC*

Colon / Rectum

Male

2.95

2

NC*

Female

1.44

2

NC*

Total

4.39

4

NC*

Female

3.16

3

NC*

Ovary

Male

14.78

12

81

Female

12.71

20

157

Total

27.49

32

116

Male

1.96

2

NC*

Male

2.53

4

NC*

Female

0.60

0

NC*

Female

2.51

1

NC*

Total

2.56

2

NC*

Total

5.03

5

99

Male

35.02

55

157 ~+

NC*

Male

2.52

1

NC*

Esophagus

Pancreas

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.48

1

NC*

Female

0.42

1

NC*

Total

0.90

2

NC*

Kidney & Renal Pelvis Male

Stomach 3.11

2

Female

1.78

2

NC*

Female

1.35

0

NC*

Total

4.89

4

NC*

Total

3.88

1

NC*

Male

0.62

1

NC*

Larynx

Testis Male

1.66

2

NC*

Female

0.40

0

NC*

Total

2.06

2

NC*

Leukemia

Thyroid Male

2.59

1

NC*

Male

0.52

0

NC*

Female

1.81

5

276

Female

1.34

1

NC*

Total

4.40

6

136

Total

1.86

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.32

3

NC*

Female

0.54

0

NC*

Total

1.86

3

NC*

Male

18.21

16

88

Female

13.44

11

Total

31.65

27

Female

5.35

9

168

Male

112.27

135

120 #+

82

Female

92.41

124

134 ~+

85

Total

204.67

259

127 ^+

Exp

Obs

SIR

All Sites / Types

Lung and Bronchus

Easthampton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

10.03

11

110

Male

7.27

8

110

Female

3.96

2

NC*

Female

5.81

4

NC*

Total

13.99

13

93

Total

13.07

12

92

Multiple Myeloma

Brain and Other Nervous System Male

3.30

3

NC*

Male

2.06

2

NC*

Female

2.83

5

177

Female

1.95

3

NC*

Total

6.13

8

131

Total

4.01

5

125

Male

0.50

1

NC*

Male

8.29

13

157

Female

64.86

73

113

Female

7.79

9

116

Total

65.36

74

113

Total

16.08

22

137

Male

6.31

6

95

Female

3.23

0

NC*

Total

9.55

6

63

Female

7.54

5

66

Non-Hodgkin('s) Lymphoma

Breast

Oral Cavity & Pharynx

Cervix Uteri Female

3.51

1

NC* Ovary

Colon / Rectum Male

25.17

21

83

Female

26.09

22

84

Total

51.26

43

84 Pancreas

Esophagus Male

3.67

6

163

Male

4.48

9

201

Female

1.23

1

NC*

Female

5.07

5

99

Total

4.90

7

143

Total

9.54

14

147

Male

63.99

55

86

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.54

1

NC*

Female

1.32

1

NC*

Total

2.86

2

NC*

Male

6.13

7

114

Male

4.37

4

NC*

Female

3.91

3

NC*

Female

2.81

2

NC*

Total

10.04

10

100

Total

7.19

6

83

Male

3.29

2

NC*

Male

2.47

1

NC*

Female

0.87

1

NC*

Total

4.16

3

NC*

Stomach

Kidney & Renal Pelvis

Testis

Larynx

Leukemia

Thyroid Male

5.08

5

98

Male

1.45

0

NC*

Female

4.20

3

NC*

Female

4.23

3

NC*

Total

9.28

8

86

Liver and Intrahepatic Bile Ducts Male

2.63

Total

5.68

3

NC*

9

73

Uteri, Corpus and Uterus, NOS 3

NC*

Female

1.11

0

NC*

Total

3.74

3

NC*

Female

12.25

All Sites / Types

Lung and Bronchus Male

32.03

31

97

Male

207.91

201

97

Female

28.04

22

78

Female

207.88

191

92

Total

60.07

53

88

Total

415.79

392

94

Exp

Obs

SIR

9.45

13

138

Easton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 11.44

11

96

Male

Female

4.07

5

123

Female

7.44

8

108

Total

15.51

16

103

Total

16.89

21

124

2.49

1

NC*

Multiple Myeloma

Brain and Other Nervous System Male

4.43

5

113

Male

Female

3.53

4

NC*

Female

2.14

3

NC*

Total

7.96

9

113

Total

4.63

4

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.61

0

NC*

Male

10.37

4

NC*

Female

82.23

92

112

Female

8.71

5

57

Total

82.84

92

111

Total

19.09

9

47 #-

Oral Cavity & Pharynx

Cervix Uteri Female

4.77

8

168

Male

8.63

14

162

Female

3.85

3

NC*

Total

12.47

17

136

Female

9.50

7

74

Ovary

Colon / Rectum Male

29.41

30

102

Female

26.47

28

106

Total

55.88

58

104 Pancreas

Esophagus Male

4.71

5

106

Male

5.41

6

111

Female

1.26

4

NC*

Female

5.13

8

156

Total

5.97

9

151

Total

10.54

14

133

Male

82.09

82

100

NC*

Male

5.14

3

NC*

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.09

2

NC*

Female

1.77

2

NC*

Total

3.86

4

NC*

Kidney & Renal Pelvis Male

Stomach 7.92

4

Female

4.60

1

NC*

Female

2.87

3

NC*

Total

12.53

5

40 #-

Total

8.01

6

75

Male

3.26

3

NC*

Testis

Larynx Male

4.40

3

NC*

Female

1.07

0

NC*

Total

5.47

3

NC*

Leukemia

Thyroid

Male

6.30

10

159

Male

2.02

4

NC*

Female

4.93

4

NC*

Female

5.94

6

101

Total

11.23

14

125

Total

7.96

10

126

15.57

7

45 #-

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.44

2

NC*

Female

1.16

0

NC*

Total

4.60

2

NC*

Lung and Bronchus

Female All Sites / Types

Male

39.08

43

110

Male

259.14

252

97

Female

31.57

23

73

Female

245.18

238

97

Total

70.66

66

93

Total

504.32

490

97

Exp

Obs

SIR

Edgartown

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

2.57

5

195

Male

1.92

2

NC*

Female

0.91

1

NC*

Female

1.44

1

NC*

Total

3.48

6

172

Total

3.36

3

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.86

2

NC*

Male

0.54

0

NC*

Female

0.68

0

NC*

Female

0.46

0

NC*

Total

1.54

2

NC*

Total

1.00

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.13

0

NC*

Male

2.15

1

NC*

Female

16.50

13

79

Female

1.83

1

NC*

Total

16.63

13

78

Total

3.98

2

NC*

1.73

1

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.88

1

NC*

Colon / Rectum

Female

0.80

2

NC*

Total

2.53

3

NC*

Female

1.90

1

NC*

Ovary

Male

6.48

4

NC*

Female

5.90

8

136

Total

12.38

12

97

Esophagus

Pancreas

Male

0.98

1

NC*

Male

1.17

2

NC*

Female

0.28

1

NC*

Female

1.16

1

NC*

Total

1.26

2

NC*

Total

2.33

3

NC*

Male

16.99

18

106

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.37

0

NC*

Female

0.31

1

NC*

Total

0.69

1

NC*

Male

1.64

2

NC*

Male

1.14

0

NC*

Female

0.96

0

NC*

Female

0.64

0

NC*

Total

2.60

2

NC*

Total

1.78

0

NC*

Male

0.56

0

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

0.89

3

NC*

Female

0.22

1

NC*

Total

1.12

4

NC*

Leukemia

Thyroid Male

1.30

0

NC*

Male

0.38

0

NC*

Female

1.00

0

NC*

Female

1.06

0

NC*

Total

2.30

0

NC*

Total

1.43

0

NC*

4

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.70

0

NC*

Female

0.26

1

NC*

Total

0.96

1

NC*

Lung and Bronchus

Female

3.17

All Sites / Types

Male

8.33

7

84

Male

54.36

54

99

Female

6.81

5

73

Female

50.70

44

87

Total

15.14

12

79

Total

105.06

98

93

Exp

Obs

SIR

0.83

0

NC*

Egremont

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 1.34

0

NC*

Male

Female

0.41

0

NC*

Female

0.54

0

NC*

Total

1.75

0

NC*

Total

1.38

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.35

0

NC*

Male

0.26

0

NC*

Female

0.26

1

NC*

Female

0.20

0

NC*

Total

0.60

1

NC*

Total

0.46

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.06

0

NC*

Male

0.97

0

NC*

Female

6.47

4

NC*

Female

0.77

0

NC*

Total

6.53

4

NC*

Total

1.73

0

NC*

Male

0.74

0

NC*

Female

0.33

1

NC*

Total

1.07

1

NC*

Female

0.74

1

NC*

0.58

1

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 0.31

1

NC*

Colon / Rectum

Ovary

Male

3.31

4

NC*

Female

2.67

0

NC*

Total

5.99

4

NC*

Esophagus Male

Pancreas 0.46

0

NC*

Male

Female

0.13

0

NC*

Female

0.52

1

NC*

Total

0.59

0

NC*

Total

1.10

2

NC*

Male

8.22

7

85

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.13

Prostate 0

NC*

Female

0.10

0

NC*

Total

0.23

0

NC* Stomach

Kidney & Renal Pelvis

Larynx

Male

0.74

1

NC*

Male

0.58

0

NC*

Female

0.39

0

NC*

Female

0.29

0

NC*

Total

1.13

1

NC*

Total

0.87

0

NC*

Testis

Male

0.16

0

NC*

NC*

Male

0.14

0

NC*

0

NC*

Female

0.35

0

NC*

0

NC*

Total

0.49

0

NC*

1.25

1

NC*

62 #-

Male

0.40

0

NC*

Female

0.09

0

NC*

Total

0.49

0

NC*

Male

0.59

0

Female

0.41

Total

1.00

Thyroid

Leukemia

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.32

0

NC*

Female

0.11

0

NC*

Total

0.43

0

NC*

Lung and Bronchus Male

Female All Sites / Types

4.12

2

NC*

Male

26.02

16

Female

2.86

0

NC*

Female

20.73

12

58

Total

6.98

2

NC*

Total

46.75

28

60 ~-

Exp

Obs

SIR

Erving

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

1.15

1

NC*

Male

0.80

0

NC*

Female

0.38

1

NC*

Female

0.57

0

NC*

Total

1.54

2

NC*

Total

1.37

0

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.35

0

NC*

Male

0.24

0

NC*

Female

0.27

0

NC*

Female

0.19

0

NC*

Total

0.62

0

NC*

Total

0.43

0

NC*

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.06

0

NC*

Male

Female

6.57

6

91

Female

0.76

2

NC*

Total

6.63

6

91

Total

1.67

4

NC*

Cervix Uteri Female

0.91

Oral Cavity & Pharynx 0.34

1

NC*

Colon / Rectum

Male

0.72

0

NC*

Female

0.32

1

NC*

Total

1.04

1

NC*

Female

0.75

2

NC*

Ovary

Male

2.89

4

NC*

Female

2.52

1

NC*

Total

5.42

5

92

Male

0.43

0

NC*

Male

0.52

0

NC*

Female

0.12

1

NC*

Female

0.49

0

NC*

Total

0.55

1

NC*

Total

1.01

0

NC*

Male

7.57

6

79

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.14

0

NC*

Female

0.12

0

NC*

Total

0.26

0

NC* Stomach

Kidney & Renal Pelvis Male

0.70

0

NC*

Male

0.50

0

NC*

Female

0.39

0

NC*

Female

0.27

0

NC*

Total

1.09

0

NC*

Larynx

Total

0.77

0

NC*

Male

0.21

0

NC*

Testis Male

0.38

1

NC*

Female

0.09

0

NC*

Total

0.47

1

NC*

Leukemia

Thyroid Male

0.55

1

NC*

Male

0.15

0

NC*

Female

0.40

0

NC*

Female

0.41

1

NC*

Total

0.95

1

NC*

Total

0.56

1

NC*

1.26

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.30

0

NC*

Female

0.11

0

NC*

Total

0.41

0

NC*

Male

3.73

3

NC*

Male

23.83

21

88

Female

2.81

2

NC*

Female

20.63

19

92

Total

6.54

5

76

Total

44.46

40

90

Exp

Obs

SIR

Lung and Bronchus

Female All Sites / Types

Essex

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

2.09

5

239

Male

1.52

2

NC*

Female

0.76

2

NC*

Female

1.14

4

NC*

Total

2.85

7

246

Total

2.66

6

225

Multiple Myeloma

Brain and Other Nervous System Male

0.69

0

NC*

Male

0.44

1

NC*

Female

0.56

5

891 ^+

Female

0.38

0

NC*

Total

1.25

5

401 #+

Total

0.82

1

NC*

Male

0.11

0

NC*

Male

1.72

2

NC*

Female

13.21

23

174 #+

Female

1.51

0

NC*

Total

13.31

23

173 #+

Total

3.23

2

NC*

Male

1.36

0

NC*

Female

0.65

1

NC*

Total

2.00

1

NC*

Female

1.52

1

NC*

0.94

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.68

3

NC*

Colon / Rectum Male

Ovary 5.25

5

95

Female

4.97

3

NC*

Total

10.22

8

78

Esophagus Male

Pancreas 0.78

2

NC*

Male

Female

0.24

0

NC*

Female

0.97

2

NC*

Total

1.02

2

NC*

Total

1.91

2

NC*

Male

13.69

16

117

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.30

0

NC*

Female

0.25

0

NC*

Total

0.54

0

NC*

Kidney & Renal Pelvis

Stomach

Male

1.31

0

NC*

Male

0.91

1

NC*

Female

0.78

1

NC*

Female

0.53

1

NC*

Total

2.09

1

NC*

Total

1.44

2

NC*

Male

0.71

1

NC*

Male

0.44

0

NC*

Female

0.18

0

NC*

Total

0.89

1

NC*

Larynx

Testis

Leukemia

Thyroid Male

1.06

0

NC*

Male

0.29

1

NC*

Female

0.83

1

NC*

Female

0.81

1

NC*

Total

1.89

1

NC*

Total

1.10

2

NC*

2.54

2

NC*

43.77

44

101

Liver and Intrahepatic Bile Ducts Male

0.56

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.21

0

NC*

Total

0.78

0

NC*

Lung and Bronchus Male

Female All Sites / Types

6.77

2

NC*

Male

Female

5.59

11

197

Female

41.27

67

162 ^+

Total

12.36

13

105

Total

85.04

111

131 ~+

Exp

Obs

SIR

Everett

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

22.33

21

94

Male

15.68

7

45 #-

Female

10.28

6

58

Female

14.23

6

42 #-

Total

32.61

27

83

Total

29.91

13

43 ^-

4.49

3

NC*

Brain and Other Nervous System Male

7.20

Multiple Myeloma 12

167

Male

Female

6.96

6

86

Female

4.92

1

NC*

Total

14.16

18

127

Total

9.41

4

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

1.09

2

NC*

Male

18.16

22

121

Female

156.38

151

97

Female

19.64

16

81

Total

157.47

153

97

Total

37.80

38

101

Oral Cavity & Pharynx

Cervix Uteri Female

8.52

8

94

Male

13.37

20

150

Female

7.99

10

125

Total

21.35

30

140

Female

18.35

20

109

Ovary

Colon / Rectum Male

55.95

62

111

Female

67.71

83

123

Total

123.66

145

117

Male

7.97

8

100

Male

9.83

15

153

Female

3.18

2

NC*

Female

13.16

14

106

Total

11.15

10

90

Total

22.99

29

126

Male

140.24

133

95

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

3.46

6

173

Female

3.31

4

NC*

Total

6.78

10

148

Kidney & Renal Pelvis Male

Stomach 13.14

15

114

Male

9.67

11

114

Female

9.65

18

187 #+

Female

7.42

11

148

Total

22.79

33

145

Total

17.09

22

129

Male

5.78

7

121

Testis

Larynx Male

7.04

11

156

Female

2.09

0

NC*

Total

9.13

11

120 Thyroid

Leukemia Male

11.15

11

99

Male

3.14

1

NC*

Female

10.62

14

132

Female

10.25

8

78

Total

21.77

25

115

Total

13.39

9

67

29.22

35

120

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

5.63

6

107

Female

2.87

2

NC*

Total

8.50

8

94

Male

70.66

95

134 ~+

Male

456.72

507

111 #+

Female

69.47

94

135 ~+

Female

515.45

559

108

Total

140.13

189

135 ^+

Total

972.17

1066

110 ~+

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Fairhaven

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

Exp

SIR

Bladder, Urinary

Melanoma of Skin

Male

12.84

13

101

Male

8.57

5

58

Female

4.95

4

NC*

Female

6.62

9

136

Total

17.79

17

96

Total

15.19

14

92

Multiple Myeloma

Brain and Other Nervous System Male

3.74

4

NC*

Male

2.60

0

NC*

Female

3.26

3

NC*

Female

2.42

2

NC*

Total

7.00

7

100

Total

5.02

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.63

0

NC*

Male

9.86

14

142

Female

77.26

82

106

Female

9.44

13

138

Total

77.88

82

105

Total

19.29

27

140

7.54

7

93

Oral Cavity & Pharynx

Cervix Uteri

Male Female

3.81

5

131

3.92

4

NC*

Total

11.46

11

96

Female

8.90

12

135

Ovary

Colon / Rectum Male

Female

31.98

23

72

Female

32.50

45

138 #+

Total

64.48

68

105 Pancreas

Esophagus Male

4.59

2

NC*

Male

5.63

5

89

Female

1.53

1

NC*

Female

6.36

8

126

Total

6.12

3

NC*

Total

11.99

13

108

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

81.20

85

105

147

Male

5.49

3

NC*

6

126

Female

3.49

6

172

17

139

Total

8.98

9

100

Male

2.19

4

NC*

NC*

Male

1.54

2

NC*

Male

1.51

1

NC*

Female

1.36

0

NC*

Total

2.87

1

NC*

Male

7.49

11

Female

4.76

Total

12.25

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

4.06

1

NC*

Female

1.08

0

NC*

Total

5.14

1

NC*

Leukemia

Thyroid Male

6.08

3

Female

4.99

10

200

Female

4.41

2

NC*

Total

11.07

13

117

Total

5.95

4

NC*

22

148

Liver and Intrahepatic Bile Ducts Male

3.21

Uteri, Corpus and Uterus, NOS 2

NC*

Female

1.38

0

NC*

Total

4.59

2

NC*

Female

14.86

All Sites / Types

Lung and Bronchus Male

40.75

50

123

Male

258.37

259

100

Female

34.94

34

97

Female

250.84

289

115 #+

Total

75.69

84

111

Total

509.22

548

108

Exp

Obs

SIR

39.93

14

35 ^-

Fall River

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 60.69

70

115

Male

Female

28.26

37

131

Female

36.03

19

53 ~-

Total

88.95

107

120

Total

75.96

33

43 ^-

Brain and Other Nervous System

Multiple Myeloma

Male

18.07

19

105

Male

12.01

17

142

Female

17.95

22

123

Female

13.31

10

75

Total

36.02

41

114

Total

25.32

27

107

Non-Hodgkin('s) Lymphoma

Breast Male

2.88

4

NC*

Male

46.84

55

117

Female

404.39

334

83 ^-

Female

52.18

53

102

Total

407.26

338

83 ^-

Total

99.02

108

109

Male

34.09

48

141 #+

Female

21.11

23

109

Total

55.20

71

129 #+

Female

47.24

40

85

Oral Cavity & Pharynx

Cervix Uteri Female

20.75

26

125 Ovary

Colon / Rectum Male

150.54

149

99

Female

186.51

159

85 #-

Total

337.05

308

91 Pancreas

Esophagus Male

20.89

23

110

Male

26.26

22

84

Female

8.73

9

103

Female

36.22

34

94

Total

29.62

32

108

Male

7.96

Total

62.48

56

90

Male

367.62

380

103

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) 8

100

Female

7.98

6

75

Total

15.95

14

88 Stomach

Kidney & Renal Pelvis Male

34.21

39

114

Male

26.03

34

131

Female

25.42

21

83

Female

20.57

35

170 ~+

Total

59.63

60

101

Total

46.60

69

148 ~+

Male

12.45

12

96

Testis

Larynx Male

18.19

28

154 #+

Female

5.44

13

239 ~+

Total

23.63

41

173 ~+

Male

29.33

33

113

Male

7.41

8

108

Female

28.51

21

74

Female

24.30

19

78

Total

57.84

54

93

Total

31.72

27

85

75.89

72

95

Thyroid

Leukemia

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

14.60

19

130

Female

7.83

8

102

Total

22.43

27

120

Female All Sites / Types

Lung and Bronchus Male

187.53

256

137 ^+

Male

1198.85

1334

111 ^+

Female

184.69

148

80 ~-

Female

1360.10

1219

90 ^-

Total

372.22

404

109

Total

2558.96

2553

100

Exp

Obs

SIR

Falmouth

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

29.34

44

150 #+

Male

17.84

32

179 ~+

Female

10.24

22

215 ~+

Female

12.81

22

172 #+

Total

39.57

66

167 ^+

Total

30.64

54

176 ^+

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

7.57

10

132

Male

5.74

10

174

Female

6.35

8

126

Female

4.95

12

243 #+

Total

13.91

18

129

Total

10.69

22

206 ~+

20.99

20

95

Non-Hodgkin('s) Lymphoma

Breast Male

1.36

7

516 ~+

Male

Female

152.47

190

125 ~+

Female

19.01

19

100

Total

153.83

197

128 ^+

Total

40.00

39

98

15.58

14

90

Oral Cavity & Pharynx

Cervix Uteri

Male Female

7.13

15

210 #+

7.87

7

89

Total

23.45

21

90

Female

17.52

22

126

Ovary

Colon / Rectum Male

72.31

73

101

Female

66.98

77

115

Total

139.29

150

108

Esophagus

Female

Pancreas

Male

9.94

5

50

Male

12.55

10

80

Female

3.16

2

NC*

Female

13.15

16

122

Total

13.10

7

53

Total

25.69

26

101

Male

177.47

231

130 ^+

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.76

0

NC*

Female

2.50

4

NC*

Total

5.26

4

NC*

Kidney & Renal Pelvis

Stomach

Male

15.84

18

114

Male

12.42

9

72

Female

9.58

10

104

Female

7.23

9

124

Total

25.42

28

110

Total

19.66

18

92

Male

3.71

2

NC*

130

Male

2.92

0

NC*

Testis

Larynx Male

8.57

14

163

Female

2.17

3

NC*

Total

10.74

17

158

Leukemia

Thyroid Male

13.06

17

Female

10.04

9

90

Female

8.04

11

137

Total

23.10

26

113

Total

10.96

11

100

38

129

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

6.78

6

89

Female

2.84

3

NC*

Total

9.61

9

94

Female

29.50

All Sites / Types

Lung and Bronchus Male

90.21

99

110

Male

564.26

664

118 ^+

Female

70.92

79

111

Female

502.34

607

121 ^+

Total

161.13

178

110

Total

1066.59

1271

119 ^+

Exp

Obs

SIR

Fitchburg

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

25.33

40

158 ~+

Male

17.08

9

53

Female

11.06

19

172 #+

Female

14.57

5

34 ~-

Total

36.39

59

162 ^+

Total

31.65

14

44 ^-

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

7.92

6

76

Male

5.02

7

139

Female

7.34

7

95

Female

5.21

1

NC*

Total

15.26

13

85

Total

10.23

8

78

23

115

Non-Hodgkin('s) Lymphoma

Breast Male

1.21

0

NC*

Male

20.02

Female

160.29

144

90

Female

20.66

19

92

Total

161.50

144

89

Total

40.68

42

103

14.55

19

131

Oral Cavity & Pharynx

Cervix Uteri

Male Female

8.54

7

82

Female

8.34

7

84

Total

22.88

26

114

Female

18.87

12

64

Ovary

Colon / Rectum Male

63.08

57

90

Female

72.83

72

99

Total

135.91

129

95

Esophagus Male

Pancreas 8.82

13

147

Male

11.03

9

82

Female

3.41

3

NC*

Female

14.15

5

35 #-

Total

12.23

16

131

Total

25.18

14

56 #-

Male

155.31

143

92

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

3.65

1

NC*

Female

3.42

2

NC*

Total

7.07

3

NC* Stomach

Kidney & Renal Pelvis Male

14.47

16

111

Male

10.92

9

82

Female

10.06

7

70

Female

8.08

9

111

Total

24.53

23

94

Total

19.00

18

95

Male

7.71

7

91

Male

5.87

7

119

Female

2.14

2

NC*

Total

9.84

9

91

Male

12.56

9

72

Male

3.30

4

NC*

Female

11.51

6

52

Female

10.20

12

118

Total

24.07

15

62

Total

13.50

16

118

29.88

28

94

507.35

499

98

Testis

Larynx

Thyroid

Leukemia

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

6.19

4

NC*

Female

3.07

2

NC*

Total

9.26

6

65 All Sites / Types

Lung and Bronchus Male

Female

78.82

86

109

Male

Female

72.27

72

100

Female

538.09

481

89 #-

Total

151.09

158

105

Total

1045.44

980

94 #-

Exp

Obs

SIR

Florida

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.53

0

NC*

Male

0.40

1

NC*

Female

0.17

0

NC*

Female

0.28

1

NC*

Total

0.70

0

NC*

Total

0.68

2

NC*

0.11

0

NC*

Brain and Other Nervous System Male

0.18

Multiple Myeloma 0

NC*

Male

Female

0.13

0

NC*

Female

0.09

0

NC*

Total

0.32

0

NC*

Total

0.20

0

NC*

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.03

0

NC*

Male

0.45

Female

3.16

2

NC*

Female

0.35

0

NC*

Total

3.19

2

NC*

Total

0.79

1

NC*

Cervix Uteri Female Colon / Rectum

Oral Cavity & Pharynx 0.17

0

NC* Ovary

Male

0.37

0

NC*

Female

0.15

0

NC*

Total

0.52

0

NC*

Male

1.34

2

NC*

Female

1.12

0

NC*

Total

2.46

2

NC*

Male

0.21

1

NC*

Female

0.05

0

NC*

Total

0.26

1

NC*

0.36

0

NC*

Male

0.24

0

NC*

Female

0.22

0

NC*

Total

0.46

0

NC*

Male

3.64

5

137

NC*

Male

0.24

0

NC*

Pancreas

Esophagus

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.08

0

NC*

Female

0.06

1

NC*

Total

0.14

1

NC* Stomach

Kidney & Renal Pelvis Male

Female

0.34

0

Female

0.18

0

NC*

Female

0.12

0

NC*

Total

0.52

0

NC*

Total

0.36

0

NC*

Male

0.12

0

NC*

Larynx

Testis Male

0.19

0

NC*

Female

0.04

1

NC*

Total

0.23

1

NC*

Leukemia

Thyroid Male

0.27

0

NC*

Male

0.08

0

NC*

Female

0.20

0

NC*

Female

0.21

0

NC*

Total

0.47

0

NC*

Total

0.29

0

NC*

0.60

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.15

0

NC*

Female

0.05

0

NC*

Total

0.20

0

NC*

Male

1.74

1

NC*

Male

11.43

11

96

Female

1.27

0

NC*

Female

9.67

7

72

Total

3.01

1

NC*

Total

21.10

18

85

Exp

Obs

SIR

7.69

12

156

Lung and Bronchus

Female All Sites / Types

Foxborough

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 10.22

5

49

Male

Female

3.49

4

NC*

Female

5.75

10

174

Total

13.71

9

66

Total

13.43

22

164 #+

2.14

2

NC*

Multiple Myeloma

Brain and Other Nervous System Male

3.52

4

NC*

Male

Female

2.75

0

NC*

Female

1.78

2

NC*

Total

6.27

4

NC*

Total

3.92

4

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.52

0

NC*

Male

8.62

6

70

Female

64.32

78

121

Female

7.16

9

126

Total

64.84

78

120

Total

15.79

15

95

6.89

8

116

Cervix Uteri

Oral Cavity & Pharynx Male

Female

3.58

2

NC*

Female

3.09

3

NC*

Total

9.98

11

110

Female

7.44

9

121

Ovary

Colon / Rectum Male

25.92

21

81

Female

22.68

27

119

Total

48.61

48

99

Male

3.95

5

127

Male

4.67

5

107

Female

1.08

1

NC*

Female

4.42

4

NC*

Total

5.02

6

119

Total

9.09

9

99

Male

69.46

72

104

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.60

2

NC*

Female

1.33

2

NC*

Total

2.92

4

NC* Stomach

Kidney & Renal Pelvis Male

6.52

6

92

Male

4.49

1

NC*

Female

3.73

6

161

Female

2.45

4

NC*

Total

10.25

12

117

Total

6.95

5

72

Male

2.48

1

NC*

152

Male

1.55

2

NC*

Testis

Larynx Male

3.60

4

NC*

Female

0.86

0

NC*

Total

4.46

4

NC*

Leukemia

Thyroid Male

5.26

8

Female

3.95

9

228 #+

Female

4.38

4

NC*

Total

9.20

17

185 #+

Total

5.94

6

101

12.23

13

106

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

2.82

0

NC*

Female

0.99

3

NC*

Total

3.81

3

NC*

Male

33.79

23

68

Male

219.85

204

93

Female

26.17

32

122

Female

197.38

242

123 ~+

Total

59.95

55

92

Total

417.23

446

107

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Framingham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

Exp

SIR

Bladder, Urinary

Melanoma of Skin

Male

39.56

36

91

Male

29.27

39

133

Female

15.76

14

89

Female

24.30

24

99

Total

55.32

50

90

Total

53.57

63

118

Multiple Myeloma

Brain and Other Nervous System Male

13.42

16

119

Male

8.15

10

123

Female

11.57

10

86

Female

7.77

9

116

Total

24.99

26

104

Total

15.92

19

119

Male

1.99

5

251

Male

33.28

26

78

Female

265.22

310

117 ~+

Female

31.30

40

128

Total

267.21

315

118 ~+

Total

64.57

66

102

Non-Hodgkin('s) Lymphoma

Breast

Cervix Uteri Female

Oral Cavity & Pharynx 15.07

17

113

100.02

101

28

110

Female

13.08

12

92

Total

38.56

40

104

Female

31.03

28

90

17.80

12

67

101

Female

103.00

108

105

Total

203.02

209

103 Pancreas

Esophagus Male

25.48

Ovary

Colon / Rectum Male

Male

14.80

13

88

Male

Female

4.86

3

NC*

Female

20.05

18

90

Total

19.66

16

81

Total

37.85

30

79

Male

260.35

259

99

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

6.49

5

77

Female

5.76

4

NC*

Total

12.25

9

73 Stomach

Kidney & Renal Pelvis Male

24.47

29

119

Male

17.30

19

110

Female

15.78

14

89

Female

11.30

10

88

Total

40.25

43

107

Total

28.60

29

101

Male

13.32

9

68

Male

10.77

16

149

Female

3.51

1

NC*

Total

16.83

10

59

Male

20.14

25

124

Male

6.04

4

NC*

Female

17.05

20

117

Female

18.46

25

135

Total

37.20

45

121

Total

24.50

29

118

49.65

46

93

836.95

833

100

Testis

Larynx

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

10.54

15

142

Female

4.42

7

158

Total

14.96

22

147 All Sites / Types

Lung and Bronchus Male

Female

128.71

103

80 #-

Male

Female

111.44

114

102

Female

841.65

897

107

Total

240.15

217

90

Total

1678.60

1730

103

Exp

Obs

SIR

Franklin

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

12.15

11

91

Male

10.48

12

114

Female

4.55

3

NC*

Female

8.53

15

176

Total

16.70

14

84

Total

19.01

27

142

2.67

3

NC*

Multiple Myeloma

Brain and Other Nervous System Male

5.20

4

NC*

Male

Female

4.19

7

167

Female

2.37

1

NC*

Total

9.39

11

117

Total

5.04

4

NC*

8

69

Breast

Non-Hodgkin('s) Lymphoma Male

0.66

0

NC*

Male

11.57

Female

91.60

94

103

Female

9.89

14

142

Total

92.26

94

102

Total

21.46

22

103

Oral Cavity & Pharynx

Cervix Uteri Female

5.54

6

108

Male

9.42

9

96

Female

4.30

4

NC*

Total

13.72

13

95

Female

10.73

11

103

Ovary

Colon / Rectum Male

31.43

39

124

Female

29.43

33

112

Total

60.86

72

118

Male

5.07

4

NC*

Male

5.79

6

104

Female

1.40

4

NC*

Female

5.72

4

NC*

Total

6.47

8

124

Total

11.51

10

87

Male

88.02

76

86

5.49

4

NC*

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.62

1

NC*

Female

2.20

1

NC*

Total

4.82

2

NC* Stomach

Kidney & Renal Pelvis Male

8.65

5

58

Male

Female

5.19

2

NC*

Female

3.21

2

NC*

Total

13.83

7

51

Total

8.70

6

69

Male

4.23

6

142

Testis

Larynx Male

4.76

4

NC*

Female

1.18

3

NC*

Total

5.94

7

118 Thyroid

Leukemia Male

7.19

4

NC*

Male

2.36

2

NC*

Female

5.79

8

138

Female

7.03

6

85

Total

12.97

12

92

Total

9.39

8

85

17.19

11

64

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.75

2

NC*

Female

1.31

2

NC*

Total

5.06

4

NC*

Male

41.96

32

76

Male

281.64

249

88

Female

35.10

38

108

Female

275.19

281

102

Total

77.06

70

91

Total

556.84

530

95

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Freetown

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

5.11

3

NC*

Male

4.28

3

NC*

Female

1.75

1

NC*

Female

3.17

3

NC*

Total

6.86

4

NC*

Total

7.45

6

81

Multiple Myeloma

Brain and Other Nervous System Male

1.95

1

NC*

Male

1.12

1

NC*

Female

1.47

0

NC*

Female

0.93

2

NC*

Total

3.43

1

NC*

Total

2.06

3

NC*

Non-Hodgkin('s) Lymphoma

Breast Male

0.27

0

NC*

Male

4.65

4

NC*

Female

36.40

38

104

Female

3.72

4

NC*

Total

36.68

38

104

Total

8.38

8

96

3.94

2

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

2.00

2

NC*

1.69

3

NC*

Total

5.63

5

89

Female

4.14

4

NC*

Ovary

Colon / Rectum Male

Female

13.12

9

69

Female

11.38

2

NC*

Total

24.50

11

45 ~-

Esophagus

Pancreas

Male

2.12

1

NC*

Male

2.44

1

NC*

Female

0.54

0

NC*

Female

2.20

4

NC*

Total

2.66

1

NC*

Total

4.63

5

108

Male

36.44

28

77

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.91

0

NC*

Female

0.69

2

NC*

Total

1.59

2

NC*

Male

3.59

2

NC*

Male

2.32

0

NC*

Female

2.01

1

NC*

Female

1.22

1

NC*

Total

5.60

3

NC*

Total

3.54

1

NC*

Male

1.99

3

NC*

Male

1.38

3

NC*

Female

0.48

0

NC*

Total

2.47

3

NC* 0.91

0

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis

Leukemia

Thyroid Male

2.79

2

NC*

Male

Female

2.07

3

NC*

Female

2.44

3

NC*

Total

4.87

5

103

Total

3.34

3

NC*

5

71

Liver and Intrahepatic Bile Ducts Male

1.56

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.50

0

NC*

Total

2.06

0

NC*

Female

7.00

All Sites / Types

Lung and Bronchus Male

17.33

16

92

Male

115.54

84

73 ~-

Female

13.88

4

NC*

Female

106.77

85

80 #-

Total

31.21

20

64 #-

Total

222.31

169

76 ^-

Gardner

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Exp

Obs

SIR

10.33

9

87

Melanoma of Skin 14.87

17

114

Male

Female

5.88

3

NC*

Female

7.74

3

NC*

Total

20.75

20

96

Total

18.08

12

66

2.98

2

NC*

Multiple Myeloma

Brain and Other Nervous System Male

4.69

1

NC*

Male

Female

3.81

3

NC*

Female

2.79

3

NC*

Total

8.50

4

NC*

Total

5.77

5

87

Non-Hodgkin('s) Lymphoma

Breast Male

0.72

1

NC*

Male

11.95

15

125

Female

86.58

77

89

Female

10.92

9

82

Total

87.30

78

89

Total

22.88

24

105

Oral Cavity & Pharynx

Cervix Uteri Female

4.52

5

111

Male

8.87

9

101

Female

4.47

6

134

Total

13.34

15

112

Female

10.11

18

178 #+

Ovary

Colon / Rectum Male

37.20

47

126

Female

38.62

46

119

Total

75.82

93

123

Esophagus

Pancreas

Male

5.29

6

113

Male

6.54

4

NC*

Female

1.81

0

NC*

Female

7.51

10

133

Total

7.11

6

84

Total

14.05

14

100

Male

92.93

87

94

6.45

4

NC*

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.20

0

NC*

Female

1.73

0

NC*

Total

3.92

0

NC*

Kidney & Renal Pelvis Male

Stomach 8.70

8

92

Male

Female

5.37

4

NC*

Female

4.29

1

NC*

Total

14.08

12

85

Total

10.75

5

47

Male

3.59

2

NC*

Testis

Larynx Male

4.67

7

150

Female

1.16

0

NC*

Total

5.83

7

120

Male

7.33

8

109

Male

2.03

1

NC*

Female

6.03

5

83

Female

5.33

5

94

Total

13.36

13

97

Total

7.37

6

81

16.24

14

86

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.73

3

NC*

Female

1.63

1

NC*

Total

5.36

4

NC*

Female All Sites / Types

Lung and Bronchus Male

46.79

43

92

Male

302.20

292

97

Female

38.66

37

96

Female

287.55

273

95

Total

85.44

80

94

Total

589.75

565

96

Exp

Obs

SIR

Georgetown

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

4.27

4

NC*

Male

3.49

6

172

Female

1.42

1

NC*

Female

2.58

4

NC*

Total

5.69

5

88

Total

6.07

10

165

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

1.62

1

NC*

Male

0.93

0

NC*

Female

1.21

1

NC*

Female

0.76

0

NC*

Total

2.83

2

NC*

Total

1.69

0

NC*

11

289 ~+

Breast

Non-Hodgkin('s) Lymphoma Male

0.23

0

NC*

Male

3.81

Female

29.44

27

92

Female

3.05

5

164

Total

29.67

27

91

Total

6.86

16

233 ~+

3.24

1

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

1.63

2

NC*

Colon / Rectum

Female

1.37

1

NC*

Total

4.61

2

NC*

Female

3.36

1

NC*

Ovary

Male

10.96

12

109

Female

9.27

11

119

Total

20.23

23

114

Esophagus

Pancreas

Male

1.77

0

NC*

Male

2.03

2

NC*

Female

0.44

1

NC*

Female

1.80

2

NC*

Total

2.21

1

NC*

Total

3.82

4

NC*

Male

30.85

23

75

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.72

0

NC*

Female

0.57

0

NC*

Total

1.29

0

NC* Stomach

Kidney & Renal Pelvis Male

2.97

3

NC*

Male

1.92

1

NC*

Female

1.64

0

NC*

Female

0.98

2

NC*

Total

4.61

3

NC*

Total

2.90

3

NC*

Male

1.05

2

NC*

NC*

Male

0.72

1

NC*

Larynx

Testis Male

1.66

0

NC*

Female

0.39

0

NC*

Total

2.05

0

NC*

Leukemia

Thyroid Male

2.32

1

Female

1.69

0

NC*

Female

1.99

1

NC*

Total

4.02

1

NC*

Total

2.72

2

NC*

5

88

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.29

0

NC*

Female

0.41

0

NC*

Total

1.70

0

NC*

Lung and Bronchus

Female All Sites / Types

5.66

Male

14.61

13

89

Male

96.50

88

91

Female

11.38

14

123

Female

86.81

81

93

Total

25.99

27

104

Total

183.31

169

92

Exp

Obs

SIR

0.84

0

NC*

Gill

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 1.11

2

NC*

Male

Female

0.34

1

NC*

Female

0.59

0

NC*

Total

1.46

3

NC*

Total

1.43

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.37

0

NC*

Male

0.23

1

NC*

Female

0.27

0

NC*

Female

0.18

0

NC*

Total

0.65

0

NC*

Total

0.41

1

NC*

Male

0.06

0

NC*

Male

0.93

2

NC*

Female

6.79

6

88

Female

0.71

1

NC*

Total

6.85

6

88

Total

1.65

3

NC*

Male

0.77

2

NC*

Female

0.32

0

NC*

Total

1.08

2

NC*

Female

0.77

0

NC*

0.51

1

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.36

0

NC*

Colon / Rectum

Ovary

Male

2.82

0

NC*

Female

2.23

2

NC*

Total

5.05

2

NC*

Esophagus Male

Pancreas 0.43

0

NC*

Male

Female

0.11

0

NC*

Female

0.43

1

NC*

Total

0.54

0

NC*

Total

0.95

2

NC*

Male

7.53

4

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.16

0

NC*

Female

0.12

0

NC*

Total

0.29

0

NC*

Kidney & Renal Pelvis

Stomach

Male

0.72

0

NC*

Male

0.49

0

NC*

Female

0.38

0

NC*

Female

0.24

1

NC*

Total

1.10

0

NC*

Total

0.73

1

NC*

Male

0.40

0

NC*

Male

0.24

0

NC*

Female

0.09

0

NC*

Total

0.49

0

NC*

Male

0.56

0

NC*

Male

0.17

0

NC*

Female

0.39

0

NC*

Female

0.44

0

NC*

Total

0.95

0

NC*

Total

0.61

0

NC*

0

NC*

Larynx

Testis

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.31

1

NC*

Female

0.10

0

NC*

Female

1.31

Total

0.41

1

NC*

Lung and Bronchus Male

All Sites / Types 3.65

4

NC*

Male

23.83

17

71

Female

2.67

2

NC*

Female

20.22

15

74

Total

6.31

6

95

Total

44.05

32

73

Exp

Obs

SIR

Gloucester

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

20.99

25

119

Male

14.54

14

96

Female

8.35

8

96

Female

11.58

14

121

Total

29.34

33

112

Total

26.11

28

107

4.26

5

118

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

6.50

9

138

Male

Female

5.62

8

142

Female

4.08

5

122

Total

12.11

17

140

Total

8.34

10

120

18

108

Non-Hodgkin('s) Lymphoma

Breast Male

1.02

1

NC*

Male

16.65

Female

132.95

152

114

Female

15.97

16

100

Total

133.97

153

114

Total

32.61

34

104

Oral Cavity & Pharynx

Cervix Uteri Female

6.79

10

147

Male

12.84

22

171 #+

Female

6.69

4

NC*

Total

19.53

26

133

Female

15.36

18

117

Ovary

Colon / Rectum Male

52.58

44

84

Female

54.60

60

110

Total

107.18

104

97

Male

7.64

14

183 #+

Male

9.32

13

140

Female

2.58

2

NC*

Female

10.67

11

103

Total

10.22

16

157

Total

19.99

24

120

Male

134.88

116

86

128

Male

9.11

12

132

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

2.82

4

NC*

Female

2.47

1

NC*

Total

5.28

5

95

Kidney & Renal Pelvis Male

Stomach 12.46

16

Female

8.09

12

148

Female

5.96

5

84

Total

20.55

28

136

Total

15.07

17

113

Male

4.29

6

140

Testis

Larynx Male

6.80

9

132

Female

1.82

4

NC*

Total

8.62

13

151

Leukemia

Thyroid Male

10.21

12

117

Male

2.77

1

NC*

Female

8.63

9

104

Female

7.98

3

NC*

Total

18.84

21

111

Total

10.75

4

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

5.36

7

131

Female

2.33

2

NC*

Total

7.69

9

117

Male

66.92

58

87

Female

58.42

68

Total

125.34

126

Female

25.38

28

110

Male

430.16

431

100

116

Female

428.03

468

109

101

Total

858.19

899

105

Exp

Obs

SIR

All Sites / Types

Lung and Bronchus

Goshen

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.59

0

NC*

Male

0.44

0

NC*

Female

0.21

0

NC*

Female

0.33

0

NC*

Total

0.81

0

NC*

Total

0.78

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.20

0

NC*

Male

0.13

0

NC*

Female

0.16

0

NC*

Female

0.11

0

NC*

Total

0.36

0

NC*

Total

0.23

0

NC*

Male

0.03

0

NC*

Male

0.49

0

NC*

Female

3.75

1

NC*

Female

0.43

0

NC*

Total

3.78

1

NC*

Total

0.92

0

NC*

Male

0.41

2

NC*

Female

0.18

0

NC*

Total

0.59

2

NC*

Female

0.43

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.21

0

NC*

Colon / Rectum Male

Ovary 1.51

2

NC*

Female

1.42

0

NC*

Total

2.93

2

NC*

Esophagus

Pancreas

Male

0.24

0

NC*

Male

0.27

0

NC*

Female

0.07

0

NC*

Female

0.27

1

NC*

Total

0.30

0

NC*

Total

0.54

1

NC*

Male

4.24

4

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.08

0

NC*

Female

0.07

0

NC*

Total

0.16

0

NC*

Male

0.38

2

NC*

Male

0.26

0

NC*

Female

0.22

0

NC*

Female

0.15

0

NC*

Total

0.60

2

NC*

Total

0.41

0

NC*

Male

0.22

0

NC*

Male

0.12

0

NC*

Female

0.05

0

NC*

Total

0.27

0

NC*

Kidney & Renal Pelvis

Stomach

Larynx

Testis

Leukemia

Thyroid Male

0.30

0

NC*

Male

0.09

1

NC*

Female

0.23

0

NC*

Female

0.25

0

NC*

Total

0.53

0

NC*

Liver and Intrahepatic Bile Ducts Male

0.17

Total

0.34

1

NC*

0.71

2

NC*

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.06

0

NC*

Total

0.23

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

2.02

1

NC*

Male

13.00

12

92

Female

1.52

2

NC*

Female

11.67

7

60

Total

3.55

3

NC*

Total

24.67

19

77

Exp

Obs

SIR

0.11

0

NC*

Gosnold

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 0.18

0

NC*

Male

Female

0.04

0

NC*

Female

0.06

0

NC*

Total

0.22

0

NC*

Total

0.17

0

NC*

0.03

0

NC*

Brain and Other Nervous System Male

0.05

Multiple Myeloma 0

NC*

Male

Female

0.03

0

NC*

Female

0.02

0

NC*

Total

0.07

0

NC*

Total

0.05

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.01

0

NC*

Male

0.13

0

NC*

Female

0.63

0

NC*

Female

0.08

0

NC*

Total

0.64

0

NC*

Total

0.20

0

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 0.03

0

NC*

Colon / Rectum

Male

0.10

0

NC*

Female

0.03

0

NC*

Total

0.13

0

NC*

Female

0.07

0

NC*

Ovary

Male

0.44

0

NC*

Female

0.27

0

NC*

Total

0.71

0

NC*

Esophagus

Pancreas

Male

0.06

0

NC*

Male

0.08

0

NC*

Female

0.01

0

NC*

Female

0.05

0

NC*

Total

0.08

0

NC*

Total

0.13

0

NC*

Male

1.16

0

NC*

NC*

Male

0.08

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.02

Prostate 0

NC*

Female

0.01

0

NC*

Total

0.03

0

NC*

Kidney & Renal Pelvis Male

Stomach 0.10

0

Female

0.04

0

NC*

Female

0.03

0

NC*

Total

0.14

0

NC*

Total

0.11

0

NC*

Male

0.02

0

NC*

Larynx

Testis Male

0.06

0

NC*

Female

0.01

0

NC*

Total

0.06

0

NC*

Leukemia

Thyroid

Male

0.08

0

NC*

Male

0.02

0

NC*

Female

0.04

0

NC*

Female

0.04

0

NC*

Total

0.12

0

NC*

Total

0.06

0

NC*

0.12

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.04

0

NC*

Female

0.01

0

NC*

Total

0.05

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

0.57

0

NC*

Male

3.56

0

NC*

Female

0.27

0

NC*

Female

2.04

0

NC*

Total

0.84

0

NC*

Total

5.60

0

NC*

Exp

Obs

SIR

Grafton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

8.71

5

57

Male

6.54

0

NC*

Female

3.21

2

NC*

Female

5.18

4

NC*

Total

11.91

7

59

Total

11.71

4

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

3.02

5

166

Male

1.82

2

NC*

Female

2.49

2

NC*

Female

1.62

5

308

Total

5.51

7

127

Total

3.44

7

203

Non-Hodgkin('s) Lymphoma

Breast Male

0.44

2

NC*

Male

7.37

13

176

Female

57.55

67

116

Female

6.56

7

107

Total

57.99

69

119

Total

13.93

20

144

5.80

3

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

3.22

1

NC*

Female

2.79

4

NC*

Total

8.58

7

82

Female

6.67

8

120

Ovary

Colon / Rectum Male

22.01

7

32 ^-

Female

21.01

19

90

Total

43.02

26

60 ~Pancreas

Esophagus Male

3.31

2

NC*

Male

3.96

7

177

Female

0.99

1

NC*

Female

4.08

3

NC*

Total

4.31

3

NC*

Total

8.04

10

124

Male

57.86

54

93

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.39

0

NC*

Female

1.21

0

NC*

Total

2.60

0

NC*

Male

5.53

3

NC*

Male

3.83

4

NC*

Female

3.36

2

NC*

Female

2.25

2

NC*

Total

8.89

5

56

Total

6.08

6

99

Male

2.17

0

NC*

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

3.01

2

NC*

Female

0.77

0

NC*

Total

3.78

2

NC*

Leukemia

Thyroid Male

4.54

2

NC*

Male

1.32

1

NC*

Female

3.58

4

NC*

Female

3.94

3

NC*

Total

8.11

6

74

Total

5.27

4

NC*

10

92

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.38

3

NC*

Female

0.91

0

NC*

Total

3.29

3

NC*

Female

10.90

All Sites / Types

Lung and Bronchus Male

28.45

13

46 ~-

Male

185.59

137

74 ^-

Female

23.77

26

109

Female

178.66

179

100

Total

52.22

39

75

Total

364.25

316

87 #-

Exp

Obs

SIR

2.77

2

NC*

Granby

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 3.66

0

NC*

Male

Female

1.28

0

NC*

Female

2.11

0

NC*

Total

4.94

0

NC*

Total

4.88

2

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

1.27

1

NC*

Male

0.78

1

NC*

Female

1.01

1

NC*

Female

0.66

1

NC*

Total

2.28

2

NC*

Total

1.44

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.19

0

NC*

Male

3.09

2

NC*

Female

23.94

26

109

Female

2.66

1

NC*

Total

24.13

26

108

Total

5.74

3

NC*

Male

2.51

6

239

Female

1.15

0

NC*

Total

3.66

6

164

Female

2.77

0

NC*

1.68

1

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 1.31

0

NC* Ovary

Colon / Rectum Male

9.32

8

86

Female

8.26

5

61

Total

17.58

13

74

Esophagus Male

Pancreas 1.44

1

NC*

Male

Female

0.39

0

NC*

Female

1.63

1

NC*

Total

1.84

1

NC*

Total

3.31

2

NC*

Male

25.66

20

78

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.56

Prostate 1

NC*

Female

0.48

1

NC*

Total

1.04

2

NC*

Kidney & Renal Pelvis

Larynx

Stomach

Male

2.38

2

NC*

Male

1.60

1

NC*

Female

1.40

0

NC*

Female

0.88

1

NC*

Total

3.78

2

NC*

Total

2.48

2

NC*

Testis

Male

0.84

4

NC*

NC*

Male

0.55

1

NC*

1

NC*

Female

1.59

2

NC*

2

NC*

Total

2.15

3

NC*

4.60

6

130

79.94

67

84

Male

1.33

1

NC*

Female

0.33

0

NC*

Total

1.66

1

NC*

Male

1.89

1

Female

1.44

Total

3.32

Thyroid

Leukemia

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.03

0

NC*

Female

0.36

0

NC*

Total

1.39

0

NC* All Sites / Types

Lung and Bronchus Male

Female

12.38

13

105

Male

Female

9.92

10

101

Female

73.14

64

88

Total

22.30

23

103

Total

153.09

131

86

Exp

Obs

SIR

Granville

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

0.91

2

NC*

Male

0.70

0

NC*

Female

0.34

0

NC*

Female

0.53

0

NC*

Total

1.25

2

NC*

Total

1.23

0

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.33

0

NC*

Male

0.20

0

NC*

Female

0.25

0

NC*

Female

0.17

0

NC*

Total

0.57

0

NC*

Total

0.37

0

NC*

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.05

0

NC*

Male

Female

6.03

5

83

Female

0.68

0

NC*

Total

6.08

5

82

Total

1.45

0

NC*

Cervix Uteri Female

0.77

Oral Cavity & Pharynx 0.32

0

NC*

Colon / Rectum

Male

0.65

0

NC*

Female

0.29

0

NC*

Total

0.94

0

NC*

Female

0.69

1

NC*

Ovary

Male

2.31

2

NC*

Female

2.22

0

NC*

Total

4.53

2

NC*

Male

0.37

0

NC*

Male

0.42

0

NC*

Female

0.11

0

NC*

Female

0.43

0

NC*

Total

0.47

0

NC*

Total

0.85

0

NC*

Male

6.46

5

77

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.14

0

NC*

Female

0.11

0

NC*

Total

0.25

0

NC* Stomach

Kidney & Renal Pelvis Male

0.60

0

NC*

Male

0.40

1

NC*

Female

0.35

0

NC*

Female

0.24

0

NC*

Total

0.96

0

NC*

Larynx

Total

0.64

1

NC*

Male

0.19

2

NC*

Testis Male

0.34

0

NC*

Female

0.08

0

NC*

Total

0.42

0

NC*

Leukemia

Thyroid Male

0.48

0

NC*

Male

0.14

0

NC*

Female

0.37

0

NC*

Female

0.38

1

NC*

Total

0.85

0

NC*

Total

0.52

1

NC*

1.15

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.26

0

NC*

Female

0.10

0

NC*

Total

0.36

0

NC*

Male

3.08

3

NC*

Male

20.04

20

100

Female

2.48

3

NC*

Female

18.66

12

64

Total

5.56

6

108

Total

38.70

32

83

Exp

Obs

SIR

Lung and Bronchus

Female All Sites / Types

Great Barrington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

5.54

1

NC*

Male

3.90

5

128

Female

2.60

1

NC*

Female

3.40

2

NC*

Total

8.14

2

NC*

Total

7.30

7

96

Multiple Myeloma

Brain and Other Nervous System Male

1.73

4

NC*

Male

1.14

0

NC*

Female

1.65

2

NC*

Female

1.25

1

NC*

Total

3.38

6

178

Total

2.39

1

NC*

Male

0.27

1

NC*

Male

4.43

6

135

Female

39.46

30

76

Female

4.81

3

NC*

Total

39.74

31

78

Total

9.24

9

97

Male

3.46

1

NC*

Female

2.02

0

NC*

Total

5.48

1

NC*

Female

4.54

5

110

2.47

5

202

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.95

3

NC*

Colon / Rectum Male

Ovary 13.87

14

101

Female

17.12

11

64

Total

30.99

25

81 Pancreas

Esophagus Male

2.04

2

NC*

Male

Female

0.81

1

NC*

Female

3.32

2

NC*

Total

2.84

3

NC*

Total

5.79

7

121

Male

35.69

36

101

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.73

1

NC*

Female

0.69

0

NC*

Total

1.42

1

NC*

Kidney & Renal Pelvis

Stomach

Male

3.36

4

NC*

Male

2.40

2

NC*

Female

2.41

1

NC*

Female

1.89

1

NC*

Total

5.77

5

87

Total

4.30

3

NC*

Male

1.83

2

NC*

Male

1.08

0

NC*

Female

0.53

1

NC*

Total

2.36

3

NC*

Larynx

Testis

Leukemia

Thyroid Male

2.73

1

NC*

Male

0.73

0

NC*

Female

2.64

2

NC*

Female

2.24

2

NC*

Total

5.37

3

NC*

Total

2.97

2

NC*

7.51

7

93

114.04

111

97

Liver and Intrahepatic Bile Ducts Male

1.44

Uteri, Corpus and Uterus, NOS 1

NC*

Female

0.72

0

NC*

Total

2.16

1

NC* All Sites / Types

Lung and Bronchus Male

Female

17.74

17

96

Male

Female

17.40

13

75

Female

128.85

102

79 #-

Total

35.14

30

85

Total

242.90

213

88

Exp

Obs

SIR

Greenfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

12.90

10

78

Male

8.60

7

81

Female

5.84

7

120

Female

7.41

5

67

Total

18.74

17

91

Total

16.01

12

75

2.58

3

NC*

Multiple Myeloma

Brain and Other Nervous System Male

3.81

5

131

Male

Female

3.63

7

193

Female

2.75

3

NC*

Total

7.44

12

161

Total

5.34

6

112

Non-Hodgkin('s) Lymphoma

Breast Male

0.62

2

NC*

Male

9.98

8

80

Female

84.17

84

100

Female

10.67

11

103

Total

84.79

86

101

Total

20.65

19

92

Oral Cavity & Pharynx

Cervix Uteri Female

4.23

5

118

Colon / Rectum

Male

7.46

3

NC*

Female

4.37

0

NC*

Total

11.83

3

NC*

Female

9.75

12

123

Ovary

Male

32.02

30

94

Female

38.65

39

101

Total

70.67

69

98

Male

4.51

0

NC*

Male

5.62

7

124

Female

1.81

1

NC*

Female

7.47

8

107

Total

6.32

1

NC*

Total

13.09

15

115

Male

79.16

58

73 #-

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.62

1

NC*

Female

1.57

3

NC*

Total

3.19

4

NC*

Kidney & Renal Pelvis Male

Stomach 7.42

4

NC*

Male

5.55

3

NC*

Female

5.22

6

115

Female

4.29

2

NC*

Total

12.64

10

79

Total

9.83

5

51

Male

2.45

2

NC*

Testis

Larynx Male

3.97

2

NC*

Female

1.12

0

NC*

Total

5.09

2

NC*

Leukemia

Thyroid Male

6.19

5

81

Male

1.58

0

NC*

Female

5.87

11

188

Female

4.90

6

122

Total

12.06

16

133

Total

6.48

6

93

15.82

21

133

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.17

3

NC*

Female

1.62

0

NC*

Total

4.78

3

NC*

Male

40.14

40

100

Male

256.53

211

82 ~-

Female

37.78

35

93

Female

281.09

290

103

Total

77.92

75

96

Total

537.62

501

93

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Groton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.52

10

221 #+

Male

3.85

6

156

Female

1.51

0

NC*

Female

2.92

0

NC*

Total

6.03

10

166

Total

6.77

6

89

Multiple Myeloma

Brain and Other Nervous System Male

1.82

3

NC*

Male

1.00

0

NC*

Female

1.38

0

NC*

Female

0.82

1

NC*

Total

3.20

3

NC*

Total

1.82

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.24

0

NC*

Male

4.18

4

NC*

Female

32.72

28

86

Female

3.33

2

NC*

Total

32.97

28

85

Total

7.51

6

80

3.56

4

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

1.88

2

NC*

Colon / Rectum Male

Female

1.50

0

NC*

Total

5.06

4

NC*

Female

3.74

3

NC*

Ovary 11.62

5

43

Female

9.90

6

61

Total

21.52

11

51 #-

Esophagus

Pancreas

Male

1.90

0

NC*

Male

2.17

0

NC*

Female

0.47

1

NC*

Female

1.90

1

NC*

Total

2.37

1

NC*

Total

4.07

1

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

32.58

30

92

NC*

Male

2.05

0

NC*

2

NC*

Female

1.05

0

NC*

4

NC*

Total

3.11

0

NC*

Male

1.24

2

NC*

NC*

Male

0.82

1

NC*

Male

0.84

0

NC*

Female

0.68

1

NC*

Total

1.52

1

NC*

Male

3.24

2

Female

1.78

Total

5.02

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

1.79

0

NC*

Female

0.42

0

NC*

Total

2.21

0

NC*

Leukemia

Thyroid Male

2.57

1

Female

1.90

2

NC*

Female

2.34

1

NC*

Total

4.47

3

NC*

Total

3.16

2

NC*

6.23

3

NC*

Liver and Intrahepatic Bile Ducts Male

1.40

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.44

0

NC*

Total

1.84

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

15.44

10

65

Male

103.41

78

75 #-

Female

12.16

5

41 #-

Female

95.38

62

65 ^-

Total

27.60

15

54 #-

Total

198.79

140

70 ^-

Exp

Obs

SIR

2.59

1

NC*

Groveland

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 3.18

5

157

Male

Female

1.14

1

NC*

Female

1.98

3

NC*

Total

4.32

6

139

Total

4.57

4

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

1.22

1

NC*

Male

0.69

0

NC*

Female

0.95

0

NC*

Female

0.60

0

NC*

Total

2.17

1

NC*

Total

1.29

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.17

0

NC*

Male

2.85

6

210

Female

22.49

20

89

Female

2.40

2

NC*

Total

22.66

20

88

Total

5.25

8

152

Male

2.35

0

NC*

Female

1.06

0

NC*

Total

3.41

0

NC*

Female

2.58

3

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

1.24

2

NC*

Colon / Rectum

Ovary

Male

8.17

10

122

Female

7.44

8

108

Total

15.61

18

115

Esophagus

Pancreas

Male

1.30

1

NC*

Male

1.50

0

NC*

Female

0.35

0

NC*

Female

1.44

0

NC*

Total

1.65

1

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.56

Total

2.94

0

NC*

Male

22.80

19

83

Prostate 1

NC*

Female

0.45

3

NC*

Total

1.01

4

NC* Stomach

Kidney & Renal Pelvis Male

2.19

2

NC*

Male

1.41

3

NC*

Female

1.27

2

NC*

Female

0.80

0

NC*

Total

3.46

4

NC*

Total

2.21

3

NC*

Male

0.87

2

NC*

Larynx

Testis Male

1.21

3

NC*

Female

0.30

0

NC*

Total

1.51

3

NC*

Male

1.75

3

NC*

Male

0.54

1

NC*

Female

1.35

1

NC*

Female

1.51

1

NC*

Total

3.10

4

NC*

Total

2.06

2

NC*

4.31

7

163

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.95

0

NC*

Female

0.33

0

NC*

Total

1.27

0

NC*

Female All Sites / Types

Lung and Bronchus Male

10.92

11

101

Male

71.77

70

98

Female

8.83

11

125

Female

67.40

67

99

Total

19.75

22

111

Total

139.16

137

98

Exp

Obs

SIR

Hadley

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

3.69

2

NC*

Male

2.46

2

NC*

Female

1.42

2

NC*

Female

1.85

4

NC*

Total

5.11

4

NC*

Total

4.31

6

139

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

1.06

1

NC*

Male

0.74

0

NC*

Female

0.91

1

NC*

Female

0.69

0

NC*

Total

1.97

2

NC*

Total

1.43

0

NC*

5

176

Breast

Non-Hodgkin('s) Lymphoma Male

0.18

0

NC*

Male

2.84

Female

21.64

29

134

Female

2.68

5

187

Total

21.82

29

133

Total

5.52

10

181

2.11

2

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

1.06

0

NC*

Colon / Rectum

1.11

0

NC*

Total

3.21

2

NC*

Female

2.49

3

NC*

Ovary

Male

9.15

7

76

Female

9.35

6

64

Total

18.50

13

70

Esophagus

Female

Pancreas

Male

1.29

0

NC*

Male

1.60

3

NC*

Female

0.44

0

NC*

Female

1.82

1

NC*

Total

1.73

0

NC*

Total

3.42

4

NC*

Male

22.63

21

93

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.45

1

NC*

Female

0.38

0

NC*

Total

0.83

1

NC* Stomach

Kidney & Renal Pelvis Male

2.13

3

NC*

Male

1.57

2

NC*

Female

1.34

0

NC*

Female

1.00

0

NC*

Total

3.47

3

NC*

Total

2.57

2

NC*

Male

0.71

0

NC*

NC*

Male

0.45

0

NC*

Larynx

Testis Male

1.13

1

NC*

Female

0.30

0

NC*

Total

1.43

1

NC*

Leukemia

Thyroid Male

1.74

2

Female

1.41

1

NC*

Female

1.22

1

NC*

Total

3.15

3

NC*

Total

1.66

1

NC*

3

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.90

1

NC*

Female

0.40

0

NC*

Total

1.30

1

NC*

Lung and Bronchus

Female

4.15

All Sites / Types

Male

11.57

8

69

Male

73.26

66

90

Female

9.88

8

81

Female

70.85

68

96

Total

21.44

16

75

Total

144.11

134

93

Exp

Obs

SIR

Halifax

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.39

8

182

Male

3.31

2

NC*

Female

1.83

2

NC*

Female

2.79

4

NC*

Total

6.21

10

161

Total

6.10

6

98

Multiple Myeloma

Brain and Other Nervous System Male

1.51

2

NC*

Male

0.92

1

NC*

Female

1.34

0

NC*

Female

0.91

1

NC*

Total

2.85

2

NC*

Total

1.84

2

NC*

Male

0.22

0

NC*

Male

3.71

4

NC*

Female

31.66

31

98

Female

3.62

3

NC*

Total

31.88

31

97

Total

7.33

7

95

Male

2.97

4

NC*

Female

1.55

1

NC*

Total

4.52

5

111

Female

3.64

2

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.70

2

NC* Ovary

Colon / Rectum Male

11.08

20

180 #+

Female

12.02

6

50

Total

23.11

26

113

Esophagus Male

Pancreas 1.68

0

NC*

Male

2.00

4

NC*

Female

0.57

1

NC*

Female

2.32

4

NC*

Total

2.25

1

NC*

Total

4.33

8

185

Male

29.12

29

100

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.68

0

NC*

Female

0.61

1

NC*

Total

1.29

1

NC* Stomach

Kidney & Renal Pelvis Male

2.81

4

NC*

Male

1.94

3

NC*

Female

1.85

1

NC*

Female

1.30

1

NC*

Total

4.66

5

107

Total

3.24

4

NC*

Male

1.53

3

NC*

Male

1.02

0

NC*

Female

0.42

0

NC*

Total

1.95

3

NC*

Male

2.28

6

263

Male

0.66

1

NC*

Female

2.00

2

NC*

Female

2.03

0

NC*

Total

4.28

8

187

Total

2.70

1

NC*

6.01

5

83

93.42

116

124 #+

Larynx

Testis

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.21

1

NC*

Female

0.51

0

NC*

Total

1.72

1

NC* All Sites / Types

Lung and Bronchus Male

Female

14.28

18

126

Male

Female

13.13

13

99

Female

98.99

85

86

Total

27.40

31

113

Total

192.41

201

104

Exp

Obs

SIR

Hamilton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

5.31

7

132

Male

4.04

7

173

Female

1.76

1

NC*

Female

2.98

3

NC*

Total

7.07

8

113

Total

7.02

10

142

1.13

1

NC*

Multiple Myeloma

Brain and Other Nervous System Male

1.85

2

NC*

Male

Female

1.41

2

NC*

Female

0.92

2

NC*

Total

3.26

4

NC*

Total

2.05

3

NC*

7

156

Breast

Non-Hodgkin('s) Lymphoma Male

0.27

0

NC*

Male

Female

34.16

32

94

Female

3.67

2

NC*

Total

34.44

32

93

Total

8.17

9

110

Oral Cavity & Pharynx

Cervix Uteri Female Colon / Rectum

4.50

1.85

2

NC* Ovary

Male

3.67

3

NC*

Female

1.62

0

NC*

Total

5.28

3

NC*

Male

13.51

8

59

Female

11.39

11

97

Total

24.90

19

76

Male

2.09

0

NC*

Female

0.54

1

NC*

Total

2.63

1

NC*

3.92

2

NC*

Male

2.45

3

NC*

Female

2.23

2

NC*

Total

4.67

5

107

Male

36.85

23

62 #-

NC*

Male

2.34

1

NC*

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.82

1

NC*

Female

0.66

2

NC*

Total

1.47

3

NC*

Kidney & Renal Pelvis Male

Female

Stomach 3.46

3

Female

1.95

0

NC*

Female

1.22

2

NC*

Total

5.41

3

NC*

Total

3.55

3

NC*

Male

1.23

1

NC*

Larynx

Testis Male

1.92

0

NC*

Female

0.46

0

NC*

Total

2.38

0

NC*

Leukemia

Thyroid Male

2.74

4

NC*

Male

0.81

0

NC*

Female

2.01

2

NC*

Female

2.25

2

NC*

Total

4.75

6

126

Total

3.06

2

NC*

6.58

3

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.50

1

NC*

Female

0.50

1

NC*

Total

2.00

2

NC*

Male

17.80

10

56

Male

115.60

90

78 #-

Female

13.74

7

51

Female

102.76

85

83

Total

31.54

17

54 ~-

Total

218.36

175

80 ~-

Exp

Obs

SIR

Lung and Bronchus

Female All Sites / Types

Hampden

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

2.88

3

NC*

Male

2.23

2

NC*

Female

1.07

0

NC*

Female

1.70

2

NC*

Total

3.95

3

NC*

Total

3.94

4

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

1.00

1

NC*

Male

0.62

2

NC*

Female

0.80

1

NC*

Female

0.55

0

NC*

Total

1.80

2

NC*

Total

1.16

2

NC*

Male

0.15

0

NC*

Male

2.46

2

NC*

Female

19.87

26

131

Female

2.13

2

NC*

Total

20.02

26

130

Total

4.59

4

NC*

Male

2.06

1

NC*

Female

0.95

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 1.03

2

NC*

Colon / Rectum Male

Total

3.01

1

NC*

Female

2.25

0

NC*

Ovary 7.34

5

68

Female

6.97

4

NC*

Total

14.32

9

63

Esophagus

Pancreas

Male

1.15

0

NC*

Male

1.34

2

NC*

Female

0.33

1

NC*

Female

1.35

0

NC*

Total

1.49

1

NC*

Total

2.69

2

NC*

Male

20.19

29

144

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.43

0

NC*

Female

0.35

0

NC*

Total

0.78

0

NC*

Male

1.91

1

NC*

Male

1.28

3

NC*

Female

1.13

0

NC*

Female

0.76

0

NC*

Total

3.04

1

NC*

Total

2.04

3

NC*

Male

1.07

0

NC*

Male

0.63

0

NC*

Female

0.26

0

NC*

Total

1.33

0

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis

Leukemia

Thyroid Male

1.49

2

NC*

Male

0.45

0

NC*

Female

1.19

4

NC*

Female

1.23

3

NC*

Total

2.68

6

224

Total

1.68

3

NC*

1

NC*

Liver and Intrahepatic Bile Ducts Male

0.83

Uteri, Corpus and Uterus, NOS 1

NC*

Female

0.30

0

NC*

Total

1.13

1

NC*

Lung and Bronchus

Female

3.82

All Sites / Types

Male

9.66

7

72

Male

63.15

63

100

Female

7.90

9

114

Female

60.17

55

91

Total

17.56

16

91

Total

123.33

118

96

Exp

Obs

SIR

0.38

1

NC*

Hancock

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 0.52

0

NC*

Male

Female

0.16

0

NC*

Female

0.27

0

NC*

Total

0.69

0

NC*

Total

0.65

1

NC*

0.11

1

NC*

Brain and Other Nervous System Male

0.17

Multiple Myeloma 0

NC*

Male

Female

0.13

0

NC*

Female

0.09

0

NC*

Total

0.29

0

NC*

Total

0.20

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.03

0

NC*

Male

0.42

0

NC*

Female

3.18

0

NC*

Female

0.34

0

NC*

Total

3.20

0

NC*

Total

0.77

0

NC*

Cervix Uteri

Oral Cavity & Pharynx

Female

0.17

1

NC*

Colon / Rectum

Male

0.34

0

NC*

Female

0.15

0

NC*

Total

0.49

0

NC*

Female

0.36

0

NC*

Ovary

Male

1.32

1

NC*

Female

1.08

0

NC*

Total

2.40

1

NC*

Esophagus

Pancreas

Male

0.20

0

NC*

Male

0.24

0

NC*

Female

0.05

0

NC*

Female

0.21

0

NC*

Total

0.25

0

NC*

Total

0.45

0

NC*

Male

3.52

1

NC*

NC*

Male

0.23

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.07

Prostate 0

NC*

Female

0.06

0

NC*

Total

0.13

0

NC*

Kidney & Renal Pelvis Male

Stomach 0.33

1

Female

0.18

0

NC*

Female

0.11

0

NC*

Total

0.51

1

NC*

Total

0.34

0

NC*

Male

0.10

0

NC*

Larynx

Testis Male

0.18

0

NC*

Female

0.04

0

NC*

Total

0.22

0

NC*

Leukemia

Thyroid Male

0.26

0

NC*

Male

0.07

0

NC*

Female

0.18

0

NC*

Female

0.20

0

NC*

Total

0.44

0

NC*

Total

0.27

0

NC*

0.62

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.14

0

NC*

Female

0.05

0

NC*

Total

0.19

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

1.74

1

NC*

Male

11.06

6

54

Female

1.31

1

NC*

Female

9.58

3

NC*

Total

3.04

2

NC*

Total

20.64

9

44 ~-

Exp

Obs

SIR

Hanover

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

7.12

7

98

Male

5.93

7

118

Female

2.72

4

NC*

Female

4.73

7

148

Total

9.84

11

112

Total

10.66

14

131

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

2.78

2

NC*

Male

1.57

0

NC*

Female

2.24

4

NC*

Female

1.44

1

NC*

Total

5.02

6

120

Total

3.01

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.39

1

NC*

Male

6.47

5

77

Female

54.44

65

119

Female

5.74

7

122

Total

54.82

66

120

Total Male

Female

12.22

12

98

5.46

3

NC*

Oral Cavity & Pharynx

Cervix Uteri 2.95

2

NC*

Female

2.56

4

NC*

Total

8.01

7

87

Female

6.21

4

NC*

Ovary

Colon / Rectum Male

18.35

16

87

Female

17.71

20

113

Total

36.06

36

100

Esophagus

Pancreas

Male

2.98

4

NC*

Male

3.39

1

NC*

Female

0.85

0

NC*

Female

3.44

1

NC*

Total

3.82

4

NC*

Total

6.83

2

NC*

Male

52.08

53

102

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

1.28

0

NC*

Female

1.03

1

NC*

Total

2.31

1

NC*

Male

5.01

8

160

Male

3.19

2

NC*

Female

3.07

3

NC*

Female

1.88

3

NC*

Total

8.08

11

136

Total

5.07

5

99

Male

1.95

3

NC*

1.26

0

NC*

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

2.80

0

NC*

Female

0.73

0

NC*

Total

3.53

0

NC*

Leukemia

Thyroid Male

3.93

2

NC*

Male

Female

3.17

4

NC*

Female

3.58

4

NC*

Total

7.10

6

85

Total

4.84

4

NC*

7

67

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.18

0

NC*

Female

0.78

0

NC*

Total

2.95

0

NC*

Female

10.49

All Sites / Types

Lung and Bronchus Male

24.67

19

77

Male

162.98

135

83 #-

Female

21.50

28

130

Female

162.12

182

112

Total

46.17

47

102

Total

325.10

317

98

Exp

Obs

SIR

Hanson

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

5.10

5

98

Male

4.06

2

NC*

Female

1.85

3

NC*

Female

3.14

4

NC*

Total

6.95

8

115

Total

7.20

6

83

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System

Breast

Male

1.89

2

NC*

Male

1.10

1

NC*

Female

1.51

0

NC*

Female

0.96

0

NC*

Total

3.40

2

NC*

Total

2.06

1

NC*

Non-Hodgkin('s) Lymphoma

Male

0.27

0

NC*

Male

4.49

2

NC*

Female

35.49

35

99

Female

3.85

2

NC*

Total

35.75

35

98

Total

8.34

4

NC*

Male

3.69

4

NC*

Female

1.68

6

356 #+

Total

5.38

10

186

Female

4.07

5

123

2.38

3

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

1.96

0

NC* Ovary

Colon / Rectum Male

13.04

17

130

Female

12.08

9

74

Total

25.12

26

104 Pancreas

Esophagus Male

2.05

4

NC*

Male

Female

0.57

0

NC*

Female

2.34

1

NC*

Total

2.62

4

NC*

Total

4.72

4

NC*

Male

35.74

31

87

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.87

Prostate 0

NC*

Female

0.71

2

NC*

Total

1.58

2

NC* Stomach

Kidney & Renal Pelvis Male

3.44

1

NC*

Male

2.27

1

NC*

Female

2.02

2

NC*

Female

1.29

0

NC*

Total

5.45

3

NC*

Total

3.57

1

NC*

Male

1.32

2

NC*

Larynx

Testis Male

1.90

3

NC*

Female

0.47

0

NC*

Total

2.37

3

NC*

Male

2.75

2

NC*

Male

0.84

3

NC*

Female

2.15

3

NC*

Female

2.39

3

NC*

Total

4.91

5

102

Total

3.23

6

185

6.77

8

118

113.10

107

95

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.49

1

NC*

Female

0.53

0

NC*

Total

2.01

1

NC* All Sites / Types

Lung and Bronchus Male

Female

17.18

18

105

Male

Female

14.07

12

85

Female

107.31

100

93

Total

31.25

30

96

Total

220.41

207

94

Exp

Obs

SIR

Hardwick

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

1.80

3

NC*

Male

1.27

0

NC*

Female

0.67

0

NC*

Female

0.96

2

NC*

Total

2.47

3

NC*

Total

2.23

2

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.58

0

NC*

Male

0.37

0

NC*

Female

0.48

0

NC*

Female

0.33

0

NC*

Total

1.05

0

NC*

Breast

Total

0.69

0

NC*

2

NC*

Non-Hodgkin('s) Lymphoma Male

0.09

0

NC*

Male

1.45

Female

10.68

12

112

Female

1.31

4

NC*

Total

10.77

12

111

Total

2.77

6

217

Oral Cavity & Pharynx

Cervix Uteri Female

0.57

2

NC*

Colon / Rectum

Male

1.12

1

NC*

Female

0.54

0

NC*

Total

1.66

1

NC*

Female

1.24

1

NC*

Ovary

Male

4.51

4

NC*

Female

4.47

4

NC*

Total

8.98

8

89

Male

0.66

0

NC*

Male

0.80

0

NC*

Female

0.21

1

NC*

Female

0.86

1

NC*

Total

0.86

1

NC*

Total

1.67

1

NC*

Male

11.43

11

96

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.26

0

NC*

Female

0.22

0

NC*

Total

0.48

0

NC* Stomach

Kidney & Renal Pelvis Male

1.08

0

NC*

Male

0.79

0

NC*

Female

0.65

1

NC*

Female

0.48

0

NC*

Total

1.73

1

NC*

Total

1.27

0

NC*

Male

0.39

0

NC*

Larynx

Testis Male

0.58

0

NC*

Female

0.14

0

NC*

Total

0.73

0

NC*

Leukemia

Thyroid Male

0.90

0

NC*

Male

0.25

0

NC*

Female

0.71

0

NC*

Female

0.69

0

NC*

Total

1.61

0

NC*

Total

0.94

0

NC*

2.01

4

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.46

0

NC*

Female

0.19

0

NC*

Total

0.65

0

NC*

Male

5.68

4

NC*

Male

36.92

27

73

Female

4.68

7

150

Female

34.70

44

127

Total

10.35

11

106

Total

71.62

71

99

Exp

Obs

SIR

Lung and Bronchus

Female All Sites / Types

Harvard

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.01

1

NC*

Male

4.51

6

133

Female

1.04

1

NC*

Female

2.94

3

NC*

Total

5.06

2

NC*

Total

7.45

9

121

Brain and Other Nervous System

Multiple Myeloma

Male

2.39

3

NC*

Male

0.93

0

NC*

Female

1.38

1

NC*

Female

0.60

0

NC*

Total

3.76

4

NC*

Total

1.53

0

NC*

Male

0.24

1

NC*

Male

4.95

1

NC*

Female

28.78

17

59 #-

Female

2.78

3

NC*

Total

29.02

18

62 #-

Total

7.73

4

NC*

Male

3.73

1

NC*

Female

1.24

1

NC*

Total

4.97

2

NC*

Female

3.43

5

146

2.01

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 2.12

1

NC*

Colon / Rectum Male

Ovary 10.66

4

NC*

Female

6.80

9

132

Total

17.46

13

74 Pancreas

Esophagus Male

1.76

0

NC*

Male

Female

0.32

1

NC*

Female

1.28

0

NC*

Total

2.09

1

NC*

Total

3.29

0

NC*

Male

28.44

22

77

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

1.58

0

NC*

Female

0.88

0

NC*

Total

2.46

0

NC*

Kidney & Renal Pelvis

Stomach

Male

3.33

3

NC*

Male

1.94

0

NC*

Female

1.47

0

NC*

Female

0.73

0

NC*

Total

4.80

3

NC*

Total

2.66

0

NC*

Male

1.71

1

NC*

Male

3.02

0

NC*

Female

0.33

0

NC*

Total

2.05

1

NC*

Larynx

Testis

Leukemia

Thyroid Male

2.97

2

NC*

Male

1.25

0

NC*

Female

1.67

1

NC*

Female

2.85

4

NC*

Total

4.64

3

NC*

Total

4.10

4

NC*

5.20

6

115

102.10

57

56 ^-

Liver and Intrahepatic Bile Ducts Male

1.42

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.32

0

NC*

Total

1.74

0

NC* All Sites / Types

Lung and Bronchus Male

Female

13.94

7

50

Male

Female

9.21

3

NC*

Female

80.28

61

76 #-

Total

23.15

10

43 ~-

Total

182.38

118

65 ^-

Exp

Obs

SIR

Harwich

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

13.53

21

155

Male

7.48

12

160

Female

5.12

11

215 #+

Female

5.58

11

197

Total

18.66

32

172 ~+

Brain and Other Nervous System Male

3.05

Total

13.06

23

176 #+

2.54

4

NC*

Multiple Myeloma 3

NC*

Male

Female

2.81

1

NC*

Female

2.38

1

NC*

Total

5.86

4

NC*

Total

4.92

5

102

Non-Hodgkin('s) Lymphoma

Breast Male

0.58

0

NC*

Male

9.09

11

121

Female

67.23

94

140 ~+

Female

9.00

16

178 #+

Total

67.82

94

139 ~+

Total

18.09

27

149

Oral Cavity & Pharynx

Cervix Uteri Female

2.91

2

NC*

Male

6.36

6

94

Female

3.63

9

248 #+

Total

9.99

15

150

Female

7.71

10

130

Ovary

Colon / Rectum Male

32.80

29

88

Female

33.92

54

159 ~+

Total

66.72

83

124

Male

4.22

4

NC*

Male

5.61

11

196

Female

1.59

1

NC*

Female

6.61

6

91

Total

5.81

5

86

Total

12.21

17

139

Male

74.20

140

189 ^+

209 #+

Male

5.72

6

105

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.02

0

NC*

Female

1.01

0

NC*

Total

2.03

0

NC*

Kidney & Renal Pelvis Male

Stomach 6.69

14

Female

4.37

5

114

Female

3.70

2

NC*

Total

11.06

19

172 #+

Total

9.42

8

85

Male

1.29

3

NC*

Testis

Larynx Male

3.50

8

228

Female

0.95

1

NC*

Total

4.45

9

202

Leukemia

Thyroid Male

5.74

8

139

Male

1.10

1

NC*

Female

4.76

7

147

Female

3.12

3

NC*

Total

10.50

15

143

Total

4.21

4

NC*

12.92

21

162 #+

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.83

3

NC*

Female

1.41

0

NC*

Total

4.23

3

NC*

Male

39.04

40

102

Male

243.27

346

142 ^+

Female

32.92

30

91

Female

232.39

304

131 ^+

Total

71.96

70

97

Total

475.66

650

137 ^+

Obs

SIR

Lung and Bronchus

Female All Sites / Types

Hatfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary

Obs

Exp

SIR Melanoma of Skin

Male

2.35

1

NC*

Male

1.64

0

NC*

Female

0.93

0

NC*

Female

1.27

0

NC*

Total

3.27

1

NC*

Total

2.90

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.71

1

NC*

Male

0.48

0

NC*

Female

0.62

2

NC*

Female

0.46

0

NC*

Total

1.33

3

NC*

Total

0.94

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.12

0

NC*

Male

1.86

1

NC*

Female

14.89

15

101

Female

1.78

0

NC*

Total

15.00

15

100

Total

3.64

1

NC*

1.44

2

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.74

1

NC*

Colon / Rectum Male

Female

0.75

0

NC*

Total

2.19

2

NC*

Female

1.70

0

NC*

Ovary 5.86

4

NC*

Female

6.09

4

NC*

Total

11.96

8

67

Esophagus

Pancreas

Male

0.85

0

NC*

Male

1.04

0

NC*

Female

0.29

0

NC*

Female

1.19

1

NC*

Total

1.14

0

NC*

Total

2.23

1

NC*

Male

14.89

14

94

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.30

2

NC*

Female

0.26

0

NC*

Total

0.55

2

NC*

Male

1.41

1

NC*

Male

1.02

0

NC*

Female

0.90

0

NC*

Female

0.65

1

NC*

Total

2.32

1

NC*

Total

1.67

1

NC*

Male

0.44

0

NC*

NC*

Male

0.30

1

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

0.76

1

NC*

Female

0.21

0

NC*

Total

0.97

1

NC*

Leukemia

Thyroid Male

1.14

0

Female

0.95

0

NC*

Female

0.85

1

NC*

Total

2.08

0

NC*

Total

1.15

2

NC*

5

174

Liver and Intrahepatic Bile Ducts Male

0.60

Uteri, Corpus and Uterus, NOS 1

NC*

Female

0.26

0

NC*

Total

0.86

1

NC*

Female

2.87

All Sites / Types

Lung and Bronchus Male

7.46

7

94

Male

47.82

39

82

Female

6.60

2

NC*

Female

47.74

37

78

Total

14.06

9

64

Total

95.56

76

80 #-

Haverhill

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Exp

Obs

SIR

Melanoma of Skin

Male

29.60

38

128

Male

22.34

10

45 ~-

Female

13.19

14

106

Female

19.76

15

76

Total

42.78

52

122

Total

42.10

25

59 ~-

6.11

5

82

Multiple Myeloma

Brain and Other Nervous System Male

10.63

12

113

Male

Female

9.69

10

103

Female

6.42

3

NC*

Total

20.32

22

108

Total

12.53

8

64

19

74

Non-Hodgkin('s) Lymphoma

Breast Male

1.50

1

NC*

Male

25.55

Female

214.21

216

101

Female

25.92

33

127

Total

215.70

217

101

Total

51.47

52

101

Oral Cavity & Pharynx

Cervix Uteri Female

12.15

14

115

Male

19.16

22

115

Female

10.70

14

131

Total

29.86

36

121

Female

25.15

28

111

Ovary

Colon / Rectum Male

74.67

71

95

Female

86.80

82

94

Total

161.47

153

95

Male

10.96

11

100

Male

13.30

17

128

Female

4.08

11

270 ~+

Female

16.80

13

77

Total

15.04

22

146

Total

30.10

30

100

Male

190.34

163

86 #-

130

Male

12.98

13

100

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

5.32

8

150

Female

4.79

7

146

Total

10.11

15

148

Kidney & Renal Pelvis Male

Stomach 18.52

24

Female

12.87

8

62

Female

9.53

14

147

Total

31.39

32

102

Total

22.51

27

120

Male

8.88

6

68

Testis

Larynx Male

9.87

6

61

Female

2.79

2

NC*

Total

12.67

8

63 Thyroid

Leukemia Male

15.84

19

120

Male

4.71

3

NC*

Female

14.44

15

104

Female

14.90

9

60

Total

30.28

34

112

Total

19.61

12

61

39.87

48

120

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

7.93

11

139

Female

3.71

4

NC*

Total

11.64

15

129

Male

95.25

97

102

Male

625.70

599

96

Female

90.80

93

102

Female

690.14

703

102

Total

186.05

190

102

Total

1315.84

1302

99

Female All Sites / Types

Lung and Bronchus

Hawley

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Exp

Obs

SIR

0.23

0

NC*

Melanoma of Skin 0.38

1

NC*

Male

Female

0.10

0

NC*

Female

0.13

0

NC*

Total

0.49

1

NC*

Total

0.36

0

NC*

0.08

0

NC*

Brain and Other Nervous System Male

0.09

Multiple Myeloma 0

NC*

Male

Female

0.06

0

NC*

Female

0.05

0

NC*

Total

0.16

0

NC*

Total

0.12

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.02

1

NC*

Male

0.27

0

NC*

Female

1.56

3

NC*

Female

0.19

0

NC*

Total

1.57

4

NC*

Total

0.46

0

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 0.07

0

NC*

Colon / Rectum

Male

0.20

0

NC*

Female

0.08

0

NC*

Total

0.28

0

NC*

Female

0.18

0

NC*

Ovary

Male

0.94

0

NC*

Female

0.67

1

NC*

Total

1.61

1

NC*

Esophagus

Pancreas

Male

0.13

0

NC*

Male

0.16

0

NC*

Female

0.03

0

NC*

Female

0.13

0

NC*

Total

0.16

0

NC*

Total

0.29

0

NC*

Male

2.22

0

NC*

NC*

Male

0.16

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.03

Prostate 0

NC*

Female

0.02

0

NC*

Total

0.05

0

NC*

Kidney & Renal Pelvis Male

Stomach 0.21

0

Female

0.10

0

NC*

Female

0.07

0

NC*

Total

0.30

0

NC*

Total

0.24

0

NC*

Male

0.03

0

NC*

Larynx

Testis Male

0.11

0

NC*

Female

0.02

0

NC*

Total

0.13

0

NC*

Male

0.17

0

NC*

Male

0.03

0

NC*

Female

0.10

0

NC*

Female

0.08

0

NC*

Total

0.27

0

NC*

Total

0.11

0

NC*

0.30

0

NC*

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.09

0

NC*

Female

0.03

0

NC*

Total

0.12

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

1.14

0

NC*

Male

7.19

3

NC*

Female

0.70

0

NC*

Female

5.05

5

99

Total

1.85

0

NC*

Total

12.24

8

65

Exp

Obs

SIR

Heath

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

0.57

1

NC*

Male

0.42

1

NC*

Female

0.16

0

NC*

Female

0.27

1

NC*

Total

0.74

1

NC*

Total

0.69

2

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.19

1

NC*

Male

0.12

0

NC*

Female

0.13

0

NC*

Female

0.08

0

NC*

Total

0.31

1

NC*

Total

0.20

0

NC*

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.03

0

NC*

Male

0.47

Female

3.10

5

162

Female

0.33

1

NC*

Total

3.12

5

160

Total

0.80

1

NC*

0.39

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.16

0

NC*

Colon / Rectum

Female

0.15

0

NC*

Total

0.53

0

NC*

Female

0.35

0

NC*

Ovary

Male

1.45

1

NC*

Female

1.05

0

NC*

Total

2.50

1

NC*

Esophagus

Pancreas

Male

0.22

0

NC*

Male

0.26

0

NC*

Female

0.05

0

NC*

Female

0.20

1

NC*

Total

0.27

0

NC*

Total

0.47

1

NC*

Male

3.78

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.08

0

NC*

Female

0.06

0

NC*

Total

0.14

0

NC*

Kidney & Renal Pelvis

Stomach

Male

0.36

1

NC*

Male

0.26

0

NC*

Female

0.18

0

NC*

Female

0.12

0

NC*

Total

0.53

1

NC*

Total

0.37

0

NC*

Male

0.11

0

NC*

NC*

Male

0.08

0

NC*

Larynx

Testis Male

0.20

0

NC*

Female

0.04

0

NC*

Total

0.24

0

NC*

Leukemia

Thyroid Male

0.29

2

Female

0.19

0

NC*

Female

0.19

1

NC*

Total

0.48

2

NC*

Total

0.27

1

NC*

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.16

0

NC*

Female

0.05

0

NC*

Total

0.20

0

NC*

Lung and Bronchus

Female All Sites / Types

0.60

Male

1.83

2

NC*

Male

12.04

9

75

Female

1.22

0

NC*

Female

9.30

9

97

Total

3.04

2

NC*

Total

21.34

18

84

Exp

Obs

SIR

10.64

13

122

Hingham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 14.48

17

117

Male

Female

5.31

7

132

Female

8.12

11

135

Total

19.79

24

121

Total

18.76

24

128

Multiple Myeloma

Brain and Other Nervous System Male

4.76

2

NC*

Male

3.05

2

NC*

Female

3.87

6

155

Female

2.71

2

NC*

Total

8.63

8

93

Total

5.76

4

NC*

Male

0.74

0

NC*

Male

11.88

11

93

Female

95.86

113

118

Female

10.55

9

85

Total

96.60

113

117

Total

22.43

20

89

Male

9.68

4

NC*

Female

4.64

4

NC*

Total

14.32

8

56

Female

10.91

16

147

6.60

6

91

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

4.84

3

NC* Ovary

Colon / Rectum Male

36.63

33

90

Female

34.47

40

116

Total

71.10

73

103 Pancreas

Esophagus Male

5.60

8

143

Male

Female

1.64

0

NC*

Female

6.74

6

89

Total

7.24

8

110

Total

13.34

12

90

Male

98.90

106

107

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.98

1

NC*

Female

1.65

3

NC*

Total

3.63

4

NC* Stomach

Kidney & Renal Pelvis Male

9.20

11

120

Male

6.32

3

NC*

Female

5.58

5

90

Female

3.73

3

NC*

Total

14.79

16

108

Total

10.05

6

60

Male

5.11

4

NC*

Male

2.85

1

NC*

Female

1.31

1

NC*

Total

6.43

5

78

Male

7.25

6

83

Male

2.05

3

NC*

Female

5.79

0

NC*

Female

5.69

11

193

Total

13.04

6

46

Total

7.73

14

181

20

108

Testis

Larynx

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.98

4

NC*

Female

1.49

2

NC*

Female

18.59

Total

5.47

6

110

Lung and Bronchus

All Sites / Types

Male

48.02

28

58 ~-

Male

Female

39.74

Total

87.76

309.28

280

91

30

75

58

66 ^-

Female

293.82

309

105

Total

603.09

589

98

Exp

Obs

SIR

Hinsdale

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

1.49

1

NC*

Male

1.07

0

NC*

Female

0.51

0

NC*

Female

0.77

0

NC*

Total

2.00

1

NC*

Total

1.84

0

NC*

0.31

0

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System Male

0.47

Multiple Myeloma 0

NC*

Male

Female

0.37

1

NC*

Female

0.25

0

NC*

Total

0.84

1

NC*

Total

0.56

0

NC*

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.07

0

NC*

Male

Female

8.63

7

81

Female

1.00

1

NC*

Total

8.71

7

80

Total

2.21

2

NC*

Cervix Uteri Female

1.21

Oral Cavity & Pharynx 0.47

1

NC*

Colon / Rectum

Male

0.97

2

NC*

Female

0.43

0

NC*

Total

1.40

2

NC*

Female

1.00

5

502 ~+

Ovary

Male

3.75

5

133

Female

3.37

5

148

Total

7.12

10

141

Male

0.56

1

NC*

Male

0.67

0

NC*

Female

0.16

0

NC*

Female

0.65

0

NC*

Total

0.72

1

NC*

Total

1.32

0

NC*

Male

9.79

10

102

NC*

Male

0.66

0

NC*

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.20

0

NC*

Female

0.17

0

NC*

Total

0.37

0

NC*

Kidney & Renal Pelvis Male

Stomach 0.92

1

Female

0.51

1

NC*

Female

0.37

1

NC*

Total

1.43

2

NC*

Total

1.03

1

NC*

Male

0.29

0

NC*

Larynx

Testis Male

0.51

1

NC*

Female

0.11

0

NC*

Total

0.62

1

NC*

Leukemia

Thyroid Male

0.74

3

NC*

Male

0.20

1

NC*

Female

0.56

1

NC*

Female

0.56

0

NC*

Total

1.29

4

NC*

Total

0.76

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.40

0

NC*

Female

0.14

0

NC*

Total

0.54

0

NC*

Male

4.79

0

NC*

Female

3.58

3

Total

8.37

3

Female

1.63

1

NC*

Male

31.09

28

90

NC*

Female

27.22

28

103

NC*

Total

58.32

56

96

Exp

Obs

SIR

All Sites / Types

Lung and Bronchus

Holbrook

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

7.67

12

156

Male

5.39

0

NC*

Female

2.99

4

NC*

Female

4.36

3

NC*

Total

10.66

16

150

Total

9.75

3

NC*

1.57

1

NC*

Brain and Other Nervous System Male

2.44

Multiple Myeloma 2

NC*

Male

Female

2.11

0

NC*

Female

1.49

0

NC*

Total

4.55

2

NC*

Total

3.06

1

NC*

8

130

Breast

Non-Hodgkin('s) Lymphoma Male

0.38

0

NC*

Male

Female

49.87

40

80

Female

5.89

6

102

Total

50.25

40

80

Total

12.03

14

116

Oral Cavity & Pharynx

Cervix Uteri Female

6.14

2.61

1

NC*

Male

4.77

10

210 #+

Female

2.48

6

242

Total

7.24

16

221 ~+

Female

5.79

5

86

Ovary

Colon / Rectum Male

19.36

28

145

Female

19.33

19

98

Total

38.68

47

122

Male

2.86

4

NC*

Male

3.43

2

NC*

Female

0.92

0

NC*

Female

3.82

5

131

Total

3.78

4

NC*

Total

7.24

7

97

Male

51.44

51

99

NC*

Male

3.30

1

NC*

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.07

1

NC*

Female

0.96

1

NC*

Total

2.03

2

NC*

Kidney & Renal Pelvis Male

Stomach 4.63

2

Female

3.03

1

NC*

Female

2.08

2

NC*

Total

7.66

3

NC*

Total

5.38

3

NC*

Male

1.66

0

NC*

Larynx

Testis Male

2.57

4

NC*

Female

0.70

0

NC*

Total

3.27

4

NC*

Leukemia

Thyroid Male

3.75

4

NC*

Male

1.05

0

NC*

Female

3.12

3

NC*

Female

3.11

0

NC*

Total

6.88

7

102

Liver and Intrahepatic Bile Ducts Male

2.00

Total

4.16

0

NC*

10

104

Uteri, Corpus and Uterus, NOS 1

NC*

Female

0.84

1

NC*

Total

2.84

2

NC*

Female

9.58

All Sites / Types

Lung and Bronchus Male

25.24

38

151 #+

Male

161.01

185

115

Female

21.94

28

128

Female

158.29

143

90

Total

47.18

66

140 #+

Total

319.30

328

103

Exp

Obs

SIR

8.26

6

73

Holden

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 11.61

6

52

Male

Female

4.31

3

NC*

Female

6.24

6

96

Total

15.92

9

57

Total

14.50

12

83

2.41

0

NC*

Multiple Myeloma

Brain and Other Nervous System Male

3.66

3

NC*

Male

Female

3.02

4

NC*

Female

2.15

3

NC*

Total

6.67

7

105

Total

4.57

3

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.58

0

NC*

Male

9.29

7

75

Female

73.35

55

75 #-

Female

8.36

9

108

Total

73.93

55

74 #-

Total

17.66

16

91

Oral Cavity & Pharynx

Cervix Uteri Female

3.67

2

NC*

Colon / Rectum

Male

7.51

1

NC*

Female

3.61

1

NC*

Total

11.12

2

NC*

Female

8.36

13

156

Ovary

Male

29.17

25

86

Female

28.24

21

74

Total

57.41

46

80 Pancreas

Esophagus Male

4.37

1

NC*

Male

5.24

3

NC*

Female

1.34

0

NC*

Female

5.48

5

91

Total

5.71

1

NC*

Total

10.72

8

75

Male

76.72

69

90

5.07

1

NC*

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.47

2

NC*

Female

1.27

4

NC*

Total

2.73

6

219 Stomach

Kidney & Renal Pelvis Male

7.19

6

83

Male

Female

4.32

2

NC*

Female

3.06

1

NC*

Total

11.51

8

70

Total

8.13

2

NC*

Male

2.02

3

NC*

Larynx

Testis Male

3.96

2

NC*

Female

0.99

0

NC*

Total

4.95

2

NC*

Leukemia

Thyroid

Male

5.73

4

NC*

Male

1.54

1

NC*

Female

4.60

5

109

Female

4.28

4

NC*

Total

10.33

9

87

Total

5.82

5

86

14.13

14

99

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.10

2

NC*

Female

1.21

0

NC*

Total

4.31

2

NC*

Female All Sites / Types

Lung and Bronchus Male

37.59

28

74

Male

242.03

179

74 ^-

Female

30.95

20

65 #-

Female

229.59

185

81 ~-

Total

68.54

48

70 #-

Total

471.62

364

77 ^-

Exp

Obs

SIR

Holland

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

1.45

3

NC*

Male

1.08

0

NC*

Female

0.44

0

NC*

Female

0.76

0

NC*

Total

1.88

3

NC*

Total

1.84

0

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.50

0

NC*

Male

0.30

0

NC*

Female

0.37

0

NC*

Female

0.23

0

NC*

Total

0.87

0

NC*

Total

0.53

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.07

0

NC*

Male

1.21

1

NC*

Female

8.41

6

71

Female

0.92

2

NC*

Total

8.49

6

71

Total

2.13

3

NC*

0.98

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.48

1

NC*

Colon / Rectum

Female

0.40

0

NC*

Total

1.38

0

NC*

Female

0.98

1

NC*

Ovary

Male

3.66

5

137

Female

2.82

4

NC*

Total

6.48

9

139

Esophagus

Pancreas

Male

0.56

0

NC*

Male

0.66

0

NC*

Female

0.13

0

NC*

Female

0.55

0

NC*

Total

0.69

0

NC*

Total

1.21

0

NC*

Male

9.72

8

82

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.22

0

NC*

Female

0.18

0

NC*

Total

0.40

0

NC*

Male

0.92

1

NC*

Male

0.64

0

NC*

Female

0.48

1

NC*

Female

0.31

0

NC*

Total

1.41

2

NC*

Total

0.95

0

NC*

Male

0.32

0

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

0.51

0

NC*

Female

0.11

0

NC*

Total

0.62

0

NC*

Leukemia

Thyroid Male

0.75

1

NC*

Male

0.21

0

NC*

Female

0.52

0

NC*

Female

0.59

0

NC*

Total

1.27

1

NC*

Total

0.81

0

NC*

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.40

0

NC*

Female

0.12

0

NC*

Total

0.52

0

NC*

Lung and Bronchus

Female

1.60

All Sites / Types

Male

4.72

2

NC*

Male

30.87

22

71

Female

3.36

4

NC*

Female

25.52

20

78

Total

8.08

6

74

Total

56.39

42

74

Exp

Obs

SIR

6.43

6

93

Holliston

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 7.24

9

124

Male

Female

2.52

1

NC*

Female

4.93

4

NC*

Total

9.76

10

102

Total

11.36

10

88

Multiple Myeloma

Brain and Other Nervous System Male

3.04

2

NC*

Male

1.64

1

NC*

Female

2.29

2

NC*

Female

1.38

1

NC*

Total

5.33

4

NC*

Total

3.02

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.41

1

NC*

Male

6.90

6

87

Female

56.33

68

121

Female

5.57

10

180

Total

56.74

69

122

Total

12.47

16

128

Male

6.00

4

NC*

Female

2.56

2

NC*

Total

8.56

6

70

Female

6.41

2

NC*

3.54

1

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

3.17

1

NC* Ovary

Colon / Rectum Male

18.86

17

90

Female

16.24

15

92

Total

35.10

32

91

Esophagus Male

Pancreas 3.19

3

NC*

Male

Female

0.78

1

NC*

Female

3.16

3

NC*

Total

3.97

4

NC*

Total

6.70

4

NC*

Male

55.54

48

86

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.43

Prostate 1

NC*

Female

1.10

0

NC*

Total

2.53

1

NC*

Kidney & Renal Pelvis

Larynx

Stomach

Male

5.39

3

NC*

Male

3.29

5

152

Female

3.07

0

NC*

Female

1.74

1

NC*

Total

8.46

3

NC*

Total

5.03

6

119

Testis

Male

2.18

3

NC*

120

Male

1.41

1

NC*

3

NC*

Female

3.91

7

179

8

110

Total

5.32

8

150

10.85

10

92

172.48

142

82 #-

Male

3.05

3

NC*

Female

0.74

2

NC*

Total

3.79

5

132

Male

4.16

5

Female

3.15

Total

7.30

Thyroid

Leukemia

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

2.35

3

NC*

Female

0.73

0

NC*

Total

3.08

3

NC* All Sites / Types

Lung and Bronchus Male

Female

25.84

13

50 ~-

Male

Female

20.94

Total

46.78

18

86

Female

161.97

162

100

31

66 #-

Total

334.45

304

91

Exp

Obs

SIR

Holyoke

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

24.45

29

119

Male

16.16

16

99

Female

10.56

9

85

Female

14.38

16

111

Total

35.01

38

109

Total

30.55

32

105

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

7.69

4

NC*

Male

4.83

7

145

Female

7.34

5

68

Female

5.02

4

NC*

Total

15.03

9

60

Total

9.85

11

112

18

94

Non-Hodgkin('s) Lymphoma

Breast Male

1.15

1

NC*

Male

19.10

Female

157.91

144

91

Female

20.01

29

145

Total

159.06

145

91

Total

39.11

47

120

Oral Cavity & Pharynx

Cervix Uteri Female

8.51

17

200 #+

Male

13.79

26

189 ~+

Female

8.13

9

111

Total

21.92

35

160 #+

Female

18.56

23

124

Ovary

Colon / Rectum Male

60.60

82

135 #+

Female

69.72

70

100

Total

130.32

152

117

Male

8.39

13

155

Male

10.58

13

123

Female

3.27

2

NC*

Female

13.49

19

141

Total

11.66

15

129

Total

24.08

32

133

Male

147.14

105

71 ^-

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

3.41

4

NC*

Female

3.44

2

NC*

Total

6.85

6

88

Kidney & Renal Pelvis

Stomach

Male

13.85

10

72

Male

10.51

17

162

Female

9.78

10

102

Female

7.72

9

117

Total

23.64

20

85

Total

18.23

26

143

Male

5.19

3

NC*

Testis

Larynx Male

7.30

7

96

Female

2.08

2

NC*

Total

9.38

9

96

Leukemia

Thyroid Male

12.36

18

146

Male

3.03

2

NC*

Female

11.37

6

53

Female

10.25

10

98

Total

23.74

24

101

Total

13.28

12

90

29.43

32

109

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

5.91

4

NC*

Female

2.95

2

NC*

Total

8.86

6

68

Male

75.18

110

146 ^+

Male

483.95

523

108

Female

69.66

66

95

Female

524.43

531

101

Total

144.84

176

122 #+

Total

1008.38

1054

105

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Hopedale

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.18

5

120

Male

2.92

0

NC*

Female

1.47

1

NC*

Female

2.23

1

NC*

Total

5.65

6

106

Total

5.15

1

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

1.31

1

NC*

Male

0.85

0

NC*

Female

1.10

2

NC*

Female

0.73

2

NC*

Total

2.41

3

NC*

Total

1.58

2

NC*

Male

0.20

0

NC*

Male

3.33

2

NC*

Female

25.18

27

107

Female

2.94

6

204

Total

25.38

27

106

Total

6.26

8

128

Male

2.61

0

NC*

Female

1.24

1

NC*

Total

3.85

1

NC*

Female

2.92

2

NC*

1.87

3

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.35

0

NC*

Colon / Rectum Male

Ovary 10.48

6

57

Female

9.56

6

63

Total

20.04

12

60

Esophagus Male

Pancreas 1.54

2

NC*

Male

Female

0.45

0

NC*

Female

1.87

1

NC*

Total

1.99

2

NC*

Total

3.74

4

NC*

Male

27.17

25

92

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.56

0

NC*

Female

0.51

0

NC*

Total

1.07

0

NC*

Kidney & Renal Pelvis

Stomach

Male

2.50

0

NC*

Male

1.83

1

NC*

Female

1.51

4

NC*

Female

1.03

0

NC*

Total

4.01

4

NC*

Total

2.86

1

NC*

Male

1.38

2

NC*

Male

0.83

1

NC*

Female

0.34

0

NC*

Total

1.72

2

NC*

Larynx

Testis

Leukemia

Thyroid Male

2.05

2

NC*

Male

0.56

0

NC*

Female

1.61

0

NC*

Female

1.64

2

NC*

Total

3.66

2

NC*

Total

2.19

2

NC*

4.80

4

NC*

86.21

70

81

Liver and Intrahepatic Bile Ducts Male

1.08

Uteri, Corpus and Uterus, NOS 2

NC*

Female

0.41

0

NC*

Total

1.49

2

NC*

Lung and Bronchus Male

Female All Sites / Types

13.35

12

90

Male

Female

10.73

12

112

Female

79.33

78

98

Total

24.08

24

100

Total

165.54

148

89

Exp

Obs

SIR

Hopkinton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

5.23

2

NC*

Male

4.76

8

168

Female

1.79

2

NC*

Female

3.61

6

166

Total

7.02

4

NC*

Total

8.37

14

167

1.20

0

NC*

Multiple Myeloma

Brain and Other Nervous System Male

2.29

3

NC*

Male

Female

1.75

2

NC*

Female

0.98

0

NC*

Total

4.05

5

124

Total

2.18

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.30

0

NC*

Male

5.11

3

NC*

Female

40.31

43

107

Female

4.05

5

124

Total

40.60

43

106

Total

9.16

8

87

Oral Cavity & Pharynx

Cervix Uteri Female

2.35

5

213

Colon / Rectum

Male

4.42

3

NC*

Female

1.84

1

NC*

Total

6.26

4

NC*

Female

4.62

4

NC*

Ovary

Male

13.61

14

103

Female

11.65

11

94

Total

25.25

25

99

Male

2.30

1

NC*

Male

2.57

3

NC*

Female

0.56

3

NC*

Female

2.24

3

NC*

Total

2.86

4

NC*

Total

4.81

6

125

Male

39.46

34

86

Esophagus

Pancreas

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.09

0

NC*

Female

0.87

1

NC*

Total

1.96

1

NC*

Kidney & Renal Pelvis Male

Stomach 3.98

2

NC*

Male

2.40

3

NC*

Female

2.19

1

NC*

Female

1.23

0

NC*

Total

6.17

3

NC*

Total

3.63

3

NC*

Male

1.64

1

NC*

Larynx

Testis Male

2.21

1

NC*

Female

0.52

0

NC*

Total

2.73

1

NC*

Leukemia

Thyroid Male

3.14

6

191

Male

1.05

3

NC*

Female

2.37

3

NC*

Female

2.94

3

NC*

Total

5.51

9

163

Total

3.99

6

150

7.70

5

65

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.73

0

NC*

Female

0.52

1

NC*

Total

2.25

1

NC*

Male

18.49

15

81

Male

124.79

108

87

Female

14.81

15

101

Female

116.47

121

104

Total

33.30

30

90

Total

241.27

229

95

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Hubbardston

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

1.77

2

NC*

Male

1.52

1

NC*

Female

0.53

0

NC*

Female

1.08

1

NC*

Total

2.30

2

NC*

Total

2.60

2

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.73

0

NC*

Male

0.39

0

NC*

Female

0.52

1

NC*

Female

0.28

0

NC*

Total

1.25

1

NC*

Total

0.68

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.10

0

NC*

Male

1.65

1

NC*

Female

11.62

5

43

Female

1.19

1

NC*

Total

11.72

5

43 #-

Total

2.84

2

NC*

1.42

1

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.72

2

NC*

Colon / Rectum Male

Female

0.53

0

NC*

Total

1.95

1

NC*

Female

1.35

2

NC*

Ovary 4.59

3

NC*

Female

3.44

3

NC*

Total

8.03

6

75

Esophagus

Pancreas

Male

0.76

2

NC*

Male

0.86

1

NC*

Female

0.16

0

NC*

Female

0.66

1

NC*

Total

0.92

2

NC*

Total

1.52

2

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

13.18

4

NC*

NC*

Male

0.81

0

NC*

1

NC*

Female

0.37

1

NC*

1

NC*

Total

1.18

1

NC*

Male

0.50

1

NC*

NC*

Male

0.33

1

NC*

Male

0.34

0

NC*

Female

0.28

0

NC*

Total

0.61

0

NC*

Male

1.28

0

Female

0.63

Total

1.91

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

0.72

0

NC*

Female

0.15

0

NC*

Total

0.86

0

NC*

Leukemia

Thyroid Male

1.02

2

Female

0.70

0

NC*

Female

0.91

1

NC*

Total

1.72

2

NC*

Total

1.24

2

NC*

0

NC*

Liver and Intrahepatic Bile Ducts Male

0.56

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.15

0

NC*

Total

0.71

0

NC*

Lung and Bronchus

Female

2.18

All Sites / Types

Male

6.15

2

NC*

Male

41.26

25

61 ~-

Female

4.22

3

NC*

Female

33.92

23

68

Total

10.37

5

48

Total

75.18

48

64 ~-

Exp

Obs

SIR

7.93

11

139

Hudson

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 10.41

9

86

Male

Female

4.14

6

145

Female

6.30

3

NC*

Total

14.54

15

103

Total

14.23

14

98

Multiple Myeloma

Brain and Other Nervous System Male

3.66

1

NC*

Male

2.17

0

NC*

Female

3.03

3

NC*

Female

2.06

1

NC*

Total

6.69

4

NC*

Total

4.23

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.53

1

NC*

Male

8.94

6

67

Female

70.45

64

91

Female

8.23

3

NC*

Total

70.98

65

92

Total

17.16

9

52 #-

Male

6.98

7

100

Female

3.47

4

NC*

Total

10.45

11

105

Female

8.18

4

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

3.85

2

NC* Ovary

Colon / Rectum Male

26.40

32

121

Female

27.02

23

85

Total

53.42

55

103

Esophagus

Pancreas

Male

3.98

3

NC*

Male

4.74

5

105

Female

1.28

0

NC*

Female

5.27

4

NC*

Total

5.26

3

NC*

Male

1.76

Total

10.01

9

90

Male

69.64

74

106

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) 1

NC*

Female

1.44

2

NC*

Total

3.20

3

NC* Stomach

Kidney & Renal Pelvis Male

6.63

8

121

Male

4.58

1

NC*

Female

4.19

2

NC*

Female

2.93

4

NC*

Total

10.82

10

92

Total

7.51

5

67

Male

2.88

3

NC*

Testis

Larynx Male

3.62

7

193

Female

0.95

2

NC*

Total

4.57

9

197

Male

5.42

5

92

Male

1.65

2

NC*

Female

4.46

7

157

Female

4.66

4

NC*

Total

9.89

12

121

Total

6.31

6

95

13.35

9

67

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

2.86

2

NC*

Female

1.16

2

NC*

Total

4.02

4

NC*

Female All Sites / Types

Lung and Bronchus Male

34.17

49

143 #+

Male

223.57

239

107

Female

29.84

26

87

Female

222.26

188

85 #-

Total

64.01

75

117

Total

445.84

427

96

Exp

Obs

SIR

Hull

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

6.58

11

167

Male

5.01

6

120

Female

2.28

4

NC*

Female

3.82

1

NC*

Total

8.86

15

169

Total

8.83

7

79

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

2.32

1

NC*

Male

1.37

1

NC*

Female

1.84

0

NC*

Female

1.17

1

NC*

Total

4.15

1

NC*

Total

2.54

2

NC*

7

124

Breast

Non-Hodgkin('s) Lymphoma Male

0.33

0

NC*

Male

5.65

Female

42.50

54

127

Female

4.77

6

126

Total

42.83

54

126

Total

10.42

13

125

4.41

7

159

Oral Cavity & Pharynx

Cervix Uteri

Male Female

2.40

2

NC*

2.04

1

NC*

Total

6.45

8

124

Female

4.93

7

142

Ovary

Colon / Rectum Male

16.66

22

132

Female

14.83

16

108

Total

31.49

38

121

Esophagus

Female

Pancreas

Male

2.51

3

NC*

Male

2.99

7

234

Female

0.70

3

NC*

Female

2.90

1

NC*

Total

3.21

6

187

Total

5.90

8

136

Male

43.68

46

105

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.11

0

NC*

Female

0.90

2

NC*

Total

2.01

2

NC* Stomach

Kidney & Renal Pelvis Male

4.19

4

NC*

Male

2.91

5

172

Female

2.48

5

202

Female

1.58

1

NC*

Total

6.66

9

135

Total

4.48

6

134

Male

1.81

2

NC*

1.04

2

NC*

Testis

Larynx Male

2.28

4

NC*

Female

0.57

0

NC*

Total

2.85

4

NC*

Leukemia

Thyroid Male

3.44

2

NC*

Male

Female

2.58

3

NC*

Female

2.95

4

NC*

Total

6.01

5

83

Total

3.99

6

150

9

111

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.80

5

277

Female

0.65

2

NC*

Total

2.45

7

285 #+

Female

8.09

All Sites / Types

Lung and Bronchus Male

21.46

29

135

Male

140.81

171

121 #+

Female

17.52

30

171 ~+

Female

130.44

158

121 #+

Total

38.98

59

151 ~+

Total

271.25

329

121 ^+

Exp

Obs

SIR

Huntington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

1.40

1

NC*

Male

1.04

0

NC*

Female

0.43

0

NC*

Female

0.73

1

NC*

Total

1.83

1

NC*

Total

1.77

1

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.47

2

NC*

Male

0.29

0

NC*

Female

0.36

0

NC*

Female

0.22

0

NC*

Total

0.83

2

NC*

Total

0.51

0

NC*

Male

0.07

0

NC*

Male

1.17

0

NC*

Female

8.21

7

85

Female

0.90

0

NC*

Total

8.28

7

85

Total

2.07

0

NC*

Male

0.92

1

NC*

Female

0.39

0

NC*

Total

1.31

1

NC*

Female

0.94

1

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.46

0

NC*

Colon / Rectum

Ovary

Male

3.51

1

NC*

Female

2.84

0

NC*

Total

6.35

1

NC*

Esophagus Male

Pancreas 0.52

1

NC*

Male

0.63

0

NC*

Female

0.13

0

NC*

Female

0.55

0

NC*

Total

0.66

1

NC*

Total

1.18

0

NC*

Male

9.01

4

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.21

0

NC*

Female

0.17

0

NC*

Total

0.38

0

NC*

Kidney & Renal Pelvis

Stomach

Male

0.88

1

NC*

Male

0.62

0

NC*

Female

0.47

1

NC*

Female

0.30

0

NC*

Total

1.35

2

NC*

Total

0.92

0

NC*

Male

0.47

2

NC*

Male

0.32

1

NC*

Female

0.11

0

NC*

Total

0.58

2

NC*

Male

0.72

0

NC*

Male

0.20

0

NC*

Female

0.51

0

NC*

Female

0.57

2

NC*

Total

1.23

0

NC*

Total

0.77

2

NC*

1.56

0

NC*

29.25

21

72

Larynx

Testis

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.38

0

NC*

Female

0.12

0

NC*

Total

0.50

0

NC*

Lung and Bronchus Male

Female All Sites / Types

4.47

4

NC*

Male

Female

3.25

3

NC*

Female

24.96

18

72

Total

7.73

7

91

Total

54.21

39

72 #-

Ipswich

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Exp

Obs

SIR

6.02

10

166

Melanoma of Skin 8.36

10

120

Male

Female

3.45

5

145

Female

4.82

8

166

Total

11.81

15

127

Total

10.85

18

166

1.74

0

NC*

Multiple Myeloma

Brain and Other Nervous System Male

2.67

3

NC*

Male

Female

2.33

6

258

Female

1.70

0

NC*

Total

5.00

9

180

Total

3.44

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.42

1

NC*

Male

6.78

6

88

Female

56.12

66

118

Female

6.59

8

121

Total

56.53

67

119

Total

13.37

14

105

Oral Cavity & Pharynx

Cervix Uteri Female

2.82

3

NC*

Colon / Rectum

Male

5.41

2

NC*

Female

2.80

1

NC*

Total

8.21

3

NC*

Female

6.43

7

109

Ovary

Male

21.04

22

105

Female

22.58

33

146 #+

Total

43.63

55

126 Pancreas

Esophagus Male

3.15

1

NC*

Male

3.77

5

133

Female

1.07

1

NC*

Female

4.39

5

114

Total

4.22

2

NC*

Total

8.17

10

122

Male

55.28

65

118

3.65

6

164

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.13

3

NC*

Female

0.99

2

NC*

Total

2.12

5

235

Kidney & Renal Pelvis Male

Stomach 5.19

6

116

Male

Female

3.36

3

NC*

Female

2.47

0

NC*

Total

8.55

9

105

Total

6.12

6

98

Male

1.66

0

NC*

Testis

Larynx Male

2.85

2

NC*

Female

0.76

0

NC*

Total

3.61

2

NC*

Male

4.14

6

145

Male

1.15

0

NC*

Female

3.60

5

139

Female

3.29

1

NC*

Total

7.74

11

142

Total

4.44

1

NC*

10

93

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.24

6

268

Female

0.96

0

NC*

Total

3.20

6

188

Note: Explanation of all symbols is on page 361

Female

59

10.75

Lung and Bronchus

All Sites / Types

Male

27.18

20

74

Male

175.11

186

106

Female

24.19

29

120

Female

178.68

209

117 #+

Total

51.36

49

95

Total

353.79

395

112 #+

Exp

Obs

SIR

4.83

2

NC*

Kingston

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 6.70

9

134

Male

Female

2.37

6

253

Female

3.75

5

133

Total

9.06

15

165

Total

8.58

7

82

Multiple Myeloma

Brain and Other Nervous System Male

2.21

1

NC*

Male

1.38

1

NC*

Female

1.83

1

NC*

Female

1.21

1

NC*

Total

4.05

2

NC*

Total

2.59

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.33

0

NC*

Male

5.48

5

91

Female

42.62

54

127

Female

4.83

7

145

Total

42.95

54

126

Total

10.32

12

116

Male

4.31

4

NC*

Female

2.07

1

NC*

Total

6.38

5

78

Female

4.92

5

102

3.01

6

199

Oral Cavity & Pharynx

Cervix Uteri Female

2.30

2

NC* Ovary

Colon / Rectum Male

16.83

22

131

Female

15.44

17

110

Total

32.26

39

121 Pancreas

Esophagus Male

2.50

1

NC*

Male

Female

0.73

2

NC*

Female

3.02

1

NC*

Total

3.23

3

NC*

Total

6.03

7

116

Male

43.61

47

108

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.96

2

NC*

Female

0.85

1

NC*

Total

1.81

3

NC* Stomach

Kidney & Renal Pelvis Male

4.14

7

169

Male

2.93

1

NC*

Female

2.51

1

NC*

Female

1.65

3

NC*

Total

6.65

8

120

Total

4.58

4

NC*

Male

1.43

3

NC*

Larynx

Testis Male

2.25

3

NC*

Female

0.58

1

NC*

Total

2.83

4

NC*

Male

3.41

3

NC*

Male

0.94

1

NC*

Female

2.65

1

NC*

Female

2.78

8

288 #+

Leukemia

Thyroid

Note: Explanation of all symbols is on page 361

60

Total

6.06

4

NC*

Total

Liver and Intrahepatic Bile Ducts Male

1.78

3.72

9

242 #+

5

61

Uteri, Corpus and Uterus, NOS 2

NC*

Female

0.67

0

NC*

Total

2.45

2

NC*

Female

8.16

All Sites / Types

Lung and Bronchus Male

21.53

23

107

Male

139.74

149

107

Female

17.82

19

107

Female

132.01

148

112

Total

39.35

42

107

Total

271.74

297

109

Exp

Obs

SIR

Lakeville

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

5.16

3

NC*

Male

4.23

5

118

Female

1.84

1

NC*

Female

3.18

6

189

Total

7.00

4

NC*

Total

7.41

11

148

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

1.97

2

NC*

Male

1.13

0

NC*

Female

1.52

4

NC*

Female

0.96

1

NC*

Total

3.49

6

172

Total

2.09

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.28

0

NC*

Male

4.63

5

108

Female

36.27

33

91

Female

3.86

7

181

Total

36.55

33

90

Total

8.49

12

141

3.89

7

180

Oral Cavity & Pharynx

Cervix Uteri

Male Female

1.98

2

NC*

Female

1.71

1

NC*

Total

5.60

8

143

Female

4.15

2

NC*

Ovary

Colon / Rectum Male

13.27

18

136

Female

11.96

14

117

Total

25.23

32

127

Esophagus

Pancreas

Male

2.14

3

NC*

Male

2.44

1

NC*

Female

0.57

0

NC*

Female

2.32

0

NC*

Total

2.71

3

NC*

Total

4.77

1

NC*

Male

37.40

40

107

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.90

1

NC*

Female

0.71

1

NC*

Total

1.61

2

NC*

Male

3.58

4

NC*

Male

2.31

2

NC*

Female

2.05

3

NC*

Female

1.28

0

NC*

Total

5.63

7

124

Total

3.59

2

NC*

Male

1.37

0

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

2.00

3

Note: Explanation of all symbols is on page 361

NC*

61

Female

0.48

1

NC*

Total

2.48

4

NC*

Leukemia

Thyroid Male

2.81

2

NC*

Male

0.89

0

NC*

Female

2.16

0

NC*

Female

2.42

3

NC*

Total

4.97

2

NC*

Total

3.31

3

NC*

6.96

5

72

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.56

1

NC*

Female

0.52

0

NC*

Total

2.08

1

NC*

Male

17.77

24

135

Male

117.05

131

112

Female

14.33

11

77

Female

108.62

106

98

Total

32.09

35

109

Total

225.68

237

105

Exp

Obs

SIR

3.31

3

NC*

Female All Sites / Types

Lung and Bronchus

Lancaster

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 4.17

5

120

Male

Female

1.41

3

NC*

Female

2.37

1

NC*

Total

5.58

8

143

Total

5.67

4

NC*

0.89

0

NC*

Brain and Other Nervous System Male

1.53

Multiple Myeloma 1

NC*

Male

Female

1.13

3

NC*

Female

0.71

0

NC*

Total

2.66

4

NC*

Total

1.60

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.22

0

NC*

Male

3.69

2

NC*

Female

25.67

17

66

Female

2.88

1

NC*

Total

25.89

17

66

Total

6.57

3

NC*

Male

2.91

4

NC*

Female

1.24

0

NC*

Total

4.15

4

NC*

Female

2.99

2

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 1.50

0

NC*

Colon / Rectum

Ovary

Male

10.63

5

47

Female

9.20

11

120

Total

19.83

16

81

Esophagus

Pancreas

Male

1.63

3

NC*

Male

1.92

0

NC*

Female

0.44

0

NC*

Female

1.78

2

NC*

Total

2.06

3

NC*

Total

3.70

2

NC*

Male

28.31

13

46 ~-

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.75

Prostate 2

NC*

Female

0.57

0

NC*

Total

1.33

2

NC*

Kidney & Renal Pelvis

Note: Explanation of all symbols is on page 361

Stomach

62

Male

2.75

2

NC*

Male

1.85

1

NC*

Female

1.48

1

NC*

Female

1.02

0

NC*

Total

4.22

3

NC*

Total

2.87

1

NC*

Male

1.50

1

NC*

Male

1.24

0

NC*

Female

0.33

0

NC*

Total

1.83

1

NC*

Larynx

Testis

Leukemia

Thyroid Male

2.23

4

NC*

Male

0.70

0

NC*

Female

1.64

1

NC*

Female

1.86

3

NC*

Total

3.86

5

129

Total

2.56

3

NC*

4.80

4

NC*

91.22

57

62 ^-

Liver and Intrahepatic Bile Ducts Male

1.18

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.40

1

NC*

Total

1.58

1

NC*

Female

Lung and Bronchus Male

All Sites / Types 13.86

9

65

Male

Female

10.16

7

69

Female

79.22

63

80

Total

24.02

16

67

Total

170.44

120

70 ^-

Exp

Obs

SIR

Lanesborough

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

2.42

0

NC*

Male

1.72

0

NC*

Female

0.74

0

NC*

Female

1.13

0

NC*

Total

3.15

0

NC*

Total

2.85

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.75

1

NC*

Male

0.50

0

NC*

Female

0.55

2

NC*

Female

0.37

0

NC*

Total

1.30

3

NC*

Total

0.87

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.12

0

NC*

Male

1.94

5

258

Female

13.08

9

69

Female

1.48

2

NC*

Total

13.20

9

68

Total

3.42

7

205

1.54

0

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

0.68

0

NC*

Colon / Rectum Male

Female

0.64

0

NC*

Total

2.18

0

NC*

Female

1.50

1

NC*

Ovary 6.07

3

NC*

Female

4.82

3

NC*

Total

10.89

6

55

Esophagus

Pancreas

Male

0.90

0

NC*

Male

1.09

2

NC*

Female

0.23

0

NC*

Female

0.94

2

NC*

Total

1.13

0

NC*

Total

2.03

4

NC*

Note: Explanation of all symbols is on page 361

63

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.32

0

NC*

Male

15.81

8

51 #-

Female

0.24

0

NC*

Total

0.56

0

NC* NC*

Male

1.06

0

NC*

Kidney & Renal Pelvis Male

Stomach 1.47

1

Female

0.77

0

NC*

Female

0.51

0

NC*

Total

2.24

1

NC*

Total

1.57

0

NC*

Male

0.48

1

NC*

Larynx

Testis Male

0.81

2

NC*

Female

0.18

0

NC*

Total

0.99

2

NC*

Leukemia

Thyroid Male

1.18

1

NC*

Male

0.33

0

NC*

Female

0.80

0

NC*

Female

0.81

1

NC*

Total

1.98

1

NC*

Total

1.14

1

NC*

2.52

3

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.63

0

NC*

Female

0.21

0

NC*

Total

0.84

0

NC*

Male

7.77

5

64

Male

50.14

30

60 ~-

Female

5.50

4

NC*

Female

40.54

28

69 #-

Total

13.27

9

68

Total

90.69

58

64 ^-

Exp

Obs

SIR

24.93

8

32 ^-

Female

Lung and Bronchus

All Sites / Types

Lawrence

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 34.91

23

66 #-

Male

Female

15.65

18

115

Female

22.54

8

35 ^-

Total

50.56

41

81

Total

47.47

16

34 ^-

7.00

4

NC*

Brain and Other Nervous System Male

Multiple Myeloma

12.31

3

NC*

Male

Female

11.53

Total

23.85

10

87

Female

7.47

3

NC*

13

55 #-

Total

14.47

7

48 #-

Breast

Non-Hodgkin('s) Lymphoma Male

1.69

1

NC*

Male

29.23

29

99

Female

241.33

164

68 ^-

Female

30.29

17

56 #-

Total

243.02

165

68 ^-

Total

59.52

46

77

Oral Cavity & Pharynx

Cervix Uteri Female

13.70

32

234 ^+

Male

21.02

28

133

Female

12.30

17

138

Total

33.31

45

135

Female

28.55

34

119

Ovary

Colon / Rectum Male

87.17

93

107

Female

103.45

79

76 #-

Note: Explanation of all symbols is on page 361

64

Total

190.62

172

90

Esophagus Male

Pancreas 12.28

14

114

Male

15.35

15

98

Female

4.84

6

124

Female

19.96

13

65

Total

17.12

20

117

Total

35.31

28

79

Male

212.42

183

86 #-

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

6.07

7

115

Female

5.69

4

NC*

Total

11.76

11

94

Kidney & Renal Pelvis

Stomach

Male

20.76

11

53 #-

Male

15.23

22

144

Female

14.77

13

88

Female

11.47

11

96

Total

35.53

24

68

Total

26.70

33

124

Male

10.83

18

166

Male

9.90

7

71

Female

3.11

4

NC*

Total

13.94

22

158

Male

18.87

17

90

Male

5.12

3

NC*

Female

17.49

13

74

Female

16.86

10

59

Total

36.35

30

83

Total

21.98

13

59

44.55

42

94

712.03

639

90 ~-

Testis

Larynx

Thyroid

Leukemia

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

8.84

10

113

Female

4.40

6

136

Total

13.24

16

121

Female All Sites / Types

Lung and Bronchus Male

108.37

103

95

Male

Female

103.72

83

80 #-

Female

795.19

651

82 ^-

Total

212.09

186

88

Total

1507.22

1290

86 ^-

Exp

Obs

SIR

Lee

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.60

3

NC*

Male

3.16

3

NC*

Female

1.62

1

NC*

Female

2.21

1

NC*

Total

6.22

4

NC*

Total

5.37

4

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

1.40

1

NC*

Male

0.94

1

NC*

Female

1.08

0

NC*

Female

0.80

0

NC*

Total

2.48

1

NC*

Total

1.73

1

NC*

Male

0.23

0

NC*

Male

3.61

3

NC*

Female

25.86

32

124

Female

3.10

2

NC*

Total

26.08

32

123

Total

6.71

5

74

2.78

4

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri

Male

Note: Explanation of all symbols is on page 361

65

Female

1.28

1

NC*

Female

1.30

1

NC*

Total

4.08

5

122

Female

2.98

2

NC*

Ovary

Colon / Rectum Male

11.52

9

78

Female

10.59

15

142

Total

22.11

24

109

Male

1.67

2

NC*

Male

2.03

2

NC*

Female

0.50

0

NC*

Female

2.08

2

NC*

Total

2.17

2

NC*

Total

4.11

4

NC*

Male

29.66

22

74

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.59

0

NC*

Female

0.46

0

NC*

Total

1.05

0

NC* Stomach

Kidney & Renal Pelvis Male

2.73

5

183

Male

1.98

1

NC*

Female

1.58

1

NC*

Female

1.15

1

NC*

Total

4.31

6

139

Total

3.13

2

NC*

Male

0.90

1

NC*

NC*

Male

0.59

0

NC*

Larynx

Testis Male

1.49

3

NC*

Female

0.36

1

NC*

Total

1.85

4

NC*

Leukemia

Thyroid Male

2.21

1

Female

1.67

2

NC*

Female

1.48

1

NC*

Total

3.88

3

NC*

Total

2.07

1

NC*

4.98

8

161

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.17

1

NC*

Female

0.45

1

NC*

Total

1.63

2

NC*

Male

14.76

19

129

Male

94.15

88

93

Female

11.51

12

104

Female

83.15

95

114

Total

26.27

31

118

Total

177.30

183

103

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Leicester

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

5.68

7

123

Male

4.35

2

NC*

Female

1.97

2

NC*

Female

3.31

5

151

Total

7.65

9

118

Total

7.66

7

91

1.19

1

NC*

Multiple Myeloma

Brain and Other Nervous System Male

2.04

1

NC*

Male

Female

1.63

2

NC*

Female

1.01

2

NC*

Total

3.68

3

NC*

Total

2.20

3

NC*

Breast

Note: Explanation of all symbols is on page 361

Non-Hodgkin('s) Lymphoma

66

Male

0.29

0

NC*

Male

4.91

5

102

Female

36.65

35

95

Female

4.14

2

NC*

Total

36.94

35

95

Total

9.04

7

77

Male

3.85

5

130

Female

1.76

1

NC*

Total

5.61

6

107

Female

4.27

5

117

2.59

1

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

2.08

5

241 Ovary

Colon / Rectum Male

14.37

17

118

Female

12.84

14

109

Total

27.21

31

114 Pancreas

Esophagus Male

2.17

2

NC*

Male

Female

0.61

0

NC*

Female

2.51

1

NC*

Total

2.78

2

NC*

Total

5.10

2

NC*

Male

37.53

37

99

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.97

Prostate 2

NC*

Female

0.80

0

NC*

Total

1.78

2

NC* Stomach

Kidney & Renal Pelvis Male

3.64

4

NC*

Male

2.52

5

198

Female

2.15

1

NC*

Female

1.37

2

NC*

Total

5.78

5

86

Total

3.89

7

180

Male

1.55

3

NC*

Testis

Larynx Male

1.97

4

NC*

Female

0.49

1

NC*

Total

2.46

5

203

Male

3.03

3

NC*

Male

0.90

0

NC*

Female

2.29

4

NC*

Female

2.57

3

NC*

Total

5.33

7

131

Total

3.48

3

NC*

6.96

8

115

121.58

120

99

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.57

1

NC*

Female

0.56

0

NC*

Total

2.13

1

NC*

Female All Sites / Types

Lung and Bronchus Male

18.43

11

60

Male

Female

15.07

18

119

Female

112.87

123

109

Total

33.49

29

87

Total

234.46

243

104

Exp

Obs

SIR

Lenox

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

3.92

4

NC*

Male

2.61

4

NC*

Female

1.91

1

NC*

Female

2.19

3

NC*

Total

5.83

5

86

Total

4.80

7

146

Note: Explanation of all symbols is on page 361

67

Brain and Other Nervous System

Multiple Myeloma

Male

1.13

1

NC*

Male

0.80

1

NC*

Female

1.05

1

NC*

Female

0.88

0

NC*

Total

2.19

2

NC*

Total

1.68

1

NC*

7

234

Breast

Non-Hodgkin('s) Lymphoma Male

0.19

0

NC*

Male

2.99

Female

25.73

32

124

Female

3.29

5

152

Total

25.92

32

123

Total

6.28

12

191

2.34

1

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

1.18

1

NC*

Colon / Rectum

Female

1.37

2

NC*

Total

3.71

3

NC*

Female

2.94

3

NC*

Ovary

Male

9.80

8

82

Female

12.63

21

166 #+

Total

22.42

29

129

Esophagus

Pancreas

Male

1.43

2

NC*

Male

1.73

1

NC*

Female

0.59

1

NC*

Female

2.43

4

NC*

Total

2.02

3

NC*

Total

4.16

5

120

Male

25.50

33

129

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.44

2

NC*

Female

0.40

2

NC*

Total

0.84

4

NC*

Male

2.30

4

NC*

Male

1.68

2

NC*

Female

1.60

0

NC*

Female

1.44

1

NC*

Total

3.90

4

NC*

Total

3.11

3

NC*

Male

0.60

0

NC*

NC*

Male

0.46

0

NC*

Kidney & Renal Pelvis

Stomach

Larynx

Testis Male

1.27

2

NC*

Female

0.34

1

NC*

Total

1.61

3

NC*

Leukemia

Thyroid Male

1.83

1

Female

1.85

0

NC*

Female

1.30

2

NC*

Total

3.68

1

NC*

Total

1.76

2

NC*

7

144

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.99

2

NC*

Female

0.52

0

NC*

Total

1.51

2

NC*

Female

4.85

All Sites / Types

Lung and Bronchus Male

12.63

12

95

Male

79.76

96

120

Female

11.62

13

112

Female

87.29

105

120

Total

24.24

25

103

Total

167.05

201

120 #+

Leominster

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Note: Explanation of all symbols is on page 361

68

Exp

Obs

SIR

Bladder, Urinary

Exp

Obs

SIR

Melanoma of Skin

Male

24.20

26

107

Male

17.85

7

39 ~-

Female

9.84

9

91

Female

14.78

7

47 #-

Total

34.04

35

103

Total

32.63

14

43 ^-

4.98

0

NC*

Brain and Other Nervous System Male

Multiple Myeloma

8.31

2

NC*

Male

Female

7.20

7

97

Female

4.82

5

104

Total

15.52

9

58

Total

9.81

5

51

10

49 #-

Non-Hodgkin('s) Lymphoma

Breast Male

1.22

1

NC*

Male

20.37

Female

161.98

134

83 #-

Female

19.44

20

103

Total

163.19

135

83 #-

Total

39.81

30

75

Oral Cavity & Pharynx

Cervix Uteri Female

9.07

10

110

Male

15.49

15

97

Female

8.06

8

99

Total

23.55

23

98

Female

18.96

17

90

Ovary

Colon / Rectum Male

61.05

75

123

Female

64.55

71

110

Total

125.60

146

116

Male

8.99

9

100

Male

10.86

13

120

Female

3.04

1

NC*

Female

12.55

10

80

Total

12.02

10

83

Total

23.41

23

98

Male

157.57

127

81 #-

127

Male

10.57

15

142

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

3.99

1

NC*

Female

3.51

0

NC*

Total

7.51

1

NC*

Kidney & Renal Pelvis Male

Stomach 14.96

19

Female

9.73

10

103

Female

7.04

6

85

Total

24.69

29

117

Total

17.61

21

119

Male

6.53

7

107

Testis

Larynx Male

8.08

7

87

Female

2.15

2

NC*

Total

10.23

9

88 Thyroid

Leukemia Male

12.53

13

104

Male

3.66

3

NC*

Female

10.65

5

47

Female

11.07

7

63

Total

23.18

18

78

Total

14.73

10

68

30.36

28

92

509.72

458

90 #-

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

6.43

5

78

Female

2.76

1

NC*

Total

9.19

6

65

78.28

75

96

Female All Sites / Types

Lung and Bronchus Male

Note: Explanation of all symbols is on page 361

Male

69

Female

69.13

60

87

Female

518.91

451

87 ~-

Total

147.41

135

92

Total

1028.63

909

88 ^-

Exp

Obs

SIR

Leverett

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

1.27

2

NC*

Male

1.02

2

NC*

Female

0.40

0

NC*

Female

0.73

0

NC*

Total

1.67

2

NC*

Total

1.76

2

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.45

0

NC*

Male

0.28

0

NC*

Female

0.33

0

NC*

Female

0.22

0

NC*

Total

0.78

0

NC*

Total

0.49

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.07

0

NC*

Male

1.11

0

NC*

Female

8.56

12

140

Female

0.85

2

NC*

Total

8.63

12

139

Total

1.97

2

NC*

0.94

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.46

0

NC*

Colon / Rectum Male

Female

0.39

0

NC*

Total

1.34

0

NC*

Female

0.96

3

NC*

Ovary 3.23

2

NC*

Female

2.63

4

NC*

Total

5.86

6

102

Esophagus

Pancreas

Male

0.51

0

NC*

Male

0.60

1

NC*

Female

0.13

0

NC*

Female

0.50

1

NC*

Total

0.64

0

NC*

Total

1.10

2

NC*

Male

8.74

3

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.20

1

NC*

Female

0.15

0

NC*

Total

0.35

1

NC*

Male

0.87

0

NC*

Male

0.58

0

NC*

Female

0.46

0

NC*

Female

0.28

0

NC*

Total

1.33

0

NC*

Total

0.86

0

NC*

Male

0.28

0

NC*

NC*

Male

0.21

0

NC*

Kidney & Renal Pelvis

Stomach

Larynx

Testis Male

0.48

0

NC*

Female

0.11

0

NC*

Total

0.59

0

NC*

Leukemia

Thyroid Male

0.66

0

Female

0.47

0

NC*

Female

0.56

1

NC*

Total

1.14

0

NC*

Total

0.76

1

NC*

Liver and Intrahepatic Bile Ducts

Note: Explanation of all symbols is on page 361

Uteri, Corpus and Uterus, NOS

70

Male

0.37

0

NC*

Female

0.12

0

NC*

Total

0.49

0

NC*

Male

4.20

1

NC*

Female

3.21

1

Total

7.41

2

Female

1.65

2

NC*

Male

27.85

13

47 ~-

NC*

Female

24.84

29

117

NC*

Total

52.69

42

80

Exp

Obs

SIR

18.12

20

110

All Sites / Types

Lung and Bronchus

Lexington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 26.71

17

64

Male

Female

9.96

12

120

Female

13.64

14

103

Total

36.67

29

79

Total

31.76

34

107

5.45

5

92

Multiple Myeloma

Brain and Other Nervous System Male

7.85

11

140

Male

Female

6.53

3

NC*

Female

4.95

7

141

Total

14.38

14

97

Total

10.40

12

115

Non-Hodgkin('s) Lymphoma

Breast Male

1.30

0

NC*

Male

20.55

16

78

Female

163.75

167

102

Female

18.95

15

79

Total

165.06

167

101

Total

39.50

31

78

Oral Cavity & Pharynx

Cervix Uteri Female

7.81

3

NC*

Male

16.45

6

36 ~-

Female

8.16

5

61

Total

24.61

11

45 ~-

Female

18.64

17

91

Ovary

Colon / Rectum Male

67.03

61

91

Female

64.69

40

62 ~-

Total

131.72

101

77 ~Pancreas

Esophagus Male

9.91

5

50

Male

11.91

6

50

Female

3.08

1

NC*

Female

12.70

10

79

Total

12.99

6

46

Total

24.62

16

65

Male

177.11

192

108

11.54

4

NC*

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

3.04

3

NC*

Female

2.60

1

NC*

Total

5.65

4

NC*

Kidney & Renal Pelvis Male

Stomach 15.88

9

57

Male

Female

9.86

10

101

Female

7.03

6

85

Total

25.75

19

74

Total

18.56

10

54 #-

Male

4.19

2

NC*

Testis

Larynx Male

8.86

1

NC*

Female

2.30

2

NC*

Total

11.16

3

NC*

Note: Explanation of all symbols is on page 361

71

Leukemia

Thyroid Male

12.52

14

112

Male

3.27

2

NC*

Female

10.16

13

128

Female

8.91

10

112

Total

22.67

27

119

Total

12.19

12

98

31.86

42

132

550.04

459

83 ^-

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

6.88

4

NC*

Female

2.77

1

NC*

Total

9.64

5

52

Female All Sites / Types

Lung and Bronchus Male

86.60

58

67 ~-

Male

Female

71.69

47

66 ~-

Female

517.53

455

88 ~-

Total

158.28

105

66 ^-

Total

1067.57

914

86 ^-

Exp

Obs

SIR

Leyden

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.52

2

NC*

Male

0.39

0

NC*

Female

0.14

0

NC*

Female

0.25

0

NC*

Total

0.66

2

NC*

Total

0.65

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.18

0

NC*

Male

0.11

0

NC*

Female

0.12

0

NC*

Female

0.07

0

NC*

Total

0.29

0

NC*

Total

0.19

0

NC*

Male

0.03

0

NC*

Male

0.43

0

NC*

Female

2.84

4

NC*

Female

0.30

0

NC*

Total

2.87

4

NC*

Total

0.73

0

NC*

0.37

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.16

0

NC*

Colon / Rectum Male

Female

0.13

0

NC*

Total

0.50

0

NC*

Female

0.33

0

NC*

Ovary 1.33

1

NC*

Female

0.91

0

NC*

Total

2.23

1

NC*

Esophagus

Pancreas

Male

0.21

0

NC*

Male

0.24

1

NC*

Female

0.04

0

NC*

Female

0.17

0

NC*

Total

0.25

0

NC*

Total

0.42

1

NC*

Male

3.67

2

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.07

0

NC*

Female

0.06

0

NC*

Total

0.13

0

NC*

Male

0.34

1

NC*

Male

0.23

0

NC*

Female

0.16

0

NC*

Female

0.10

0

NC*

Kidney & Renal Pelvis

Stomach

Note: Explanation of all symbols is on page 361

72

Total

0.50

1

NC*

Larynx

Total

0.33

0

NC*

Male

0.09

0

NC*

Testis Male

0.19

0

NC*

Female

0.04

0

NC*

Total

0.23

0

NC*

Leukemia

Thyroid Male

0.27

0

NC*

Male

0.07

0

NC*

Female

0.17

0

NC*

Female

0.20

2

NC*

Total

0.43

0

NC*

Total

0.27

2

NC*

0.54

0

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.15

0

NC*

Female

0.04

0

NC*

Total

0.19

0

NC*

Male

1.75

0

NC*

Male

11.35

7

62

Female

1.09

1

NC*

Female

8.41

7

83

Total

2.84

1

NC*

Total

19.76

14

71

Exp

Obs

SIR

Female

Lung and Bronchus

All Sites / Types

Lincoln

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

5.12

5

98

Male

4.01

6

150

Female

1.66

1

NC*

Female

3.05

3

NC*

Total

6.79

6

88

Total

7.07

9

127

1.09

0

NC*

Multiple Myeloma

Brain and Other Nervous System Male

1.84

3

NC*

Male

Female

1.43

1

NC*

Female

0.88

1

NC*

Total

3.27

4

NC*

Total

1.97

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.27

0

NC*

Male

4.46

4

NC*

Female

33.77

32

95

Female

3.58

3

NC*

Total

34.04

32

94

Total

8.04

7

87

Oral Cavity & Pharynx

Cervix Uteri Female

1.96

1

NC*

Male

3.61

3

NC*

Female

1.58

2

NC*

Total

5.19

5

96

Female

3.91

4

NC*

Ovary

Colon / Rectum Male

13.06

6

46

Female

10.75

7

65

Total

23.81

13

55 #-

Male

2.02

1

NC*

Male

2.37

1

NC*

Female

0.51

1

NC*

Female

2.10

5

239

Total

2.54

2

NC*

Total

4.47

6

134

Male

35.35

39

110

Esophagus

Pancreas

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.86

3

Note: Explanation of all symbols is on page 361

NC*

73

Female

0.73

1

NC*

Total

1.58

4

NC*

Kidney & Renal Pelvis

Stomach

Male

3.37

0

NC*

Male

2.28

2

NC*

Female

1.90

1

NC*

Female

1.16

0

NC*

Total

5.27

1

NC*

Total

3.44

2

NC*

Male

1.86

1

NC*

Male

1.35

1

NC*

Female

0.45

0

NC*

Total

2.31

1

NC*

Male

2.69

3

NC*

Male

0.83

1

NC*

Female

1.98

3

NC*

Female

2.45

4

NC*

Total

4.68

6

128

Total

3.28

5

152

6.41

9

140

112.20

87

78 #-

Larynx

Testis

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.46

0

NC*

Female

0.47

0

NC*

Total

1.93

0

NC*

Female All Sites / Types

Lung and Bronchus Male

17.08

Female

13.11

Total

30.19

4

NC*

Male

7

53

Female

100.55

93

92

11

36 ^-

Total

212.75

180

85 #-

Exp

Obs

SIR

Littleton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.52

4

NC*

Male

3.47

2

NC*

Female

1.66

1

NC*

Female

2.74

3

NC*

Total

6.19

5

81

Total

6.21

5

81

Multiple Myeloma

Brain and Other Nervous System Male

1.60

4

NC*

Male

0.96

0

NC*

Female

1.32

1

NC*

Female

0.85

1

NC*

Total

2.91

5

172

Total

1.81

1

NC*

Male

0.23

0

NC*

Male

3.87

4

NC*

Female

30.62

41

134

Female

3.39

5

147

Total

30.86

41

133

Total

7.26

9

124

Male

3.14

3

NC*

Female

1.47

1

NC*

Total

4.62

4

NC*

Female

3.54

4

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.70

3

NC*

Colon / Rectum Male

Ovary 11.51

10

87

Female

10.83

9

83

Total

22.34

19

85

Esophagus

Note: Explanation of all symbols is on page 361

Pancreas

74

Male

1.78

1

NC*

Male

2.09

3

NC*

Female

0.51

1

NC*

Female

2.10

4

NC*

Total

2.29

2

NC*

Total

4.19

7

167

Male

31.23

29

93

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.72

0

NC*

Female

0.63

0

NC*

Total

1.35

0

NC* Stomach

Kidney & Renal Pelvis Male

2.95

5

169

Male

2.00

3

NC*

Female

1.76

2

NC*

Female

1.18

1

NC*

Total

4.72

7

148

Total

3.18

4

NC*

Male

1.09

2

NC*

NC*

Male

0.71

1

NC*

Larynx

Testis Male

1.63

1

NC*

Female

0.40

1

NC*

Total

2.04

2

NC*

Leukemia

Thyroid Male

2.36

1

Female

1.91

2

NC*

Female

2.08

2

NC*

Total

4.27

3

NC*

Total

2.79

3

NC*

4

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.28

2

NC*

Female

0.47

0

NC*

Total

1.75

2

NC*

Female

Lung and Bronchus

5.81

All Sites / Types

Male

15.09

15

99

Male

98.53

95

96

Female

12.29

15

122

Female

93.90

108

115

Total

27.38

30

110

Total

192.43

203

105

Exp

Obs

SIR

Longmeadow

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

12.79

7

55

Male

8.79

13

148

Female

4.29

4

NC*

Female

6.24

4

NC*

Total

17.08

11

64

Total

15.03

17

113

2.65

0

NC*

Multiple Myeloma

Brain and Other Nervous System Male

3.80

4

NC*

Male

Female

3.02

5

165

Female

2.20

1

NC*

Total

6.83

9

132

Total

4.84

1

NC*

5

51

Breast

Non-Hodgkin('s) Lymphoma Male

0.63

0

NC*

Male

Female

76.26

71

93

Female

8.44

7

83

Total

76.89

71

92

Total

18.32

12

65

Oral Cavity & Pharynx

Cervix Uteri Female

9.88

3.60

5

Note: Explanation of all symbols is on page 361

139

75

Male

8.08

5

62

Female

3.72

2

NC*

Total

11.80

7

59

Ovary

Colon / Rectum Male

32.10

25

78

Female

27.95

26

93

Total

60.06

51

85

Female

12

140

5.75

3

NC*

Pancreas

Esophagus Male

8.59

4.81

4

NC*

Male

Female

1.33

2

NC*

Female

5.47

6

110

Total

6.15

6

98

Total

11.21

9

80

Male

85.64

85

99

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.40

1

NC*

Female

1.17

0

NC*

Total

2.57

1

NC* Stomach

Kidney & Renal Pelvis Male

7.77

7

90

Male

5.54

6

108

Female

4.48

6

134

Female

2.97

3

NC*

Total

12.25

13

106

Total

8.50

9

106

Male

1.79

3

NC*

Testis

Larynx Male

4.34

2

NC*

Female

1.07

0

NC*

Total

5.41

2

NC*

Male

6.06

7

116

Male

1.56

2

NC*

Female

4.56

6

132

Female

4.12

2

NC*

Total

10.62

13

122

Total

5.68

4

NC*

14.98

18

120

78 ^-

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

3.36

1

NC*

Female

1.21

0

NC*

Total

4.57

1

NC*

Female All Sites / Types

Lung and Bronchus Male

41.71

16

38 ^-

Male

265.11

208

Female

32.45

Total

74.16

30

92

Female

234.53

230

98

46

62 ^-

Total

499.64

438

88 ~-

Exp

Obs

SIR

Lowell

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

49.27

63

128

Male

37.98

14

37 ^-

Female

22.10

27

122

Female

34.03

14

41 ^-

Total

71.37

90

126 #+

Total

72.01

28

39 ^-

Brain and Other Nervous System

Multiple Myeloma

Male

18.73

20

107

Male

10.10

11

109

Female

17.00

17

100

Female

10.75

12

112

Total

35.73

37

104

Total

20.85

23

110

Male

2.49

1

NC*

Male

43.78

43

98

Female

360.39

303

84 ~-

Female

44.25

40

90

Non-Hodgkin('s) Lymphoma

Breast

Note: Explanation of all symbols is on page 361

76

Total

362.88

304

84 ~-

Total

Female

88.03

83

94

Male

31.97

54

169 ^+

Female

18.01

19

105

Total

49.98

73

146 ~+

Female

42.80

32

75

Oral Cavity & Pharynx

Cervix Uteri 21.27

30

141 Ovary

Colon / Rectum Male

124.64

127

102

Female

145.03

150

103

Total

269.67

277

103 Pancreas

Esophagus Male

18.15

23

127

Male

22.14

20

90

Female

6.81

5

73

Female

28.18

28

99

Total

24.96

28

112

Total

50.32

48

95

Male

314.43

274

87 #-

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

9.98

9

90

Female

8.79

10

114

Total

18.76

19

101

Male

30.87

29

94

Male

21.71

20

92

Female

21.86

28

128

Female

15.89

16

101

Total

52.73

57

108

Total

37.60

36

96

Male

17.32

12

69

113

Male

8.39

1

NC*

Kidney & Renal Pelvis

Stomach

Testis

Larynx Male

16.30

34

209 ^+

Female

4.72

9

191

Total

21.02

43

205 ^+ Thyroid

Leukemia Male

27.36

31

Female

24.77

24

97

Female

26.55

14

53 #-

Total

52.13

55

106

Total

34.94

15

43 ^-

70

105

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

13.22

25

189 ~+

Female

6.23

12

192

Total

19.45

37

190 ^+

Female

66.63

All Sites / Types

Lung and Bronchus Male

158.04

213

135 ^+

Male

1049.10

1119

107 #+

Female

153.58

160

104

Female

1166.35

1097

94 #-

Total

311.63

373

120 ^+

Total

2215.46

2216

100

Exp

Obs

SIR

Ludlow

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

13.10

14

107

Male

9.08

5

55

Female

4.98

5

100

Female

6.98

9

129

Total

18.08

19

105

Total

16.06

14

87

2.67

3

NC*

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

4.05

4

Note: Explanation of all symbols is on page 361

NC*

Male

77

Female

3.43

4

NC*

Female

2.46

2

NC*

Total

7.48

8

107

Total

5.13

5

97

Non-Hodgkin('s) Lymphoma

Breast Male

0.64

1

NC*

Male

10.40

19

183 #+

Female

80.51

76

94

Female

9.68

11

114

Total

81.16

77

95

Total

20.08

30

149 #+

Male

7.97

6

75

Female

4.04

1

NC*

Total

12.01

7

58

Female

9.29

7

75

Oral Cavity & Pharynx

Cervix Uteri Female

4.10

5

122 Ovary

Colon / Rectum Male

32.76

44

134

Female

32.73

30

92

Total

65.48

74

113 Pancreas

Esophagus Male

4.75

4

NC*

Male

5.80

2

NC*

Female

1.54

1

NC*

Female

6.39

7

110

Total

6.29

5

79

Total

12.18

9

74

Male

83.62

101

121

5.65

6

106

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.75

5

286

Female

1.49

0

NC*

Total

3.24

5

154 Stomach

Kidney & Renal Pelvis Male

7.82

13

166

Male

Female

4.90

3

NC*

Female

3.50

3

NC*

Total

12.72

16

126

Total

9.15

9

98

Male

2.66

2

NC*

Testis

Larynx Male

4.23

5

118

Female

1.11

0

NC*

Total

5.35

5

94

Male

6.40

5

78

Male

1.71

4

NC*

Female

5.16

5

97

Female

4.82

3

NC*

Total

11.56

10

87

Total

6.54

7

107

15.43

26

169 #+

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

3.35

1

NC*

Female

1.40

0

NC*

Total

4.75

1

NC*

Female

Lung and Bronchus

All Sites / Types

Male

41.80

48

115

Male

267.80

307

115 #+

Female

35.68

33

93

Female

258.53

254

98

Total

77.47

81

105

Total

526.34

561

107

Obs

SIR

Lunenburg

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

Exp

SIR

Bladder, Urinary

Note: Explanation of all symbols is on page 361

Melanoma of Skin

78

Male

6.11

10

164

Male

4.61

5

109

Female

2.12

2

NC*

Female

3.36

1

NC*

Total

8.23

12

146

Total

7.97

6

75

Multiple Myeloma

Brain and Other Nervous System Male

2.07

3

NC*

Male

1.30

1

NC*

Female

1.61

3

NC*

Female

1.09

1

NC*

Total

3.69

6

163

Total

2.39

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.31

0

NC*

Male

5.13

2

NC*

Female

38.91

44

113

Female

4.30

4

NC*

Total

39.22

44

112

Total

9.43

6

64

4.17

3

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

2.04

3

NC*

Colon / Rectum Male

Female

1.87

0

NC*

Total

6.04

3

NC*

Female

4.45

4

NC*

Ovary 15.47

16

103

Female

13.88

22

158

Total

29.35

38

129

Esophagus

Pancreas

Male

2.37

1

NC*

Male

2.80

1

NC*

Female

0.66

0

NC*

Female

2.70

3

NC*

Total

3.03

1

NC*

Total

5.50

4

NC*

Male

41.57

32

77

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.90

1

NC*

Female

0.72

1

NC*

Total

1.62

2

NC*

Male

3.95

3

NC*

Male

2.68

3

NC*

Female

2.25

2

NC*

Female

1.48

0

NC*

Total

6.21

5

81

Total

4.17

3

NC*

Male

1.33

1

NC*

0.91

1

NC*

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

2.18

2

NC*

Female

0.53

0

NC*

Total

2.70

2

NC*

Leukemia

Thyroid Male

3.12

3

NC*

Male

Female

2.35

2

NC*

Female

2.44

3

NC*

Total

5.48

5

91

Total

3.35

4

NC*

5

67

Liver and Intrahepatic Bile Ducts Male

1.70

Uteri, Corpus and Uterus, NOS 4

NC*

Female

0.60

1

NC*

Total

2.31

5

217

Female

7.49

All Sites / Types

Lung and Bronchus Male

20.25

16

79

Male

131.32

113

86

Female

16.01

15

94

Female

119.20

117

98

Total

36.26

31

85

Total

250.52

230

92

Note: Explanation of all symbols is on page 361

79

Lynn

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Exp

Obs

SIR

34.05

29

85

Melanoma of Skin 48.52

56

115

Male

Female

21.65

26

120

Female

29.99

25

83

Total

70.17

82

117

Total

64.04

54

84

9.76

14

143

Multiple Myeloma

Brain and Other Nervous System Male

15.96

20

125

Male

Female

14.95

11

74

Female

10.36

19

183 #+

Total

30.91

31

100

Total

20.12

33

164 #+

Non-Hodgkin('s) Lymphoma

Breast Male

2.35

2

NC*

Male

39.53

54

137 #+

Female

330.72

321

97

Female

41.21

52

126

Total

333.06

323

97

Total

80.75

106

131 ~+

Oral Cavity & Pharynx

Cervix Uteri Female

17.85

21

118

Male

29.22

41

140 #+

Female

16.88

19

113

Total

46.10

60

130

Female

38.74

36

93

Ovary

Colon / Rectum Male

121.18

159

131 ~+

Female

142.60

143

100

Total

263.78

302

114 #+ Pancreas

Esophagus Male

17.24

21

122

Male

21.38

27

126

Female

6.69

3

NC*

Female

27.64

30

109

Total

23.93

24

100

Total

49.02

57

116

Male

300.22

307

102

21.12

33

156 #+

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

7.49

11

147

Female

7.02

5

71

Total

14.51

16

110

Kidney & Renal Pelvis Male

Stomach 28.69

24

84

Male

Female

20.30

24

118

Female

15.75

20

127

Total

48.99

48

98

Total

36.87

53

144 #+

Male

12.01

13

108

Testis

Larynx Male

15.23

25

164 #+

Female

4.37

5

114

Total

19.61

30

153 #+

Male

24.84

28

113

Male

6.75

2

NC*

Female

23.04

20

87

Female

21.46

18

84

Total

47.88

48

100

Total

28.21

20

71

63

102

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

12.26

26

212 ^+

Female

6.04

9

149

Total

18.31

35

191 ^+

Note: Explanation of all symbols is on page 361

Female

80

61.82

Lung and Bronchus

All Sites / Types

Male

151.73

193

127 ~+

Male

986.74

1161

118 ^+

Female

144.79

182

126 ~+

Female

1087.37

1160

107 #+

Total

296.53

375

126 ^+

Total

2074.11

2321

112 ^+

Exp

Obs

SIR

6.92

13

188

Lynnfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 10.15

13

128

Male

Female

3.30

3

NC*

Female

4.84

16

330 ^+

Total

13.45

16

119

Total

11.77

29

246 ^+

Multiple Myeloma

Brain and Other Nervous System Male

3.00

3

NC*

Male

2.08

3

NC*

Female

2.31

4

NC*

Female

1.68

3

NC*

Total

5.31

7

132

Total

3.76

6

160

Non-Hodgkin('s) Lymphoma

Breast Male

0.50

1

NC*

Male

7.85

8

102

Female

57.74

62

107

Female

6.49

13

200 #+

Total

58.24

63

108

Total

14.34

21

146

Male

6.25

2

NC*

Female

2.82

3

NC*

Total

9.08

5

55

Female

6.55

4

NC*

4.52

3

NC*

Oral Cavity & Pharynx

Cervix Uteri Female

2.84

2

NC* Ovary

Colon / Rectum Male

25.43

35

138

Female

21.58

26

120

Total

47.01

61

130

Esophagus Male

Pancreas 3.75

3

NC*

Male

Female

1.03

0

NC*

Female

4.21

3

NC*

Total

4.78

3

NC*

Total

8.73

6

69

Male

66.79

82

123

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.16

1

NC*

Female

0.95

1

NC*

Total

2.11

2

NC* Stomach

Kidney & Renal Pelvis Male

6.08

4

NC*

Male

4.37

4

NC*

Female

3.40

2

NC*

Female

2.30

1

NC*

Total

9.48

6

63

Total

6.68

5

75

Male

1.59

2

NC*

Testis

Larynx Male

3.37

2

NC*

Female

0.80

0

NC*

Total

4.16

2

NC*

Male

4.80

4

NC*

Male

1.24

1

NC*

Female

3.48

5

144

Female

3.30

0

NC*

Leukemia

Thyroid

Note: Explanation of all symbols is on page 361

81

Total

8.27

9

109

Total

Liver and Intrahepatic Bile Ducts Male

2.62

4.54

1

NC*

12

107

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.93

1

NC*

Total

3.55

1

NC*

Female

11.22

All Sites / Types

Lung and Bronchus Male

32.86

30

91

Male

208.63

227

109

Female

24.57

19

77

Female

179.02

198

111

Total

57.44

49

85

Total

387.65

425

110

Note: Explanation of all symbols is on page 361

82

Malden

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 33.60 Male Female 15.17 48.77 Total Brain and Other Nervous System Male 10.62 10.05 Female 20.67 Total Breast 1.61 Male 228.90 Female Total 230.51 Cervix Uteri Female

12.70

Colon / Rectum 84.00 Male Female 99.85 Total 183.85 Esophagus 11.87 Male Female 4.68 Total 16.55 Hodgkin's Disease (Hodgkin Lymphoma) Male 5.18 4.90 Female Total 10.08 Kidney & Renal Pelvis Male 19.52 13.99 Female 33.51 Total Larynx Male 10.42 2.99 Female Total 13.42 Leukemia Male 16.56 15.60 Female Total 32.15 Liver and Intrahepatic Bile Ducts Male 8.36 4.21 Female 12.57 Total Lung and Bronchus Male 104.58 Female 99.83 Total 204.41

Obs

SIR

33 19 52

98 125 107

11 11 22

104 109 106

1 219 220

NC* 96 95

22

173 #+

88 107 195

105 107 106

Exp

Obs

SIR

15 22 37

64 104 83

8 6 14

120 83 101

34 25 59

125 87 106

19 12 31

95 103 98

26.88

23

86

14.77 19.35 34.12

13 10 23

88 52 #67

207.08

193

93

Male Female Total

14.67 11.13 25.80

15 21 36

102 189 #+ 140

Male

8.75

6

69

Male 4.72 15.31 Female Total 20.04 Uteri, Corpus and Uterus, NOS

2 17 19

NC* 111 95

42.39

41

97

679.97 754.63 1434.60

689 769 1458

101 102 102

Melanoma of Skin 23.48 Male Female 21.06 44.54 Total Multiple Myeloma Male 6.69 7.20 Female 13.89 Total Non-Hodgkin('s) Lymphoma 27.23 Male 28.62 Female Total 55.85 Oral Cavity & Pharynx 20.00 Male Female 11.68 Total 31.68 Ovary Female Pancreas

12 4 16

101 NC* 97

4 3 7

NC* NC* 69

28 18 46

143 129 137 #+

Male Female Total Prostate Male

Stomach

Testis 11 4 15

106 NC* 112

16 25 41

97 160 #+ 128

12 7 19

144 166 151

Thyroid

132 100 232

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

126 #+ 100 113

174

Manchester

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.30 Male Female 1.61 5.92 Total Brain and Other Nervous System Male 1.29 1.10 Female 2.40 Total Breast 0.21 Male 27.29 Female Total 27.50 Cervix Uteri Female

1.35

Colon / Rectum 10.79 Male Female 10.54 Total 21.33 Esophagus 1.59 Male Female 0.50 Total 2.09 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.52 0.46 Female Total 0.98 Kidney & Renal Pelvis Male 2.58 1.62 Female 4.21 Total Larynx Male 1.43 0.38 Female Total 1.81 Leukemia Male 2.05 1.68 Female Total 3.72 Liver and Intrahepatic Bile Ducts Male 1.11 0.45 Female 1.57 Total Lung and Bronchus Male 13.91 Female 11.75 Total 25.66

Obs

SIR

3 2 5

NC* NC* 85

5 1 6

386 #+ NC* 250

0 36 36

NC* 132 131

2

NC*

12 9 21

111 85 98

Exp

Obs

SIR

6 3 9

202 NC* 171

0 2 2

NC* NC* NC*

2 1 3

NC* NC* NC*

1 1 2

NC* NC* NC*

3.11

4

NC*

1.92 2.06 3.98

1 2 3

NC* NC* NC*

28.30

33

117

Male Female Total

1.86 1.13 3.00

1 2 3

NC* NC* NC*

Male

0.75

0

NC*

Male 0.55 1.56 Female Total 2.11 Uteri, Corpus and Uterus, NOS

0 2 2

NC* NC* NC*

5.28

3

NC*

88.74 85.61 174.35

89 86 175

100 100 100

Melanoma of Skin 2.97 Male Female 2.31 5.27 Total Multiple Myeloma Male 0.88 0.81 Female 1.69 Total Non-Hodgkin('s) Lymphoma 3.36 Male 3.13 Female Total 6.50 Oral Cavity & Pharynx 2.67 Male Female 1.35 Total 4.02 Ovary Female Pancreas

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

2 2 4

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

1 1 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

11 10 21

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

79 85 82

175

Mansfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 8.10 Male Female 2.75 10.85 Total Brain and Other Nervous System Male 3.58 2.78 Female 6.36 Total Breast 0.44 Male 60.06 Female Total 60.50 Cervix Uteri Female

3.85

Colon / Rectum 20.86 Male Female 17.93 Total 38.79 Esophagus 3.33 Male Female 0.85 Total 4.18 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.89 1.55 Female Total 3.43 Kidney & Renal Pelvis Male 5.82 3.30 Female 9.12 Total Larynx Male 3.13 0.75 Female Total 3.88 Leukemia Male 4.94 3.69 Female Total 8.64 Liver and Intrahepatic Bile Ducts Male 2.51 0.80 Female 3.31 Total Lung and Bronchus Male 27.21 Female 21.93 Total 49.14

Obs

SIR

8 2 10

99 NC* 92

4 4 8

NC* NC* 126

1 63 64

NC* 105 106

5

130

21 26 47

101 145 121

Exp

Obs

SIR

11 8 19

153 139 147

3 3 6

NC* NC* 185

9 2 11

113 NC* 77

4 4 8

NC* NC* 88

7.05

11

156

3.86 3.44 7.31

1 4 5

NC* NC* 68

56.28

40

71 #-

Male Female Total

3.71 1.93 5.64

3 1 4

NC* NC* NC*

Male

3.13

9

288 #+

Male 1.66 4.98 Female Total 6.63 Uteri, Corpus and Uterus, NOS

1 5 6

NC* 100 90

11.15

16

144

186.17 176.79 362.96

174 205 379

93 116 #+ 104

Melanoma of Skin 7.19 Male Female 5.74 12.92 Total Multiple Myeloma Male 1.78 1.47 Female 3.25 Total Non-Hodgkin('s) Lymphoma 7.95 Male 6.29 Female Total 14.24 Oral Cavity & Pharynx 6.36 Male Female 2.75 Total 9.11 Ovary Female Pancreas

5 0 5

150 NC* 120

2 2 4

NC* NC* NC*

4 3 7

NC* NC* 77

Male Female Total Prostate Male

Stomach

Testis 1 2 3

NC* NC* NC*

4 4 8

NC* NC* 93

0 0 0

NC* NC* NC*

Thyroid

29 27 56

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

107 123 114

176

Marblehead

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 16.72 Male Female 6.04 22.76 Total Brain and Other Nervous System Male 5.00 4.14 Female 9.14 Total Breast 0.81 Male 103.31 Female Total 104.13 Cervix Uteri Female

5.15

Colon / Rectum 41.89 Male Female 39.45 Total 81.34 Esophagus 6.18 Male Female 1.87 Total 8.05 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.99 1.74 Female Total 3.72 Kidney & Renal Pelvis Male 10.01 6.09 Female 16.10 Total Larynx Male 5.53 1.41 Female Total 6.94 Leukemia Male 7.95 6.33 Female Total 14.28 Liver and Intrahepatic Bile Ducts Male 4.32 1.69 Female 6.01 Total Lung and Bronchus Male 53.59 Female 43.73 Total 97.32

Obs

SIR

14 8 22

84 132 97

6 4 10

120 NC* 109

1 124 125

NC* 120 120

4

NC*

26 42 68

62 #106 84

Exp

Obs

SIR

29 16 45

252 ^+ 183 #+ 222 ^+

1 3 4

NC* NC* NC*

12 8 20

92 68 81

8 6 14

77 118 90

11.76

19

162

7.47 7.69 15.16

6 12 18

80 156 119

109.14

142

130 ~+

Male Female Total

7.28 4.28 11.56

6 4 10

82 NC* 87

Male

2.77

7

253 #+

Male 2.10 6.00 Female Total 8.10 Uteri, Corpus and Uterus, NOS

2 8 10

NC* 133 123

19.94

19

95

343.18 322.36 665.54

350 347 697

102 108 105

Melanoma of Skin 11.50 Male Female 8.76 20.26 Total Multiple Myeloma Male 3.42 3.03 Female 6.45 Total Non-Hodgkin('s) Lymphoma 13.04 Male 11.71 Female Total 24.74 Oral Cavity & Pharynx 10.41 Male Female 5.08 Total 15.49 Ovary Female Pancreas

4 3 7

NC* NC* 87

2 1 3

NC* NC* NC*

12 3 15

120 NC* 93

Male Female Total Prostate Male

Stomach

Testis 4 0 4

NC* NC* NC*

10 6 16

126 95 112

1 0 1

NC* NC* NC*

Thyroid

36 38 74

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

67 #87 76 #-

177

Marion

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.38 Male Female 1.38 5.76 Total Brain and Other Nervous System Male 1.41 1.08 Female 2.49 Total Breast 0.22 Male 27.05 Female Total 27.28 Cervix Uteri Female

1.34

Colon / Rectum 11.07 Male Female 8.88 Total 19.95 Esophagus 1.69 Male Female 0.43 Total 2.12 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.56 0.45 Female Total 1.01 Kidney & Renal Pelvis Male 2.78 1.58 Female 4.36 Total Larynx Male 1.55 0.39 Female Total 1.93 Leukemia Male 2.18 1.51 Female Total 3.70 Liver and Intrahepatic Bile Ducts Male 1.20 0.39 Female 1.59 Total Lung and Bronchus Male 14.54 Female 11.41 Total 25.95

Obs

SIR

7 2 9

160 NC* 156

1 0 1

NC* NC* NC*

1 21 22

NC* 78 81

1

NC*

7 4 11

63 NC* 55 #-

Exp

Obs

SIR

7 1 8

220 NC* 148

1 2 3

NC* NC* NC*

2 2 4

NC* NC* NC*

2 0 2

NC* NC* NC*

3.06

3

NC*

2.00 1.76 3.76

1 2 3

NC* NC* NC*

29.95

31

104

Male Female Total

1.91 0.91 2.82

2 0 2

NC* NC* NC*

Male

0.76

1

NC*

Male 0.59 1.58 Female Total 2.17 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

5.35

7

131

93.20 81.00 174.20

80 61 141

86 75 #81 #-

Melanoma of Skin 3.17 Male Female 2.24 5.41 Total Multiple Myeloma Male 0.93 0.74 Female 1.66 Total Non-Hodgkin('s) Lymphoma 3.54 Male 2.89 Female Total 6.44 Oral Cavity & Pharynx 2.91 Male Female 1.28 Total 4.19 Ovary Female Pancreas

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

1 3 4

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

10 9 19

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

69 79 73

178

Marlborough

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 16.91 Male Female 7.05 23.96 Total Brain and Other Nervous System Male 6.46 5.39 Female 11.86 Total Breast 0.89 Male 120.13 Female Total 121.02 Cervix Uteri Female

6.98

Colon / Rectum 43.06 Male Female 46.12 Total 89.18 Esophagus 6.50 Male Female 2.18 Total 8.67 Hodgkin's Disease (Hodgkin Lymphoma) Male 3.37 2.74 Female Total 6.12 Kidney & Renal Pelvis Male 11.09 7.11 Female 18.21 Total Larynx Male 5.95 1.57 Female Total 7.51 Leukemia Male 9.32 7.89 Female Total 17.22 Liver and Intrahepatic Bile Ducts Male 4.76 1.99 Female 6.75 Total Lung and Bronchus Male 55.86 Female 49.69 Total 105.55

Obs

SIR

17 5 22

101 71 92

3 4 7

NC* NC* 59

2 130 132

NC* 108 109

7

100

49 44 93

114 95 104

Exp

Obs

SIR

9 5 14

66 45 57 #-

8 5 13

224 144 184

15 17 32

98 120 109

19 7 26

163 118 148

14.11

10

71

7.74 8.95 16.69

7 11 18

90 123 108

112.66

122

108

Male Female Total

7.47 5.08 12.55

9 5 14

121 98 112

Male

5.80

8

138

Male 2.98 8.64 Female Total 11.62 Uteri, Corpus and Uterus, NOS

2 7 9

NC* 81 77

22.37

18

80

369.51 380.46 749.97

400 392 792

108 103 106

Melanoma of Skin 13.54 Male Female 11.15 24.69 Total Multiple Myeloma Male 3.57 3.48 Female 7.05 Total Non-Hodgkin('s) Lymphoma 15.28 Male 14.14 Female Total 29.42 Oral Cavity & Pharynx 11.63 Male Female 5.91 Total 17.54 Ovary Female Pancreas

3 1 4

NC* NC* NC*

6 4 10

178 NC* 163

16 2 18

144 NC* 99

Male Female Total Prostate Male

Stomach

Testis 5 1 6

84 NC* 80

13 13 26

139 165 151

7 4 11

147 NC* 163

Thyroid

57 60 117

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

102 121 111

179

Marshfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 11.17 Male Female 4.18 15.35 Total Brain and Other Nervous System Male 4.52 3.62 Female 8.14 Total Breast 0.60 Male 84.86 Female Total 85.46 Cervix Uteri Female

4.81

Colon / Rectum 28.80 Male Female 27.10 Total 55.90 Esophagus 4.65 Male Female 1.29 Total 5.94 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.19 1.77 Female Total 3.95 Kidney & Renal Pelvis Male 7.89 4.78 Female 12.67 Total Larynx Male 4.37 1.13 Female Total 5.49 Leukemia Male 6.34 5.02 Female Total 11.36 Liver and Intrahepatic Bile Ducts Male 3.42 1.20 Female 4.62 Total Lung and Bronchus Male 38.40 Female 33.12 Total 71.52

Obs

SIR

8 5 13

72 120 85

3 4 7

NC* NC* 86

0 75 75

NC* 88 88

4

NC*

34 35 69

118 129 123

Exp

Obs

SIR

10 7 17

106 93 100

4 3 7

NC* NC* 150

5 8 13

48 89 67

7 6 13

81 151 103

9.77

12

123

5.32 5.27 10.59

8 6 14

150 114 132

80.62

88

109

Male Female Total

5.04 2.89 7.93

3 2 5

NC* NC* 63

Male

3.45

3

NC*

Male 2.07 5.94 Female Total 8.01 Uteri, Corpus and Uterus, NOS

4 6 10

NC* 101 125

16.22

19

117

256.08 252.56 508.64

295 266 561

115 #+ 105 110 #+

Melanoma of Skin 9.47 Male Female 7.56 17.03 Total Multiple Myeloma Male 2.45 2.21 Female 4.66 Total Non-Hodgkin('s) Lymphoma 10.38 Male 8.98 Female Total 19.36 Oral Cavity & Pharynx 8.60 Male Female 3.97 Total 12.57 Ovary Female Pancreas

10 1 11

215 #+ NC* 185

4 0 4

NC* NC* NC*

9 6 15

114 125 118

Male Female Total Prostate Male

Stomach

Testis 4 2 6

NC* NC* 109

7 7 14

110 139 123

1 1 2

NC* NC* NC*

Thyroid

56 42 98

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

146 ~+ 127 137 ~+

180

Mashpee

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.09 Male Female 2.49 9.58 Total Brain and Other Nervous System Male 2.10 1.79 Female 3.89 Total Breast 0.33 Male 39.83 Female Total 40.17 Cervix Uteri Female

2.20

Colon / Rectum 17.58 Male Female 16.34 Total 33.93 Esophagus 2.45 Male Female 0.77 Total 3.22 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.90 0.86 Female Total 1.76 Kidney & Renal Pelvis Male 3.99 2.42 Female 6.41 Total Larynx Male 2.13 0.53 Female Total 2.66 Leukemia Male 3.43 2.69 Female Total 6.12 Liver and Intrahepatic Bile Ducts Male 1.71 0.70 Female 2.40 Total Lung and Bronchus Male 21.86 Female 17.21 Total 39.07

Obs

SIR

16 2 18

226 ~+ NC* 188 #+

5 2 7

238 NC* 180

2 68 70

NC* 171 ^+ 174 ^+

2

NC*

27 19 46

154 #+ 116 136

Exp

Obs

SIR

10 4 14

216 #+ NC* 169

1 0 1

NC* NC* NC*

6 2 8

110 NC* 78

7 4 11

175 NC* 183

4.67

3

NC*

3.07 3.18 6.25

6 5 11

195 157 176

43.05

83

193 ^+

Male Female Total

3.05 1.79 4.85

9 3 12

295 ~+ NC* 248 ~+

Male

1.37

3

NC*

Male 0.85 2.67 Female Total 3.52 Uteri, Corpus and Uterus, NOS

1 3 4

NC* NC* NC*

7.47

9

121

139.93 128.94 268.88

245 179 424

175 ^+ 139 ^+ 158 ^+

Melanoma of Skin 4.64 Male Female 3.62 8.26 Total Multiple Myeloma Male 1.40 1.21 Female 2.61 Total Non-Hodgkin('s) Lymphoma 5.44 Male 4.85 Female Total 10.30 Oral Cavity & Pharynx 4.00 Male Female 2.00 Total 6.00 Ovary Female Pancreas

1 4 5

NC* NC* 155

0 0 0

NC* NC* NC*

6 6 12

150 248 187

Male Female Total Prostate Male

Stomach

Testis 0 1 1

NC* NC* NC*

3 3 6

NC* NC* 98

4 1 5

NC* NC* 208

Thyroid

36 27 63

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

165 ~+ 157 #+ 161 ^+

181

Mattapoisett

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.83 Male Female 1.81 6.64 Total Brain and Other Nervous System Male 1.46 1.22 Female 2.68 Total Breast 0.24 Male 30.10 Female Total 30.33 Cervix Uteri Female

1.47

Colon / Rectum 12.13 Male Female 11.84 Total 23.97 Esophagus 1.80 Male Female 0.56 Total 2.36 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.58 0.50 Female Total 1.09 Kidney & Renal Pelvis Male 2.91 1.80 Female 4.71 Total Larynx Male 1.62 0.42 Female Total 2.03 Leukemia Male 2.30 1.88 Female Total 4.18 Liver and Intrahepatic Bile Ducts Male 1.26 0.51 Female 1.76 Total Lung and Bronchus Male 15.58 Female 13.03 Total 28.61

Obs

SIR

4 2 6

NC* NC* 90

1 0 1

NC* NC* NC*

0 32 32

NC* 106 106

2

NC*

14 11 25

115 93 104

Exp

Obs

SIR

5 8 13

149 315 #+ 221 #+

4 0 4

NC* NC* NC*

3 4 7

NC* NC* 96

4 0 4

NC* NC* NC*

3.43

2

NC*

2.17 2.31 4.48

2 2 4

NC* NC* NC*

31.90

34

107

Male Female Total

2.11 1.28 3.39

2 0 2

NC* NC* NC*

Male

0.82

1

NC*

Male 0.62 1.70 Female Total 2.32 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

5.82

7

120

99.88 95.00 194.88

100 102 202

100 107 104

Melanoma of Skin 3.35 Male Female 2.54 5.89 Total Multiple Myeloma Male 0.99 0.90 Female 1.89 Total Non-Hodgkin('s) Lymphoma 3.79 Male 3.48 Female Total 7.27 Oral Cavity & Pharynx 3.04 Male Female 1.49 Total 4.54 Ovary Female Pancreas

1 1 2

NC* NC* NC*

0 0 0

NC* NC* NC*

3 2 5

NC* NC* 106

Male Female Total Prostate Male

Stomach

Testis 3 0 3

NC* NC* NC*

2 1 3

NC* NC* NC*

1 0 1

NC* NC* NC*

Thyroid

9 17 26

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

58 130 91

182

Maynard

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 6.01 Male Female 2.66 8.67 Total Brain and Other Nervous System Male 2.13 1.91 Female 4.03 Total Breast 0.31 Male 44.13 Female Total 44.43 Cervix Uteri Female

2.38

Colon / Rectum 15.23 Male Female 17.49 Total 32.72 Esophagus 2.31 Male Female 0.82 Total 3.13 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.01 0.89 Female Total 1.90 Kidney & Renal Pelvis Male 3.85 2.64 Female 6.49 Total Larynx Male 2.10 0.59 Female Total 2.69 Leukemia Male 3.15 2.85 Female Total 6.00 Liver and Intrahepatic Bile Ducts Male 1.66 0.75 Female 2.41 Total Lung and Bronchus Male 19.65 Female 18.87 Total 38.52

Obs

SIR

4 0 4

NC* NC* NC*

5 2 7

235 NC* 174

1 34 35

NC* 77 79

5

210

19 20 39

125 114 119

Exp

Obs

SIR

2 5 7

NC* 127 82

1 1 2

NC* NC* NC*

6 8 14

116 153 135

4 0 4

NC* NC* NC*

5.12

6

117

2.75 3.40 6.14

2 4 6

NC* NC* 98

40.15

38

95

Male Female Total

2.66 1.90 4.56

2 2 4

NC* NC* NC*

Male

1.62

1

NC*

Male 0.95 2.86 Female Total 3.81 Uteri, Corpus and Uterus, NOS

1 4 5

NC* NC* 131

8.35

7

84

129.08 140.55 269.63

137 128 265

106 91 98

Melanoma of Skin 4.60 Male Female 3.93 8.53 Total Multiple Myeloma Male 1.26 1.31 Female 2.57 Total Non-Hodgkin('s) Lymphoma 5.17 Male 5.23 Female Total 10.40 Oral Cavity & Pharynx 4.08 Male Female 2.19 Total 6.27 Ovary Female Pancreas

4 0 4

NC* NC* NC*

3 1 4

NC* NC* NC*

4 3 7

NC* NC* 108

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

1 5 6

NC* 176 100

2 0 2

NC* NC* NC*

Thyroid

28 14 42

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

143 74 109

183

Medfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 6.78 Male Female 2.25 9.03 Total Brain and Other Nervous System Male 2.56 1.91 Female 4.47 Total Breast 0.36 Male 46.00 Female Total 46.37 Cervix Uteri Female

2.49

Colon / Rectum 17.41 Male Female 14.54 Total 31.95 Esophagus 2.80 Male Female 0.70 Total 3.50 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.12 0.88 Female Total 2.01 Kidney & Renal Pelvis Male 4.68 2.59 Female 7.27 Total Larynx Male 2.62 0.62 Female Total 3.24 Leukemia Male 3.69 2.69 Female Total 6.38 Liver and Intrahepatic Bile Ducts Male 2.04 0.64 Female 2.68 Total Lung and Bronchus Male 23.43 Female 18.02 Total 41.45

Obs

SIR

3 1 4

NC* NC* NC*

5 3 8

195 NC* 179

1 50 51

NC* 109 110

1

NC*

8 14 22

46 #96 69

Exp

Obs

SIR

8 5 13

146 125 137

1 0 1

NC* NC* NC*

7 2 9

117 NC* 83

3 2 5

NC* NC* 69

5.25

1

NC*

3.20 2.84 6.04

4 1 5

NC* NC* 83

49.34

52

105

Male Female Total

3.01 1.55 4.56

1 1 2

NC* NC* NC*

Male

1.63

0

NC*

Male 1.12 3.04 Female Total 4.16 Uteri, Corpus and Uterus, NOS

0 4 4

NC* NC* NC*

8.89

7

79

153.34 136.10 289.44

133 127 260

87 93 90

Melanoma of Skin 5.47 Male Female 3.99 9.46 Total Multiple Myeloma Male 1.48 1.20 Female 2.68 Total Non-Hodgkin('s) Lymphoma 5.99 Male 4.79 Female Total 10.78 Oral Cavity & Pharynx 5.05 Male Female 2.15 Total 7.20 Ovary Female Pancreas

3 1 4

NC* NC* NC*

0 0 0

NC* NC* NC*

4 2 6

NC* NC* 82

Male Female Total Prostate Male

Stomach

Testis 3 0 3

NC* NC* NC*

8 3 11

217 NC* 172

1 2 3

NC* NC* NC*

Thyroid

16 20 36

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

68 111 87

184

Medford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 39.20 Male Female 16.90 56.09 Total Brain and Other Nervous System Male 12.00 11.28 Female 23.28 Total Breast 1.90 Male 258.95 Female Total 260.85 Cervix Uteri Female

13.97

Colon / Rectum 97.85 Male Female 110.97 Total 208.82 Esophagus 13.84 Male Female 5.21 Total 19.05 Hodgkin's Disease (Hodgkin Lymphoma) Male 5.52 5.32 Female Total 10.84 Kidney & Renal Pelvis Male 22.70 15.95 Female 38.65 Total Larynx Male 12.18 3.49 Female Total 15.67 Leukemia Male 19.01 17.20 Female Total 36.21 Liver and Intrahepatic Bile Ducts Male 9.72 4.70 Female 14.42 Total Lung and Bronchus Male 123.56 Female 115.30 Total 238.85

Obs

SIR

27 16 43

69 95 77

11 10 21

92 89 90

1 262 263

NC* 101 101

13

93

105 99 204

107 89 98

Exp

Obs

SIR

27 18 45

101 77 90

12 7 19

153 86 119

21 47 68

68 146 #+ 107

20 17 37

87 129 103

30.30

33

109

17.14 21.63 38.77

17 19 36

99 88 93

244.28

194

79 ^-

Male Female Total

16.85 12.13 28.98

27 14 41

160 #+ 115 141 #+

Male

9.01

11

122

Male 5.16 16.72 Female Total 21.88 Uteri, Corpus and Uterus, NOS

3 18 21

NC* 108 96

48.59

57

117

791.34 849.63 1640.97

736 876 1612

93 #103 98

Melanoma of Skin 26.75 Male Female 23.37 50.12 Total Multiple Myeloma Male 7.86 8.13 Female 15.98 Total Non-Hodgkin('s) Lymphoma 31.03 Male 32.27 Female Total 63.29 Oral Cavity & Pharynx 22.86 Male Female 13.18 Total 36.04 Ovary Female Pancreas

13 6 19

94 115 100

2 5 7

NC* 94 65

22 18 40

97 113 104

Male Female Total Prostate Male

Stomach

Testis 6 7 13

49 200 83

18 17 35

95 99 97

8 7 15

82 149 104

Thyroid

133 120 253

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

108 104 106

185

Medway

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 5.85 Male Female 2.07 7.92 Total Brain and Other Nervous System Male 2.28 1.79 Female 4.07 Total Breast 0.31 Male 41.27 Female Total 41.57 Cervix Uteri Female

2.35

Colon / Rectum 15.01 Male Female 13.34 Total 28.35 Esophagus 2.38 Male Female 0.64 Total 3.02 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.07 0.88 Female Total 1.95 Kidney & Renal Pelvis Male 4.00 2.34 Female 6.34 Total Larynx Male 2.22 0.55 Female Total 2.76 Leukemia Male 3.26 2.52 Female Total 5.78 Liver and Intrahepatic Bile Ducts Male 1.74 0.59 Female 2.33 Total Lung and Bronchus Male 19.90 Female 16.03 Total 35.93

Obs

SIR

14 2 16

239 ~+ NC* 202 #+

0 4 4

NC* NC* NC*

0 43 43

NC* 104 103

1

NC*

16 12 28

107 90 99

Exp

Obs

SIR

9 6 15

189 162 177

0 0 0

NC* NC* NC*

6 10 16

114 228 #+ 166

2 2 4

NC* NC* NC*

4.77

2

NC*

2.75 2.60 5.35

3 1 4

NC* NC* NC*

41.65

44

106

Male Female Total

2.62 1.45 4.07

5 0 5

191 NC* 123

Male

1.64

3

NC*

Male 1.01 2.91 Female Total 3.93 Uteri, Corpus and Uterus, NOS

1 3 4

NC* NC* NC*

7.86

6

76

131.71 123.45 255.16

146 116 262

111 94 103

Melanoma of Skin 4.76 Male Female 3.70 8.46 Total Multiple Myeloma Male 1.27 1.08 Female 2.35 Total Non-Hodgkin('s) Lymphoma 5.26 Male 4.39 Female Total 9.65 Oral Cavity & Pharynx 4.33 Male Female 1.94 Total 6.27 Ovary Female Pancreas

2 2 4

NC* NC* NC*

2 0 2

NC* NC* NC*

4 3 7

NC* NC* 110

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

3 1 4

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

19 10 29

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

95 62 81

186

Melrose

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 19.31 Male Female 8.52 27.83 Total Brain and Other Nervous System Male 5.77 5.41 Female 11.19 Total Breast 0.92 Male 128.89 Female Total 129.81 Cervix Uteri Female

6.49

Colon / Rectum 48.16 Male Female 56.12 Total 104.29 Esophagus 6.90 Male Female 2.64 Total 9.54 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.47 2.33 Female Total 4.80 Kidney & Renal Pelvis Male 11.24 7.87 Female 19.11 Total Larynx Male 6.10 1.73 Female Total 7.82 Leukemia Male 9.24 8.61 Female Total 17.85 Liver and Intrahepatic Bile Ducts Male 4.83 2.36 Female 7.19 Total Lung and Bronchus Male 60.53 Female 56.88 Total 117.42

Obs

SIR

17 6 23

88 70 83

8 7 15

139 129 134

0 134 134

NC* 104 103

5

77

42 57 99

87 102 95

Exp

Obs

SIR

12 14 26

92 125 107

2 3 5

NC* NC* 63

21 9 30

139 57 97

7 4 11

61 NC* 61

14.86

28

188 ~+

8.51 10.88 19.39

12 12 24

141 110 124

121.11

171

141 ^+

Male Female Total

8.39 6.19 14.59

7 2 9

83 NC* 62

Male

3.75

7

187

Male 2.45 7.54 Female Total 9.99 Uteri, Corpus and Uterus, NOS

3 9 12

NC* 119 120

24.41

26

107

389.09 421.84 810.94

411 411 822

106 97 101

Melanoma of Skin 13.11 Male Female 11.24 24.35 Total Multiple Myeloma Male 3.88 4.08 Female 7.96 Total Non-Hodgkin('s) Lymphoma 15.09 Male 15.82 Female Total 30.90 Oral Cavity & Pharynx 11.53 Male Female 6.59 Total 18.12 Ovary Female Pancreas

5 4 9

72 NC* 94

5 3 8

202 NC* 166

13 11 24

116 140 126

Male Female Total Prostate Male

Stomach

Testis 6 1 7

98 NC* 89

14 6 20

151 70 112

2 4 6

NC* NC* 83

Thyroid

43 48 91

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

71 #84 78 #-

187

Mendon

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.73 Male Female 0.94 3.67 Total Brain and Other Nervous System Male 1.02 0.77 Female 1.80 Total Breast 0.14 Male 18.31 Female Total 18.46 Cervix Uteri Female

1.03

Colon / Rectum 7.00 Male Female 6.09 Total 13.08 Esophagus 1.12 Male Female 0.29 Total 1.41 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.46 0.37 Female Total 0.84 Kidney & Renal Pelvis Male 1.87 1.04 Female 2.91 Total Larynx Male 1.04 0.24 Female Total 1.28 Leukemia Male 1.48 1.11 Female Total 2.58 Liver and Intrahepatic Bile Ducts Male 0.81 0.27 Female 1.08 Total Lung and Bronchus Male 9.27 Female 7.15 Total 16.43

Obs

SIR

3 1 4

NC* NC* NC*

0 0 0

NC* NC* NC*

0 20 20

NC* 109 108

1

NC*

12 4 16

172 NC* 122

Exp

Obs

SIR

3 2 5

NC* NC* 130

3 2 5

NC* NC* 463 #+

3 3 6

NC* NC* 137

0 1 1

NC* NC* NC*

2.11

3

NC*

1.29 1.18 2.47

3 1 4

NC* NC* NC*

19.48

10

51 #-

Male Female Total

1.22 0.66 1.89

1 0 1

NC* NC* NC*

Male

0.69

0

NC*

Male 0.46 1.26 Female Total 1.72 Uteri, Corpus and Uterus, NOS

3 3 6

NC* NC* 349 #+

3.49

2

NC*

61.21 55.02 116.23

50 57 107

82 104 92

Melanoma of Skin 2.21 Male Female 1.63 3.84 Total Multiple Myeloma Male 0.59 0.49 Female 1.08 Total Non-Hodgkin('s) Lymphoma 2.42 Male 1.96 Female Total 4.38 Oral Cavity & Pharynx 2.03 Male Female 0.86 Total 2.90 Ovary Female Pancreas

1 0 1

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 2 2

NC* NC* NC*

Thyroid

6 7 13

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

65 98 79

188

Merrimac

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 3.63 Male Female 1.33 4.96 Total Brain and Other Nervous System Male 1.31 1.06 Female 2.37 Total Breast 0.19 Male 24.89 Female Total 25.08 Cervix Uteri Female

1.38

Colon / Rectum 9.23 Male Female 8.64 Total 17.87 Esophagus 1.43 Male Female 0.41 Total 1.84 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.59 0.51 Female Total 1.10 Kidney & Renal Pelvis Male 2.39 1.43 Female 3.82 Total Larynx Male 1.31 0.33 Female Total 1.64 Leukemia Male 1.94 1.53 Female Total 3.47 Liver and Intrahepatic Bile Ducts Male 1.03 0.38 Female 1.41 Total Lung and Bronchus Male 12.01 Female 10.01 Total 22.01

Obs

SIR

9 0 9

248 #+ NC* 181

1 1 2

NC* NC* NC*

0 23 23

NC* 92 92

1

NC*

7 10 17

76 116 95

Exp

Obs

SIR

1 2 3

NC* NC* NC*

2 1 3

NC* NC* NC*

1 2 3

NC* NC* NC*

0 0 0

NC* NC* NC*

2.87

2

NC*

1.68 1.68 3.36

0 2 2

NC* NC* NC*

24.79

23

93

Male Female Total

1.62 0.94 2.56

2 0 2

NC* NC* NC*

Male

0.90

1

NC*

Male 0.58 1.69 Female Total 2.26 Uteri, Corpus and Uterus, NOS

1 1 2

NC* NC* NC*

4.74

7

148

79.02 75.94 154.96

74 71 145

94 93 94

Melanoma of Skin 2.82 Male Female 2.21 5.04 Total Multiple Myeloma Male 0.77 0.68 Female 1.45 Total Non-Hodgkin('s) Lymphoma 3.15 Male 2.74 Female Total 5.88 Oral Cavity & Pharynx 2.56 Male Female 1.19 Total 3.75 Ovary Female Pancreas

1 1 2

NC* NC* NC*

0 1 1

NC* NC* NC*

2 2 4

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 3 0 3

NC* NC* NC*

2 1 3

NC* NC* NC*

3 0 3

NC* NC* NC*

Thyroid

12 10 22

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

100 100 100

189

Methuen

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 28.87 Male Female 12.28 41.15 Total Brain and Other Nervous System Male 8.98 8.05 Female 17.03 Total Breast 1.40 Male 186.13 Female Total 187.53 Cervix Uteri Female

9.35

Colon / Rectum 72.04 Male Female 80.78 Total 152.82 Esophagus 10.31 Male Female 3.80 Total 14.11 Hodgkin's Disease (Hodgkin Lymphoma) Male 3.92 3.47 Female Total 7.39 Kidney & Renal Pelvis Male 16.96 11.50 Female 28.46 Total Larynx Male 9.13 2.54 Female Total 11.67 Leukemia Male 14.23 12.59 Female Total 26.82 Liver and Intrahepatic Bile Ducts Male 7.27 3.42 Female 10.68 Total Lung and Bronchus Male 91.08 Female 83.49 Total 174.57

Obs

SIR

30 9 39

104 73 95

9 10 19

100 124 112

3 185 188

NC* 99 100

12

128

87 69 156

121 85 102

Exp

Obs

SIR

14 14 28

71 86 78

9 8 17

154 135 145

24 22 46

105 95 100

9 11 20

52 #115 75

21.55

25

116

12.70 15.72 28.43

8 14 22

63 89 77

181.29

195

108

Male Female Total

12.47 8.83 21.29

21 12 33

168 #+ 136 155 #+

Male

5.99

7

117

Male 3.74 10.90 Female Total 14.64 Uteri, Corpus and Uterus, NOS

3 7 10

NC* 64 68

35.40

39

110

584.96 611.11 1196.07

583 605 1188

100 99 99

Melanoma of Skin 19.77 Male Female 16.22 35.99 Total Multiple Myeloma Male 5.83 5.91 Female 11.74 Total Non-Hodgkin('s) Lymphoma 22.83 Male 23.08 Female Total 45.91 Oral Cavity & Pharynx 17.22 Male Female 9.53 Total 26.75 Ovary Female Pancreas

13 3 16

126 NC* 113

8 4 12

204 NC* 162

18 9 27

106 78 95

Male Female Total Prostate Male

Stomach

Testis 9 5 14

99 197 120

9 10 19

63 79 71

6 3 9

83 NC* 84

Thyroid

76 89 165

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

83 107 95

190

Middleborough

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 10.04 Male Female 4.06 14.10 Total Brain and Other Nervous System Male 3.81 3.22 Female 7.03 Total Breast 0.53 Male 73.42 Female Total 73.94 Cervix Uteri Female

4.20

Colon / Rectum 25.59 Male Female 26.60 Total 52.19 Esophagus 3.97 Male Female 1.26 Total 5.23 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.81 1.60 Female Total 3.40 Kidney & Renal Pelvis Male 6.73 4.23 Female 10.96 Total Larynx Male 3.67 0.95 Female Total 4.62 Leukemia Male 5.54 4.69 Female Total 10.22 Liver and Intrahepatic Bile Ducts Male 2.90 1.15 Female 4.05 Total Lung and Bronchus Male 33.42 Female 29.29 Total 62.71

Obs

SIR

11 1 12

110 NC* 85

3 6 9

NC* 186 128

1 80 81

NC* 109 110

4

NC*

27 27 54

106 101 103

Exp

Obs

SIR

2 3 5

NC* NC* 34 ~-

1 4 5

NC* NC* 119

10 9 19

112 109 110

7 1 8

97 NC* 75

8.53

6

70

4.66 5.13 9.80

6 4 10

129 NC* 102

68.77

63

92

Male Female Total

4.48 2.91 7.39

5 2 7

112 NC* 95

Male

2.83

3

NC*

Male 1.69 5.18 Female Total 6.88 Uteri, Corpus and Uterus, NOS

4 6 10

NC* 116 145

13.77

13

94

221.17 226.99 448.15

224 227 451

101 100 101

Melanoma of Skin 8.03 Male Female 6.69 14.72 Total Multiple Myeloma Male 2.15 2.04 Female 4.19 Total Non-Hodgkin('s) Lymphoma 8.95 Male 8.26 Female Total 17.21 Oral Cavity & Pharynx 7.19 Male Female 3.54 Total 10.73 Ovary Female Pancreas

4 1 5

NC* NC* 96

2 2 4

NC* NC* NC*

5 6 11

74 142 100

Male Female Total Prostate Male

Stomach

Testis 5 1 6

136 NC* 130

9 7 16

163 149 157

0 1 1

NC* NC* NC*

Thyroid

42 31 73

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

126 106 116

191

Middlefield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.29 Male Female 0.08 0.38 Total Brain and Other Nervous System Male 0.10 0.07 Female 0.17 Total Breast 0.02 Male 1.62 Female Total 1.64 Cervix Uteri Female

0.08

Colon / Rectum 0.74 Male Female 0.54 Total 1.28 Esophagus 0.12 Male Female 0.03 Total 0.14 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.05 0.03 Female Total 0.08 Kidney & Renal Pelvis Male 0.20 0.09 Female 0.29 Total Larynx Male 0.11 0.02 Female Total 0.13 Leukemia Male 0.15 0.10 Female Total 0.25 Liver and Intrahepatic Bile Ducts Male 0.08 0.02 Female 0.11 Total Lung and Bronchus Male 0.96 Female 0.68 Total 1.63

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0

NC*

0 0 0

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0.19

0

NC*

0.14 0.11 0.24

0 0 0

NC* NC* NC*

1.97

2

NC*

Male Female Total

0.13 0.06 0.19

0 0 0

NC* NC* NC*

Male

0.07

0

NC*

Male 0.05 0.10 Female Total 0.15 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

0.32

1

NC*

6.33 4.88 11.22

3 4 7

NC* NC* 62

Melanoma of Skin 0.23 Male Female 0.14 0.37 Total Multiple Myeloma Male 0.06 0.04 Female 0.11 Total Non-Hodgkin('s) Lymphoma 0.26 Male 0.18 Female Total 0.43 Oral Cavity & Pharynx 0.21 Male Female 0.08 Total 0.29 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

1 0 1

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

192

Middleton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.09 Male Female 1.35 5.45 Total Brain and Other Nervous System Male 1.37 1.07 Female 2.43 Total Breast 0.20 Male 25.29 Female Total 25.49 Cervix Uteri Female

1.36

Colon / Rectum 10.32 Male Female 8.81 Total 19.14 Esophagus 1.55 Male Female 0.42 Total 1.97 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.60 0.49 Female Total 1.09 Kidney & Renal Pelvis Male 2.57 1.47 Female 4.04 Total Larynx Male 1.41 0.35 Female Total 1.75 Leukemia Male 2.08 1.52 Female Total 3.60 Liver and Intrahepatic Bile Ducts Male 1.11 0.38 Female 1.49 Total Lung and Bronchus Male 13.28 Female 10.46 Total 23.74

Obs

SIR

9 0 9

220 #+ NC* 165

2 2 4

NC* NC* NC*

0 30 30

NC* 119 118

1

NC*

8 5 13

77 57 68

Exp

Obs

SIR

5 0 5

166 NC* 96

0 0 0

NC* NC* NC*

1 3 4

NC* NC* NC*

4 2 6

NC* NC* 153

2.91

2

NC*

1.86 1.72 3.58

0 0 0

NC* NC* NC*

27.12

16

59 #-

Male Female Total

1.80 0.93 2.74

1 1 2

NC* NC* NC*

Male

0.90

0

NC*

Male 0.59 1.65 Female Total 2.24 Uteri, Corpus and Uterus, NOS

1 2 3

NC* NC* NC*

4.86

3

NC*

86.44 77.28 163.73

85 64 149

98 83 91

Melanoma of Skin 3.01 Male Female 2.21 5.23 Total Multiple Myeloma Male 0.85 0.70 Female 1.55 Total Non-Hodgkin('s) Lymphoma 3.39 Male 2.80 Female Total 6.20 Oral Cavity & Pharynx 2.71 Male Female 1.21 Total 3.92 Ovary Female Pancreas

0 0 0

NC* NC* NC*

3 0 3

NC* NC* NC*

1 1 2

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

17 4 21

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

128 NC* 88

193

Milford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 14.68 Male Female 5.97 20.64 Total Brain and Other Nervous System Male 4.98 4.36 Female 9.34 Total Breast 0.73 Male 99.26 Female Total 99.99 Cervix Uteri Female

5.42

Colon / Rectum 36.94 Male Female 39.32 Total 76.26 Esophagus 5.45 Male Female 1.85 Total 7.30 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.32 2.05 Female Total 4.38 Kidney & Renal Pelvis Male 9.09 5.92 Female 15.01 Total Larynx Male 4.91 1.31 Female Total 6.22 Leukemia Male 7.58 6.47 Female Total 14.05 Liver and Intrahepatic Bile Ducts Male 3.91 1.68 Female 5.58 Total Lung and Bronchus Male 47.04 Female 42.08 Total 89.12

Obs

SIR

11 7 18

75 117 87

6 5 11

120 115 118

1 98 99

NC* 99 99

2

NC*

44 39 83

119 99 109

Exp

Obs

SIR

12 15 27

111 168 137

2 4 6

NC* NC* 101

17 13 30

138 110 125

10 4 14

106 NC* 97

11.53

12

104

6.61 7.61 14.21

5 8 13

76 105 91

94.80

102

108

Male Female Total

6.45 4.26 10.71

14 4 18

217 #+ NC* 168

Male

3.68

2

NC*

Male 2.18 6.56 Female Total 8.74 Uteri, Corpus and Uterus, NOS

2 8 10

NC* 122 114

18.71

22

118

307.37 316.17 623.54

328 329 657

107 104 105

Melanoma of Skin 10.80 Male Female 8.92 19.72 Total Multiple Myeloma Male 3.02 2.94 Female 5.97 Total Non-Hodgkin('s) Lymphoma 12.29 Male 11.77 Female Total 24.06 Oral Cavity & Pharynx 9.48 Male Female 4.92 Total 14.40 Ovary Female Pancreas

4 0 4

NC* NC* NC*

0 3 3

NC* NC* NC*

14 3 17

154 NC* 113

Male Female Total Prostate Male

Stomach

Testis 7 2 9

143 NC* 145

7 6 13

92 93 93

5 3 8

128 NC* 143

Thyroid

51 54 105

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

108 128 118

194

Millbury

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 8.45 Male Female 3.39 11.84 Total Brain and Other Nervous System Male 2.65 2.32 Female 4.97 Total Breast 0.41 Male 54.77 Female Total 55.18 Cervix Uteri Female

2.86

Colon / Rectum 21.20 Male Female 22.03 Total 43.23 Esophagus 3.08 Male Female 1.04 Total 4.12 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.17 1.05 Female Total 2.22 Kidney & Renal Pelvis Male 5.00 3.32 Female 8.33 Total Larynx Male 2.73 0.75 Female Total 3.49 Leukemia Male 4.14 3.54 Female Total 7.68 Liver and Intrahepatic Bile Ducts Male 2.16 0.94 Female 3.10 Total Lung and Bronchus Male 26.91 Female 23.88 Total 50.78

Obs

SIR

10 0 10

118 NC* 84

0 1 1

NC* NC* NC*

0 49 49

NC* 89 89

3

NC*

21 8 29

99 36 ~67 #-

Exp

Obs

SIR

4 3 7

NC* NC* 66

0 0 0

NC* NC* NC*

5 9 14

74 138 106

5 2 7

97 NC* 88

6.35

10

157

3.76 4.32 8.08

2 5 7

NC* 116 87

54.39

44

81

Male Female Total

3.68 2.42 6.10

2 3 5

NC* NC* 82

Male

1.79

0

NC*

Male 1.13 3.40 Female Total 4.53 Uteri, Corpus and Uterus, NOS

2 2 4

NC* NC* NC*

10.43

17

163

173.55 175.47 349.02

161 171 332

93 97 95

Melanoma of Skin 5.86 Male Female 4.82 10.68 Total Multiple Myeloma Male 1.71 1.66 Female 3.37 Total Non-Hodgkin('s) Lymphoma 6.73 Male 6.53 Female Total 13.26 Oral Cavity & Pharynx 5.18 Male Female 2.74 Total 7.92 Ovary Female Pancreas

5 1 6

162 NC* 146

2 1 3

NC* NC* NC*

7 6 13

140 180 156

Male Female Total Prostate Male

Stomach

Testis 2 1 3

NC* NC* NC*

4 2 6

NC* NC* 78

1 2 3

NC* NC* NC*

Thyroid

38 31 69

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

141 130 136 #+

195

Millis

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 3.93 Male Female 1.30 5.23 Total Brain and Other Nervous System Male 1.52 1.16 Female 2.68 Total Breast 0.21 Male 26.60 Female Total 26.81 Cervix Uteri Female

1.55

Colon / Rectum 10.07 Male Female 8.43 Total 18.49 Esophagus 1.58 Male Female 0.40 Total 1.98 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.73 0.59 Female Total 1.32 Kidney & Renal Pelvis Male 2.66 1.50 Female 4.16 Total Larynx Male 1.47 0.35 Female Total 1.82 Leukemia Male 2.18 1.58 Female Total 3.76 Liver and Intrahepatic Bile Ducts Male 1.15 0.37 Female 1.53 Total Lung and Bronchus Male 13.24 Female 10.38 Total 23.62

Obs

SIR

5 1 6

127 NC* 115

2 0 2

NC* NC* NC*

0 28 28

NC* 105 104

1

NC*

8 12 20

79 142 108

Exp

Obs

SIR

4 4 8

NC* NC* 143

0 1 1

NC* NC* NC*

5 4 9

141 NC* 141

1 1 2

NC* NC* NC*

3.09

5

162

1.84 1.64 3.48

3 1 4

NC* NC* NC*

27.58

32

116

Male Female Total

1.76 0.90 2.66

1 2 3

NC* NC* NC*

Male

1.15

4

NC*

Male 0.68 1.94 Female Total 2.63 Uteri, Corpus and Uterus, NOS

0 2 2

NC* NC* NC*

5.05

2

NC*

87.85 79.31 167.16

94 94 188

107 119 112

Melanoma of Skin 3.18 Male Female 2.41 5.60 Total Multiple Myeloma Male 0.84 0.69 Female 1.53 Total Non-Hodgkin('s) Lymphoma 3.54 Male 2.84 Female Total 6.37 Oral Cavity & Pharynx 2.87 Male Female 1.24 Total 4.11 Ovary Female Pancreas

3 1 4

NC* NC* NC*

1 1 2

NC* NC* NC*

2 4 6

NC* NC* 144

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

15 12 27

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

113 116 114

196

Millville

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.22 Male Female 0.45 1.67 Total Brain and Other Nervous System Male 0.51 0.41 Female 0.91 Total Breast 0.07 Male 8.65 Female Total 8.72 Cervix Uteri Female

0.54

Colon / Rectum 3.15 Male Female 2.92 Total 6.07 Esophagus 0.50 Male Female 0.14 Total 0.64 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.26 0.22 Female Total 0.48 Kidney & Renal Pelvis Male 0.85 0.50 Female 1.35 Total Larynx Male 0.46 0.11 Female Total 0.58 Leukemia Male 0.71 0.56 Female Total 1.26 Liver and Intrahepatic Bile Ducts Male 0.37 0.13 Female 0.50 Total Lung and Bronchus Male 4.19 Female 3.42 Total 7.61

Obs

SIR

2 0 2

NC* NC* NC*

1 0 1

NC* NC* NC*

0 7 7

NC* 81 80

2

NC*

4 3 7

NC* NC* 115

Exp

Obs

SIR

1 3 4

NC* NC* NC*

2 0 2

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

1.03

0

NC*

0.58 0.57 1.15

0 0 0

NC* NC* NC*

8.68

5

58

Male Female Total

0.55 0.32 0.86

0 0 0

NC* NC* NC*

Male

0.43

0

NC*

Male 0.23 0.69 Female Total 0.92 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

1.61

3

NC*

27.91 26.53 54.45

24 26 50

86 98 92

Melanoma of Skin 1.03 Male Female 0.83 1.86 Total Multiple Myeloma Male 0.27 0.23 Female 0.50 Total Non-Hodgkin('s) Lymphoma 1.15 Male 0.98 Female Total 2.12 Oral Cavity & Pharynx 0.91 Male Female 0.41 Total 1.32 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

2 0 2

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

2 1 3

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

4 2 6

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* 79

197

Milton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 20.24 Male Female 8.33 28.57 Total Brain and Other Nervous System Male 6.08 5.44 Female 11.53 Total Breast 0.97 Male 130.32 Female Total 131.29 Cervix Uteri Female

6.45

Colon / Rectum 50.55 Male Female 54.50 Total 105.04 Esophagus 7.28 Male Female 2.57 Total 9.86 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.53 2.30 Female Total 4.83 Kidney & Renal Pelvis Male 11.83 7.96 Female 19.79 Total Larynx Male 6.45 1.80 Female Total 8.24 Leukemia Male 9.73 8.50 Female Total 18.23 Liver and Intrahepatic Bile Ducts Male 5.09 2.32 Female 7.40 Total Lung and Bronchus Male 64.04 Female 57.80 Total 121.84

Obs

SIR

14 14 28

69 168 98

3 8 11

NC* 147 95

3 131 134

NC* 101 102

5

78

43 54 97

85 99 92

Exp

Obs

SIR

23 14 37

168 #+ 125 149 #+

4 0 4

NC* NC* NC*

10 19 29

64 121 92

9 5 14

74 76 75

14.99

19

127

8.93 10.64 19.58

8 5 13

90 47 66

128.65

130

101

Male Female Total

8.76 5.95 14.71

5 5 10

57 84 68

Male

3.72

2

NC*

Male 2.53 7.47 Female Total 9.99 Uteri, Corpus and Uterus, NOS

2 7 9

NC* 94 90

24.98

19

76

409.88 421.35 831.23

368 403 771

90 #96 93 #-

Melanoma of Skin 13.68 Male Female 11.18 24.86 Total Multiple Myeloma Male 4.08 4.06 Female 8.14 Total Non-Hodgkin('s) Lymphoma 15.73 Male 15.72 Female Total 31.45 Oral Cavity & Pharynx 12.10 Male Female 6.60 Total 18.70 Ovary Female Pancreas

4 1 5

NC* NC* 51

4 0 4

NC* NC* NC*

9 7 16

76 88 81

Male Female Total Prostate Male

Stomach

Testis 7 2 9

109 NC* 109

14 6 20

144 71 110

6 1 7

118 NC* 95

Thyroid

42 51 93

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

66 ~88 76 ~-

198

Monroe

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.12 Male Female 0.03 0.15 Total Brain and Other Nervous System Male 0.03 0.02 Female 0.05 Total Breast 0.01 Male 0.43 Female Total 0.44 Cervix Uteri Female

0.02

Colon / Rectum 0.30 Male Female 0.19 Total 0.49 Esophagus 0.04 Male Female 0.01 Total 0.05 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.01 0.01 Female Total 0.02 Kidney & Renal Pelvis Male 0.06 0.03 Female 0.09 Total Larynx Male 0.03 0.01 Female Total 0.04 Leukemia Male 0.05 0.03 Female Total 0.08 Liver and Intrahepatic Bile Ducts Male 0.03 0.01 Female 0.03 Total Lung and Bronchus Male 0.35 Female 0.20 Total 0.55

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0

NC*

0 0 0

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0.05

0

NC*

0.05 0.04 0.09

0 0 0

NC* NC* NC*

0.64

1

NC*

Male Female Total

0.05 0.02 0.07

0 0 0

NC* NC* NC*

Male

0.01

0

NC*

Male 0.01 0.02 Female Total 0.03 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.08

0

NC*

2.19 1.41 3.60

2 1 3

NC* NC* NC*

Melanoma of Skin 0.07 Male Female 0.04 0.10 Total Multiple Myeloma Male 0.02 0.01 Female 0.04 Total Non-Hodgkin('s) Lymphoma 0.09 Male 0.05 Female Total 0.14 Oral Cavity & Pharynx 0.06 Male Female 0.02 Total 0.08 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

0 0 0

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

199

Monson

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 5.43 Male Female 1.80 7.24 Total Brain and Other Nervous System Male 1.98 1.50 Female 3.48 Total Breast 0.29 Male 35.69 Female Total 35.98 Cervix Uteri Female

1.99

Colon / Rectum 13.89 Male Female 11.74 Total 25.63 Esophagus 2.20 Male Female 0.56 Total 2.76 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.90 0.72 Female Total 1.62 Kidney & Renal Pelvis Male 3.68 2.03 Female 5.71 Total Larynx Male 2.04 0.48 Female Total 2.52 Leukemia Male 2.88 2.09 Female Total 4.97 Liver and Intrahepatic Bile Ducts Male 1.60 0.52 Female 2.11 Total Lung and Bronchus Male 18.39 Female 14.20 Total 32.59

Obs

SIR

5 3 8

92 NC* 111

1 1 2

NC* NC* NC*

0 26 26

NC* 73 72

4

NC*

6 8 14

43 #68 55 #-

Exp

Obs

SIR

7 2 9

161 NC* 120

1 2 3

NC* NC* NC*

2 3 5

NC* NC* 58

2 3 5

NC* NC* 89

4.10

2

NC*

2.54 2.28 4.83

2 3 5

NC* NC* 104

38.30

22

57 ~-

Male Female Total

2.42 1.24 3.66

3 6 9

NC* 483 ~+ 246 #+

Male

1.38

1

NC*

Male 0.90 2.45 Female Total 3.35 Uteri, Corpus and Uterus, NOS

1 3 4

NC* NC* NC*

6.83

4

NC*

120.74 107.04 227.78

90 105 195

75 ~98 86 #-

Melanoma of Skin 4.35 Male Female 3.16 7.51 Total Multiple Myeloma Male 1.18 0.95 Female 2.12 Total Non-Hodgkin('s) Lymphoma 4.78 Male 3.83 Female Total 8.61 Oral Cavity & Pharynx 3.97 Male Female 1.68 Total 5.65 Ovary Female Pancreas

2 0 2

NC* NC* NC*

3 2 5

NC* NC* 308

3 3 6

NC* NC* 105

Male Female Total Prostate Male

Stomach

Testis 2 0 2

NC* NC* NC*

5 0 5

174 NC* 101

2 1 3

NC* NC* NC*

Thyroid

15 23 38

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

82 162 #+ 117

200

Montague

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 5.65 Male Female 2.26 7.92 Total Brain and Other Nervous System Male 1.68 1.50 Female 3.18 Total Breast 0.27 Male 34.66 Female Total 34.94 Cervix Uteri Female

1.71

Colon / Rectum 14.06 Male Female 14.82 Total 28.88 Esophagus 1.99 Male Female 0.70 Total 2.69 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.71 0.64 Female Total 1.35 Kidney & Renal Pelvis Male 3.27 2.16 Female 5.43 Total Larynx Male 1.76 0.48 Female Total 2.24 Leukemia Male 2.72 2.32 Female Total 5.04 Liver and Intrahepatic Bile Ducts Male 1.40 0.63 Female 2.03 Total Lung and Bronchus Male 17.71 Female 15.78 Total 33.48

Obs

SIR

5 2 7

88 NC* 88

1 1 2

NC* NC* NC*

0 38 38

NC* 110 109

2

NC*

11 16 27

78 108 93

Exp

Obs

SIR

3 6 9

NC* 201 133

0 0 0

NC* NC* NC*

7 7 14

160 163 161

3 3 6

NC* NC* 118

4.01

3

NC*

2.47 2.90 5.38

3 3 6

NC* NC* 112

35.05

33

94

Male Female Total

2.43 1.60 4.03

0 0 0

NC* NC* NC*

Male

1.06

1

NC*

Male 0.69 1.99 Female Total 2.69 Uteri, Corpus and Uterus, NOS

1 3 4

NC* NC* NC*

6.65

16

241 ~+

113.07 113.50 226.57

104 124 228

92 109 101

Melanoma of Skin 3.79 Male Female 2.99 6.78 Total Multiple Myeloma Male 1.14 1.10 Female 2.24 Total Non-Hodgkin('s) Lymphoma 4.38 Male 4.29 Female Total 8.68 Oral Cavity & Pharynx 3.30 Male Female 1.77 Total 5.07 Ovary Female Pancreas

1 0 1

NC* NC* NC*

0 1 1

NC* NC* NC*

2 1 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 5 0 5

284 NC* 223

3 2 5

NC* NC* 99

1 0 1

NC* NC* NC*

Thyroid

17 12 29

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

96 76 87

201

Monterey

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.77 Male Female 0.22 1.00 Total Brain and Other Nervous System Male 0.22 0.16 Female 0.38 Total Breast 0.04 Male 4.11 Female Total 4.15 Cervix Uteri Female

0.19

Colon / Rectum 1.93 Male Female 1.42 Total 3.35 Esophagus 0.28 Male Female 0.07 Total 0.35 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.09 0.06 Female Total 0.15 Kidney & Renal Pelvis Male 0.45 0.24 Female 0.69 Total Larynx Male 0.25 0.06 Female Total 0.31 Leukemia Male 0.36 0.24 Female Total 0.60 Liver and Intrahepatic Bile Ducts Male 0.19 0.06 Female 0.25 Total Lung and Bronchus Male 2.42 Female 1.77 Total 4.19

Obs

SIR

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 3 3

NC* NC* NC*

0

NC*

1 2 3

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0.47

0

NC*

0.34 0.28 0.63

0 0 0

NC* NC* NC*

4.91

4

NC*

Male Female Total

0.34 0.15 0.49

0 0 0

NC* NC* NC*

Male

0.13

1

NC*

Male 0.09 0.22 Female Total 0.32 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.82

1

NC*

15.55 12.49 28.03

11 7 18

71 56 64

Melanoma of Skin 0.52 Male Female 0.33 0.85 Total Multiple Myeloma Male 0.15 0.12 Female 0.27 Total Non-Hodgkin('s) Lymphoma 0.59 Male 0.45 Female Total 1.04 Oral Cavity & Pharynx 0.46 Male Female 0.20 Total 0.66 Ovary Female Pancreas

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

1 1 2

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

202

Montgomery

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.55 Male Female 0.18 0.73 Total Brain and Other Nervous System Male 0.17 0.13 Female 0.30 Total Breast 0.03 Male 3.28 Female Total 3.31 Cervix Uteri Female

0.17

Colon / Rectum 1.38 Male Female 1.16 Total 2.54 Esophagus 0.20 Male Female 0.06 Total 0.26 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.07 0.06 Female Total 0.13 Kidney & Renal Pelvis Male 0.34 0.19 Female 0.53 Total Larynx Male 0.19 0.04 Female Total 0.23 Leukemia Male 0.27 0.20 Female Total 0.47 Liver and Intrahepatic Bile Ducts Male 0.15 0.05 Female 0.20 Total Lung and Bronchus Male 1.79 Female 1.34 Total 3.12

Obs

SIR

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 4 4

NC* NC* NC*

1

NC*

1 0 1

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0.37

1

NC*

0.25 0.23 0.47

0 0 0

NC* NC* NC*

3.55

3

NC*

Male Female Total

0.24 0.13 0.36

0 0 0

NC* NC* NC*

Male

0.10

1

NC*

Male 0.07 0.20 Female Total 0.27 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.63

0

NC*

11.40 10.00 21.40

8 8 16

70 80 75

Melanoma of Skin 0.40 Male Female 0.28 0.68 Total Multiple Myeloma Male 0.12 0.09 Female 0.21 Total Non-Hodgkin('s) Lymphoma 0.45 Male 0.36 Female Total 0.80 Oral Cavity & Pharynx 0.35 Male Female 0.16 Total 0.51 Ovary Female Pancreas

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

1 1 2

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

203

Mount Washington

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.20 Male Female 0.05 0.26 Total Brain and Other Nervous System Male 0.05 0.03 Female 0.08 Total Breast 0.01 Male 0.83 Female Total 0.84 Cervix Uteri Female

0.03

Colon / Rectum 0.50 Male Female 0.34 Total 0.85 Esophagus 0.07 Male Female 0.02 Total 0.09 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.02 0.01 Female Total 0.03 Kidney & Renal Pelvis Male 0.11 0.05 Female 0.16 Total Larynx Male 0.06 0.01 Female Total 0.07 Leukemia Male 0.09 0.05 Female Total 0.14 Liver and Intrahepatic Bile Ducts Male 0.05 0.01 Female 0.06 Total Lung and Bronchus Male 0.61 Female 0.37 Total 0.98

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0

NC*

0 1 1

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0.09

0

NC*

0.09 0.07 0.16

0 0 0

NC* NC* NC*

1.23

1

NC*

Male Female Total

0.09 0.03 0.13

0 1 1

NC* NC* NC*

Male

0.02

0

NC*

Male 0.02 0.04 Female Total 0.06 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.16

0

NC*

3.92 2.63 6.55

1 4 5

NC* NC* 76

Melanoma of Skin 0.13 Male Female 0.06 0.19 Total Multiple Myeloma Male 0.04 0.03 Female 0.07 Total Non-Hodgkin('s) Lymphoma 0.15 Male 0.10 Female Total 0.24 Oral Cavity & Pharynx 0.12 Male Female 0.04 Total 0.16 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

0 0 0

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

204

Nahant

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 3.36 Male Female 1.15 4.51 Total Brain and Other Nervous System Male 0.94 0.75 Female 1.69 Total Breast 0.16 Male 18.05 Female Total 18.21 Cervix Uteri Female

0.92

Colon / Rectum 8.34 Male Female 7.55 Total 15.89 Esophagus 1.18 Male Female 0.36 Total 1.53 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.39 0.32 Female Total 0.71 Kidney & Renal Pelvis Male 1.91 1.10 Female 3.01 Total Larynx Male 1.03 0.25 Female Total 1.28 Leukemia Male 1.55 1.15 Female Total 2.70 Liver and Intrahepatic Bile Ducts Male 0.82 0.32 Female 1.14 Total Lung and Bronchus Male 10.37 Female 7.99 Total 18.37

Obs

SIR

4 1 5

NC* NC* 111

1 1 2

NC* NC* NC*

0 17 17

NC* 94 93

1

NC*

8 9 17

96 119 107

Exp

Obs

SIR

8 2 10

362 ~+ NC* 265 #+

0 0 0

NC* NC* NC*

5 1 6

196 NC* 127

4 3 7

NC* NC* 246

2.08

2

NC*

1.47 1.47 2.94

4 4 8

NC* NC* 272 #+

20.57

19

92

Male Female Total

1.46 0.81 2.27

0 2 2

NC* NC* NC*

Male

0.58

2

NC*

Male 0.40 1.07 Female Total 1.46 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

3.44

2

NC*

66.31 58.32 124.63

73 61 134

110 105 108

Melanoma of Skin 2.21 Male Female 1.56 3.78 Total Multiple Myeloma Male 0.67 0.56 Female 1.23 Total Non-Hodgkin('s) Lymphoma 2.56 Male 2.18 Female Total 4.74 Oral Cavity & Pharynx 1.94 Male Female 0.91 Total 2.85 Ovary Female Pancreas

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

2 0 2

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 2 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

9 5 14

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

87 63 76

205

Nantucket

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.77 Male Female 1.72 6.48 Total Brain and Other Nervous System Male 1.61 1.30 Female 2.91 Total Breast 0.24 Male 30.18 Female Total 30.42 Cervix Uteri Female

1.73

Colon / Rectum 12.02 Male Female 11.22 Total 23.24 Esophagus 1.81 Male Female 0.53 Total 2.34 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.74 0.65 Female Total 1.39 Kidney & Renal Pelvis Male 3.01 1.76 Female 4.77 Total Larynx Male 1.64 0.39 Female Total 2.03 Leukemia Male 2.44 1.89 Female Total 4.33 Liver and Intrahepatic Bile Ducts Male 1.29 0.48 Female 1.78 Total Lung and Bronchus Male 15.36 Female 12.34 Total 27.70

Obs

SIR

3 5 8

NC* 291 123

3 3 6

NC* NC* 206

0 34 34

NC* 113 112

1

NC*

7 7 14

58 62 60

Exp

Obs

SIR

6 10 16

168 362 ~+ 253 ~+

0 2 2

NC* NC* NC*

4 8 12

NC* 231 161

7 2 9

220 NC* 194

3.52

3

NC*

2.17 2.18 4.35

2 4 6

NC* NC* 138

31.28

38

122

Male Female Total

2.11 1.23 3.34

4 1 5

NC* NC* 150

Male

1.14

3

NC*

Male 0.72 2.13 Female Total 2.84 Uteri, Corpus and Uterus, NOS

1 1 2

NC* NC* NC*

5.66

7

124

100.70 94.20 194.90

118 117 235

117 124 #+ 121 ~+

Melanoma of Skin 3.57 Male Female 2.76 6.33 Total Multiple Myeloma Male 0.99 0.86 Female 1.85 Total Non-Hodgkin('s) Lymphoma 4.01 Male 3.46 Female Total 7.47 Oral Cavity & Pharynx 3.18 Male Female 1.47 Total 4.65 Ovary Female Pancreas

1 0 1

NC* NC* NC*

2 0 2

NC* NC* NC*

4 2 6

NC* NC* 126

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

5 4 9

205 NC* 208

0 0 0

NC* NC* NC*

Thyroid

24 17 41

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

156 #+ 138 148 #+

206

Natick

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 20.29 Male Female 7.76 28.06 Total Brain and Other Nervous System Male 6.71 5.68 Female 12.39 Total Breast 1.02 Male 132.23 Female Total 133.25 Cervix Uteri Female

7.20

Colon / Rectum 51.17 Male Female 50.67 Total 101.84 Esophagus 7.56 Male Female 2.40 Total 9.96 Hodgkin's Disease (Hodgkin Lymphoma) Male 3.08 2.69 Female Total 5.76 Kidney & Renal Pelvis Male 12.47 7.89 Female 20.36 Total Larynx Male 6.80 1.79 Female Total 8.59 Leukemia Male 10.22 8.34 Female Total 18.56 Liver and Intrahepatic Bile Ducts Male 5.37 2.18 Female 7.55 Total Lung and Bronchus Male 66.10 Female 56.38 Total 122.48

Obs

SIR

16 6 22

79 77 78

7 3 10

104 NC* 81

1 162 163

NC* 123 #+ 122 #+

3

NC*

61 52 113

119 103 111

Exp

Obs

SIR

16 17 33

109 144 125

4 4 8

NC* NC* 99

17 17 34

102 110 106

20 10 30

155 154 155 #+

15.36

25

163 #+

9.10 9.90 19.00

10 8 18

110 81 95

133.64

141

106

Male Female Total

8.81 5.47 14.28

7 6 13

79 110 91

Male

4.90

6

123

Male 2.92 8.71 Female Total 11.63 Uteri, Corpus and Uterus, NOS

5 9 14

171 103 120

25.10

26

104

426.42 417.35 843.77

443 477 920

104 114 ~+ 109 #+

Melanoma of Skin 14.68 Male Female 11.79 26.48 Total Multiple Myeloma Male 4.18 3.87 Female 8.05 Total Non-Hodgkin('s) Lymphoma 16.71 Male 15.47 Female Total 32.18 Oral Cavity & Pharynx 12.87 Male Female 6.51 Total 19.39 Ovary Female Pancreas

7 4 11

93 NC* 110

1 5 6

NC* 186 104

10 8 18

80 101 88

Male Female Total Prostate Male

Stomach

Testis 5 2 7

74 NC* 81

13 10 23

127 120 124

6 4 10

112 NC* 132

Thyroid

59 57 116

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

89 101 95

207

Needham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Exp Bladder, Urinary Male 22.63 8.59 Female Total 31.22 Brain and Other Nervous System 6.60 Male 5.60 Female Total 12.20 Breast 1.09 Male Female 136.23 137.32 Total Cervix Uteri Female

6.61

Colon / Rectum Male 56.53 Female 56.09 Total 112.62 Esophagus Male 8.19 Female 2.66 10.85 Total Hodgkin's Disease (Hodgkin Lymphoma) 2.58 Male Female 2.30 Total 4.87 Kidney & Renal Pelvis 13.16 Male Female 8.28 21.44 Total Larynx 7.26 Male Female 1.88 9.14 Total Leukemia 10.66 Male Female 8.79 19.45 Total Liver and Intrahepatic Bile Ducts 5.68 Male 2.39 Female Total 8.06 Lung and Bronchus Male 72.28 Female 60.02 132.29 Total

Obs

SIR

21 6 27

93 70 86

11 9 20

167 161 164 #+

0 151 151

NC* 111 110

5

76

50 45 95

88 80 84

7 3 10

85 NC* 92

1 3 4

NC* NC* NC*

18 3 21

137 NC* 98

1 1 2

NC* NC* NC*

17 17 34

160 193 #+ 175 ~+

2 5 7

NC* 209 87

40 53 93

55 ^88 70 ^-

Note: Explanation of all symbols is on page 361

Obs

SIR

20 15 35

133 130 132

4 4 8

NC* NC* 91

8 17 25

46 #105 75

11 3 14

82 NC* 69

15.60

21

135

9.98 10.97 20.95

3 13 16

NC* 119 76

146.14

170

116

Male Female Total

9.73 6.13 15.86

6 3 9

62 NC* 57

Male

3.57

4

NC*

Male 2.68 7.60 Female Total 10.28 Uteri, Corpus and Uterus, NOS

5 8 13

187 105 126

26.26

22

84

458.57 437.30 895.86

420 439 859

92 100 96

Melanoma of Skin 15.01 Male Female 11.55 26.55 Total Multiple Myeloma Male 4.57 4.21 Female 8.77 Total Non-Hodgkin('s) Lymphoma 17.23 Male 16.19 Female Total 33.42 Oral Cavity & Pharynx 13.44 Male Female 6.87 Total 20.31 Ovary Female Pancreas Male Female Total Prostate Male

Stomach

Testis

Thyroid

Female All Sites / Types Male Female Total

208

New Ashford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.19 Male Female 0.05 0.23 Total Brain and Other Nervous System Male 0.06 0.03 Female 0.09 Total Breast 0.01 Male 0.77 Female Total 0.78 Cervix Uteri Female

0.04

Colon / Rectum 0.47 Male Female 0.30 Total 0.77 Esophagus 0.07 Male Female 0.01 Total 0.08 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.02 0.02 Female Total 0.04 Kidney & Renal Pelvis Male 0.11 0.05 Female 0.15 Total Larynx Male 0.06 0.01 Female Total 0.07 Leukemia Male 0.09 0.05 Female Total 0.14 Liver and Intrahepatic Bile Ducts Male 0.05 0.01 Female 0.06 Total Lung and Bronchus Male 0.60 Female 0.33 Total 0.93

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0

NC*

0 0 0

NC* NC* NC*

Exp

Obs

SIR

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0.09

0

NC*

0.08 0.06 0.14

0 0 0

NC* NC* NC*

1.21

0

NC*

Male Female Total

0.08 0.03 0.11

0 0 0

NC* NC* NC*

Male

0.03

0

NC*

Male 0.02 0.05 Female Total 0.07 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

0.15

0

NC*

3.82 2.43 6.25

1 1 2

NC* NC* NC*

Melanoma of Skin 0.13 Male Female 0.07 0.19 Total Multiple Myeloma Male 0.04 0.02 Female 0.06 Total Non-Hodgkin('s) Lymphoma 0.14 Male 0.09 Female Total 0.24 Oral Cavity & Pharynx 0.11 Male Female 0.04 Total 0.15 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

0 1 1

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

209

New Bedford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 66.56 Male Female 28.91 95.47 Total Brain and Other Nervous System Male 19.75 18.63 Female 38.39 Total Breast 3.15 Male 423.67 Female Total 426.82 Cervix Uteri Female

21.57

Colon / Rectum 165.11 Male Female 190.37 Total 355.48 Esophagus 22.98 Male Female 8.94 Total 31.92 Hodgkin's Disease (Hodgkin Lymphoma) Male 8.56 8.20 Female Total 16.76 Kidney & Renal Pelvis Male 37.57 26.45 Female 64.01 Total Larynx Male 20.03 5.74 Female Total 25.77 Leukemia Male 32.11 29.42 Female Total 61.54 Liver and Intrahepatic Bile Ducts Male 16.04 8.03 Female 24.07 Total Lung and Bronchus Male 205.78 Female 191.89 Total 397.67

Obs

SIR

54 26 80

81 90 84

22 14 36

111 75 94

2 348 350

NC* 82 ^82 ^-

25

116

201 199 400

122 ~+ 105 113 #+

Exp

Obs

SIR

26 12 38

59 ~32 ^47 ^-

20 15 35

152 109 130

40 45 85

78 84 81

43 25 68

115 114 114

49.33

53

107

28.85 37.02 65.87

31 47 78

107 127 118

404.60

364

90 #-

Male Female Total

28.58 20.95 49.53

48 25 73

168 ~+ 119 147 ~+

Male

13.15

15

114

Male 8.06 25.24 Female Total 33.30 Uteri, Corpus and Uterus, NOS

9 17 26

112 67 78

79.95

90

113

1315.47 1410.58 2726.05

1369 1284 2653

104 91 ^97

Melanoma of Skin 43.71 Male Female 37.43 81.14 Total Multiple Myeloma Male 13.17 13.74 Female 26.91 Total Non-Hodgkin('s) Lymphoma 51.21 Male 53.75 Female Total 104.96 Oral Cavity & Pharynx 37.54 Male Female 21.94 Total 59.48 Ovary Female Pancreas

31 9 40

135 101 125

13 12 25

152 146 149

51 28 79

136 #+ 106 123

Male Female Total Prostate Male

Stomach

Testis 33 7 40

165 ~+ 122 155 #+

32 36 68

100 122 111

17 10 27

106 125 112

Thyroid

247 138 385

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

120 ~+ 72 ^97

210

New Braintree

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.52 Male Female 0.16 0.67 Total Brain and Other Nervous System Male 0.21 0.14 Female 0.35 Total Breast 0.03 Male 3.33 Female Total 3.36 Cervix Uteri Female

0.20

Colon / Rectum 1.32 Male Female 1.02 Total 2.34 Esophagus 0.21 Male Female 0.05 Total 0.26 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.10 0.07 Female Total 0.18 Kidney & Renal Pelvis Male 0.37 0.18 Female 0.55 Total Larynx Male 0.19 0.04 Female Total 0.24 Leukemia Male 0.30 0.20 Female Total 0.50 Liver and Intrahepatic Bile Ducts Male 0.16 0.04 Female 0.20 Total Lung and Bronchus Male 1.71 Female 1.21 Total 2.92

Obs

SIR

1 0 1

NC* NC* NC*

0 1 1

NC* NC* NC*

0 3 3

NC* NC* NC*

0

NC*

2 1 3

NC* NC* NC*

Exp

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0.38

0

NC*

0.24 0.19 0.44

0 0 0

NC* NC* NC*

3.48

4

NC*

Male Female Total

0.23 0.11 0.34

0 0 0

NC* NC* NC*

Male

0.17

0

NC*

Male 0.10 0.25 Female Total 0.35 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

0.62

1

NC*

11.53 9.76 21.29

11 9 20

95 92 94

Melanoma of Skin 0.44 Male Female 0.31 0.75 Total Multiple Myeloma Male 0.11 0.08 Female 0.20 Total Non-Hodgkin('s) Lymphoma 0.49 Male 0.34 Female Total 0.83 Oral Cavity & Pharynx 0.39 Male Female 0.15 Total 0.54 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

1 0 1

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

211

New Marlborough

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 1.16 Male Female 0.39 1.55 Total Brain and Other Nervous System Male 0.34 0.29 Female 0.63 Total Breast 0.06 Male 6.89 Female Total 6.95 Cervix Uteri Female

0.38

Colon / Rectum 2.89 Male Female 2.56 Total 5.45 Esophagus 0.42 Male Female 0.12 Total 0.54 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.14 0.14 Female Total 0.28 Kidney & Renal Pelvis Male 0.69 0.40 Female 1.09 Total Larynx Male 0.37 0.09 Female Total 0.47 Leukemia Male 0.56 0.43 Female Total 0.98 Liver and Intrahepatic Bile Ducts Male 0.30 0.11 Female 0.41 Total Lung and Bronchus Male 3.67 Female 2.86 Total 6.53

Obs

SIR

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 3 3

NC* NC* NC*

1

NC*

2 1 3

NC* NC* NC*

Exp

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

1 0 1

NC* NC* NC*

0.80

0

NC*

0.51 0.50 1.01

0 1 1

NC* NC* NC*

7.33

2

NC*

Male Female Total

0.50 0.28 0.78

0 1 1

NC* NC* NC*

Male

0.19

1

NC*

Male 0.14 0.46 Female Total 0.61 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

1.30

0

NC*

23.43 21.48 44.91

8 11 19

34 ^51 #42 ^-

Melanoma of Skin 0.79 Male Female 0.62 1.41 Total Multiple Myeloma Male 0.24 0.20 Female 0.43 Total Non-Hodgkin('s) Lymphoma 0.90 Male 0.79 Female Total 1.69 Oral Cavity & Pharynx 0.70 Male Female 0.34 Total 1.04 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

Thyroid

1 1 2

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

212

New Salem

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 0.60 Male Female 0.18 0.78 Total Brain and Other Nervous System Male 0.20 0.13 Female 0.33 Total Breast 0.03 Male 3.39 Female Total 3.42 Cervix Uteri Female

0.18

Colon / Rectum 1.51 Male Female 1.16 Total 2.67 Esophagus 0.24 Male Female 0.06 Total 0.29 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.08 0.06 Female Total 0.14 Kidney & Renal Pelvis Male 0.39 0.19 Female 0.58 Total Larynx Male 0.22 0.04 Female Total 0.26 Leukemia Male 0.30 0.20 Female Total 0.50 Liver and Intrahepatic Bile Ducts Male 0.17 0.05 Female 0.22 Total Lung and Bronchus Male 1.96 Female 1.30 Total 3.27

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 2 2

NC* NC* NC*

0

NC*

2 1 3

NC* NC* NC*

Exp

Obs

SIR

1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0.39

0

NC*

0.28 0.22 0.50

0 0 0

NC* NC* NC*

4.09

4

NC*

Male Female Total

0.27 0.13 0.40

0 0 0

NC* NC* NC*

Male

0.10

0

NC*

Male 0.08 0.22 Female Total 0.30 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

0.65

0

NC*

12.81 10.17 22.98

11 6 17

86 59 74

Melanoma of Skin 0.45 Male Female 0.30 0.74 Total Multiple Myeloma Male 0.13 0.09 Female 0.22 Total Non-Hodgkin('s) Lymphoma 0.49 Male 0.36 Female Total 0.85 Oral Cavity & Pharynx 0.42 Male Female 0.16 Total 0.58 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

1 2 3

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* NC*

213

Newbury

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.13 Male Female 1.55 5.68 Total Brain and Other Nervous System Male 1.47 1.15 Female 2.62 Total Breast 0.22 Male 28.22 Female Total 28.43 Cervix Uteri Female

1.45

Colon / Rectum 10.58 Male Female 10.08 Total 20.67 Esophagus 1.70 Male Female 0.48 Total 2.18 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.62 0.50 Female Total 1.11 Kidney & Renal Pelvis Male 2.80 1.63 Female 4.42 Total Larynx Male 1.58 0.38 Female Total 1.96 Leukemia Male 2.14 1.72 Female Total 3.86 Liver and Intrahepatic Bile Ducts Male 1.22 0.44 Female 1.65 Total Lung and Bronchus Male 14.20 Female 11.53 Total 25.73

Obs

SIR

1 1 2

NC* NC* NC*

1 2 3

NC* NC* NC*

0 30 30

NC* 106 106

1

NC*

12 11 23

113 109 111

Exp

Obs

SIR

1 2 3

NC* NC* NC*

1 1 2

NC* NC* NC*

4 4 8

NC* NC* 121

4 3 7

NC* NC* 159

3.21

2

NC*

1.94 1.96 3.90

2 3 5

NC* NC* 128

30.07

32

106

Male Female Total

1.83 1.09 2.92

2 0 2

NC* NC* NC*

Male

0.87

1

NC*

Male 0.65 1.71 Female Total 2.36 Uteri, Corpus and Uterus, NOS

2 1 3

NC* NC* NC*

5.45

8

147

92.40 86.25 178.65

83 88 171

90 102 96

Melanoma of Skin 3.24 Male Female 2.41 5.65 Total Multiple Myeloma Male 0.90 0.79 Female 1.69 Total Non-Hodgkin('s) Lymphoma 3.54 Male 3.09 Female Total 6.63 Oral Cavity & Pharynx 3.03 Male Female 1.36 Total 4.39 Ovary Female Pancreas

1 0 1

NC* NC* NC*

1 1 2

NC* NC* NC*

1 1 2

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

1 1 2

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

9 11 20

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

63 95 78

214

Newburyport

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 10.29 Male Female 4.39 14.68 Total Brain and Other Nervous System Male 3.49 3.10 Female 6.59 Total Breast 0.52 Male 75.42 Female Total 75.94 Cervix Uteri Female

3.97

Colon / Rectum 25.98 Male Female 28.74 Total 54.72 Esophagus 3.94 Male Female 1.36 Total 5.30 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.56 1.39 Female Total 2.95 Kidney & Renal Pelvis Male 6.59 4.41 Female 11.00 Total Larynx Male 3.60 1.00 Female Total 4.60 Leukemia Male 5.28 4.69 Female Total 9.96 Liver and Intrahepatic Bile Ducts Male 2.83 1.23 Female 4.06 Total Lung and Bronchus Male 33.38 Female 31.32 Total 64.70

Obs

SIR

8 4 12

78 NC* 82

3 5 8

NC* 161 121

0 95 95

NC* 126 #+ 125 #+

2

NC*

32 34 66

123 118 121

Exp

Obs

SIR

4 17 21

NC* 258 ~+ 146

1 4 5

NC* NC* 115

13 11 24

150 128 139

4 7 11

NC* 189 103

8.65

12

139

4.70 5.57 10.28

8 7 15

170 126 146

68.15

65

95

Male Female Total

4.56 3.14 7.70

0 3 3

NC* NC* NC*

Male

2.37

1

NC*

Male 1.55 4.72 Female Total 6.26 Uteri, Corpus and Uterus, NOS

1 3 4

NC* NC* NC*

14.37

16

111

218.61 235.55 454.16

208 301 509

95 128 ^+ 112 #+

Melanoma of Skin 7.77 Male Female 6.59 14.35 Total Multiple Myeloma Male 2.16 2.19 Female 4.35 Total Non-Hodgkin('s) Lymphoma 8.68 Male 8.58 Female Total 17.26 Oral Cavity & Pharynx 6.98 Male Female 3.69 Total 10.67 Ovary Female Pancreas

2 2 4

NC* NC* NC*

2 2 4

NC* NC* NC*

3 5 8

NC* 113 73

Male Female Total Prostate Male

Stomach

Testis 3 2 5

NC* NC* 109

5 6 11

95 128 110

1 0 1

NC* NC* NC*

Thyroid

40 37 77

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

120 118 119

215

Newton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 58.33 Male Female 22.99 81.32 Total Brain and Other Nervous System Male 18.63 16.53 Female 35.16 Total Breast 2.86 Male 390.44 Female Total 393.31 Cervix Uteri Female

21.41

Colon / Rectum 146.32 Male Female 150.67 Total 297.00 Esophagus 21.37 Male Female 7.11 Total 28.48 Hodgkin's Disease (Hodgkin Lymphoma) Male 8.45 7.86 Female Total 16.31 Kidney & Renal Pelvis Male 35.31 22.93 Female 58.24 Total Larynx Male 19.12 5.13 Female Total 24.25 Leukemia Male 28.91 24.82 Female Total 53.73 Liver and Intrahepatic Bile Ducts Male 15.16 6.44 Female 21.60 Total Lung and Bronchus Male 185.45 Female 161.80 Total 347.25

Obs

SIR

50 16 66

86 70 81

18 16 34

97 97 97

3 466 469

NC* 119 ^+ 119 ^+

9

42 ~-

124 125 249

85 83 #84 ~-

Exp

Obs

SIR

40 52 92

96 149 ~+ 120

15 14 29

126 123 125

59 61 120

124 135 #+ 130 ~+

25 18 43

68 94 77

45.19

52

115

26.05 29.19 55.25

27 29 56

104 99 101

372.67

383

103

Male Female Total

25.54 16.57 42.11

21 7 28

82 42 #66 #-

Male

13.34

16

120

Male 8.18 25.86 Female Total 34.04 Uteri, Corpus and Uterus, NOS

16 28 44

196 #+ 108 129

73.56

55

75 #-

1203.10 1228.95 2432.06

1117 1261 2378

93 #103 98

Melanoma of Skin 41.71 Male Female 35.00 76.71 Total Multiple Myeloma Male 11.92 11.37 Female 23.29 Total Non-Hodgkin('s) Lymphoma 47.51 Male 45.14 Female Total 92.65 Oral Cavity & Pharynx 36.62 Male Female 19.19 Total 55.81 Ovary Female Pancreas

12 11 23

56 #155 81

9 13 22

106 165 135

29 27 56

82 118 96

Male Female Total Prostate Male

Stomach

Testis 10 4 14

52 #NC* 58 #-

41 39 80

142 #+ 157 #+ 149 ^+

14 6 20

92 93 93

Thyroid

129 134 263

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

70 ^83 #76 ^-

216

Norfolk

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 4.96 Male Female 1.16 6.12 Total Brain and Other Nervous System Male 2.32 1.17 Female 3.49 Total Breast 0.29 Male 27.46 Female Total 27.75 Cervix Uteri Female

1.59

Colon / Rectum 13.03 Male Female 7.45 Total 20.47 Esophagus 2.21 Male Female 0.36 Total 2.58 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.28 0.58 Female Total 1.86 Kidney & Renal Pelvis Male 3.90 1.48 Female 5.38 Total Larynx Male 2.14 0.36 Female Total 2.50 Leukemia Male 3.06 1.58 Female Total 4.64 Liver and Intrahepatic Bile Ducts Male 1.69 0.34 Female 2.03 Total Lung and Bronchus Male 17.59 Female 9.89 Total 27.48

Obs

SIR

4 3 7

NC* NC* 114

2 1 3

NC* NC* NC*

0 26 26

NC* 95 94

1

NC*

9 2 11

69 NC* 54 #-

Exp

Obs

SIR

7 6 13

143 246 177

0 0 0

NC* NC* NC*

4 1 5

NC* NC* 63

2 1 3

NC* NC* NC*

3.14

1

NC*

2.47 1.45 3.92

3 1 4

NC* NC* NC*

37.32

40

107

Male Female Total

2.32 0.80 3.12

3 0 3

NC* NC* NC*

Male

2.20

3

NC*

Male 1.17 2.00 Female Total 3.17 Uteri, Corpus and Uterus, NOS

0 2 2

NC* NC* NC*

5.28

7

133

121.38 78.01 199.39

106 71 177

87 91 89

Melanoma of Skin 4.88 Male Female 2.44 7.32 Total Multiple Myeloma Male 1.15 0.65 Female 1.80 Total Non-Hodgkin('s) Lymphoma 5.22 Male 2.66 Female Total 7.89 Oral Cavity & Pharynx 4.39 Male Female 1.24 Total 5.63 Ovary Female Pancreas

1 0 1

NC* NC* NC*

1 2 3

NC* NC* NC*

5 2 7

128 NC* 130

Male Female Total Prostate Male

Stomach

Testis 1 2 3

NC* NC* NC*

3 3 6

NC* NC* 129

0 0 0

NC* NC* NC*

Thyroid

12 6 18

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

68 61 65

217

North Adams

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 10.36 Male Female 4.91 15.28 Total Brain and Other Nervous System Male 3.28 3.23 Female 6.51 Total Breast 0.50 Male 72.74 Female Total 73.24 Cervix Uteri Female

3.79

Colon / Rectum 25.89 Male Female 32.45 Total 58.34 Esophagus 3.68 Male Female 1.52 Total 5.20 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.52 1.45 Female Total 2.98 Kidney & Renal Pelvis Male 6.06 4.52 Female 10.58 Total Larynx Male 3.25 0.98 Female Total 4.22 Leukemia Male 5.15 5.03 Female Total 10.17 Liver and Intrahepatic Bile Ducts Male 2.60 1.37 Female 3.96 Total Lung and Bronchus Male 32.52 Female 32.79 Total 65.32

Obs

SIR

12 5 17

116 102 111

4 3 7

NC* NC* 108

0 67 67

NC* 92 91

4

NC*

33 39 72

127 120 123

Exp

Obs

SIR

5 4 9

70 NC* 66

1 1 2

NC* NC* NC*

9 14 23

108 152 131

9 1 10

146 NC* 101

8.49

7

82

4.56 6.30 10.85

9 3 12

198 NC* 111

64.55

77

119

Male Female Total

4.50 3.55 8.05

3 4 7

NC* NC* 87

Male

2.46

0

NC*

Male 1.41 4.47 Female Total 5.87 Uteri, Corpus and Uterus, NOS

0 6 6

NC* 134 102

13.68

18

132

210.19 241.74 451.93

245 246 491

117 #+ 102 109

Melanoma of Skin 7.18 Male Female 6.49 13.66 Total Multiple Myeloma Male 2.08 2.34 Female 4.42 Total Non-Hodgkin('s) Lymphoma 8.32 Male 9.23 Female Total 17.54 Oral Cavity & Pharynx 6.17 Male Female 3.75 Total 9.92 Ovary Female Pancreas

2 3 5

NC* NC* 96

2 1 3

NC* NC* NC*

11 9 20

182 199 189 #+

Male Female Total Prostate Male

Stomach

Testis 3 1 4

NC* NC* NC*

10 3 13

194 NC* 128

1 0 1

NC* NC* NC*

Thyroid

38 30 68

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

117 91 104

218

North Andover

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 13.99 Male Female 5.42 19.41 Total Brain and Other Nervous System Male 5.27 4.36 Female 9.63 Total Breast 0.74 Male 102.86 Female Total 103.59 Cervix Uteri Female

5.70

Colon / Rectum 35.80 Male Female 35.31 Total 71.11 Esophagus 5.66 Male Female 1.68 Total 7.33 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.43 2.08 Female Total 4.51 Kidney & Renal Pelvis Male 9.49 5.90 Female 15.39 Total Larynx Male 5.25 1.37 Female Total 6.62 Leukemia Male 7.61 6.21 Female Total 13.82 Liver and Intrahepatic Bile Ducts Male 4.11 1.54 Female 5.65 Total Lung and Bronchus Male 47.26 Female 41.40 Total 88.66

Obs

SIR

17 9 26

121 166 134

3 5 8

NC* 115 83

1 80 81

NC* 78 #78 #-

3

NC*

32 43 75

89 122 105

Exp

Obs

SIR

20 6 26

178 #+ 66 128

3 4 7

NC* NC* 120

12 11 23

97 98 97

6 3 9

59 NC* 59

11.85

13

110

6.56 6.87 13.42

7 6 13

107 87 97

98.57

108

110

Male Female Total

6.25 3.78 10.03

6 1 7

96 NC* 70

Male

3.71

4

NC*

Male 2.35 6.97 Female Total 9.32 Uteri, Corpus and Uterus, NOS

4 9 13

NC* 129 139

19.63

21

107

311.85 312.51 624.36

330 299 629

106 96 101

Melanoma of Skin 11.25 Male Female 9.12 20.37 Total Multiple Myeloma Male 3.02 2.80 Female 5.82 Total Non-Hodgkin('s) Lymphoma 12.42 Male 11.27 Female Total 23.69 Oral Cavity & Pharynx 10.24 Male Female 4.90 Total 15.14 Ovary Female Pancreas

7 3 10

124 NC* 136

3 2 5

NC* NC* 111

10 4 14

105 NC* 91

Male Female Total Prostate Male

Stomach

Testis 7 0 7

133 NC* 106

6 8 14

79 129 101

6 0 6

146 NC* 106

Thyroid

49 42 91

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

104 101 103

219

North Attleboro

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 13.66 Male Female 4.91 18.58 Total Brain and Other Nervous System Male 5.10 4.12 Female 9.22 Total Breast 0.70 Male 93.47 Female Total 94.18 Cervix Uteri Female

5.54

Colon / Rectum 34.74 Male Female 32.09 Total 66.83 Esophagus 5.31 Male Female 1.52 Total 6.83 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.52 2.13 Female Total 4.65 Kidney & Renal Pelvis Male 8.99 5.33 Female 14.32 Total Larynx Male 4.87 1.21 Female Total 6.08 Leukemia Male 7.43 5.80 Female Total 13.23 Liver and Intrahepatic Bile Ducts Male 3.87 1.40 Female 5.27 Total Lung and Bronchus Male 44.76 Female 36.76 Total 81.51

Obs

SIR

13 0 13

95 NC* 70

9 3 12

176 NC* 130

0 100 100

NC* 107 106

4

NC*

34 37 71

98 115 106

Exp

Obs

SIR

18 9 27

166 104 138

1 2 3

NC* NC* NC*

8 11 19

66 106 84

10 10 20

104 225 #+ 143

10.90

17

156

6.30 6.21 12.51

8 5 13

127 81 104

91.42

69

75 #-

Male Female Total

6.11 3.49 9.60

2 3 5

NC* NC* 52

Male

4.12

1

NC*

Male 2.32 6.93 Female Total 9.26 Uteri, Corpus and Uterus, NOS

0 12 12

NC* 173 130

17.51

11

63

297.39 285.11 582.49

272 304 576

91 107 99

Melanoma of Skin 10.86 Male Female 8.64 19.50 Total Multiple Myeloma Male 2.89 2.52 Female 5.40 Total Non-Hodgkin('s) Lymphoma 12.16 Male 10.34 Female Total 22.50 Oral Cavity & Pharynx 9.59 Male Female 4.44 Total 14.04 Ovary Female Pancreas

7 3 10

132 NC* 146

3 1 4

NC* NC* NC*

9 0 9

100 NC* 63

Male Female Total Prostate Male

Stomach

Testis 3 1 4

NC* NC* NC*

5 8 13

67 138 98

1 0 1

NC* NC* NC*

Thyroid

50 42 92

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

112 114 113

220

North Brookfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 3.04 Male Female 1.11 4.15 Total Brain and Other Nervous System Male 1.02 0.84 Female 1.87 Total Breast 0.15 Male 19.07 Female Total 19.22 Cervix Uteri Female

1.06

Colon / Rectum 7.62 Male Female 7.31 Total 14.93 Esophagus 1.11 Male Female 0.34 Total 1.46 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.48 0.40 Female Total 0.89 Kidney & Renal Pelvis Male 1.88 1.13 Female 3.01 Total Larynx Male 1.00 0.25 Female Total 1.25 Leukemia Male 1.57 1.23 Female Total 2.80 Liver and Intrahepatic Bile Ducts Male 0.80 0.31 Female 1.12 Total Lung and Bronchus Male 9.59 Female 8.01 Total 17.59

Obs

SIR

5 1 6

164 NC* 144

3 0 3

NC* NC* NC*

0 18 18

NC* 94 94

1

NC*

6 4 10

79 NC* 67

Exp

Obs

SIR

2 2 4

NC* NC* NC*

1 0 1

NC* NC* NC*

4 1 5

NC* NC* 105

0 0 0

NC* NC* NC*

2.22

0

NC*

1.36 1.42 2.78

0 1 1

NC* NC* NC*

19.07

13

68

Male Female Total

1.34 0.79 2.13

0 1 1

NC* NC* NC*

Male

0.77

0

NC*

Male 0.45 1.29 Female Total 1.74 Uteri, Corpus and Uterus, NOS

0 0 0

NC* NC* NC*

3.60

4

NC*

62.87 60.18 123.05

50 50 100

80 83 81 #-

Melanoma of Skin 2.24 Male Female 1.72 3.96 Total Multiple Myeloma Male 0.63 0.55 Female 1.18 Total Non-Hodgkin('s) Lymphoma 2.55 Male 2.23 Female Total 4.78 Oral Cavity & Pharynx 1.95 Male Female 0.94 Total 2.88 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 1 1

NC* NC* NC*

3 0 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

1 0 1

NC* NC* NC*

Thyroid

9 7 16

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

94 87 91

221

North Reading

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.60 Male Female 2.61 10.21 Total Brain and Other Nervous System Male 2.71 2.10 Female 4.81 Total Breast 0.40 Male 50.02 Female Total 50.42 Cervix Uteri Female

2.73

Colon / Rectum 19.44 Male Female 16.92 Total 36.36 Esophagus 3.05 Male Female 0.81 Total 3.86 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.20 0.99 Female Total 2.19 Kidney & Renal Pelvis Male 5.02 2.88 Female 7.90 Total Larynx Male 2.82 0.68 Female Total 3.50 Leukemia Male 3.96 2.99 Female Total 6.95 Liver and Intrahepatic Bile Ducts Male 2.18 0.74 Female 2.93 Total Lung and Bronchus Male 26.02 Female 20.29 Total 46.31

Obs

SIR

3 2 5

NC* NC* 49

1 3 4

NC* NC* NC*

0 48 48

NC* 96 95

0

NC*

20 14 34

103 83 94

Exp

Obs

SIR

11 4 15

188 NC* 146

1 0 1

NC* NC* NC*

3 9 12

NC* 165 100

4 3 7

NC* NC* 91

5.76

3

NC*

3.52 3.31 6.84

4 2 6

NC* NC* 88

54.45

43

79

Male Female Total

3.33 1.81 5.14

3 0 3

NC* NC* NC*

Male

1.80

6

334 #+

Male 1.19 3.32 Female Total 4.52 Uteri, Corpus and Uterus, NOS

1 4 5

NC* NC* 111

9.61

4

NC*

168.52 151.46 319.98

141 132 273

84 #87 85 ~-

Melanoma of Skin 5.86 Male Female 4.39 10.25 Total Multiple Myeloma Male 1.63 1.36 Female 2.99 Total Non-Hodgkin('s) Lymphoma 6.50 Male 5.45 Female Total 11.94 Oral Cavity & Pharynx 5.35 Male Female 2.38 Total 7.73 Ovary Female Pancreas

3 2 5

NC* NC* 129

1 1 2

NC* NC* NC*

4 5 9

NC* 173 114

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

2 1 3

NC* NC* NC*

2 0 2

NC* NC* NC*

Thyroid

24 19 43

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

92 94 93

222

Northampton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 18.01 Male Female 7.57 25.58 Total Brain and Other Nervous System Male 5.75 5.50 Female 11.25 Total Breast 0.89 Male 123.87 Female Total 124.75 Cervix Uteri Female

7.24

Colon / Rectum 45.17 Male Female 50.04 Total 95.20 Esophagus 6.57 Male Female 2.34 Total 8.91 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.67 2.81 Female Total 5.48 Kidney & Renal Pelvis Male 10.91 7.31 Female 18.22 Total Larynx Male 5.88 1.57 Female Total 7.44 Leukemia Male 8.91 8.22 Female Total 17.13 Liver and Intrahepatic Bile Ducts Male 4.68 2.12 Female 6.80 Total Lung and Bronchus Male 57.09 Female 51.15 Total 108.24

Obs

SIR

11 10 21

61 132 82

6 4 10

104 NC* 89

0 111 111

NC* 90 89

4

NC*

47 45 92

104 90 97

Exp

Obs

SIR

15 11 26

116 95 106

8 3 11

217 NC* 150

11 10 21

74 67 71

12 8 20

106 130 115

14.53

17

117

8.04 9.62 17.65

4 5 9

NC* 52 51 #-

114.14

103

90

Male Female Total

7.89 5.54 13.43

4 5 9

NC* 90 67

Male

4.33

5

115

Male 2.57 8.92 Female Total 11.49 Uteri, Corpus and Uterus, NOS

2 9 11

NC* 101 96

22.81

19

83

370.89 397.25 768.14

351 354 705

95 89 #92 #-

Melanoma of Skin 12.97 Male Female 11.60 24.57 Total Multiple Myeloma Male 3.68 3.67 Female 7.35 Total Non-Hodgkin('s) Lymphoma 14.77 Male 14.84 Female Total 29.61 Oral Cavity & Pharynx 11.30 Male Female 6.15 Total 17.45 Ovary Female Pancreas

9 1 10

137 NC* 112

4 2 6

NC* NC* 109

12 16 28

110 219 ~+ 154 #+

Male Female Total Prostate Male

Stomach

Testis 5 1 6

85 NC* 81

8 4 12

90 NC* 70

2 1 3

NC* NC* NC*

Thyroid

60 49 109

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

105 96 101

223

Northborough

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.14 Male Female 2.45 9.59 Total Brain and Other Nervous System Male 2.76 2.08 Female 4.84 Total Breast 0.38 Male 50.25 Female Total 50.63 Cervix Uteri Female

2.79

Colon / Rectum 18.37 Male Female 15.81 Total 34.18 Esophagus 2.97 Male Female 0.76 Total 3.72 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.28 1.00 Female Total 2.27 Kidney & Renal Pelvis Male 4.99 2.82 Female 7.80 Total Larynx Male 2.78 0.67 Female Total 3.45 Leukemia Male 3.92 2.94 Female Total 6.86 Liver and Intrahepatic Bile Ducts Male 2.17 0.70 Female 2.87 Total Lung and Bronchus Male 24.60 Female 19.46 Total 44.05

Obs

SIR

5 2 7

70 NC* 73

1 2 3

NC* NC* NC*

0 49 49

NC* 98 97

0

NC*

9 14 23

49 #89 67

Exp

Obs

SIR

6 2 8

101 NC* 77

1 2 3

NC* NC* NC*

9 5 14

139 96 120

7 5 12

129 213 154

5.76

6

104

3.39 3.09 6.48

1 4 5

NC* NC* 77

51.77

49

95

Male Female Total

3.20 1.71 4.91

0 0 0

NC* NC* NC*

Male

1.96

0

NC*

Male 1.25 3.42 Female Total 4.68 Uteri, Corpus and Uterus, NOS

0 3 3

NC* NC* NC*

9.65

10

104

162.50 148.51 311.02

129 124 253

79 ~83 #81 ^-

Melanoma of Skin 5.92 Male Female 4.42 10.33 Total Multiple Myeloma Male 1.57 1.30 Female 2.87 Total Non-Hodgkin('s) Lymphoma 6.47 Male 5.22 Female Total 11.69 Oral Cavity & Pharynx 5.43 Male Female 2.34 Total 7.77 Ovary Female Pancreas

1 1 2

NC* NC* NC*

2 0 2

NC* NC* NC*

4 0 4

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 1 1

NC* NC* NC*

3 2 5

NC* NC* 73

2 1 3

NC* NC* NC*

Thyroid

17 12 29

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

69 62 66 #-

224

Northbridge

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 8.45 Male Female 3.36 11.81 Total Brain and Other Nervous System Male 2.76 2.42 Female 5.18 Total Breast 0.41 Male 54.15 Female Total 54.56 Cervix Uteri Female

2.99

Colon / Rectum 21.16 Male Female 22.15 Total 43.31 Esophagus 3.06 Male Female 1.04 Total 4.10 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.26 1.16 Female Total 2.41 Kidney & Renal Pelvis Male 5.07 3.25 Female 8.32 Total Larynx Male 2.72 0.71 Female Total 3.43 Leukemia Male 4.28 3.65 Female Total 7.94 Liver and Intrahepatic Bile Ducts Male 2.17 0.94 Female 3.12 Total Lung and Bronchus Male 26.67 Female 23.00 Total 49.67

Obs

SIR

5 3 8

59 NC* 68

2 0 2

NC* NC* NC*

0 57 57

NC* 105 104

6

201

16 21 37

76 95 85

Exp

Obs

SIR

8 7 15

134 142 138

2 0 2

NC* NC* NC*

5 7 12

73 107 89

5 2 7

96 NC* 88

6.32

3

NC*

3.76 4.28 8.03

5 8 13

133 187 162

53.36

57

107

Male Female Total

3.70 2.43 6.12

4 1 5

NC* NC* 82

Male

1.96

2

NC*

Male 1.18 3.62 Female Total 4.80 Uteri, Corpus and Uterus, NOS

5 5 10

425 #+ 138 208

10.13

12

118

173.39 174.52 347.91

159 176 335

92 101 96

Melanoma of Skin 5.98 Male Female 4.92 10.90 Total Multiple Myeloma Male 1.71 1.63 Female 3.35 Total Non-Hodgkin('s) Lymphoma 6.88 Male 6.54 Female Total 13.42 Oral Cavity & Pharynx 5.22 Male Female 2.71 Total 7.94 Ovary Female Pancreas

0 3 3

NC* NC* NC*

1 0 1

NC* NC* NC*

4 7 11

NC* 215 132

Male Female Total Prostate Male

Stomach

Testis 0 1 1

NC* NC* NC*

5 1 6

117 NC* 76

4 0 4

NC* NC* NC*

Thyroid

20 24 44

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

75 104 89

225

Northfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 2.08 Male Female 0.84 2.91 Total Brain and Other Nervous System Male 0.65 0.56 Female 1.21 Total Breast 0.10 Male 13.50 Female Total 13.60 Cervix Uteri Female

0.68

Colon / Rectum 5.20 Male Female 5.50 Total 10.70 Esophagus 0.78 Male Female 0.26 Total 1.03 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.27 0.24 Female Total 0.51 Kidney & Renal Pelvis Male 1.27 0.80 Female 2.08 Total Larynx Male 0.70 0.18 Female Total 0.88 Leukemia Male 1.02 0.88 Female Total 1.89 Liver and Intrahepatic Bile Ducts Male 0.55 0.23 Female 0.78 Total Lung and Bronchus Male 6.60 Female 5.76 Total 12.36

Obs

SIR

1 0 1

NC* NC* NC*

0 1 1

NC* NC* NC*

1 14 15

NC* 104 110

1

NC*

2 3 5

NC* NC* 47

Exp

Obs

SIR

0 0 0

NC* NC* NC*

1 0 1

NC* NC* NC*

1 5 6

NC* 315 #+ 185

0 1 1

NC* NC* NC*

1.55

1

NC*

0.94 1.06 2.00

1 1 2

NC* NC* NC*

13.45

9

67

Male Female Total

0.92 0.60 1.52

2 1 3

NC* NC* NC*

Male

0.37

1

NC*

Male 0.28 0.80 Female Total 1.08 Uteri, Corpus and Uterus, NOS

1 2 3

NC* NC* NC*

2.57

4

NC*

42.87 43.08 85.96

25 43 68

58 ~100 79

Melanoma of Skin 1.48 Male Female 1.17 2.65 Total Multiple Myeloma Male 0.43 0.41 Female 0.84 Total Non-Hodgkin('s) Lymphoma 1.66 Male 1.59 Female Total 3.25 Oral Cavity & Pharynx 1.34 Male Female 0.68 Total 2.02 Ovary Female Pancreas

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 3 3

NC* NC* NC*

Male Female Total Prostate Male

Stomach

Testis 0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

0 0 0

NC* NC* NC*

Thyroid

3 3 6

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

NC* NC* 49

226

Norton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 7.13 Male Female 2.66 9.79 Total Brain and Other Nervous System Male 2.89 2.47 Female 5.36 Total Breast 0.38 Male 54.28 Female Total 54.66 Cervix Uteri Female

3.33

Colon / Rectum 18.31 Male Female 17.32 Total 35.63 Esophagus 2.92 Male Female 0.82 Total 3.74 Hodgkin's Disease (Hodgkin Lymphoma) Male 1.40 1.32 Female Total 2.72 Kidney & Renal Pelvis Male 4.96 3.04 Female 8.00 Total Larynx Male 2.72 0.69 Female Total 3.41 Leukemia Male 4.09 3.40 Female Total 7.48 Liver and Intrahepatic Bile Ducts Male 2.15 0.77 Female 2.91 Total Lung and Bronchus Male 24.19 Female 20.52 Total 44.71

Obs

SIR

6 3 9

84 NC* 92

5 3 8

173 NC* 149

0 47 47

NC* 87 86

3

NC*

21 12 33

115 69 93

Exp

Obs

SIR

4 10 14

NC* 196 127

1 2 3

NC* NC* NC*

2 7 9

NC* 120 73

7 1 8

130 NC* 101

6.36

5

79

3.37 3.35 6.71

1 7 8

NC* 209 119

50.48

30

59 ~-

Male Female Total

3.21 1.89 5.10

3 1 4

NC* NC* NC*

Male

2.18

1

NC*

Male 1.29 4.25 Female Total 5.54 Uteri, Corpus and Uterus, NOS

0 1 1

NC* NC* NC*

10.14

11

109

161.55 162.52 324.07

128 159 287

79 ~98 89 #-

Melanoma of Skin 5.95 Male Female 5.09 11.04 Total Multiple Myeloma Male 1.55 1.39 Female 2.94 Total Non-Hodgkin('s) Lymphoma 6.58 Male 5.83 Female Total 12.41 Oral Cavity & Pharynx 5.38 Male Female 2.53 Total 7.91 Ovary Female Pancreas

4 0 4

NC* NC* NC*

1 1 2

NC* NC* NC*

4 4 8

NC* NC* 100

Male Female Total Prostate Male

Stomach

Testis 5 0 5

184 NC* 146

1 0 1

NC* NC* NC*

5 1 6

233 NC* 206

Thyroid

18 28 46

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

74 136 103

227

Norwell

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 6.41 Male Female 2.02 8.42 Total Brain and Other Nervous System Male 2.30 1.70 Female 3.99 Total Breast 0.34 Male 42.60 Female Total 42.94 Cervix Uteri Female

2.22

Colon / Rectum 16.41 Male Female 13.00 Total 29.41 Esophagus 2.63 Male Female 0.63 Total 3.26 Hodgkin's Disease (Hodgkin Lymphoma) Male 0.97 0.74 Female Total 1.71 Kidney & Renal Pelvis Male 4.35 2.39 Female 6.74 Total Larynx Male 2.46 0.59 Female Total 3.04 Leukemia Male 3.35 2.35 Female Total 5.70 Liver and Intrahepatic Bile Ducts Male 1.89 0.58 Female 2.47 Total Lung and Bronchus Male 22.01 Female 16.87 Total 38.88

Obs

SIR

8 3 11

125 NC* 131

2 2 4

NC* NC* NC*

0 46 46

NC* 108 107

1

NC*

18 10 28

110 77 95

Exp

Obs

SIR

7 6 13

139 167 150

2 2 4

NC* NC* NC*

5 4 9

91 NC* 91

4 1 5

NC* NC* 75

4.82

5

104

3.01 2.55 5.56

3 2 5

NC* NC* 90

46.46

39

84

Male Female Total

2.84 1.35 4.19

3 2 5

NC* NC* 119

Male

1.38

0

NC*

Male 1.01 2.67 Female Total 3.68 Uteri, Corpus and Uterus, NOS

3 5 8

NC* 188 217

8.35

6

72

143.34 124.43 267.76

123 121 244

86 97 91

Melanoma of Skin 5.05 Male Female 3.59 8.64 Total Multiple Myeloma Male 1.39 1.10 Female 2.49 Total Non-Hodgkin('s) Lymphoma 5.52 Male 4.34 Female Total 9.87 Oral Cavity & Pharynx 4.71 Male Female 1.97 Total 6.68 Ovary Female Pancreas

2 0 2

NC* NC* NC*

0 0 0

NC* NC* NC*

3 4 7

NC* NC* 104

Male Female Total Prostate Male

Stomach

Testis 1 0 1

NC* NC* NC*

2 2 4

NC* NC* NC*

2 0 2

NC* NC* NC*

Thyroid

14 12 26

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

64 71 67 #-

228

Norwood

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp Bladder, Urinary 19.27 Male Female 8.53 27.80 Total Brain and Other Nervous System Male 6.04 5.58 Female 11.63 Total Breast 0.95 Male 129.33 Female Total 130.28 Cervix Uteri Female

6.86

Colon / Rectum 48.29 Male Female 55.95 Total 104.24 Esophagus 6.93 Male Female 2.63 Total 9.56 Hodgkin's Disease (Hodgkin Lymphoma) Male 2.79 2.59 Female Total 5.38 Kidney & Renal Pelvis Male 11.35 7.97 Female 19.32 Total Larynx Male 6.14 1.74 Female Total 7.88 Leukemia Male 9.43 8.67 Female Total 18.10 Liver and Intrahepatic Bile Ducts Male 4.87 2.37 Female 7.24 Total Lung and Bronchus Male 61.61 Female 57.48 Total 119.09

Obs

SIR

21 8 29

109 94 104

9 6 15

149 107 129

2 138 140

NC* 107 107

4

NC*

59 72 131

122 129 #+ 126 #+

Exp

Obs

SIR

25 16 41

187 ~+ 138 164 ~+

3 4 7

NC* NC* 88

16 19 35

104 118 111

7 1 8

61 NC* 44 #-

15.10

12

79

8.49 10.91 19.39

10 10 20

118 92 103

122.80

146

119 #+

Male Female Total

8.29 6.18 14.46

14 11 25

169 178 173 #+

Male

4.55

5

110

Male 2.62 8.15 Female Total 10.77 Uteri, Corpus and Uterus, NOS

5 12 17

191 147 158

24.30

31

128

394.74 425.07 819.81

468 489 957

119 ^+ 115 ~+ 117 ^+

Melanoma of Skin 13.38 Male Female 11.60 24.97 Total Multiple Myeloma Male 3.89 4.09 Female 7.98 Total Non-Hodgkin('s) Lymphoma 15.43 Male 16.09 Female Total 31.52 Oral Cavity & Pharynx 11.51 Male Female 6.61 Total 18.12 Ovary Female Pancreas

13 3 16

188 NC* 167

1 2 3

NC* NC* NC*

11 11 22

97 138 114

Male Female Total Prostate Male

Stomach

Testis 9 2 11

147 NC* 140

9 10 19

95 115 105

4 1 5

NC* NC* 69

Thyroid

75 65 140

Note: Explanation of all symbols is on page 361

Female All Sites / Types Male Female Total

122 113 118

229

Oak Bluffs

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Exp

Obs

SIR

1.76

3

NC*

Melanoma of Skin 2.44

5

205

Male

Female

0.94

2

NC*

Female

1.36

3

NC*

Total

3.38

7

207

Total

3.12

6

193

0.50

0

NC*

Multiple Myeloma

Brain and Other Nervous System Male

0.79

4

NC*

Male

Female

0.66

0

NC*

Female

0.47

0

NC*

Total

1.46

4

NC*

Total

0.97

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.12

0

NC*

Male

1.99

0

NC*

Female

15.70

19

121

Female

1.85

7

379 ~+

Total

15.82

19

120

Total

3.84

7

182

Oral Cavity & Pharynx

Cervix Uteri Female

0.80

2

NC*

Colon / Rectum

Male

1.56

2

NC*

Female

0.78

0

NC*

Total

2.34

2

NC*

Female

1.81

2

NC*

Ovary

Male

6.13

5

82

Female

6.15

5

81

Total

12.28

10

81

Esophagus

Pancreas

Male

0.91

4

NC*

Male

1.09

2

NC*

Female

0.29

0

NC*

Female

1.20

2

NC*

Total

1.20

4

NC*

Total

2.30

4

NC*

Male

15.87

19

120

NC*

Male

1.06

1

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.35

Prostate 0

NC*

Female

0.29

2

NC*

Total

0.64

2

NC*

Kidney & Renal Pelvis Male

Stomach 1.50

2

Female

0.95

1

NC*

Female

0.66

2

NC*

Total

2.45

3

NC*

Total

1.72

3

NC*

Male

0.54

0

NC*

Larynx

Testis Male

0.82

2

NC*

Female

0.22

0

NC*

Total

1.03

2

NC*

Male

1.22

2

NC*

Male

0.34

1

NC*

Female

0.99

1

NC*

Female

0.95

1

NC*

Total

2.21

3

NC*

Total

1.29

2

NC*

3.02

2

NC*

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.65

1

NC*

Female

0.26

0

NC*

Total

0.91

1

NC*

Lung and Bronchus

Female All Sites / Types

Male

7.87

8

102

Male

50.83

63

124 >

Female

6.86

5

73

Female

49.81

60

120 >

Total

14.73

13

88

Total

100.64

123

122 #+

Exp

Obs

SIR

Oakham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

0.98

0

NC*

Male

0.80

0

NC*

Female

0.30

0

NC*

Female

0.57

0

NC*

Total

1.28

0

NC*

Total

1.36

0

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.37

0

NC*

Male

0.22

0

NC*

Female

0.28

0

NC*

Female

0.16

0

NC*

Total

0.65

0

NC*

Total

0.38

0

NC*

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.05

1

NC*

Male

0.87

Female

6.41

2

NC*

Female

0.66

1

NC*

Total

6.46

3

NC*

Total

1.53

3

NC*

0.74

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.36

0

NC*

Colon / Rectum

Female

0.30

0

NC*

Total

1.04

0

NC*

Female

0.73

0

NC*

Ovary

Male

2.50

3

NC*

Female

1.98

3

NC*

Total

4.49

6

134

Esophagus

Pancreas

Male

0.41

1

NC*

Male

0.46

0

NC*

Female

0.09

0

NC*

Female

0.38

0

NC*

Total

0.50

1

NC*

Total

0.85

0

NC*

Male

7.08

5

71

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.16

0

NC*

Female

0.13

1

NC*

Total

0.29

1

NC* Stomach

Kidney & Renal Pelvis Male

0.69

0

NC*

Male

0.43

0

NC*

Female

0.36

1

NC*

Female

0.21

0

NC*

Total

1.04

1

NC*

Total

0.65

0

NC*

Male

0.22

0

NC*

NC*

Male

0.16

0

NC*

Larynx

Testis Male

0.38

1

NC*

Female

0.08

0

NC*

Total

0.47

1

NC*

Leukemia

Thyroid Male

0.54

1

Female

0.38

0

NC*

Female

0.45

0

NC*

Total

0.92

1

NC*

Total

0.61

0

NC*

2

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.30

0

NC*

Female

0.09

0

NC*

Total

0.38

0

NC*

Lung and Bronchus

Female All Sites / Types

1.23

Male

3.37

1

NC*

Male

22.10

18

81 >

Female

2.44

1

NC*

Female

18.85

11

58 >

Total

5.81

2

NC*

Total

40.95

29

71 >

Exp

Obs

SIR

3.35

3

NC*

Orange

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 4.59

5

109

Male

Female

1.99

1

NC*

Female

2.85

3

NC*

Total

6.57

6

91

Total

6.19

6

97

Multiple Myeloma

Brain and Other Nervous System Male

1.56

1

NC*

Male

0.95

0

NC*

Female

1.41

1

NC*

Female

0.97

1

NC*

Total

2.97

2

NC*

Total

1.92

1

NC*

Male

0.23

0

NC*

Male

3.81

5

131

Female

31.98

21

66

Female

3.85

7

182

Total

32.21

21

65 #-

Total

7.66

12

157

Male

2.94

4

NC*

Female

1.61

1

NC*

Total

4.55

5

110

Female

3.72

5

135

2.06

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Oral Cavity & Pharynx

Cervix Uteri Female

1.70

3

NC* Ovary

Colon / Rectum Male

11.55

4

NC*

Female

13.06

13

100

Total

24.60

17

69 Pancreas

Esophagus Male

1.71

2

NC*

Male

Female

0.61

0

NC*

Female

2.54

2

NC*

Total

2.33

2

NC*

Total

4.60

2

NC*

Male

30.08

18

60 #-

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.70

0

NC*

Female

0.65

1

NC*

Total

1.35

1

NC*

Kidney & Renal Pelvis

Stomach

Male

2.86

1

NC*

Male

1.99

1

NC*

Female

1.94

3

NC*

Female

1.43

0

NC*

Total

4.79

4

NC*

Total

3.41

1

NC*

Male

1.55

1

NC*

Male

1.08

1

NC*

Female

0.43

0

NC*

Total

1.98

1

NC*

Male

2.38

6

252

Male

0.66

2

NC*

Female

2.14

3

NC*

Female

2.04

5

246

Total

4.51

9

199

Total

2.70

7

260 #+

5

83

Larynx

Testis

Leukemia

Thyroid

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.23

3

NC*

Female

0.56

0

NC*

Female

6.05

Total

1.79

3

NC*

Lung and Bronchus Male

All Sites / Types 14.93

10

67

Male

96.53

74

77 #-

Female

13.82

10

72

Female

102.99

95

92

Total

28.75

20

70

Total

199.53

169

85 #-

Exp

Obs

SIR

Orleans

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

9.08

15

165

Male

5.01

9

179

Female

3.32

6

181

Female

3.48

8

230

Total

12.40

21

169 #+

Total

8.49

17

200 #+

1.71

2

NC*

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

1.99

1

NC*

Male

Female

1.72

1

NC*

Female

1.53

1

NC*

Total

3.71

2

NC*

Total

3.24

3

NC*

5

83

Breast

Non-Hodgkin('s) Lymphoma Male

0.39

1

NC*

Male

6.06

Female

42.52

66

155 ~+

Female

5.70

11

193

Total

42.91

67

156 ^+

Total

11.76

16

136

Oral Cavity & Pharynx

Cervix Uteri Female

1.77

0

NC*

Male

4.28

5

117

Female

2.31

3

NC*

Total

6.59

8

121

Female

4.84

6

124

Ovary

Colon / Rectum Male

22.02

20

91

Female

22.05

18

82

Total

44.08

38

86

Male

2.85

2

NC*

Male

3.77

5

133

Female

1.03

2

NC*

Female

4.28

4

NC*

Total

3.88

4

NC*

Total

8.04

9

112

Male

50.30

102

203 ^+

NC*

Male

3.83

2

NC*

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.64

0

NC*

Female

0.58

0

NC*

Total

1.22

0

NC*

Kidney & Renal Pelvis Male

Stomach 4.50

3

Female

2.76

1

NC*

Female

2.43

1

NC*

Total

7.26

4

NC*

Total

6.26

3

NC*

Male

0.80

0

NC*

Larynx

Testis Male

2.37

2

NC*

Female

0.59

0

NC*

Total

2.97

2

NC*

Leukemia

Thyroid Male

3.77

3

NC*

Male

0.72

0

NC*

Female

3.02

2

NC*

Female

1.83

3

NC*

Total

6.79

5

74

Total

2.56

3

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

1.90

1

NC*

Female

0.91

2

NC*

Total

2.81

3

NC*

Male

26.38

27

102

Female

20.79

22

Total

47.17

49

Female

8.17

13

159

Male

163.60

219

134 ^+

106

Female

147.76

184

125 ~+

104

Total

311.36

403

129 ^+

Exp

Obs

SIR

All Sites / Types

Lung and Bronchus

Otis

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.65

1

NC*

Male

0.51

1

NC*

Female

0.23

0

NC*

Female

0.38

0

NC*

Total

0.88

1

NC*

Total

0.89

1

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.24

2

NC*

Male

0.14

0

NC*

Female

0.18

1

NC*

Female

0.11

0

NC*

Total

0.42

3

NC*

Total

0.25

0

NC*

Male

0.03

0

NC*

Male

0.57

0

NC*

Female

4.11

3

NC*

Female

0.46

1

NC*

Total

4.15

3

NC*

Total

1.03

1

NC*

Male

0.46

0

NC*

Female

0.20

0

NC*

Total

0.66

0

NC*

Female

0.48

1

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.24

1

NC*

Colon / Rectum Male

Ovary 1.67

3

NC*

Female

1.49

2

NC*

Total

3.15

5

159

Esophagus

Pancreas

Male

0.26

0

NC*

Male

0.30

0

NC*

Female

0.07

0

NC*

Female

0.29

0

NC*

Total

0.33

0

NC*

Total

0.59

0

NC*

Male

4.58

4

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.11

0

NC*

Female

0.09

0

NC*

Total

0.20

0

NC*

Male

0.43

0

NC*

Male

0.29

0

NC*

Female

0.24

0

NC*

Female

0.16

0

NC*

Total

0.67

0

NC*

Total

0.45

0

NC*

Male

0.24

2

NC*

Male

0.18

0

NC*

Female

0.05

0

NC*

Total

0.29

2

NC*

Kidney & Renal Pelvis

Stomach

Larynx

Testis

Leukemia

Thyroid Male

0.35

0

NC*

Male

0.11

0

NC*

Female

0.26

2

NC*

Female

0.29

0

NC*

Total

0.61

2

NC*

Liver and Intrahepatic Bile Ducts Male

0.19

Total

0.40

0

NC*

1

NC*

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.06

0

NC*

Total

0.25

0

NC*

Lung and Bronchus

Female

0.77

All Sites / Types

Male

2.22

3

NC*

Male

14.47

17

117 >

Female

1.63

3

NC*

Female

12.69

16

126 >

Total

3.85

6

156

Total

27.16

33

122 >

Exp

Obs

SIR

5.78

6

104

Oxford

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 7.64

7

92

Male

Female

2.88

3

NC*

Female

4.63

5

108

Total

10.52

10

95

Total

10.41

11

106

1.59

1

NC*

Multiple Myeloma

Brain and Other Nervous System Male

2.69

3

NC*

Male

Female

2.24

4

NC*

Female

1.45

1

NC*

Total

4.93

7

142

Total

3.05

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.39

1

NC*

Male

6.53

6

92

Female

51.58

48

93

Female

5.86

5

85

Total

51.96

49

94

Total

12.39

11

89

Oral Cavity & Pharynx

Cervix Uteri Female

2.87

4

NC*

Colon / Rectum

Male

5.10

3

NC*

Female

2.50

1

NC*

Total

7.60

4

NC*

Female

5.99

9

150

Ovary

Male

19.31

16

83

Female

18.76

18

96

Total

38.08

34

89 Pancreas

Esophagus Male

2.89

1

NC*

Male

3.47

4

NC*

Female

0.89

1

NC*

Female

3.65

5

137

Total

3.78

2

NC*

Total

7.13

9

126

Male

50.23

40

80

3.38

2

NC*

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.26

2

NC*

Female

1.08

0

NC*

Total

2.35

2

NC* Stomach

Kidney & Renal Pelvis Male

4.85

10

206

Male

Female

3.02

3

NC*

Female

2.03

2

NC*

Total

7.87

13

165

Total

5.41

4

NC*

Male

2.00

2

NC*

Larynx

Testis Male

2.63

2

NC*

Female

0.69

1

NC*

Total

3.31

3

NC*

Leukemia

Thyroid

Male

4.02

6

149

Male

1.18

2

NC*

Female

3.24

3

NC*

Female

3.52

2

NC*

Total

7.26

9

124

Total

4.70

4

NC*

9.77

6

61

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.09

2

NC*

Female

0.81

0

NC*

Total

2.90

2

NC*

Female All Sites / Types

Lung and Bronchus Male

24.75

22

89

Male

162.54

149

92

Female

21.24

13

61

Female

160.03

146

91

Total

45.99

35

76

Total

322.57

295

91

Exp

Obs

SIR

Palmer

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

8.36

12

144

Male

5.84

2

NC*

Female

3.41

3

NC*

Female

4.73

5

106

Total

11.77

15

127

Total

10.57

7

66

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

2.64

2

NC*

Male

1.70

1

NC*

Female

2.33

4

NC*

Female

1.65

1

NC*

Total

4.97

6

121

Total

3.36

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.41

0

NC*

Male

6.71

4

NC*

Female

53.34

48

90

Female

6.53

4

NC*

Total

53.76

48

89

Total

13.24

8

60

5.06

7

138

Oral Cavity & Pharynx

Cervix Uteri

Male Female

2.80

6

215

Female

2.70

2

NC*

Total

7.76

9

116

Female

6.20

11

178

Ovary

Colon / Rectum Male

20.90

19

91

Female

22.45

20

89

Total

43.35

39

90 Pancreas

Esophagus Male

3.01

2

NC*

Male

3.69

1

NC*

Female

1.06

1

NC*

Female

4.36

4

NC*

Total

4.07

3

NC*

Total

8.06

5

62

Male

52.82

47

89

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.18

0

NC*

Female

1.05

2

NC*

Total

2.23

2

NC*

Male

4.99

5

100

Male

3.61

6

166

Female

3.26

3

NC*

Female

2.45

5

204

Total

8.25

8

97

Total

6.06

11

182

Male

1.84

3

NC*

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

2.68

8

299 #+

Female

0.72

2

NC*

Total

3.40

10

294 ~+

Leukemia

Thyroid Male

4.16

5

120

Male

1.12

0

NC*

Female

3.57

5

140

Female

3.32

3

NC*

Total

7.72

10

129

Total

4.44

3

NC*

12

119

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

2.14

4

NC*

Female

0.95

2

NC*

Total

3.09

6

194

Female

10.09

All Sites / Types

Lung and Bronchus Male

26.58

37

139

Male

170.77

172

101

Female

23.45

20

85

Female

173.49

168

97

Total

50.03

57

114

Total

344.26

340

99

Exp

Obs

SIR

2.44

4

NC*

Paxton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 3.43

2

NC*

Male

Female

1.14

0

NC*

Female

1.77

3

NC*

Total

4.57

2

NC*

Total

4.21

7

166

Multiple Myeloma

Brain and Other Nervous System Male

1.08

0

NC*

Male

0.72

0

NC*

Female

0.86

1

NC*

Female

0.59

1

NC*

Total

1.94

1

NC*

Total

1.30

1

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.17

1

NC*

Male

2.74

2

NC*

Female

20.79

18

87

Female

2.31

0

NC*

Total

20.96

19

91

Total

5.04

2

NC*

Male

2.23

0

NC*

Female

1.01

0

NC*

Total

3.24

0

NC*

Female

2.38

1

NC*

1.56

1

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 1.06

0

NC*

Colon / Rectum

Ovary

Male

8.67

4

NC*

Female

7.36

4

NC*

Total

16.03

8

50 #-

Esophagus Male

Pancreas 1.32

0

NC*

Male

Female

0.35

0

NC*

Female

1.45

1

NC*

Total

1.67

0

NC*

Total

3.01

2

NC*

Male

23.59

17

72

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.43

Prostate 0

NC*

Female

0.37

0

NC*

Total

0.80

0

NC*

Kidney & Renal Pelvis

Larynx

Stomach

Male

2.13

5

234

Male

1.49

1

NC*

Female

1.22

1

NC*

Female

0.79

0

NC*

Total

3.36

6

179

Total

2.27

1

NC*

Testis

Male

0.59

1

NC*

NC*

Male

0.46

1

NC*

1

NC*

Female

1.26

2

NC*

3

NC*

Total

1.72

3

NC*

4.04

5

124

72.81

53

73 #->

Male

1.20

1

NC*

Female

0.29

0

NC*

Total

1.49

1

NC*

Male

1.67

2

Female

1.25

Total

2.92

Thyroid

Leukemia

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.93

0

NC*

Female

0.32

0

NC*

Total

1.25

0

NC* All Sites / Types

Lung and Bronchus Male

Female

11.41

7

61

Male

Female

8.75

6

69

Female

63.75

48

75 #->

Total

20.16

13

64

Total

136.56

101

74 ~-

Exp

Obs

SIR

Peabody

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

35.96

41

114

Male

25.43

28

110

Female

14.07

19

135

Female

20.04

15

75

Total

50.02

60

120

Total

45.47

43

95

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

11.42

7

61

Male

7.41

9

121

Female

9.71

9

93

Female

6.97

13

187

Total

21.13

16

76

Total

14.38

22

153

34

118

Non-Hodgkin('s) Lymphoma

Breast Male

1.81

2

NC*

Male

28.86

Female

230.88

248

107

Female

27.35

31

113

Total

232.69

250

107

Total

56.21

65

116

Oral Cavity & Pharynx

Cervix Uteri Female

11.85

11

93

Male

22.63

20

88

Female

11.52

10

87

Total

34.15

30

88

Female

26.68

26

97

Ovary

Colon / Rectum Male

90.72

98

108

Female

91.48

101

110

Total

182.20

199

109

Male

13.49

14

104

Male

16.11

20

124

Female

4.34

2

NC*

Female

17.97

19

106

Total

17.83

16

90

Total

34.08

39

114

Male

241.19

256

106

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

4.93

11

223 #+

Female

4.29

3

NC*

Total

9.22

14

152 Stomach

Kidney & Renal Pelvis Male

21.92

28

128

Male

15.51

15

97

Female

14.01

16

114

Female

9.90

7

71

Total

35.93

44

122

Total

25.40

22

87

Male

7.52

8

106

Testis

Larynx Male

12.13

14

115

Female

3.21

2

NC*

Total

15.35

16

104 Thyroid

Leukemia Male

17.60

18

102

Male

4.90

4

NC*

Female

14.62

20

137

Female

13.99

16

114

Total

32.22

38

118

Total

18.89

20

106

44.31

52

117

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

9.48

11

116

Female

3.93

3

NC*

Total

13.41

14

104

Male

118.30

142

120 #+

Male

755.57

828

110 ~+

Female

101.36

115

113

Female

735.73

801

109 #+

Total

219.66

257

117 #+

Total

1491.30

1629

109 ^+

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Pelham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

1.01

1

NC*

Male

0.73

1

NC*

Female

0.30

0

NC*

Female

0.53

0

NC*

Total

1.31

1

NC*

Total

1.27

1

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.33

0

NC*

Male

0.21

0

NC*

Female

0.25

0

NC*

Female

0.16

0

NC*

Total

0.58

0

NC*

Total

0.37

0

NC*

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.05

0

NC*

Male

Female

6.01

6

100

Female

0.64

0

NC*

Total

6.06

6

99

Total

1.47

0

NC*

Cervix Uteri Female

0.82

Oral Cavity & Pharynx 0.34

0

NC*

Colon / Rectum

Male

0.67

0

NC*

Female

0.28

0

NC*

Total

0.95

0

NC*

Female

0.69

1

NC*

Ovary

Male

2.56

2

NC*

Female

1.95

2

NC*

Total

4.51

4

NC*

Male

0.39

0

NC*

Male

0.46

0

NC*

Female

0.09

0

NC*

Female

0.38

0

NC*

Total

0.48

0

NC*

Total

0.84

0

NC*

Male

6.91

8

116

Esophagus

Pancreas

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.14

0

NC*

Female

0.12

0

NC*

Total

0.26

0

NC*

Kidney & Renal Pelvis

Stomach

Male

0.63

2

NC*

Male

0.45

0

NC*

Female

0.34

1

NC*

Female

0.20

0

NC*

Total

0.97

3

NC*

Total

0.65

0

NC*

Male

0.35

0

NC*

Male

0.21

0

NC*

Female

0.08

0

NC*

Total

0.43

0

NC*

Larynx

Testis

Leukemia

Thyroid Male

0.50

0

NC*

Male

0.14

1

NC*

Female

0.34

0

NC*

Female

0.42

0

NC*

Total

0.84

0

NC*

Total

0.56

1

NC*

1.15

3

NC*

21.50

21

98 >

Liver and Intrahepatic Bile Ducts Male

0.27

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.09

0

NC*

Total

0.36

0

NC*

Lung and Bronchus Male

Female All Sites / Types

3.31

2

NC*

Male

Female

2.40

0

NC*

Female

17.98

14

78 >

Total

5.71

2

NC*

Total

39.48

35

89

Exp

Obs

SIR

Pembroke

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

8.01

24

300 ^+

Male

6.64

7

105

Female

2.77

4

NC*

Female

5.05

5

99

Total

10.78

28

260 ^+

Total

11.69

12

103

1.75

3

NC*

Multiple Myeloma

Brain and Other Nervous System Male

3.14

0

NC*

Male

Female

2.42

6

248

Female

1.46

4

NC*

Total

5.56

6

108

Total

3.21

7

218

Non-Hodgkin('s) Lymphoma

Breast Male

0.43

0

NC*

Male

7.29

7

96

Female

56.44

70

124

Female

5.93

3

NC*

Total

56.86

70

123

Total

13.23

10

76

Oral Cavity & Pharynx

Cervix Uteri Female

3.22

7

218

Male

6.06

6

99

Female

2.64

4

NC*

Total

8.70

10

115

Female

6.49

10

154

Ovary

Colon / Rectum Male

20.56

14

68

Female

18.06

12

66

Total

38.62

26

67 #-

Male

3.29

5

152

Male

3.79

7

185

Female

0.86

3

NC*

Female

3.49

5

143

Total

4.15

8

193

Total

7.28

12

165

Male

56.98

53

93

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

1.48

1

NC*

Female

1.19

0

NC*

Total

2.66

1

NC*

Kidney & Renal Pelvis Male

Stomach 5.56

9

162

Male

3.61

5

138

Female

3.15

2

NC*

Female

1.95

1

NC*

Total

8.71

11

126

Total

5.56

6

108

Male

2.27

2

NC*

Testis

Larynx Male

3.08

1

NC*

Female

0.73

0

NC*

Total

3.81

1

NC*

Leukemia

Thyroid Male

4.47

2

NC*

Male

1.42

1

NC*

Female

3.40

2

NC*

Female

3.98

6

151

Total

7.87

4

NC*

Total

5.40

7

130

10.74

11

102

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

2.41

0

NC*

Female

0.80

1

NC*

Total

3.21

1

NC*

Male

27.18

30

110

Male

180.99

188

104

Female

21.60

29

134

Female

167.72

196

117 #+

Total

48.79

59

121

Total

348.71

384

110

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Pepperell

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

4.87

10

206

Male

4.37

6

137

Female

1.84

1

NC*

Female

3.50

0

NC*

Total

6.71

11

164

Total

7.88

6

76

Multiple Myeloma

Brain and Other Nervous System Male

2.15

1

NC*

Male

1.09

1

NC*

Female

1.68

0

NC*

Female

0.97

1

NC*

Total

3.83

1

NC*

Total

2.06

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.27

0

NC*

Male

4.76

2

NC*

Female

38.18

38

100

Female

4.01

7

175

Total

38.45

38

99

Total

8.77

9

103

3.98

1

NC*

Oral Cavity & Pharynx

Cervix Uteri

Male Female

2.27

4

NC*

Colon / Rectum Male

Female

1.77

2

NC*

Total

5.76

3

NC*

Female

4.42

3

NC*

Ovary 12.63

10

79

Female

12.02

14

117

Total

24.64

24

97

Esophagus

Pancreas

Male

2.09

0

NC*

Male

2.36

3

NC*

Female

0.57

1

NC*

Female

2.31

1

NC*

Total

2.66

1

NC*

Total

4.68

4

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

35.72

33

92

NC*

Male

2.23

2

NC*

4

NC*

Female

1.31

0

NC*

6

105

Total

3.54

2

NC*

Male

1.71

1

NC*

0.99

0

NC*

Male

1.08

0

NC*

Female

0.87

3

NC*

Total

1.94

3

NC*

Male

3.60

2

Female

2.12

Total

5.72

Stomach

Kidney & Renal Pelvis

Larynx

Testis Male

1.98

0

NC*

Female

0.49

0

NC*

Total

2.47

0

NC*

Leukemia

Thyroid Male

2.94

4

NC*

Male

Female

2.33

3

NC*

Female

2.86

4

NC*

Total

5.28

7

133

Total

3.85

4

NC*

5

70

Liver and Intrahepatic Bile Ducts Male

1.56

Uteri, Corpus and Uterus, NOS 1

NC*

Female

0.53

1

NC*

Total

2.09

2

NC*

Female

7.19

All Sites / Types

Lung and Bronchus Male

16.90

9

53

Male

114.65

92

80 #-

Female

14.29

14

98

Female

113.21

109

96 >

Total

31.19

23

74

Total

227.86

201

88

Exp

Obs

SIR

0.39

0

NC*

Peru

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 0.52

1

NC*

Male

Female

0.14

0

NC*

Female

0.26

1

NC*

Total

0.65

1

NC*

Total

0.64

1

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.18

0

NC*

Male

0.11

0

NC*

Female

0.13

0

NC*

Female

0.07

0

NC*

Total

0.30

0

NC*

Total

0.18

0

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.03

0

NC*

Male

0.43

1

NC*

Female

2.80

0

NC*

Female

0.31

0

NC*

Total

2.82

0

NC*

Total

0.74

1

NC*

Male

0.35

0

NC*

Female

0.13

0

NC*

Total

0.48

0

NC*

Female

0.33

0

NC*

Cervix Uteri Female

Oral Cavity & Pharynx 0.17

0

NC*

Colon / Rectum

Ovary

Male

1.30

0

NC*

Female

0.91

0

NC*

Total

2.21

0

NC*

Esophagus

Pancreas

Male

0.20

0

NC*

Male

0.24

0

NC*

Female

0.04

0

NC*

Female

0.18

0

NC*

Total

0.24

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.08

Total

0.41

0

NC*

Male

3.36

1

NC*

Prostate 0

NC*

Female

0.07

0

NC*

Total

0.14

0

NC*

Kidney & Renal Pelvis

Stomach

Male

0.33

0

NC*

Male

0.23

0

NC*

Female

0.16

0

NC*

Female

0.10

0

NC*

Total

0.49

0

NC*

Total

0.33

0

NC*

Male

0.12

0

NC*

Larynx

Testis Male

0.18

0

NC*

Female

0.04

0

NC*

Total

0.21

0

NC*

Male

0.27

0

NC*

Male

0.08

0

NC*

Female

0.17

0

NC*

Female

0.21

1

NC*

Total

0.44

0

NC*

Total

0.29

1

NC*

0.53

1

NC*

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.14

0

NC*

Female

0.04

0

NC*

Total

0.18

0

NC*

Lung and Bronchus

Female All Sites / Types

Male

1.64

2

NC*

Male

10.86

5

46 >

Female

1.10

0

NC*

Female

8.44

4

NC*

Total

2.74

2

NC*

Total

19.29

9

47 #->

Exp

Obs

SIR

Petersham

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

0.92

1

NC*

Male

0.65

0

NC*

Female

0.38

1

NC*

Female

0.49

0

NC*

Total

1.30

2

NC*

Total

1.14

0

NC*

Bladder, Urinary

Melanoma of Skin

Brain and Other Nervous System

Multiple Myeloma

Male

0.28

0

NC*

Male

0.19

0

NC*

Female

0.24

0

NC*

Female

0.18

0

NC*

Total

0.52

0

NC*

Total

0.37

0

NC*

3

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.05

1

NC*

Male

0.73

Female

5.82

6

103

Female

0.70

0

NC*

Total

5.86

7

119

Total

1.44

3

NC*

0.57

0

NC*

Cervix Uteri

Oral Cavity & Pharynx Male

Female

0.28

1

NC*

Colon / Rectum

0.30

0

NC*

Total

0.87

0

NC*

Female

0.66

2

NC*

Ovary

Male

2.30

4

NC*

Female

2.51

1

NC*

Total

4.82

5

104

Esophagus

Female

Pancreas

Male

0.34

0

NC*

Male

0.41

0

NC*

Female

0.12

0

NC*

Female

0.49

1

NC*

Total

0.45

0

NC*

Total

0.90

1

NC*

Male

5.84

8

137

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.12

0

NC*

Female

0.09

0

NC*

Total

0.21

0

NC* Stomach

Kidney & Renal Pelvis Male

0.56

0

NC*

Male

0.40

0

NC*

Female

0.35

0

NC*

Female

0.28

0

NC*

Total

0.91

0

NC*

Total

0.68

0

NC*

Male

0.17

1

NC*

NC*

Male

0.12

0

NC*

Larynx

Testis Male

0.30

0

NC*

Female

0.08

0

NC*

Total

0.38

0

NC*

Leukemia

Thyroid Male

0.45

0

Female

0.38

0

NC*

Female

0.32

0

NC*

Total

0.83

0

NC*

Total

0.44

0

NC*

1

NC*

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.24

0

NC*

Female

0.11

0

NC*

Total

0.34

0

NC*

Lung and Bronchus

Female

1.11

All Sites / Types

Male

2.92

2

NC*

Male

18.81

20

106 >

Female

2.56

1

NC*

Female

18.90

17

90 >

Total

5.48

3

NC*

Total

37.71

37

98 >

Exp

Obs

SIR

Phillipston

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.98

0

NC*

Male

0.83

0

NC*

Female

0.25

0

NC*

Female

0.55

0

NC*

Total

1.23

0

NC*

Total

1.38

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.39

0

NC*

Male

0.21

0

NC*

Female

0.26

0

NC*

Female

0.14

1

NC*

Total

0.65

0

NC*

Total

0.35

1

NC*

Male

0.05

0

NC*

Male

0.91

1

NC*

Female

5.75

1

NC*

Female

0.59

0

NC*

Total

5.80

1

NC*

Total

1.50

1

NC*

Male

0.75

0

NC*

Female

0.26

0

NC*

Total

1.01

0

NC*

Female

0.67

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.37

0

NC*

Colon / Rectum

Ovary

Male

2.52

1

NC*

Female

1.62

0

NC*

Total

4.14

1

NC*

Esophagus Male

Pancreas 0.41

0

NC*

Male

0.47

0

NC*

Female

0.08

0

NC*

Female

0.31

0

NC*

Total

0.48

0

NC*

Total

0.78

0

NC*

Male

7.04

3

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.20

0

NC*

Female

0.15

0

NC*

Total

0.34

0

NC*

Kidney & Renal Pelvis

Stomach

Male

0.68

0

NC*

Male

0.44

0

NC*

Female

0.31

0

NC*

Female

0.17

0

NC*

Total

0.99

0

NC*

Total

0.62

0

NC*

Male

0.38

0

NC*

Male

0.32

0

NC*

Female

0.07

0

NC*

Total

0.45

0

NC*

Male

0.55

0

NC*

Male

0.18

0

NC*

Female

0.34

0

NC*

Female

0.48

0

NC*

Total

0.88

0

NC*

Total

0.67

0

NC*

1.07

1

NC*

22.36

7

31 ^->

Larynx

Testis

Leukemia

Thyroid

Liver and Intrahepatic Bile Ducts

Uteri, Corpus and Uterus, NOS

Male

0.30

0

NC*

Female

0.07

0

NC*

Total

0.37

0

NC*

Lung and Bronchus Male

Female All Sites / Types

3.34

1

NC*

Male

Female

2.07

1

NC*

Female

16.67

5

30 ~->

Total

5.40

2

NC*

Total

39.03

12

31 ^->

Exp

Obs

SIR

Pittsfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

34.83

26

75

Male

23.06

21

91

Female

14.41

10

69

Female

18.73

14

75

Total

49.24

36

73

Total

41.79

35

84

6.93

9

130

Multiple Myeloma

Brain and Other Nervous System Male

10.27

10

97

Male

Female

9.26

7

76

Female

6.91

3

NC*

Total

19.53

17

87

Total

13.84

12

87

26.84

20

75

Non-Hodgkin('s) Lymphoma

Breast Male

1.66

2

NC*

Male

Female

214.97

237

110

Female

26.93

18

67

Total

216.63

239

110

Total

53.77

38

71 #-

Oral Cavity & Pharynx

Cervix Uteri Female Colon / Rectum

10.75

12

112 Ovary

Male

19.96

19

95

Female

11.07

4

NC*

Total

31.03

23

74

Male

86.60

98

113

Female

94.74

80

84

Total

181.34

178

98

Male

12.18

10

82

Female

4.46

3

NC*

Total

16.64

13

78

24.91

29

116

Male

15.17

21

138

Female

18.47

11

60

Total

33.64

32

95

Male

215.00

199

93

14.97

12

80

Pancreas

Esophagus

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

4.41

2

NC*

Female

3.98

1

NC*

Total

8.39

3

NC* Stomach

Kidney & Renal Pelvis Male

Female

19.84

16

81

Male

Female

13.38

12

90

Female

10.34

6

58

Total

33.22

28

84

Total

25.32

18

71

Male

6.77

5

74

Testis

Larynx Male

10.67

12

112

Female

2.95

4

NC*

Total

13.62

16

117 Thyroid

Leukemia Male

16.63

14

84

Male

4.25

3

NC*

Female

14.54

10

69

Female

12.49

11

88

Total

31.17

24

77

Total

16.74

14

84

40.88

36

88

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

8.49

5

59

Female

4.00

4

NC*

Total

12.50

9

72

Male

108.64

111

102

Male

693.55

675

97

Female

97.57

97

99

Female

710.02

645

91 #-

Total

206.21

208

101

Total

1403.57

1320

94 #-

Exp

Obs

SIR

Female All Sites / Types

Lung and Bronchus

Plainfield

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary

Melanoma of Skin

Male

0.51

0

NC*

Male

0.34

0

NC*

Female

0.13

0

NC*

Female

0.21

0

NC*

Total

0.64

0

NC*

Total

0.55

0

NC*

Brain and Other Nervous System

Multiple Myeloma

Male

0.14

0

NC*

Male

0.10

0

NC*

Female

0.10

0

NC*

Female

0.07

0

NC*

Total

0.25

0

NC*

Total

0.17

0

NC*

Male

0.02

0

NC*

Male

0.38

0

NC*

Female

2.50

4

NC*

Female

0.28

0

NC*

Total

2.52

4

NC*

Total

0.66

0

NC*

Male

0.30

0

NC*

Female

0.12

0

NC*

Breast

Non-Hodgkin('s) Lymphoma

Cervix Uteri Female

Oral Cavity & Pharynx 0.13

0

NC*

Colon / Rectum Male

Total

0.42

0

NC*

Female

0.28

0

NC*

Ovary 1.26

0

NC*

Female

0.87

1

NC*

Total

2.13

1

NC*

Esophagus

Pancreas

Male

0.18

0

NC*

Male

0.22

0

NC*

Female

0.04

0

NC*

Female

0.17

0

NC*

Total

0.22

0

NC*

Total

0.39

0

NC*

Male

3.19

3

NC*

Hodgkin's Disease (Hodgkin Lymphoma)

Prostate

Male

0.05

0

NC*

Female

0.04

0

NC*

Total

0.10

0

NC*

Male

0.30

0

NC*

Male

0.22

0

NC*

Female

0.15

0

NC*

Female

0.09

0

NC*

Total

0.44

0

NC*

Total

0.31

0

NC*

Male

0.16

0

NC*

Male

0.07

0

NC*

Female

0.03

0

NC*

Total

0.20

0

NC*

Kidney & Renal Pelvis

Stomach

Larynx

Testis

Leukemia

Thyroid Male

0.24

0

NC*

Male

0.06

0

NC*

Female

0.15

0

NC*

Female

0.15

0

NC*

Total

0.39

0

NC*

Total

0.21

0

NC*

0

NC*

Liver and Intrahepatic Bile Ducts Male

0.13

Uteri, Corpus and Uterus, NOS 0

NC*

Female

0.04

0

NC*

Total

0.17

0

NC*

Lung and Bronchus

Female

0.49

All Sites / Types

Male

1.60

1

NC*

Male

10.13

4

NC*

Female

1.05

1

NC*

Female

7.61

6

79 >

Total

2.65

2

NC*

Total

17.74

10

56 >

Exp

Obs

SIR

3.50

4

NC*

Plainville

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Melanoma of Skin 4.55

5

110

Male

Female

1.94

3

NC*

Female

2.91

4

NC*

Total

6.49

8

123

Total

6.40

8

125

0.95

1

NC*

Multiple Myeloma

Brain and Other Nervous System Male

1.62

3

NC*

Male

Female

1.39

2

NC*

Female

0.96

1

NC*

Total

3.01

5

166

Total

1.91

2

NC*

Breast

Non-Hodgkin('s) Lymphoma Male

0.23

0

NC*

Male

3.94

5

127

Female

32.36

25

77

Female

3.79

3

NC*

Total

32.59

25

77

Total

7.74

8

103

Cervix Uteri

Oral Cavity & Pharynx

Female

1.77

2

NC*

Colon / Rectum

Male

3.08

0

NC*

Female

1.60

1

NC*

Total

4.68

1

NC*

Female

3.76

1

NC*

Ovary

Male

11.55

9

78

Female

12.69

9

71

Total

24.24

18

74

Esophagus

Pancreas

Male

1.74

2

NC*

Male

2.08

0

NC*

Female

0.60

0

NC*

Female

2.47

1

NC*

Total

2.34

2

NC*

Total

4.55

1

NC*

Male

30.33

29

96

NC*

Male

2.02

1

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.79

Prostate 1

NC*

Female

0.66

2

NC*

Total

1.45

3

NC* Stomach

Kidney & Renal Pelvis Male

2.91

1

Female

1.92

2

NC*

Female

1.40

0

NC*

Total

4.83

3

NC*

Total

3.42

1

NC*

Male

1.29

1

NC*

Larynx

Testis Male

1.58

1

NC*

Female

0.43

0

NC*

Total

2.01

1

NC*

Leukemia

Thyroid Male

2.40

0

NC*

Male

0.74

1

NC*

Female

2.09

1

NC*

Female

2.14

4

NC*

Total

4.49

1

NC*

Total

2.87

5

174

6.10

4

NC*

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

1.25

1

NC*

Female

0.54

0

NC*

Total

1.80

1

NC*

Lung and Bronchus

Female All Sites / Types

Male

14.87

22

148

Male

97.88

91

93 >

Female

13.60

16

118

Female

102.64

91

89

Total

28.47

38

133

Total

200.52

182

91

Exp

Obs

SIR

Plymouth

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Male

29.07

35

120

Male

22.10

30

136

Female

11.29

15

133

Female

17.57

13

74

Total

40.36

50

124

Total

39.67

43

108

Bladder, Urinary

Melanoma of Skin

Multiple Myeloma

Brain and Other Nervous System Male

10.24

13

127

Male

6.09

9

148

Female

8.54

12

141

Female

5.63

9

160

Total

18.78

25

133

Total

11.72

18

154

Non-Hodgkin('s) Lymphoma

Breast Male

1.47

0

NC*

Male

24.89

25

100

Female

196.33

194

99

Female

22.53

24

107

Total

197.80

194

98

Total Male

Female

47.42

49

103

19.58

25

128

Oral Cavity & Pharynx

Cervix Uteri 10.77

14

130

Female

9.60

8

83

Total

29.18

33

113

Female

22.68

15

66

Ovary

Colon / Rectum Male

73.34

84

115

Female

74.45

70

94

Total

147.80

154

104 Pancreas

Esophagus Male

11.02

7

63

Male

13.24

6

45 #-

Female

3.51

2

NC*

Female

14.34

13

91

Total

14.53

9

62

Total

27.58

19

69

Male

190.06

209

110

Prostate

Hodgkin's Disease (Hodgkin Lymphoma) Male

4.76

6

126

Female

4.02

5

124

Total

8.77

11

125

Male

18.60

24

129

Male

12.88

14

109

Female

11.45

16

140

Female

8.10

5

62

Total

30.05

40

133

Total

20.98

19

91

Male

7.41

11

148

4.50

6

133

Stomach

Kidney & Renal Pelvis

Testis

Larynx Male

10.04

8

80

Female

2.56

5

196

Total

12.59

13

103 Thyroid

Leukemia Male

15.38

10

65

Male

Female

12.65

15

119

Female

13.06

12

92

Total

28.03

25

89

Total

17.56

18

103

27

73

Uteri, Corpus and Uterus, NOS

Liver and Intrahepatic Bile Ducts Male

7.99

4

NC*

Female

3.19

2

NC*

Total

11.18

6

54

Female

37.05

All Sites / Types

Lung and Bronchus Male

93.82

90

96

Male

617.37

656

106

Female

80.47

93

116

Female

614.54

608

99

Total

174.29

183

105

Total

1231.91

1264

103

Exp

Obs

SIR

1.36

2

NC*

Plympton

Expected and Observed Case Counts, with Standardized Incidence Ratios, 1996 – 2000

Exp

Obs

SIR

Bladder, Urinary Male

Bladder, Urinary 1.36

2

NC*

Male

Female

0.47

0

NC*

Female

0.47

0

NC*

Total

1.83

2

NC*

Total

1.83

2

NC*

Brain and Other Nervous System

Breast

Brain and Other Nervous System

Male

0.56

0

NC*

Male

0.56

0

NC*

Female

0.42

1

NC*

Female

0.42

1

NC*

Total

0.98

1

NC*

Total

0.98

1

NC*

Breast

Male

0.08

0

NC*

Male

0.08

0

NC*

Female

10.43

10

96

Female

10.43

10

96

Total

10.51

10

95

Total

10.51

10

95

0.57

0

NC*

Cervix Uteri

Cervix Uteri Female

0.57

0

NC*

Colon / Rectum

Female Colon / Rectum

Male

3.53

3

NC*

Male

3.53

3

NC*

Female

3.03

1

NC*

Female

3.03

1

NC*

Total

6.56

4

NC*

Total

6.56

4

NC*

0.60

1

NC*

Esophagus Male

Esophagus 0.60

1

NC*

Male

Female

0.15

0

NC*

Female

0.15

0

NC*

Total

0.74

1

NC*

Total

0.74

1

NC*

0

NC*

Hodgkin's Disease (Hodgkin Lymphoma) Male

0.25

Hodgkin's Disease (Hodgkin Lymphoma) 0

NC*

Male

0.25

Female

0.19

0

NC*

Female

0.19

0

NC*

Total

0.45

0

NC*

Total

0.45

0

NC*

Kidney & Renal Pelvis